GT,Diagnosis 1
['Vitamin B12-unresponsive methylmalonic acidemia'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Methylmalonic Acidemia:
This is a rare genetic disorder caused by a deficiency of the enzyme methylmalonyl-CoA mutase. The patient's symptoms of 'Metabolic acidosis' and 'Decreased methylmalonyl-CoA mutase activity' are consistent with this disease. However, not all patients with Methylmalonic Acidemia experience 'Death in infancy' or 'Death in childhood', so further testing is needed to confirm this diagnosis.

\n\n+2. Methylmalonyl-CoA Mutase Deficiency:
This is another rare genetic disorder that affects the breakdown of certain amino acids. The patient's symptoms of 'Decreased methylmalonyl-CoA mutase activity' and 'Metabolic acidosis' are consistent with this disease. However, this disease does not typically cause 'Death in infancy' or 'Death in childhood', so further testing is needed to confirm this diagnosis.

\n\n+3. Vitamin B12 Deficiency:
Vitamin B12 is essential for the breakdown of fatty acids and amino acids. A deficiency in this vitamin can cause 'Metabolic acidosis' and 'Decreased methylmalonyl-CoA mutase activity', which are both present in the patient. However, Vitamin B12 Deficiency does not typically cause 'Death in infancy' or 'Death in childhood', so further testing is needed to confirm this diagnosis.

\n\n+4. Propionic Acidemia:
This is a rare genetic disorder caused by a deficiency of the enzyme propionyl-CoA carboxylase. The patient's symptoms of 'Metabolic acidosis' and 'Death in infancy' are consistent with this disease. However, not all patients with Propionic Acidemia experience 'Decreased methylmalonyl-CoA mutase activity' or 'Death in childhood', so further testing is needed to confirm this diagnosis.

\n\n+5. Isovaleric Acidemia:
This is a rare genetic disorder caused by a deficiency of the enzyme isovaleryl-CoA dehydrogenase. The patient's symptoms of 'Metabolic acidosis' and 'Death in infancy' are consistent with this disease. However, not all patients with Isovaleric Acidemia experience 'Decreased methylmalonyl-CoA mutase activity' or 'Death in childhood', so further testing is needed to confirm this diagnosis.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms and to rule out other potential diseases."
['Succinic semialdehyde dehydrogenase deficiency'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Glutaric Acidemia Type I:
This is a rare genetic disorder that affects the breakdown of certain amino acids. The patient's symptoms of Motor delay, Generalized hypotonia, and Elevated urinary carboxylic acid are consistent with this disease. However, the patient does not exhibit symptoms of macrocephaly (enlarged head) or seizures, which are commonly associated with Glutaric Acidemia Type I.

\n\n+2. Methylmalonic Acidemia:
This is a genetic disorder that affects the body's ability to break down certain fats and proteins. The patient's symptoms of Motor delay, Generalized hypotonia, and Elevated urinary carboxylic acid are consistent with this disease. However, the patient does not exhibit symptoms of vomiting, diarrhea, or dehydration, which are commonly associated with Methylmalonic Acidemia.

\n\n+3. Propionic Acidemia:
This is a rare genetic disorder that affects the body's ability to break down certain fats and proteins. The patient's symptoms of Motor delay, Generalized hypotonia, and Elevated urinary carboxylic acid are consistent with this disease. However, the patient does not exhibit symptoms of seizures, developmental delays, or intellectual disability, which are commonly associated with Propionic Acidemia.

\n\n+4. Isovaleric Acidemia:
This is a rare genetic disorder that affects the body's ability to break down certain amino acids. The patient's symptoms of Motor delay, Generalized hypotonia, and Elevated urinary carboxylic acid are consistent with this disease. However, the patient does not exhibit symptoms of vomiting, diarrhea, or a characteristic ""sweaty feet"" odor, which are commonly associated with Isovaleric Acidemia.

\n\n+5. Multiple Carboxylase Deficiency:
This is a rare genetic disorder that affects the body's ability to break down certain fats and proteins. The patient's symptoms of Motor delay, Generalized hypotonia, and Elevated urinary carboxylic acid are consistent with this disease. However, the patient does not exhibit symptoms of skin rash, hair loss, or developmental delays, which are commonly associated with Multiple Carboxylase Deficiency.

\n\n+6. Zellweger Syndrome:
This is a rare genetic disorder that affects the development of the brain and other organs. The patient's symptoms of Motor delay, Generalized hypotonia, and Death in infancy are consistent with this disease. However, the patient does not exhibit symptoms of facial abnormalities, liver dysfunction, or vision loss, which are commonly associated with Zellweger Syndrome.

\n\n+7. Neonatal Adrenoleukodystrophy:
This is a rare genetic disorder that affects the development of the brain and other organs. The patient's symptoms of Motor delay, Generalized hypotonia, and Death in infancy are consistent with this disease. However, the patient does not exhibit symptoms of seizures, vision loss, or adrenal insufficiency, which are commonly associated with Neonatal Adrenoleukodystrophy.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms."
['Phenylketonuria'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Tyrosinemia type I:
This is a rare genetic disorder caused by a deficiency of the enzyme fumarylacetoacetate hydrolase. Symptoms in common with the patient: Abnormality of prenatal development or birth, Hypertyrosinemia, Neonatal death. Symptoms not in common: None.

\n\n+2. Phenylketonuria (PKU):
This is a genetic disorder caused by a deficiency of the enzyme phenylalanine hydroxylase. Symptoms in common with the patient: Hyperphenylalaninemia. Symptoms not in common: Abnormality of prenatal development or birth, Death in infancy, Hypertyrosinemia, Neonatal death.

\n\n+3. Maple syrup urine disease (MSUD):
This is a rare genetic disorder caused by a deficiency of the enzyme branched-chain alpha-keto acid dehydrogenase complex. Symptoms in common with the patient: Abnormality of prenatal development or birth, Death in infancy, Neonatal death. Symptoms not in common: Hypertyrosinemia, Hyperphenylalaninemia.

\n\n+4. Homocystinuria:
This is a rare genetic disorder caused by a deficiency of the enzyme cystathionine beta-synthase. Symptoms in common with the patient: Abnormality of prenatal development or birth, Death in infancy. Symptoms not in common: Hypertyrosinemia, Hyperphenylalaninemia, Neonatal death.

\n\n+5. Methylmalonic acidemia:
This is a rare genetic disorder caused by a deficiency of the enzyme methylmalonyl-CoA mutase. Symptoms in common with the patient: Abnormality of prenatal development or birth, Death in infancy, Neonatal death. Symptoms not in common: Hypertyrosinemia, Hyperphenylalaninemia.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms and to rule out other potential diseases."
['PMM2-CDG'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Marden-Walker Syndrome:
This is a rare genetic disorder characterized by congenital anomalies, intellectual disability, and growth retardation. The patient's symptoms that match this disease include Congenital diaphragmatic hernia, Motor delay, Failure to thrive, and Cerebellar atrophy. However, the patient does not exhibit symptoms such as microcephaly, joint contractures, or facial dysmorphism, which are commonly seen in Marden-Walker Syndrome.

\n\n+2. Cohen Syndrome:
This is a rare genetic disorder characterized by intellectual disability, microcephaly, and various physical abnormalities. The patient's symptoms that match this disease include Motor delay, Failure to thrive, and Cerebellar atrophy. However, the patient does not exhibit symptoms such as microcephaly, facial dysmorphism, or joint laxity, which are commonly seen in Cohen Syndrome.

\n\n+3. Pontocerebellar Hypoplasia:
This is a group of rare genetic disorders characterized by abnormal development of the brain, particularly the cerebellum and pons. The patient's symptoms that match this disease include Cerebellar atrophy, Motor delay, and Failure to thrive. However, the patient does not exhibit symptoms such as microcephaly, seizures, or intellectual disability, which are commonly seen in Pontocerebellar Hypoplasia.

\n\n+4. Lipodystrophy Syndrome:
This is a group of rare genetic disorders characterized by abnormal fat distribution and various physical abnormalities. The patient's symptoms that match this disease include Lipodystrophy and Failure to thrive. However, the patient does not exhibit symptoms such as insulin resistance, hypertriglyceridemia, or hepatic steatosis, which are commonly seen in Lipodystrophy Syndrome.

\n\n+5. Joubert Syndrome:
This is a rare genetic disorder characterized by abnormal brain development, particularly the cerebellum and brainstem. The patient's symptoms that match this disease include Cerebellar atrophy, Motor delay, and Failure to thrive. However, the patient does not exhibit symptoms such as intellectual disability, seizures, or oculomotor apraxia, which are commonly seen in Joubert Syndrome.

\n\n+6. Neuhauser-Daly Syndrome:
This is a rare genetic disorder characterized by intellectual disability, growth retardation, and various physical abnormalities. The patient's symptoms that match this disease include Motor delay, Failure to thrive, and Cerebellar atrophy. However, the patient does not exhibit symptoms such as microcephaly, facial dysmorphism, or joint laxity, which are commonly seen in Neuhauser-Daly Syndrome.

\n\n+7. Hiatus Hernia Syndrome:
This is a rare genetic disorder characterized by a congenital diaphragmatic hernia and various physical abnormalities. The patient's symptoms that match this disease include Hiatus hernia and Congenital diaphragmatic hernia. However, the patient does not exhibit symptoms such as intellectual disability, growth retardation, or facial dysmorphism, which are commonly seen in Hiatus Hernia Syndrome.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms and to rule out other potential diseases."
['Maple syrup urine disease'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Maple Syrup Urine Disease (MSUD): 
This rare genetic disorder affects the breakdown of certain amino acids. The patient's symptoms that match MSUD include: Delayed speech and language development, Intellectual disability, Motor delay, Generalized hypotonia, Feeding difficulties, Elevated urinary carboxylic acid, Hyperleucinemia, Hyperisoleucinemia, and Hypervalinemia. However, the patient does not exhibit the characteristic ""maple syrup"" odor in their urine, which is a hallmark of this disease.

\n\n+2. Methylmalonic Acidemia (MMA): 
This inherited disorder affects the breakdown of fatty acids and amino acids. The patient's symptoms that match MMA include: Delayed speech and language development, Intellectual disability, Motor delay, Generalized hypotonia, Feeding difficulties, Elevated urinary carboxylic acid, and Death in infancy/childhood. However, the patient does not exhibit the typical symptoms of vomiting, seizures, and lethargy associated with MMA.

\n\n+3. Propionic Acidemia (PA): 
This rare genetic disorder affects the breakdown of fatty acids and amino acids. The patient's symptoms that match PA include: Delayed speech and language development, Intellectual disability, Motor delay, Generalized hypotonia, Feeding difficulties, Elevated urinary carboxylic acid, and Death in infancy/childhood. However, the patient does not exhibit the typical symptoms of seizures, vomiting, and lethargy associated with PA.

\n\n+4. Isovaleric Acidemia (IVA): 
This rare genetic disorder affects the breakdown of the amino acid leucine. The patient's symptoms that match IVA include: Delayed speech and language development, Intellectual disability, Motor delay, Generalized hypotonia, Feeding difficulties, Elevated urinary carboxylic acid, and Hyperleucinemia. However, the patient does not exhibit the typical symptoms of vomiting, seizures, and lethargy associated with IVA.

\n\n+5. 3-Methylcrotonyl-CoA Carboxylase Deficiency (3MCCD): 
This rare genetic disorder affects the breakdown of the amino acid leucine. The patient's symptoms that match 3MCCD include: Delayed speech and language development, Intellectual disability, Motor delay, Generalized hypotonia, Feeding difficulties, Elevated urinary carboxylic acid, and Hyperleucinemia. However, the patient does not exhibit the typical symptoms of seizures, vomiting, and lethargy associated with 3MCCD.

\n\n+6. Mitochondrial Complex I Deficiency: 
This genetic disorder affects the energy production within cells. The patient's symptoms that match this condition include: Delayed speech and language development, Intellectual disability, Motor delay, Generalized hypotonia, Feeding difficulties, and Death in infancy/childhood. However, the patient does not exhibit the typical symptoms of seizures, vomiting, and lethargy associated with this condition.

\n\n+7. Peroxisomal Biogenesis Disorder (PBD): 
This group of genetic disorders affects the breakdown of fatty acids and amino acids. The patient's symptoms that match PBD include: Delayed speech and language development, Intellectual disability, Motor delay, Generalized hypotonia, Feeding difficulties, and Death in infancy/childhood. However, the patient does not exhibit the typical symptoms of seizures, vomiting, and lethargy associated with PBD.

\n\n+8. Zellweger Syndrome: 
This rare genetic disorder affects the breakdown of fatty acids and amino acids. The patient's symptoms that match Zellweger Syndrome include: Delayed speech and language development, Intellectual disability, Motor delay, Generalized hypotonia, Feeding difficulties, and Death in infancy/childhood. However, the patient does not exhibit the typical symptoms of seizures, vomiting, and lethargy associated with this condition.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms."
['Phenylketonuria'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. **Maple Syrup Urine Disease**: 
This rare genetic disorder affects the breakdown of certain amino acids. The patient's symptoms that match this disease include: Abnormality of prenatal development or birth, Death in infancy, Neonatal death, Death in childhood, Recurrent viral infections. However, the patient does not exhibit the characteristic sweet-smelling urine, which is a hallmark of this disease.

\n\n+2. **Tyrosinemia Type 1**: 
This inherited disorder affects the breakdown of the amino acid tyrosine. The patient's symptoms that match this disease include: Hypertyrosinemia, Liver problems, Gastrointestinal inflammation, Death in infancy, Neonatal death, Death in childhood. However, the patient does not exhibit the typical liver and kidney damage associated with this disease.

\n\n+3. **Phenylketonuria (PKU)**: 
This genetic disorder affects the breakdown of the amino acid phenylalanine. The patient's symptoms that match this disease include: Hyperphenylalaninemia, Abnormality of prenatal development or birth, Death in infancy, Neonatal death, Death in childhood. However, the patient does not exhibit the typical intellectual disability and seizures associated with this disease.

\n\n+4. **Ehlers-Danlos Syndrome**: 
This group of genetic disorders affects the body's connective tissue. The patient's symptoms that match this disease include: Hernia, Skin rash, Gastrointestinal inflammation. However, the patient does not exhibit the typical joint hypermobility and skin hyperextensibility associated with this disease.

\n\n+5. **Incontinentia Pigmenti**: 
This rare genetic disorder affects the skin and other tissues. The patient's symptoms that match this disease include: Erythematous plaque, Erythematous macule, Erythematous papule, Skin rash. However, the patient does not exhibit the typical dental and eye abnormalities associated with this disease.

\n\n+6. **Mucopolysaccharidosis Type VII**: 
This rare genetic disorder affects the body's ability to break down sugar molecules. The patient's symptoms that match this disease include: Abnormality of prenatal development or birth, Death in infancy, Neonatal death, Death in childhood, Gastrointestinal inflammation. However, the patient does not exhibit the typical coarse facial features and skeletal abnormalities associated with this disease.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms."
['Biotinidase deficiency'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Menkes disease:
This is a rare genetic disorder that affects the production of copper in the body. The patient's symptoms of skin rash, alopecia, and increased circulating lactate concentration are consistent with this disease. However, Menkes disease typically presents with seizures, intellectual disability, and kinky hair, which are not mentioned in the patient's symptoms.

\n\n+2. Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS):
This is a mitochondrial disorder that affects energy production in cells. The patient's symptoms of increased circulating lactate concentration and increased CSF lactate are consistent with this disease. However, MELAS typically presents with seizures, muscle weakness, and stroke-like episodes, which are not mentioned in the patient's symptoms.

\n\n+3. Leigh syndrome:
This is a rare genetic disorder that affects the production of energy in cells. The patient's symptoms of increased circulating lactate concentration and increased CSF lactate are consistent with this disease. However, Leigh syndrome typically presents with seizures, muscle weakness, and developmental delays, which are not mentioned in the patient's symptoms.

\n\n+4. Trichothiodystrophy:
This is a rare genetic disorder that affects the production of proteins in the body. The patient's symptoms of skin rash, alopecia, and increased circulating lactate concentration are consistent with this disease. However, trichothiodystrophy typically presents with intellectual disability, short stature, and recurrent infections, which are not mentioned in the patient's symptoms.

\n\n+5. Erythrokeratodermia variabilis:
This is a rare genetic disorder that affects the skin. The patient's symptoms of skin rash and alopecia are consistent with this disease. However, erythrokeratodermia variabilis typically presents with redness and inflammation of the skin, which are not mentioned in the patient's symptoms.

\n\n+6. Keratosis follicularis spinulosa decalvans:
This is a rare genetic disorder that affects the skin and hair. The patient's symptoms of skin rash and alopecia are consistent with this disease. However, keratosis follicularis spinulosa decalvans typically presents with scaly skin lesions and sparse hair, which are not mentioned in the patient's symptoms.

Further testing and evaluation are needed to determine the underlying cause of the patient's symptoms."
['PMM2-CDG'],ERROR
['Glutaryl-CoA dehydrogenase deficiency'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Glutaric acidemia type I:
This is a rare genetic disorder caused by a deficiency of the enzyme glutaryl-CoA dehydrogenase. It affects the breakdown of certain amino acids and can lead to the accumulation of toxic compounds in the body.

Common symptoms: Glutaric aciduria, Macrocephaly, Generalized hypotonia, Dystonia, Dyskinesia, Lethargy, Drowsiness, Sleep abnormality
Not common symptoms: Cystic hygroma, Fever, Vomiting, Diarrhea, Dyspnea, Neonatal death, Decreased plasma free carnitine

\n\n+2. Carnitine palmitoyltransferase I deficiency:
This is a rare genetic disorder that affects the body's ability to break down fatty acids for energy. It can lead to a range of symptoms, including muscle weakness and liver problems.

Common symptoms: Decreased plasma free carnitine, Lethargy, Drowsiness, Sleep abnormality, Generalized hypotonia
Not common symptoms: Macrocephaly, Cystic hygroma, Glutaric aciduria, Dystonia, Dyskinesia, Fever, Vomiting, Diarrhea, Dyspnea, Neonatal death

\n\n+3. Mucopolysaccharidosis type VII:
This is a rare genetic disorder caused by a deficiency of the enzyme beta-glucuronidase. It affects the breakdown of mucopolysaccharides, leading to their accumulation in the body.

Common symptoms: Macrocephaly, Cystic hygroma, Generalized hypotonia, Dystonia, Dyskinesia
Not common symptoms: Glutaric aciduria, Lethargy, Fever, Vomiting, Diarrhea, Dyspnea, Neonatal death, Decreased plasma free carnitine

\n\n+4. Leigh syndrome:
This is a rare genetic disorder that affects the mitochondria, the energy-producing structures within cells. It can lead to a range of symptoms, including muscle weakness and developmental delays.

Common symptoms: Lethargy, Drowsiness, Sleep abnormality, Generalized hypotonia, Dystonia, Dyskinesia
Not common symptoms: Macrocephaly, Cystic hygroma, Glutaric aciduria, Fever, Vomiting, Diarrhea, Dyspnea, Neonatal death, Decreased plasma free carnitine

\n\n+5. Multiple acyl-CoA dehydrogenase deficiency:
This is a rare genetic disorder that affects the breakdown of fatty acids and amino acids for energy. It can lead to a range of symptoms, including muscle weakness and developmental delays.

Common symptoms: Lethargy, Drowsiness, Sleep abnormality, Generalized hypotonia, Decreased plasma free carnitine
Not common symptoms: Macrocephaly, Cystic hygroma, Glutaric aciduria, Dystonia, Dyskinesia, Fever, Vomiting, Diarrhea, Dyspnea, Neonatal death

Further testing and evaluation are needed to determine the underlying cause of the patient's symptoms."
['Isovaleric acidemia'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Non-ketotic hyperglycinemia (NKH): 
This is a rare genetic disorder that affects the breakdown of certain amino acids. The patient's symptoms that match NKH include: Abnormality of prenatal development or birth, Lethargy, Hyperammonemia, Drowsiness, Sleep abnormality, Abnormal circulating glycine concentration. However, the patient does not exhibit seizures, which are a common symptom of NKH.

\n\n+2. Propionic acidemia:
This is a rare genetic disorder that affects the breakdown of certain amino acids. The patient's symptoms that match propionic acidemia include: Abnormality of prenatal development or birth, Lethargy, Death in infancy, Hyperammonemia, Drowsiness, Sleep abnormality, Abnormal circulating carnitine concentration. However, the patient does not exhibit vomiting, which is a common symptom of propionic acidemia.

\n\n+3. Isovaleric acidemia:
This is a rare genetic disorder that affects the breakdown of certain amino acids. The patient's symptoms that match isovaleric acidemia include: Abnormality of prenatal development or birth, Lethargy, Death in infancy, Hyperammonemia, Drowsiness, Sleep abnormality. However, the patient does not exhibit a characteristic ""sweaty feet"" odor, which is a common symptom of isovaleric acidemia.

\n\n+4. Methylmalonic acidemia:
This is a rare genetic disorder that affects the breakdown of certain amino acids. The patient's symptoms that match methylmalonic acidemia include: Abnormality of prenatal development or birth, Lethargy, Death in infancy, Hyperammonemia, Drowsiness, Sleep abnormality, Abnormal circulating carnitine concentration. However, the patient does not exhibit muscle weakness, which is a common symptom of methylmalonic acidemia.

\n\n+5. Carnitine palmitoyltransferase I deficiency:
This is a rare genetic disorder that affects the breakdown of fatty acids. The patient's symptoms that match carnitine palmitoyltransferase I deficiency include: Lethargy, Death in infancy, Hyperammonemia, Drowsiness, Sleep abnormality, Abnormal circulating carnitine concentration. However, the patient does not exhibit muscle weakness, which is a common symptom of carnitine palmitoyltransferase I deficiency.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms."
['PMM2-CDG'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here is the list:

\n\n+1. Joubert Syndrome:
This rare genetic disorder affects the cerebellum and brainstem, leading to intellectual disability, ataxia, and abnormal eye movements. 
Common symptoms: Microcephaly, Strabismus, Nystagmus, Intellectual disability, Ataxia, Hyporeflexia, Motor delay, Cerebellar atrophy, Generalized hypotonia
Not common symptoms: Encephalopathy, Growth delay, Death in infancy, Cerebellar agenesis

\n\n+2. Lissencephaly:
A rare brain disorder characterized by the absence or incomplete development of the folds in the cerebral cortex. 
Common symptoms: Microcephaly, Intellectual disability, Ataxia, Hyporeflexia, Motor delay, Generalized hypotonia
Not common symptoms: Strabismus, Nystagmus, Cerebellar atrophy, Encephalopathy, Growth delay, Death in infancy, Cerebellar agenesis

\n\n+3. Pontocerebellar Hypoplasia:
A group of rare genetic disorders that affect the development of the brain, particularly the cerebellum and pons. 
Common symptoms: Microcephaly, Intellectual disability, Ataxia, Hyporeflexia, Motor delay, Cerebellar atrophy, Generalized hypotonia
Not common symptoms: Strabismus, Nystagmus, Encephalopathy, Growth delay, Death in infancy, Cerebellar agenesis

\n\n+4. Walker-Warburg Syndrome:
A rare genetic disorder that affects the development of the brain and eyes. 
Common symptoms: Microcephaly, Strabismus, Nystagmus, Intellectual disability, Ataxia, Hyporeflexia, Motor delay, Cerebellar atrophy, Generalized hypotonia, Encephalopathy
Not common symptoms: Growth delay, Death in infancy, Cerebellar agenesis

\n\n+5. Dandy-Walker Syndrome:
A rare genetic disorder that affects the development of the cerebellum and brainstem. 
Common symptoms: Microcephaly, Intellectual disability, Ataxia, Hyporeflexia, Motor delay, Cerebellar atrophy, Generalized hypotonia, Cerebellar agenesis
Not common symptoms: Strabismus, Nystagmus, Encephalopathy, Growth delay, Death in infancy

\n\n+6. Cerebro-Oculo-Facio-Skeletal Syndrome:
A rare genetic disorder that affects the development of the brain, eyes, and skeleton. 
Common symptoms: Microcephaly, Strabismus, Nystagmus, Intellectual disability, Ataxia, Hyporeflexia, Motor delay, Cerebellar atrophy, Generalized hypotonia, Encephalopathy
Not common symptoms: Growth delay, Death in infancy, Cerebellar agenesis

Please note that this is not an exhaustive list, and further testing and evaluation are necessary to determine the exact diagnosis."
"['Methylmalonic acidemia with homocystinuria, type cblC']","After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Methylmalonic Acidemia:
This is a rare genetic disorder caused by a deficiency of the enzyme methylmalonyl-CoA mutase. Symptoms in common with the patient: Methylmalonic aciduria, Hyperammonemia, Hyperhomocystinemia, Hyperalaninemia, Abnormal circulating carnitine concentration, Ventricular septal defect. Symptoms not in common: None.

\n\n+2. Non-Ketotic Hyperglycinemia:
This is a rare genetic disorder caused by a deficiency of the enzyme glycine cleavage system. Symptoms in common with the patient: Strabismus, Nystagmus, Optic atrophy, Abnormality of prenatal development or birth, Motor delay, Generalized hypotonia, Death in infancy, Neonatal death, Death in childhood. Symptoms not in common: Methylmalonic aciduria, Hyperammonemia, Hyperhomocystinemia, Hyperalaninemia, Abnormal circulating carnitine concentration, Ventricular septal defect.

\n\n+3. Methylmalonyl-CoA Epimerase Deficiency:
This is a rare genetic disorder caused by a deficiency of the enzyme methylmalonyl-CoA epimerase. Symptoms in common with the patient: Methylmalonic aciduria, Hyperammonemia, Hyperhomocystinemia, Hyperalaninemia, Abnormal circulating carnitine concentration. Symptoms not in common: Strabismus, Nystagmus, Optic atrophy, Abnormality of prenatal development or birth, Motor delay, Generalized hypotonia, Death in infancy, Neonatal death, Death in childhood, Ventricular septal defect.

\n\n+4. Combined Methylmalonic Aciduria and Homocystinuria:
This is a rare genetic disorder caused by a deficiency of the enzymes methionine synthase and methylmalonyl-CoA mutase. Symptoms in common with the patient: Methylmalonic aciduria, Hyperammonemia, Hyperhomocystinemia, Hyperalaninemia, Abnormal circulating carnitine concentration, Ventricular septal defect. Symptoms not in common: Strabismus, Nystagmus, Optic atrophy, Abnormality of prenatal development or birth, Motor delay, Generalized hypotonia, Death in infancy, Neonatal death, Death in childhood.

\n\n+5. Holocarboxylase Synthetase Deficiency:
This is a rare genetic disorder caused by a deficiency of the enzyme holocarboxylase synthetase. Symptoms in common with the patient: Hyperammonemia, Hyperhomocystinemia, Hyperalaninemia, Abnormal circulating carnitine concentration. Symptoms not in common: Strabismus, Nystagmus, Optic atrophy, Abnormality of prenatal development or birth, Motor delay, Generalized hypotonia, Death in infancy, Neonatal death, Death in childhood, Methylmalonic aciduria, Ventricular septal defect.

After reviewing these potential diseases, I believe that further testing is necessary to determine the underlying cause of the patient's symptoms."
['Medium chain acyl-CoA dehydrogenase deficiency'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Carnitine Palmitoyltransferase I Deficiency:
This is a rare genetic disorder that affects the body's ability to break down fatty acids. The patient's symptoms of hypoglycemia, vomiting, diarrhea, and abnormal circulating carnitine concentration are consistent with this disease. However, the patient does not exhibit the typical symptom of muscle weakness, which is often seen in this condition.

\n\n+2. Medium-Chain Acyl-CoA Dehydrogenase Deficiency (MCADD):
This is another genetic disorder that affects the body's ability to break down fatty acids. The patient's symptoms of hypoglycemia, vomiting, diarrhea, and elevated circulating hepatic transaminase concentration are consistent with this disease. However, the patient does not exhibit the typical symptom of lethargy, which is often seen in this condition.

\n\n+3. Carnitine-Acylcarnitine Translocase Deficiency:
This is a rare genetic disorder that affects the transport of fatty acids into the mitochondria. The patient's symptoms of hypoglycemia, vomiting, diarrhea, and abnormal circulating carnitine concentration are consistent with this disease. However, the patient does not exhibit the typical symptom of seizures, which are often seen in this condition.

\n\n+4. Very-Long-Chain Acyl-CoA Dehydrogenase Deficiency (VLCADD):
This is a genetic disorder that affects the body's ability to break down fatty acids. The patient's symptoms of hypoglycemia, vomiting, diarrhea, and elevated circulating hepatic transaminase concentration are consistent with this disease. However, the patient does not exhibit the typical symptom of muscle pain, which is often seen in this condition.

\n\n+5. Glutaric Acidemia Type II:
This is a rare genetic disorder that affects the body's ability to break down fatty acids and amino acids. The patient's symptoms of hypoglycemia, vomiting, diarrhea, and elevated circulating hepatic transaminase concentration are consistent with this disease. However, the patient does not exhibit the typical symptom of developmental delays, which are often seen in this condition.

\n\n+6. Multiple Acyl-CoA Dehydrogenase Deficiency (MADD):
This is a rare genetic disorder that affects the body's ability to break down fatty acids and amino acids. The patient's symptoms of hypoglycemia, vomiting, diarrhea, and elevated circulating hepatic transaminase concentration are consistent with this disease. However, the patient does not exhibit the typical symptom of intellectual disability, which is often seen in this condition.

Based on these findings, I recommend further testing to determine the underlying cause of the patient's symptoms."
['Succinic semialdehyde dehydrogenase deficiency'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Methylmalonic acidemia:
This is a rare genetic disorder that affects the body's ability to break down certain amino acids. The patient's symptoms of elevated urinary carboxylic acid, hyperkalemia, and hyponatremia are consistent with this disease. However, the patient does not exhibit symptoms of developmental delays, intellectual disability, or seizures, which are commonly associated with methylmalonic acidemia.

\n\n+2. Propionic acidemia:
This is another rare genetic disorder that affects the body's ability to break down certain amino acids. The patient's symptoms of elevated urinary carboxylic acid, hyperkalemia, and hyponatremia are consistent with this disease. However, the patient does not exhibit symptoms of vomiting, diarrhea, or abdominal pain, which are commonly associated with propionic acidemia.

\n\n+3. Isovaleric acidemia:
This is a rare genetic disorder that affects the body's ability to break down the amino acid leucine. The patient's symptoms of elevated urinary carboxylic acid and coma are consistent with this disease. However, the patient does not exhibit symptoms of vomiting, diarrhea, or seizures, which are commonly associated with isovaleric acidemia.

\n\n+4. Multiple carboxylase deficiency:
This is a rare genetic disorder that affects the body's ability to break down certain amino acids. The patient's symptoms of elevated urinary carboxylic acid, hyperkalemia, and hyponatremia are consistent with this disease. However, the patient does not exhibit symptoms of skin rash, hair loss, or developmental delays, which are commonly associated with multiple carboxylase deficiency.

\n\n+5. Organic acidemia:
This is a group of rare genetic disorders that affect the body's ability to break down certain amino acids. The patient's symptoms of elevated urinary carboxylic acid, hyperkalemia, and hyponatremia are consistent with this disease. However, the patient does not exhibit symptoms of developmental delays, intellectual disability, or seizures, which are commonly associated with organic acidemia.

\n\n+6. Maple syrup urine disease:
This is a rare genetic disorder that affects the body's ability to break down certain amino acids. The patient's symptoms of elevated urinary carboxylic acid and coma are consistent with this disease. However, the patient does not exhibit symptoms of sweet-smelling urine, intellectual disability, or seizures, which are commonly associated with maple syrup urine disease.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms and to rule out other potential diseases."
['Classic homocystinuria'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Marfan Syndrome:
This genetic disorder affects the body's connective tissue, leading to abnormalities in the heart, eyes, and skeleton. 
Common symptoms: Ectopia lentis, Long foot, Ptosis
Not common symptoms: Hyperhomocystinemia, Hypermethioninemia, Death in childhood, Death in adolescence, Fatigue

\n\n+2. Homocystinuria:
A rare genetic disorder caused by a deficiency of the enzyme cystathionine beta-synthetaase, leading to elevated homocysteine levels in the blood.
Common symptoms: Hyperhomocystinemia, Ectopia lentis, Ptosis, Intellectual disability, Motor delay
Not common symptoms: Large hands, Long foot, Death in childhood, Death in adolescence, Fatigue

\n\n+3. Methionine adenosyltransferase deficiency:
A rare genetic disorder caused by a deficiency of the enzyme methionine adenosyltransferase, leading to elevated methionine levels in the blood.
Common symptoms: Hypermethioninemia, Intellectual disability, Motor delay
Not common symptoms: Ectopia lentis, Ptosis, Large hands, Long foot, Death in childhood, Death in adolescence, Fatigue

\n\n+4. Ehlers-Danlos syndrome:
A group of genetic disorders affecting the body's connective tissue, leading to skin hyperextensibility, joint hypermobility, and tissue fragility.
Common symptoms: Ectopia lentis, Ptosis, Large hands, Long foot
Not common symptoms: Hyperhomocystinemia, Hypermethioninemia, Intellectual disability, Motor delay, Death in childhood, Death in adolescence, Fatigue

\n\n+5. Loeys-Dietz syndrome:
A rare genetic disorder affecting the body's connective tissue, leading to abnormalities in the heart, blood vessels, and skeleton.
Common symptoms: Ectopia lentis, Ptosis, Large hands, Long foot, Intellectual disability, Motor delay
Not common symptoms: Hyperhomocystinemia, Hypermethioninemia, Death in childhood, Death in adolescence, Fatigue

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms and to rule out other potential diseases."
[],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Beckwith-Wiedemann syndrome: 
This syndrome is a congenital disorder characterized by overgrowth, macroglossia (enlarged tongue), and various other symptoms. 
Common symptoms: Wide mouth, Feeding difficulties
Not common symptoms: Epicanthus, Carious teeth, Hyperinsulinemia, Sparse hair, Seizure, Death in infancy, Hypoglycemia, Neonatal death, Death in childhood, Abnormal hemoglobin

\n\n+2. Costello syndrome: 
This is a rare genetic disorder characterized by multiple congenital anomalies and intellectual disability. 
Common symptoms: Wide mouth, Feeding difficulties, Seizure, Hypoglycemia
Not common symptoms: Epicanthus, Carious teeth, Hyperinsulinemia, Sparse hair, Death in infancy, Neonatal death, Death in childhood, Abnormal hemoglobin

\n\n+3. Donohue syndrome: 
This is a rare genetic disorder characterized by growth retardation, dysmorphic features, and intellectual disability. 
Common symptoms: Wide mouth, Epicanthus, Sparse hair, Feeding difficulties, Hypoglycemia
Not common symptoms: Carious teeth, Hyperinsulinemia, Seizure, Death in infancy, Neonatal death, Death in childhood, Abnormal hemoglobin

\n\n+4. Leopard syndrome: 
This is a rare genetic disorder characterized by multiple congenital anomalies, including skin, hair, and cardiac defects. 
Common symptoms: Wide mouth, Epicanthus, Sparse hair, Feeding difficulties
Not common symptoms: Carious teeth, Hyperinsulinemia, Seizure, Death in infancy, Neonatal death, Death in childhood, Abnormal hemoglobin, Hypoglycemia

\n\n+5. Mucolipidosis IV: 
This is a rare genetic disorder characterized by intellectual disability, seizures, and various physical abnormalities. 
Common symptoms: Seizure, Hypoglycemia
Not common symptoms: Wide mouth, Epicanthus, Carious teeth, Hyperinsulinemia, Sparse hair, Feeding difficulties, Death in infancy, Neonatal death, Death in childhood, Abnormal hemoglobin

\n\n+6. Perlman syndrome: 
This is a rare genetic disorder characterized by fetal gigantism, renal dysplasia, and various other symptoms. 
Common symptoms: Wide mouth, Feeding difficulties, Hypoglycemia
Not common symptoms: Epicanthus, Carious teeth, Hyperinsulinemia, Sparse hair, Seizure, Death in infancy, Neonatal death, Death in childhood, Abnormal hemoglobin

\n\n+7. Sotos syndrome: 
This is a rare genetic disorder characterized by overgrowth, intellectual disability, and various physical abnormalities. 
Common symptoms: Wide mouth, Feeding difficulties
Not common symptoms: Epicanthus, Carious teeth, Hyperinsulinemia, Sparse hair, Seizure, Death in infancy, Neonatal death, Death in childhood, Abnormal hemoglobin, Hypoglycemia

\n\n+8. Timothy syndrome: 
This is a rare genetic disorder characterized by long QT syndrome, intellectual disability, and various physical abnormalities. 
Common symptoms: Wide mouth, Feeding difficulties
Not common symptoms: Epicanthus, Carious teeth, Hyperinsulinemia, Sparse hair, Seizure, Death in infancy, Neonatal death, Death in childhood, Abnormal hemoglobin, Hypoglycemia

Please note that this is not an exhaustive list, and further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms."
['Propionic acidemia'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Propionic Acidemia:
This is a rare genetic disorder that affects the body's ability to break down certain fats and proteins. The patient's symptoms that match this disease include: Abnormality of prenatal development or birth, Intellectual disability, Seizure, Motor delay, Anemia, Hyperammonemia, Hepatomegaly, and Abnormal circulating carnitine concentration. However, the patient does not exhibit symptoms of vomiting, diarrhea, or skin rash, which are commonly associated with Propionic Acidemia.

\n\n+2. Isovaleric Acidemia:
This is another rare genetic disorder that affects the body's ability to break down certain fats and proteins. The patient's symptoms that match this disease include: Abnormality of prenatal development or birth, Intellectual disability, Seizure, Motor delay, Anemia, Hyperammonemia, and Hepatomegaly. However, the patient does not exhibit symptoms of a distinctive ""sweaty feet"" odor, which is a hallmark of Isovaleric Acidemia.

\n\n+3. Methylmalonic Acidemia:
This is a rare genetic disorder that affects the body's ability to break down certain fats and proteins. The patient's symptoms that match this disease include: Abnormality of prenatal development or birth, Intellectual disability, Seizure, Motor delay, Anemia, Hyperammonemia, Hepatomegaly, and Abnormal circulating carnitine concentration. However, the patient does not exhibit symptoms of pancreatitis or vision loss, which are commonly associated with Methylmalonic Acidemia.

\n\n+4. Non-Ketotic Hyperglycinemia:
This is a rare genetic disorder that affects the body's ability to break down certain amino acids. The patient's symptoms that match this disease include: Intellectual disability, Seizure, Motor delay, Hyperglycinemia, and Hepatomegaly. However, the patient does not exhibit symptoms of hypotonia or a characteristic ""burst-suppression"" pattern on EEG, which are commonly associated with Non-Ketotic Hyperglycinemia.

\n\n+5. Carnitine Palmitoyltransferase I Deficiency:
This is a rare genetic disorder that affects the body's ability to break down certain fats. The patient's symptoms that match this disease include: Intellectual disability, Seizure, Motor delay, Anemia, Hyperammonemia, Hepatomegaly, and Abnormal circulating carnitine concentration. However, the patient does not exhibit symptoms of hypoketotic hypoglycemia or muscle weakness, which are commonly associated with Carnitine Palmitoyltransferase I Deficiency.

\n\n+6. Glycine Encephalopathy:
This is a rare genetic disorder that affects the body's ability to break down certain amino acids. The patient's symptoms that match this disease include: Intellectual disability, Seizure, Motor delay, Hyperglycinemia, and Hepatomegaly. However, the patient does not exhibit symptoms of hypotonia or a characteristic ""burst-suppression"" pattern on EEG, which are commonly associated with Glycine Encephalopathy.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms and to rule out other potential diseases."
['Vitamin B12-unresponsive methylmalonic acidemia'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Methylmalonic Acidemia:
This is a rare genetic disorder caused by a deficiency of the enzyme methylmalonyl-CoA mutase. The patient's symptoms that match this disease include: Decreased methylmalonyl-CoA mutase activity, Methylmalonic aciduria, Metabolic acidosis, and Apnea. However, the patient does not exhibit symptoms of developmental delay, intellectual disability, and seizures, which are commonly associated with this disease.

\n\n+2. Propionic Acidemia:
This is another rare genetic disorder caused by a deficiency of the enzyme propionyl-CoA carboxylase. The patient's symptoms that match this disease include: Metabolic acidosis, Leukopenia, Thrombocytopenia, and Apnea. However, the patient does not exhibit symptoms of vomiting, diarrhea, and seizures, which are commonly associated with this disease.

\n\n+3. Methylmalonyl-CoA Mutase Deficiency:
This is a rare genetic disorder caused by a deficiency of the enzyme methylmalonyl-CoA mutase. The patient's symptoms that match this disease include: Decreased methylmalonyl-CoA mutase activity, Methylmalonic aciduria, Metabolic acidosis, and Apnea. However, the patient does not exhibit symptoms of developmental delay, intellectual disability, and seizures, which are commonly associated with this disease.

\n\n+4. Combined Malonic and Methylmalonic Aciduria (CMAMMA):
This is a rare genetic disorder caused by a deficiency of the enzyme malonyl-CoA decarboxylase and methylmalonyl-CoA mutase. The patient's symptoms that match this disease include: Methylmalonic aciduria, Metabolic acidosis, and Apnea. However, the patient does not exhibit symptoms of developmental delay, intellectual disability, and seizures, which are commonly associated with this disease.

\n\n+5. Mitochondrial Complex I Deficiency:
This is a rare genetic disorder caused by a deficiency of the enzyme complex I in the mitochondria. The patient's symptoms that match this disease include: Generalized hypotonia, Apnea, and Metabolic acidosis. However, the patient does not exhibit symptoms of seizures, developmental delay, and intellectual disability, which are commonly associated with this disease.

After reviewing these potential diseases, I believe that further testing is necessary to determine the underlying cause of the patient's symptoms. I recommend conducting genetic testing, enzyme assays, and other diagnostic tests to confirm the diagnosis."
['Systemic primary carnitine deficiency'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Carnitine Palmitoyltransferase I Deficiency:
This is a rare genetic disorder that affects the breakdown of fatty acids. The patient's symptoms of hypoglycemia, vomiting, and decreased plasma free carnitine are consistent with this disease. However, the patient does not exhibit symptoms of muscle weakness, seizures, or developmental delays, which are also common in this condition.

\n\n+2. Carnitine-Acylcarnitine Translocase Deficiency:
This is another rare genetic disorder that affects the transport of fatty acids into the mitochondria. The patient's symptoms of hypoglycemia, vomiting, and decreased plasma free carnitine are consistent with this disease. However, the patient does not exhibit symptoms of cardiomyopathy, which is often seen in this condition.

\n\n+3. Very-Long-Chain Acyl-CoA Dehydrogenase Deficiency:
This is a rare genetic disorder that affects the breakdown of fatty acids. The patient's symptoms of hypoglycemia, vomiting, and elevated circulating alkaline phosphatase concentration are consistent with this disease. However, the patient does not exhibit symptoms of muscle weakness, seizures, or developmental delays, which are also common in this condition.

\n\n+4. Medium-Chain Acyl-CoA Dehydrogenase Deficiency:
This is a rare genetic disorder that affects the breakdown of fatty acids. The patient's symptoms of hypoglycemia, vomiting, and elevated circulating alkaline phosphatase concentration are consistent with this disease. However, the patient does not exhibit symptoms of muscle weakness, seizures, or developmental delays, which are also common in this condition.

\n\n+5. Glutaric Acidemia Type II:
This is a rare genetic disorder that affects the breakdown of fatty acids and amino acids. The patient's symptoms of hypoglycemia, vomiting, and abnormal circulating aspartate family amino acid concentration are consistent with this disease. However, the patient does not exhibit symptoms of muscle weakness, seizures, or developmental delays, which are also common in this condition.

\n\n+6. Multiple Acyl-CoA Dehydrogenase Deficiency:
This is a rare genetic disorder that affects the breakdown of fatty acids and amino acids. The patient's symptoms of hypoglycemia, vomiting, and abnormal circulating aspartate family amino acid concentration are consistent with this disease. However, the patient does not exhibit symptoms of muscle weakness, seizures, or developmental delays, which are also common in this condition.

\n\n+7. Propionic Acidemia:
This is a rare genetic disorder that affects the breakdown of amino acids. The patient's symptoms of vomiting, abnormal circulating alanine concentration, and increased circulating lactate dehydrogenase concentration are consistent with this disease. However, the patient does not exhibit symptoms of muscle weakness, seizures, or developmental delays, which are also common in this condition.

\n\n+8. Methylmalonic Acidemia:
This is a rare genetic disorder that affects the breakdown of amino acids. The patient's symptoms of vomiting, abnormal circulating alanine concentration, and increased circulating lactate dehydrogenase concentration are consistent with this disease. However, the patient does not exhibit symptoms of muscle weakness, seizures, or developmental delays, which are also common in this condition.

Further testing and evaluation are needed to determine the underlying cause of the patient's symptoms and to rule out other potential diseases."
['3-methylcrotonyl-CoA carboxylase deficiency'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Carnitine Palmitoyltransferase I Deficiency:
This is a rare genetic disorder that affects the body's ability to break down fatty acids for energy. The patient's symptoms that match this disease include: Lethargy, Drowsiness, Poor coordination, Decreased plasma free carnitine, and Feeding difficulties. However, the patient does not exhibit symptoms of muscle weakness, seizures, or hypoglycemia, which are commonly associated with this disease.

\n\n+2. Carnitine-Acylcarnitine Translocase Deficiency:
This is another rare genetic disorder that affects the transport of fatty acids into the mitochondria. The patient's symptoms that match this disease include: Lethargy, Death in infancy, Clumsiness, Drowsiness, Sleep abnormality, Poor coordination, Neonatal death, and Decreased plasma free carnitine. However, the patient does not exhibit symptoms of cardiomyopathy, which is commonly associated with this disease.

\n\n+3. Very-Long-Chain Acyl-CoA Dehydrogenase Deficiency:
This is a rare genetic disorder that affects the breakdown of fatty acids in the mitochondria. The patient's symptoms that match this disease include: Lethargy, Death in infancy, Clumsiness, Drowsiness, Sleep abnormality, Poor coordination, Neonatal death, and Decreased plasma free carnitine. However, the patient does not exhibit symptoms of muscle weakness, seizures, or hypoglycemia, which are commonly associated with this disease.

\n\n+4. Medium-Chain Acyl-CoA Dehydrogenase Deficiency:
This is a rare genetic disorder that affects the breakdown of fatty acids in the mitochondria. The patient's symptoms that match this disease include: Lethargy, Death in infancy, Clumsiness, Drowsiness, Sleep abnormality, Poor coordination, and Decreased plasma free carnitine. However, the patient does not exhibit symptoms of muscle weakness, seizures, or hypoglycemia, which are commonly associated with this disease.

\n\n+5. Glutaric Acidemia Type II:
This is a rare genetic disorder that affects the breakdown of fatty acids and amino acids in the mitochondria. The patient's symptoms that match this disease include: Lethargy, Death in infancy, Clumsiness, Drowsiness, Sleep abnormality, Poor coordination, Neonatal death, and Decreased plasma free carnitine. However, the patient does not exhibit symptoms of muscle weakness, seizures, or hypoglycemia, which are commonly associated with this disease.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms and to rule out other potential diseases."
[],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Nonketotic Hyperglycinemia (NKH): 
This is a rare genetic disorder that affects the breakdown of certain amino acids. The patient's symptoms of delayed speech and language development, hypothyroidism, dysarthria, hyperreflexia, and abnormal circulating glycine concentration are consistent with NKH. However, the patient does not exhibit symptoms of seizures, which are commonly seen in NKH patients.

\n\n+2. Leigh Syndrome:
This is a rare genetic disorder that affects the brain and nervous system. The patient's symptoms of delayed speech and language development, hypothyroidism, dysarthria, hyperreflexia, and encephalopathy are consistent with Leigh Syndrome. However, the patient does not exhibit symptoms of optic atrophy or retinitis pigmentosa, which are commonly seen in Leigh Syndrome patients.

\n\n+3. Ethylmalonic Encephalopathy:
This is a rare genetic disorder that affects the brain and nervous system. The patient's symptoms of delayed speech and language development, dysarthria, encephalopathy, and ethylmalonic aciduria are consistent with Ethylmalonic Encephalopathy. However, the patient does not exhibit symptoms of petechiae or acrocyanosis, which are commonly seen in Ethylmalonic Encephalopathy patients.

\n\n+4. Mitochondrial Myopathy:
This is a group of genetic disorders that affect the mitochondria, the energy-producing structures within cells. The patient's symptoms of delayed speech and language development, dysarthria, hyperreflexia, and cytochrome C oxidase-negative muscle fibers are consistent with Mitochondrial Myopathy. However, the patient does not exhibit symptoms of muscle weakness or fatigue, which are commonly seen in Mitochondrial Myopathy patients.

\n\n+5. Spastic Paraplegia:
This is a group of genetic disorders that affect the brain and spinal cord. The patient's symptoms of spastic diplegia and spastic tetraplegia are consistent with Spastic Paraplegia. However, the patient does not exhibit symptoms of muscle atrophy or wasting, which are commonly seen in Spastic Paraplegia patients.

\n\n+6. Glycine Encephalopathy:
This is a rare genetic disorder that affects the breakdown of glycine. The patient's symptoms of delayed speech and language development, dysarthria, and abnormal circulating glycine concentration are consistent with Glycine Encephalopathy. However, the patient does not exhibit symptoms of seizures or hypotonia, which are commonly seen in Glycine Encephalopathy patients.

\n\n+7. Mucolipidosis IV:
This is a rare genetic disorder that affects the lysosomes, the cellular structures responsible for breaking down waste. The patient's symptoms of delayed speech and language development, dysarthria, and recurrent viral infections are consistent with Mucolipidosis IV. However, the patient does not exhibit symptoms of corneal clouding or retinal degeneration, which are commonly seen in Mucolipidosis IV patients.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms and to rule out other potential diagnoses."
['Medium chain acyl-CoA dehydrogenase deficiency'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Carnitine Palmitoyltransferase I Deficiency:
This is a rare genetic disorder that affects the breakdown of fatty acids. The patient's symptoms of abnormal circulating carnitine concentration and abnormality of prenatal development or birth are consistent with this disease. However, the patient does not exhibit symptoms of muscle weakness, seizures, or hypoglycemia, which are commonly associated with this condition.

\n\n+2. Carnitine-Acylcarnitine Translocase Deficiency:
This is another rare genetic disorder that affects the transport of fatty acids into the mitochondria. The patient's symptoms of abnormal circulating carnitine concentration, abnormality of prenatal development or birth, and neonatal death are consistent with this disease. However, the patient does not exhibit symptoms of cardiomyopathy, which is commonly associated with this condition.

\n\n+3. Very-Long-Chain Acyl-CoA Dehydrogenase Deficiency:
This is a rare genetic disorder that affects the breakdown of fatty acids. The patient's symptoms of abnormal circulating carnitine concentration, abnormality of prenatal development or birth, and death in infancy are consistent with this disease. However, the patient does not exhibit symptoms of muscle weakness, seizures, or hypoglycemia, which are commonly associated with this condition.

\n\n+4. Carnitine Deficiency:
This is a condition characterized by a lack of carnitine in the body. The patient's symptoms of abnormal circulating carnitine concentration and abnormality of prenatal development or birth are consistent with this disease. However, the patient does not exhibit symptoms of muscle weakness, fatigue, or heart problems, which are commonly associated with this condition.

\n\n+5. Barth Syndrome:
This is a rare genetic disorder that affects the production of cardiolipin, a type of lipid found in the mitochondria. The patient's symptoms of abnormal circulating carnitine concentration, abnormality of prenatal development or birth, and neonatal death are consistent with this disease. However, the patient does not exhibit symptoms of cardiomyopathy, muscle weakness, or neutropenia, which are commonly associated with this condition.

These are just a few potential diseases that may be causing the patient's symptoms. Further testing and evaluation are necessary to determine the underlying cause of their condition."
['Glutaryl-CoA dehydrogenase deficiency'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Glutaric acidemia type I:
This is a rare genetic disorder caused by a deficiency of the enzyme glutaryl-CoA dehydrogenase. It affects the breakdown of certain amino acids and can lead to a buildup of toxic compounds in the body.

Common symptoms: Macrocephaly, Glutaric aciduria, Elevated circulating glutaric acid concentration, Metabolic acidosis, Lethargy, Generalized hypotonia, Dystonia, Death in infancy, Neonatal death, Death in childhood
Uncommon symptoms: Cystic hygroma, Hyperhidrosis, Fever, Vomiting, Diarrhea, Dyspnea, Drowsiness, Sleep abnormality, Decreased plasma free carnitine, Dyskinesia

\n\n+2. Carnitine palmitoyltransferase I deficiency:
This is a rare genetic disorder that affects the body's ability to break down fatty acids for energy. It can lead to a buildup of toxic compounds in the body.

Common symptoms: Lethargy, Generalized hypotonia, Dystonia, Metabolic acidosis, Decreased plasma free carnitine
Uncommon symptoms: Macrocephaly, Cystic hygroma, Hyperhidrosis, Glutaric aciduria, Elevated circulating glutaric acid concentration, Fever, Vomiting, Diarrhea, Dyspnea, Drowsiness, Sleep abnormality, Death in infancy, Neonatal death, Death in childhood, Dyskinesia

\n\n+3. Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS):
This is a rare genetic disorder that affects the mitochondria, the energy-producing structures within cells. It can lead to a buildup of lactic acid in the body.

Common symptoms: Lethargy, Generalized hypotonia, Dystonia, Metabolic acidosis, Fever, Vomiting, Diarrhea, Dyspnea, Drowsiness, Sleep abnormality
Uncommon symptoms: Macrocephaly, Cystic hygroma, Hyperhidrosis, Glutaric aciduria, Elevated circulating glutaric acid concentration, Death in infancy, Neonatal death, Death in childhood, Decreased plasma free carnitine, Dyskinesia

\n\n+4. Leigh syndrome:
This is a rare genetic disorder that affects the mitochondria, leading to a buildup of lactic acid in the body. It can cause progressive damage to the brain and other organs.

Common symptoms: Lethargy, Generalized hypotonia, Dystonia, Metabolic acidosis, Fever, Vomiting, Diarrhea, Dyspnea, Drowsiness, Sleep abnormality
Uncommon symptoms: Macrocephaly, Cystic hygroma, Hyperhidrosis, Glutaric aciduria, Elevated circulating glutaric acid concentration, Death in infancy, Neonatal death, Death in childhood, Decreased plasma free carnitine, Dyskinesia

\n\n+5. Multiple acyl-CoA dehydrogenase deficiency (MADD):
This is a rare genetic disorder that affects the breakdown of fatty acids and amino acids. It can lead to a buildup of toxic compounds in the body.

Common symptoms: Lethargy, Generalized hypotonia, Dystonia, Metabolic acidosis, Decreased plasma free carnitine
Uncommon symptoms: Macrocephaly, Cystic hygroma, Hyperhidrosis, Glutaric aciduria, Elevated circulating glutaric acid concentration, Fever, Vomiting, Diarrhea, Dyspnea, Drowsiness, Sleep abnormality, Death in infancy, Neonatal death, Death in childhood, Dyskinesia

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms."
['Phenylketonuria'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Tyrosinemia Type I:
This is a rare genetic disorder caused by a deficiency of the enzyme fumarylacetoacetate hydrolase. Symptoms in common with the patient: Abnormality of prenatal development or birth, Hypertyrosinemia, Death in infancy, Neonatal death. Symptoms not in common: None.

\n\n+2. Phenylketonuria (PKU):
This is a genetic disorder caused by a deficiency of the enzyme phenylalanine hydroxylase. Symptoms in common with the patient: Hyperphenylalaninemia, Death in infancy, Death in childhood. Symptoms not in common: Abnormality of prenatal development or birth, Hypertyrosinemia, Neonatal death.

\n\n+3. Homocystinuria:
This is a rare genetic disorder caused by a deficiency of the enzyme cystathionine beta-synthase. Symptoms in common with the patient: Abnormality of prenatal development or birth, Death in infancy, Death in childhood. Symptoms not in common: Hypertyrosinemia, Hyperphenylalaninemia, Neonatal death, Death in adolescence.

\n\n+4. Maple Syrup Urine Disease (MSUD):
This is a rare genetic disorder caused by a deficiency of the enzyme branched-chain alpha-keto acid dehydrogenase complex. Symptoms in common with the patient: Abnormality of prenatal development or birth, Death in infancy, Neonatal death. Symptoms not in common: Hypertyrosinemia, Hyperphenylalaninemia, Death in childhood, Death in adolescence.

\n\n+5. Methylmalonic Acidemia:
This is a rare genetic disorder caused by a deficiency of the enzyme methylmalonyl-CoA mutase. Symptoms in common with the patient: Abnormality of prenatal development or birth, Death in infancy, Neonatal death. Symptoms not in common: Hypertyrosinemia, Hyperphenylalaninemia, Death in childhood, Death in adolescence.

\n\n+6. Isovaleric Acidemia:
This is a rare genetic disorder caused by a deficiency of the enzyme isovaleryl-CoA dehydrogenase. Symptoms in common with the patient: Abnormality of prenatal development or birth, Death in infancy, Neonatal death. Symptoms not in common: Hypertyrosinemia, Hyperphenylalaninemia, Death in childhood, Death in adolescence.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms and to rule out other potential diseases."
['L-2-hydroxyglutaric aciduria'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Pelizaeus-Merzbacher Disease:
This is a rare genetic disorder that affects the central nervous system. It is characterized by delayed speech and language development, intellectual disability, and abnormal cerebral white matter morphology, all of which are present in the patient. However, Pelizaeus-Merzbacher Disease typically does not cause hyperreflexia, difficulty walking, difficulty climbing stairs, or difficulty running, which are all symptoms exhibited by the patient.

\n\n+2. Mucolipidosis IV:
This is a lysosomal storage disorder that can cause intellectual disability, delayed speech and language development, and abnormal cerebral white matter morphology, all of which are present in the patient. However, Mucolipidosis IV typically does not cause hyperreflexia, difficulty walking, difficulty climbing stairs, or difficulty running, which are all symptoms exhibited by the patient.

\n\n+3. Krabbe Disease:
This is a lysosomal storage disorder that can cause intellectual disability, delayed speech and language development, and abnormal cerebral white matter morphology, all of which are present in the patient. Additionally, Krabbe Disease can cause hyperreflexia, which is also present in the patient. However, Krabbe Disease typically does not cause difficulty walking, difficulty climbing stairs, or difficulty running, which are all symptoms exhibited by the patient.

\n\n+4. Metachromatic Leukodystrophy:
This is a lysosomal storage disorder that can cause intellectual disability, delayed speech and language development, and abnormal cerebral white matter morphology, all of which are present in the patient. Additionally, Metachromatic Leukodystrophy can cause difficulty walking, difficulty climbing stairs, and difficulty running, which are all symptoms exhibited by the patient. However, Metachromatic Leukodystrophy typically does not cause hyperreflexia, which is present in the patient.

\n\n+5. Canavan Disease:
This is a genetic disorder that can cause intellectual disability, delayed speech and language development, and abnormal cerebral white matter morphology, all of which are present in the patient. Additionally, Canavan Disease can cause hyperreflexia, which is also present in the patient. However, Canavan Disease typically does not cause difficulty walking, difficulty climbing stairs, or difficulty running, which are all symptoms exhibited by the patient.

\n\n+6. Alexander Disease:
This is a genetic disorder that can cause intellectual disability, delayed speech and language development, and abnormal cerebral white matter morphology, all of which are present in the patient. Additionally, Alexander Disease can cause difficulty walking, difficulty climbing stairs, and difficulty running, which are all symptoms exhibited by the patient. However, Alexander Disease typically does not cause hyperreflexia, which is present in the patient.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms."
['Maple syrup urine disease'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Maple Syrup Urine Disease: 
This rare genetic disorder affects the breakdown of certain amino acids. The patient's symptoms that match this disease include: Hypervalinemia, Hyperleucinemia, Hyperisoleucinemia. However, the patient does not exhibit the characteristic sweet odor of urine, which is a hallmark of this disease.

\n\n+2. Methylmalonic Acidemia: 
This is a genetic disorder that affects the breakdown of fatty acids and amino acids. The patient's symptoms that match this disease include: Hypoglycemia, Apathy, Generalized hypotonia. However, the patient does not exhibit the characteristic metabolic acidosis and methylmalonic aciduria, which are typical of this disease.

\n\n+3. Propionic Acidemia: 
This is a rare genetic disorder that affects the breakdown of fatty acids and amino acids. The patient's symptoms that match this disease include: Hypoglycemia, Apathy, Generalized hypotonia, Death in infancy. However, the patient does not exhibit the characteristic metabolic acidosis and propionic aciduria, which are typical of this disease.

\n\n+4. Isovaleric Acidemia: 
This is a rare genetic disorder that affects the breakdown of fatty acids and amino acids. The patient's symptoms that match this disease include: Hypoglycemia, Apathy, Generalized hypotonia. However, the patient does not exhibit the characteristic sweaty feet odor, which is a hallmark of this disease.

\n\n+5. 3-Methylcrotonyl-CoA Carboxylase Deficiency: 
This is a rare genetic disorder that affects the breakdown of fatty acids and amino acids. The patient's symptoms that match this disease include: Hypoglycemia, Apathy, Generalized hypotonia. However, the patient does not exhibit the characteristic 3-methylcrotonylglycinuria, which is typical of this disease.

\n\n+6. Multiple Carboxylase Deficiency: 
This is a rare genetic disorder that affects the breakdown of fatty acids and amino acids. The patient's symptoms that match this disease include: Hypoglycemia, Apathy, Generalized hypotonia, Death in infancy. However, the patient does not exhibit the characteristic skin rash and hair loss, which are typical of this disease.

\n\n+7. Holocarboxylase Synthetase Deficiency: 
This is a rare genetic disorder that affects the breakdown of fatty acids and amino acids. The patient's symptoms that match this disease include: Hypoglycemia, Apathy, Generalized hypotonia, Death in infancy. However, the patient does not exhibit the characteristic skin rash and hair loss, which are typical of this disease.

\n\n+8. Biotinidase Deficiency: 
This is a rare genetic disorder that affects the breakdown of fatty acids and amino acids. The patient's symptoms that match this disease include: Hypoglycemia, Apathy, Generalized hypotonia. However, the patient does not exhibit the characteristic skin rash and hair loss, which are typical of this disease.

\n\n+9. MADD (Multiple Acyl-CoA Dehydrogenase Deficiency): 
This is a rare genetic disorder that affects the breakdown of fatty acids and amino acids. The patient's symptoms that match this disease include: Hypoglycemia, Apathy, Generalized hypotonia, Death in infancy. However, the patient does not exhibit the characteristic metabolic acidosis and elevated creatine kinase levels, which are typical of this disease.

\n\n+10. VLCAD Deficiency: 
This is a rare genetic disorder that affects the breakdown of fatty acids. The patient's symptoms that match this disease include: Hypoglycemia, Apathy, Generalized hypotonia. However, the patient does not exhibit the characteristic cardiomyopathy and rhabdomyolysis, which are typical of this disease.

After reviewing these potential diseases, I believe that further testing is necessary to determine the underlying cause of the patient's symptoms."
['Classic galactosemia'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Galactosemia:
This is a rare genetic disorder that affects the body's ability to metabolize galactose, a sugar found in milk. The patient's symptoms of delayed speech and language development, obesity, hypergalactosemia, abnormality of galactoside metabolism, and increased total bilirubin are all consistent with this disease. However, the patient does not exhibit symptoms of seizures, which are commonly associated with galactosemia.

\n\n+2. Maple Syrup Urine Disease (MSUD):
This is a rare genetic disorder that affects the breakdown of certain amino acids. The patient's symptoms of hyperalaninemia, aminoaciduria, and abnormal circulating aspartate family amino acid concentration are all consistent with MSUD. However, the patient does not exhibit symptoms of intellectual disability, which are commonly associated with MSUD.

\n\n+3. Tyrosinemia Type I:
This is a rare genetic disorder that affects the breakdown of the amino acid tyrosine. The patient's symptoms of abnormal circulating tyrosine concentration, increased total bilirubin, and death in infancy or adolescence are all consistent with Tyrosinemia Type I. However, the patient does not exhibit symptoms of liver or kidney failure, which are commonly associated with this disease.

\n\n+4. Galactokinase Deficiency:
This is a rare genetic disorder that affects the body's ability to metabolize galactose. The patient's symptoms of hypergalactosemia, abnormality of galactoside metabolism, and increased total bilirubin are all consistent with Galactokinase Deficiency. However, the patient does not exhibit symptoms of cataracts, which are commonly associated with this disease.

\n\n+5. Hereditary Fructose Intolerance:
This is a rare genetic disorder that affects the body's ability to metabolize fructose. The patient's symptoms of delayed speech and language development, obesity, and increased total bilirubin are all consistent with Hereditary Fructose Intolerance. However, the patient does not exhibit symptoms of hypoglycemia, which are commonly associated with this disease.

Further testing and evaluation are needed to determine the underlying cause of the patient's symptoms and to rule out other potential diseases."
['3-hydroxy-3-methylglutaric aciduria'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Isovaleric Acidemia:
This is a rare genetic disorder that affects the breakdown of certain amino acids. The patient's symptoms of Metabolic acidosis, Vomiting, and Elevated urinary carboxylic acid are consistent with this disease. However, the patient does not exhibit the typical symptom of a strong ""cheesy"" or ""sweaty feet"" odor. 

\n\n+2. Propionic Acidemia:
This is another rare genetic disorder that affects the breakdown of certain amino acids. The patient's symptoms of Metabolic acidosis, Fever, Vomiting, and Elevated urinary carboxylic acid are consistent with this disease. However, the patient does not exhibit the typical symptom of seizures. 

\n\n+3. Methylmalonic Acidemia:
This is a rare genetic disorder that affects the breakdown of certain amino acids. The patient's symptoms of Metabolic acidosis, Vomiting, and Elevated urinary carboxylic acid are consistent with this disease. However, the patient does not exhibit the typical symptom of developmental delays. 

\n\n+4. 3-Methylglutaric Aciduria:
This is a rare genetic disorder that affects the breakdown of certain amino acids. The patient's symptoms of 3-Methylglutaric aciduria, Metabolic acidosis, and Elevated urinary carboxylic acid are consistent with this disease. However, the patient does not exhibit the typical symptom of intellectual disability. 

\n\n+5. Glutaric Acidemia Type I:
This is a rare genetic disorder that affects the breakdown of certain amino acids. The patient's symptoms of Metabolic acidosis, Vomiting, and Elevated urinary carboxylic acid are consistent with this disease. However, the patient does not exhibit the typical symptom of macrocephaly (an abnormally large head). 

\n\n+6. Multiple Carboxylase Deficiency:
This is a rare genetic disorder that affects the breakdown of certain amino acids. The patient's symptoms of Metabolic acidosis, Vomiting, and Elevated urinary carboxylic acid are consistent with this disease. However, the patient does not exhibit the typical symptom of skin rash. 

\n\n+7. Hyperammonemia-Hyperornithinemia-Homocitrullinuria (HHH) Syndrome:
This is a rare genetic disorder that affects the breakdown of certain amino acids. The patient's symptoms of Hyperammonemia, Metabolic acidosis, and Vomiting are consistent with this disease. However, the patient does not exhibit the typical symptom of intellectual disability. 

\n\n+8. Glycine Encephalopathy (Non-Ketotic Hyperglycinemia):
This is a rare genetic disorder that affects the breakdown of glycine. The patient's symptoms of Abnormal circulating glycine concentration, Metabolic acidosis, and Vomiting are consistent with this disease. However, the patient does not exhibit the typical symptom of seizures. 

Further testing is needed to determine the underlying cause of the patient's symptoms and to rule out other potential diseases."
['Classic homocystinuria'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Homocystinuria:
This is a rare genetic disorder caused by a deficiency of the enzyme cystathionine beta-synthase. It affects the metabolism of the amino acid methionine, leading to elevated levels of homocysteine in the blood and urine.
Common symptoms: Hyperhomocystinemia, Hypomethioninemia, Anemia, Progressive neurologic deterioration, Recurrent viral infections
Not common symptoms: Jaundice, Generalized hypotonia, Abnormal circulating porphyrin concentration, Abnormality of folate metabolism, Death in childhood

\n\n+2. Methylmalonic acidemia:
This is a rare genetic disorder caused by a deficiency of the enzyme methylmalonyl-CoA mutase. It affects the metabolism of certain amino acids, leading to the accumulation of toxic compounds in the body.
Common symptoms: Anemia, Hyperhomocystinemia, Hypomethioninemia, Progressive neurologic deterioration, Recurrent viral infections
Not common symptoms: Jaundice, Generalized hypotonia, Abnormal circulating porphyrin concentration, Abnormality of folate metabolism, Death in childhood

\n\n+3. Cobalamin deficiency:
This is a condition caused by a lack of vitamin B12 (cobalamin) in the body. It can lead to a range of symptoms, including anemia, fatigue, and neurological problems.
Common symptoms: Anemia, Hyperhomocystinemia, Hypomethioninemia, Progressive neurologic deterioration, Recurrent viral infections
Not common symptoms: Jaundice, Generalized hypotonia, Abnormal circulating porphyrin concentration, Abnormality of folate metabolism, Death in childhood

\n\n+4. Porphyrin metabolism disorder:
This is a group of rare genetic disorders caused by defects in the production of heme, a molecule essential for the function of hemoglobin. It can lead to a range of symptoms, including anemia, neurological problems, and skin sensitivity to light.
Common symptoms: Abnormal circulating porphyrin concentration, Anemia, Hyperhomocystinemia, Hypomethioninemia, Progressive neurologic deterioration
Not common symptoms: Jaundice, Generalized hypotonia, Recurrent viral infections, Abnormality of folate metabolism, Death in childhood

\n\n+5. Folate deficiency:
This is a condition caused by a lack of folate (vitamin B9) in the body. It can lead to a range of symptoms, including anemia, fatigue, and neurological problems.
Common symptoms: Anemia, Hyperhomocystinemia, Hypomethioninemia, Progressive neurologic deterioration, Abnormality of folate metabolism
Not common symptoms: Jaundice, Generalized hypotonia, Abnormal circulating porphyrin concentration, Recurrent viral infections, Death in childhood

After reviewing these potential diseases, I believe that further testing is necessary to determine the underlying cause of the patient's symptoms."
['Phenylketonuria'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Tyrosinemia Type I:
This is a rare genetic disorder caused by a deficiency of the enzyme fumarylacetoacetate hydrolase. Symptoms in common with the patient: Abnormality of prenatal development or birth, Hypertyrosinemia, Death in infancy, Neonatal death. Symptoms not in common: None.

\n\n+2. Phenylketonuria (PKU):
This is a genetic disorder caused by a deficiency of the enzyme phenylalanine hydroxylase. Symptoms in common with the patient: Abnormality of prenatal development or birth, Hyperphenylalaninemia, Death in infancy, Death in childhood. Symptoms not in common: Upper airway obstruction, Chronic pulmonary obstruction.

\n\n+3. Mucopolysaccharidosis Type VII:
This is a rare genetic disorder caused by a deficiency of the enzyme beta-glucuronidase. Symptoms in common with the patient: Abnormality of prenatal development or birth, Death in infancy, Death in childhood. Symptoms not in common: Hypertyrosinemia, Hyperphenylalaninemia, Upper airway obstruction, Chronic pulmonary obstruction.

\n\n+4. Cystic Fibrosis:
This is a genetic disorder that affects the respiratory, digestive, and reproductive systems. Symptoms in common with the patient: Upper airway obstruction, Chronic pulmonary obstruction, Death in childhood, Death in adolescence. Symptoms not in common: Abnormality of prenatal development or birth, Hypertyrosinemia, Hyperphenylalaninemia.

\n\n+5. Homocystinuria:
This is a rare genetic disorder caused by a deficiency of the enzyme cystathionine beta-synthase. Symptoms in common with the patient: Abnormality of prenatal development or birth, Death in infancy, Death in childhood. Symptoms not in common: Upper airway obstruction, Chronic pulmonary obstruction, Hypertyrosinemia, Hyperphenylalaninemia.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms and to rule out other potential diseases."
['Biotinidase deficiency'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Menkes Syndrome:
This is a rare genetic disorder that affects the production of copper in the body. The patient's symptoms of Apathy, Seizure, Spasticity, and Alopecia are consistent with this disease. However, Menkes Syndrome typically presents with kinky or brittle hair, which is not mentioned in the patient's symptoms. Additionally, the patient's symptoms of Death in infancy, Dyspnea, Fatigue, and Elevated urinary carboxylic acid are not typical of Menkes Syndrome.

\n\n+2. Maple Syrup Urine Disease (MSUD):
This is a rare genetic disorder that affects the breakdown of certain amino acids. The patient's symptoms of Seizure, Fatigue, and Elevated urinary carboxylic acid are consistent with MSUD. However, the patient's symptoms of Apathy, Spasticity, Death in infancy, Alopecia, and Dyspnea are not typical of MSUD.

\n\n+3. Leigh Syndrome:
This is a rare genetic disorder that affects the mitochondria, the energy-producing structures within cells. The patient's symptoms of Seizure, Spasticity, Fatigue, and Death in infancy are consistent with Leigh Syndrome. However, the patient's symptoms of Apathy, Alopecia, Dyspnea, and Elevated urinary carboxylic acid are not typical of Leigh Syndrome.

\n\n+4. Methylmalonic Acidemia (MMA):
This is a rare genetic disorder that affects the breakdown of certain amino acids. The patient's symptoms of Seizure, Fatigue, and Elevated urinary carboxylic acid are consistent with MMA. However, the patient's symptoms of Apathy, Spasticity, Death in infancy, Alopecia, and Dyspnea are not typical of MMA.

\n\n+5. Propionic Acidemia (PA):
This is a rare genetic disorder that affects the breakdown of certain amino acids. The patient's symptoms of Seizure, Fatigue, and Elevated urinary carboxylic acid are consistent with PA. However, the patient's symptoms of Apathy, Spasticity, Death in infancy, Alopecia, and Dyspnea are not typical of PA.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms."
['Phenylketonuria'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Tyrosinemia Type I:
This is a rare genetic disorder caused by a deficiency of the enzyme fumarylacetoacetate hydrolase. Symptoms in common with the patient: Hypertyrosinemia, Vomiting, Gastrointestinal inflammation, Death in infancy, Death in childhood, Death in adolescence. Symptoms not in common: Obesity, Fever, Hyperphenylalaninemia.

\n\n+2. Phenylketonuria (PKU):
This is a genetic disorder caused by a deficiency of the enzyme phenylalanine hydroxylase. Symptoms in common with the patient: Hyperphenylalaninemia, Death in infancy, Death in childhood, Death in adolescence. Symptoms not in common: Obesity, Fever, Vomiting, Gastrointestinal inflammation, Hypertyrosinemia.

\n\n+3. Maple Syrup Urine Disease (MSUD):
This is a rare genetic disorder caused by a deficiency of the enzyme branched-chain alpha-keto acid dehydrogenase complex. Symptoms in common with the patient: Vomiting, Fever, Death in infancy, Death in childhood. Symptoms not in common: Obesity, Hypertyrosinemia, Hyperphenylalaninemia, Gastrointestinal inflammation, Death in adolescence.

\n\n+4. Homocystinuria:
This is a rare genetic disorder caused by a deficiency of the enzyme cystathionine beta-synthase. Symptoms in common with the patient: Death in infancy, Death in childhood, Death in adolescence. Symptoms not in common: Obesity, Fever, Vomiting, Gastrointestinal inflammation, Hypertyrosinemia, Hyperphenylalaninemia.

\n\n+5. Methylmalonic Acidemia:
This is a rare genetic disorder caused by a deficiency of the enzyme methylmalonyl-CoA mutase. Symptoms in common with the patient: Vomiting, Fever, Death in infancy, Death in childhood. Symptoms not in common: Obesity, Hypertyrosinemia, Hyperphenylalaninemia, Gastrointestinal inflammation, Death in adolescence.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms and to rule out other potential diseases."
['Biotinidase deficiency'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Nonketotic Hyperglycinemia (NKH):
This is a rare genetic disorder that affects the breakdown of certain amino acids. The patient's symptoms that match NKH include: Abnormal circulating glycine concentration, Aminoaciduria, Elevated urinary carboxylic acid, and Metabolic acidosis. However, NKH typically does not present with skin rash, Alopecia, Erythematous plaque, Erythematous macule, or Erythematous papule.

\n\n+2. Isovaleric Acidemia (IVA):
This is a rare genetic disorder that affects the breakdown of certain amino acids. The patient's symptoms that match IVA include: Metabolic acidosis, Aminoaciduria, Elevated urinary carboxylic acid, and Skin rash. However, IVA typically does not present with Death in infancy, Alopecia, Abnormal circulating glycine concentration, Erythematous plaque, Erythematous macule, or Erythematous papule.

\n\n+3. Propionic Acidemia (PA):
This is a rare genetic disorder that affects the breakdown of certain amino acids. The patient's symptoms that match PA include: Metabolic acidosis, Aminoaciduria, Elevated urinary carboxylic acid, and Skin rash. However, PA typically does not present with Death in infancy, Alopecia, Abnormal circulating glycine concentration, Erythematous plaque, Erythematous macule, or Erythematous papule.

\n\n+4. Methylmalonic Acidemia (MMA):
This is a rare genetic disorder that affects the breakdown of certain amino acids. The patient's symptoms that match MMA include: Metabolic acidosis, Aminoaciduria, Elevated urinary carboxylic acid, and Skin rash. However, MMA typically does not present with Death in infancy, Alopecia, Abnormal circulating glycine concentration, Erythematous plaque, Erythematous macule, or Erythematous papule.

\n\n+5. Glutaric Acidemia Type I (GA1):
This is a rare genetic disorder that affects the breakdown of certain amino acids. The patient's symptoms that match GA1 include: Metabolic acidosis, Aminoaciduria, Elevated urinary carboxylic acid, and Skin rash. However, GA1 typically does not present with Death in infancy, Alopecia, Abnormal circulating glycine concentration, Erythematous plaque, Erythematous macule, or Erythematous papule.

\n\n+6. Multiple Carboxylase Deficiency (MCD):
This is a rare genetic disorder that affects the breakdown of certain amino acids. The patient's symptoms that match MCD include: Metabolic acidosis, Aminoaciduria, Elevated urinary carboxylic acid, Skin rash, and Alopecia. However, MCD typically does not present with Death in infancy, Abnormal circulating glycine concentration, Erythematous plaque, Erythematous macule, or Erythematous papule.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms."
['Vitamin B12-unresponsive methylmalonic acidemia'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Methylmalonic Acidemia:
This is a rare genetic disorder caused by a deficiency of the enzyme methylmalonyl-CoA mutase. Symptoms in common with the patient: Decreased methylmalonyl-CoA mutase activity, Dehydration, Feeding difficulties. Symptoms not in common: None.

\n\n+2. Methylmalonyl-CoA Mutase Deficiency:
This is a rare genetic disorder caused by a deficiency of the enzyme methylmalonyl-CoA mutase. Symptoms in common with the patient: Decreased methylmalonyl-CoA mutase activity, Dehydration, Feeding difficulties. Symptoms not in common: None.

\n\n+3. Vitamin B12 Deficiency:
This is a condition where the body does not have enough vitamin B12, which is essential for the production of red blood cells and nerve function. Symptoms in common with the patient: Dehydration. Symptoms not in common: Death in infancy, Neonatal death, Decreased methylmalonyl-CoA mutase activity, Feeding difficulties.

\n\n+4. Maple Syrup Urine Disease:
This is a rare genetic disorder caused by a deficiency of the enzyme branched-chain alpha-keto acid dehydrogenase complex. Symptoms in common with the patient: Dehydration, Feeding difficulties. Symptoms not in common: Death in infancy, Neonatal death, Decreased methylmalonyl-CoA mutase activity.

\n\n+5. Propionic Acidemia:
This is a rare genetic disorder caused by a deficiency of the enzyme propionyl-CoA carboxylase. Symptoms in common with the patient: Dehydration, Feeding difficulties. Symptoms not in common: Death in infancy, Neonatal death, Decreased methylmalonyl-CoA mutase activity.

\n\n+6. Isovaleric Acidemia:
This is a rare genetic disorder caused by a deficiency of the enzyme isovaleryl-CoA dehydrogenase. Symptoms in common with the patient: Dehydration, Feeding difficulties. Symptoms not in common: Death in infancy, Neonatal death, Decreased methylmalonyl-CoA mutase activity.

Based on the patient's symptoms, I believe that Methylmalonic Acidemia or Methylmalonyl-CoA Mutase Deficiency are the most likely diagnoses. However, further testing is needed to confirm the diagnosis and rule out other potential causes."
['Biotinidase deficiency'],ERROR
['Phenylketonuria'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Tyrosinemia Type I:
This is a rare genetic disorder caused by a deficiency of the enzyme fumarylacetoacetate hydrolase. Symptoms in common with the patient: Abnormality of prenatal development or birth, Hypertyrosinemia, Death in infancy, Neonatal death, Death in childhood. Symptoms not in common: None.

\n\n+2. Phenylketonuria (PKU):
This is a genetic disorder caused by a deficiency of the enzyme phenylalanine hydroxylase. Symptoms in common with the patient: Hyperphenylalaninemia, Abnormality of prenatal development or birth, Death in infancy, Death in childhood. Symptoms not in common: None.

\n\n+3. Maple Syrup Urine Disease (MSUD):
This is a rare genetic disorder caused by a deficiency of the enzyme branched-chain alpha-keto acid dehydrogenase complex. Symptoms in common with the patient: Abnormality of prenatal development or birth, Death in infancy, Death in childhood. Symptoms not in common: Hypertyrosinemia, Hyperphenylalaninemia.

\n\n+4. Homocystinuria:
This is a rare genetic disorder caused by a deficiency of the enzyme cystathionine beta-synthase. Symptoms in common with the patient: Abnormality of prenatal development or birth, Death in infancy, Death in childhood. Symptoms not in common: Hypertyrosinemia, Hyperphenylalaninemia.

\n\n+5. Methylmalonic Acidemia:
This is a rare genetic disorder caused by a deficiency of the enzyme methylmalonyl-CoA mutase. Symptoms in common with the patient: Abnormality of prenatal development or birth, Death in infancy, Death in childhood. Symptoms not in common: Hypertyrosinemia, Hyperphenylalaninemia.

Based on these findings, I would like to conduct further tests to determine the exact cause of the patient's condition."
['3-hydroxy-3-methylglutaric aciduria'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. 3-Methylglutaconic aciduria type I:
This is a rare genetic disorder characterized by the accumulation of 3-methylglutaconic acid in the urine. The patient's symptoms of 3-Methylglutaric aciduria and Elevated urinary carboxylic acid are consistent with this disease. However, the patient does not exhibit the typical symptoms of intellectual disability, seizures, and muscle weakness associated with this condition.

\n\n+2. 3-Methylglutaconic aciduria type II:
This is another rare genetic disorder that affects the breakdown of certain fatty acids. The patient's symptoms of 3-Methylglutaric aciduria and Elevated urinary carboxylic acid are similar to those seen in this disease. However, the patient does not exhibit the typical symptoms of muscle weakness, seizures, and intellectual disability associated with this condition.

\n\n+3. Dicarboxylic aciduria:
This is a rare genetic disorder characterized by the accumulation of dicarboxylic acids in the urine. The patient's symptoms of Dicarboxylic aciduria and Elevated urinary carboxylic acid are consistent with this disease. However, the patient does not exhibit the typical symptoms of intellectual disability, seizures, and muscle weakness associated with this condition.

\n\n+4. 3-Hydroxy-3-methylglutaryl-CoA lyase deficiency:
This is a rare genetic disorder that affects the breakdown of certain fatty acids. The patient's symptoms of 3-Methylglutaric aciduria and Elevated urinary carboxylic acid are similar to those seen in this disease. However, the patient does not exhibit the typical symptoms of intellectual disability, seizures, and muscle weakness associated with this condition.

\n\n+5. Glutaric acidemia type I:
This is a rare genetic disorder characterized by the accumulation of glutaric acid in the urine. The patient's symptoms of Elevated urinary carboxylic acid are consistent with this disease. However, the patient does not exhibit the typical symptoms of intellectual disability, seizures, and muscle weakness associated with this condition.

\n\n+6. Methylmalonic acidemia:
This is a rare genetic disorder characterized by the accumulation of methylmalonic acid in the urine. The patient's symptoms of Elevated urinary carboxylic acid are similar to those seen in this disease. However, the patient does not exhibit the typical symptoms of intellectual disability, seizures, and muscle weakness associated with this condition.

Based on the patient's symptoms, I believe that further testing is necessary to determine the underlying cause of their condition. I recommend conducting genetic testing and metabolic studies to confirm the diagnosis."
['Wilson disease'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Wilson's disease:
This is a genetic disorder that affects the body's ability to metabolize copper. The patient's symptoms that match this disease include: Decreased circulating ceruloplasmin concentration, Increased urinary copper concentration, Decreased circulating copper concentration. However, the patient does not exhibit other common symptoms of Wilson's disease, such as tremors, muscle stiffness, and liver damage.

\n\n+2. Menkes syndrome:
This is a rare genetic disorder that affects the body's ability to absorb copper. The patient's symptoms that match this disease include: Decreased circulating copper concentration, Abnormal circulating aspartate family amino acid concentration, Abnormal circulating alanine concentration. However, the patient does not exhibit other common symptoms of Menkes syndrome, such as kinky hair, seizures, and intellectual disability.

\n\n+3. Acute intermittent porphyria:
This is a genetic disorder that affects the production of heme, a molecule that helps carry oxygen in the blood. The patient's symptoms that match this disease include: Abnormal circulating porphyrin concentration. However, the patient does not exhibit other common symptoms of acute intermittent porphyria, such as abdominal pain, nausea, and vomiting.

\n\n+4. Hemochromatosis:
This is a genetic disorder that affects the body's ability to absorb iron. The patient's symptoms that match this disease include: Decreased serum iron. However, the patient does not exhibit other common symptoms of hemochromatosis, such as joint pain, fatigue, and skin discoloration.

\n\n+5. Non-alcoholic fatty liver disease (NAFLD):
This is a condition characterized by the accumulation of fat in the liver. The patient's symptoms that match this disease include: Elevated circulating hepatic transaminase concentration, Obesity. However, the patient does not exhibit other common symptoms of NAFLD, such as fatigue, abdominal pain, and loss of appetite.

\n\n+6. Porphyria cutanea tarda:
This is a genetic disorder that affects the production of heme, a molecule that helps carry oxygen in the blood. The patient's symptoms that match this disease include: Abnormal circulating porphyrin concentration. However, the patient does not exhibit other common symptoms of porphyria cutanea tarda, such as blistering skin lesions, increased hair growth, and dark urine.

\n\n+7. Tyrosinemia type I:
This is a genetic disorder that affects the breakdown of the amino acid tyrosine. The patient's symptoms that match this disease include: Elevated circulating hepatic transaminase concentration, Abnormal circulating aspartate family amino acid concentration, Abnormal circulating alanine concentration. However, the patient does not exhibit other common symptoms of tyrosinemia type I, such as failure to thrive, diarrhea, and vomiting.

Further testing and evaluation are needed to determine the underlying cause of the patient's symptoms and to rule out other potential diseases."
['Medium chain acyl-CoA dehydrogenase deficiency'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Carnitine Palmitoyltransferase I Deficiency:
This is a rare genetic disorder that affects the breakdown of fatty acids. The patient's symptoms of abnormal circulating carnitine concentration and abnormality of prenatal development or birth are consistent with this disease. However, the patient does not exhibit symptoms of muscle weakness, seizures, or hypoglycemia, which are commonly associated with this condition.

\n\n+2. Carnitine-Acylcarnitine Translocase Deficiency:
This is another rare genetic disorder that affects the transport of fatty acids into the mitochondria. The patient's symptoms of abnormal circulating carnitine concentration, abnormality of prenatal development or birth, and neonatal death are consistent with this disease. However, the patient does not exhibit symptoms of cardiomyopathy, which is commonly associated with this condition.

\n\n+3. Very-Long-Chain Acyl-CoA Dehydrogenase Deficiency:
This is a rare genetic disorder that affects the breakdown of fatty acids. The patient's symptoms of abnormal circulating carnitine concentration, abnormality of prenatal development or birth, and death in infancy are consistent with this disease. However, the patient does not exhibit symptoms of muscle weakness, seizures, or hypoglycemia, which are commonly associated with this condition.

\n\n+4. Carnitine Deficiency:
This is a condition characterized by a lack of carnitine in the body. The patient's symptoms of abnormal circulating carnitine concentration and abnormality of prenatal development or birth are consistent with this disease. However, the patient does not exhibit symptoms of muscle weakness, fatigue, or heart problems, which are commonly associated with this condition.

\n\n+5. Barth Syndrome:
This is a rare genetic disorder that affects the production of cardiolipin, a type of lipid found in the mitochondria. The patient's symptoms of abnormal circulating carnitine concentration, abnormality of prenatal development or birth, and neonatal death are consistent with this disease. However, the patient does not exhibit symptoms of cardiomyopathy, muscle weakness, or neutropenia, which are commonly associated with this condition.

These are just a few potential diseases that may be causing the patient's symptoms. Further testing and evaluation are necessary to determine the underlying cause of their condition."
['Phenylketonuria'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Tyrosinemia Type I:
This is a rare genetic disorder caused by a deficiency of the enzyme fumarylacetoacetate hydrolase. Symptoms in common with the patient: Hypertyrosinemia, Death in infancy, Death in childhood. Symptoms not in common: None.

\n\n+2. Phenylketonuria (PKU):
This is a genetic disorder caused by a deficiency of the enzyme phenylalanine hydroxylase. Symptoms in common with the patient: Hyperphenylalaninemia. Symptoms not in common: Death in infancy, Death in childhood, Recurrent viral infections.

\n\n+3. Adenosine Deaminase (ADA) Deficiency:
This is a rare genetic disorder that affects the immune system. Symptoms in common with the patient: Recurrent viral infections. Symptoms not in common: Death in infancy, Death in childhood, Hypertyrosinemia, Hyperphenylalaninemia.

\n\n+4. Mucopolysaccharidosis Type I (Hurler Syndrome):
This is a rare genetic disorder caused by a deficiency of the enzyme alpha-L-iduronidase. Symptoms in common with the patient: Death in infancy, Death in childhood. Symptoms not in common: Hypertyrosinemia, Hyperphenylalaninemia, Recurrent viral infections.

\n\n+5. Homocystinuria:
This is a rare genetic disorder caused by a deficiency of the enzyme cystathionine beta-synthase. Symptoms in common with the patient: Hyperphenylalaninemia. Symptoms not in common: Death in infancy, Death in childhood, Recurrent viral infections, Hypertyrosinemia.

After reviewing these potential diseases, I believe that Tyrosinemia Type I is the most likely diagnosis, given the patient's symptoms. However, further testing and evaluation are necessary to confirm this diagnosis."
['3-methylcrotonyl-CoA carboxylase deficiency'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Propionic Acidemia:
This is a rare genetic disorder that affects the body's ability to break down certain amino acids. The patient's symptoms of Aminoaciduria, Abnormal circulating glycine concentration, and Elevated urinary carboxylic acid are consistent with this disease. However, Propionic Acidemia typically also presents with symptoms such as vomiting, lethargy, and developmental delays, which are not mentioned in the patient's symptoms.

\n\n+2. Isovaleric Acidemia:
This is another rare genetic disorder that affects the body's ability to break down the amino acid leucine. The patient's symptoms of Aminoaciduria, Abnormal circulating carnitine concentration, and Elevated urinary carboxylic acid are consistent with this disease. However, Isovaleric Acidemia typically also presents with symptoms such as vomiting, diarrhea, and seizures, which are not mentioned in the patient's symptoms.

\n\n+3. Methylmalonic Acidemia:
This is a genetic disorder that affects the body's ability to break down certain amino acids and fats. The patient's symptoms of Aminoaciduria, Abnormal circulating glycine concentration, and Elevated urinary carboxylic acid are consistent with this disease. However, Methylmalonic Acidemia typically also presents with symptoms such as vomiting, lethargy, and developmental delays, which are not mentioned in the patient's symptoms.

\n\n+4. Carnitine Palmitoyltransferase I Deficiency:
This is a rare genetic disorder that affects the body's ability to break down fats for energy. The patient's symptoms of Abnormal circulating carnitine concentration and Elevated urinary carboxylic acid are consistent with this disease. However, Carnitine Palmitoyltransferase I Deficiency typically also presents with symptoms such as muscle weakness, seizures, and developmental delays, which are not mentioned in the patient's symptoms.

\n\n+5. Glycine Encephalopathy:
This is a rare genetic disorder that affects the body's ability to break down the amino acid glycine. The patient's symptoms of Abnormal circulating glycine concentration and Aminoaciduria are consistent with this disease. However, Glycine Encephalopathy typically also presents with symptoms such as seizures, developmental delays, and intellectual disability, which are not mentioned in the patient's symptoms.

Further testing and evaluation are needed to determine the underlying cause of the patient's symptoms and to rule out other potential diseases."
['Carbamoyl-phosphate synthetase 1 deficiency'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Barth Syndrome:
This is a rare genetic disorder that affects the mitochondria, leading to muscle weakness, heart problems, and other symptoms. The patient's symptoms that match this disease include: Generalized hypotonia, Hepatomegaly, Feeding difficulties. However, the patient does not exhibit the typical symptoms of cardiomyopathy, neutropenia, or growth delays.

\n\n+2. 3-Methylglutaconic Aciduria Type I:
This is a rare genetic disorder that affects the breakdown of certain amino acids, leading to the accumulation of toxic compounds. The patient's symptoms that match this disease include: 3-Methylglutaconic aciduria, Hepatomegaly, Tachypnea. However, the patient does not exhibit the typical symptoms of intellectual disability, seizures, or developmental delays.

\n\n+3. Costeff Syndrome:
This is a rare genetic disorder that affects the breakdown of certain fatty acids, leading to the accumulation of toxic compounds. The patient's symptoms that match this disease include: 3-Methylglutaconic aciduria, Hepatomegaly, Tachypnea. However, the patient does not exhibit the typical symptoms of intellectual disability, seizures, or optic atrophy.

\n\n+4. Mitochondrial DNA Depletion Syndrome 1:
This is a rare genetic disorder that affects the mitochondria, leading to muscle weakness, liver problems, and other symptoms. The patient's symptoms that match this disease include: Generalized hypotonia, Hepatomegaly, Feeding difficulties. However, the patient does not exhibit the typical symptoms of lactic acidosis, developmental delays, or seizures.

\n\n+5. Mitochondrial Complex I Deficiency:
This is a rare genetic disorder that affects the mitochondria, leading to muscle weakness, liver problems, and other symptoms. The patient's symptoms that match this disease include: Generalized hypotonia, Hepatomegaly, Tachypnea. However, the patient does not exhibit the typical symptoms of lactic acidosis, developmental delays, or seizures.

\n\n+6. Pearson Syndrome:
This is a rare genetic disorder that affects the mitochondria, leading to muscle weakness, liver problems, and other symptoms. The patient's symptoms that match this disease include: Generalized hypotonia, Hepatomegaly, Feeding difficulties. However, the patient does not exhibit the typical symptoms of sideroblastic anemia, pancreatic insufficiency, or developmental delays.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms and to rule out other potential diseases."
['Citrullinemia type I'],ERROR
['Glutaryl-CoA dehydrogenase deficiency'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Glutaric acidemia type I:
This is a rare genetic disorder caused by a deficiency of the enzyme glutaryl-CoA dehydrogenase. It affects the breakdown of certain amino acids and can lead to a buildup of toxic compounds in the body.

Common symptoms: Glutaric aciduria, Macrocephaly, Seizure, Generalized hypotonia, Death in infancy
Not common symptoms: Abnormality of visual evoked potentials, Irritability, Athetosis, Neonatal death

\n\n+2. Canavan disease:
This is a rare genetic disorder caused by a deficiency of the enzyme aspartoacylase. It affects the breakdown of certain fatty acids and can lead to a buildup of toxic compounds in the brain.

Common symptoms: Macrocephaly, Seizure, Generalized hypotonia, Death in infancy
Not common symptoms: Abnormality of visual evoked potentials, Irritability, Athetosis, Glutaric aciduria, Neonatal death

\n\n+3. Mucopolysaccharidosis type VII:
This is a rare genetic disorder caused by a deficiency of the enzyme beta-glucuronidase. It affects the breakdown of certain sugars and can lead to a buildup of toxic compounds in the body.

Common symptoms: Macrocephaly, Seizure, Generalized hypotonia
Not common symptoms: Abnormality of visual evoked potentials, Irritability, Athetosis, Glutaric aciduria, Death in infancy, Neonatal death

\n\n+4. Zellweger syndrome:
This is a rare genetic disorder caused by a deficiency of certain enzymes involved in the breakdown of fatty acids. It can lead to a buildup of toxic compounds in the body.

Common symptoms: Macrocephaly, Seizure, Generalized hypotonia, Death in infancy, Neonatal death
Not common symptoms: Abnormality of visual evoked potentials, Irritability, Athetosis, Glutaric aciduria

\n\n+5. Leigh syndrome:
This is a rare genetic disorder caused by a deficiency of certain enzymes involved in the breakdown of fatty acids. It can lead to a buildup of toxic compounds in the body.

Common symptoms: Seizure, Generalized hypotonia, Death in infancy, Athetosis
Not common symptoms: Macrocephaly, Abnormality of visual evoked potentials, Irritability, Glutaric aciduria, Neonatal death

After reviewing these potential diseases, I believe that Glutaric acidemia type I is the most likely diagnosis, given the presence of glutaric aciduria and the combination of other symptoms. However, further testing is needed to confirm this diagnosis."
['Tyrosinemia type 1'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Tyrosinemia Type I:
This is a rare genetic disorder caused by a deficiency of the enzyme fumarylacetoacetate hydrolase. It is characterized by elevated levels of tyrosine in the blood and urine, which can lead to liver and kidney damage.

Common symptoms: Hypertyrosinemia, Elevated urinary delta-aminolevulinic acid
Not common symptoms: Delayed speech and language development, 4-Hydroxyphenylpyruvic aciduria, Abnormal circulating phenylalanine concentration, Death in childhood

\n\n+2. Phenylketonuria (PKU):
This is a genetic disorder caused by a deficiency of the enzyme phenylalanine hydroxylase. It is characterized by elevated levels of phenylalanine in the blood, which can lead to intellectual disability and other neurological problems if left untreated.

Common symptoms: Abnormal circulating phenylalanine concentration, Delayed speech and language development
Not common symptoms: Hypertyrosinemia, Elevated urinary delta-aminolevulinic acid, 4-Hydroxyphenylpyruvic aciduria, Death in childhood

\n\n+3. Hereditary Tyrosinemia:
This is a group of rare genetic disorders caused by defects in the enzymes involved in the breakdown of tyrosine. It is characterized by elevated levels of tyrosine in the blood and urine, which can lead to liver and kidney damage.

Common symptoms: Hypertyrosinemia, Elevated urinary delta-aminolevulinic acid, 4-Hydroxyphenylpyruvic aciduria
Not common symptoms: Delayed speech and language development, Abnormal circulating phenylalanine concentration, Death in childhood

\n\n+4. Acute Intermittent Porphyria:
This is a rare genetic disorder caused by a deficiency of the enzyme hydroxymethylbilane synthase. It is characterized by intermittent attacks of abdominal pain, nausea, and vomiting, as well as elevated levels of delta-aminolevulinic acid in the urine.

Common symptoms: Elevated urinary delta-aminolevulinic acid
Not common symptoms: Delayed speech and language development, Hypertyrosinemia, 4-Hydroxyphenylpyruvic aciduria, Abnormal circulating phenylalanine concentration, Death in childhood

\n\n+5. Hawkinsinuria:
This is a rare genetic disorder caused by a deficiency of the enzyme 4-hydroxyphenylpyruvate dioxygenase. It is characterized by elevated levels of 4-hydroxyphenylpyruvate in the urine, which can lead to developmental delays and intellectual disability.

Common symptoms: 4-Hydroxyphenylpyruvic aciduria, Delayed speech and language development
Not common symptoms: Hypertyrosinemia, Elevated urinary delta-aminolevulinic acid, Abnormal circulating phenylalanine concentration, Death in childhood

Based on the patient's symptoms, I believe that Tyrosinemia Type I or Hereditary Tyrosinemia are the most likely diagnoses. However, further testing and evaluation are needed to confirm the diagnosis and rule out other potential causes."
['Phenylketonuria'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Homocystinuria:
This is a rare genetic disorder caused by a deficiency of the enzyme cystathionine beta-synthase. It can lead to abnormal development, intellectual disability, and blood clots.
Common symptoms: Abnormality of prenatal development or birth, Elevated urinary carboxylic acid
Not common symptoms: Obesity, Death in infancy, Hypertyrosinemia, Neonatal death, Death in childhood, Hyperphenylalaninemia

\n\n+2. Phenylketonuria (PKU):
This is a genetic disorder caused by a deficiency of the enzyme phenylalanine hydroxylase. It can lead to intellectual disability, seizures, and behavioral problems if left untreated.
Common symptoms: Hyperphenylalaninemia
Not common symptoms: Abnormality of prenatal development or birth, Obesity, Death in infancy, Hypertyrosinemia, Neonatal death, Death in childhood, Elevated urinary carboxylic acid

\n\n+3. Tyrosinemia type I:
This is a rare genetic disorder caused by a deficiency of the enzyme fumarylacetoacetate hydrolase. It can lead to liver and kidney damage, and increased risk of liver cancer.
Common symptoms: Hypertyrosinemia, Elevated urinary carboxylic acid
Not common symptoms: Abnormality of prenatal development or birth, Obesity, Death in infancy, Neonatal death, Death in childhood, Hyperphenylalaninemia

\n\n+4. Maple syrup urine disease (MSUD):
This is a rare genetic disorder caused by a deficiency of the enzyme branched-chain alpha-keto acid dehydrogenase complex. It can lead to intellectual disability, seizures, and death if left untreated.
Common symptoms: Elevated urinary carboxylic acid
Not common symptoms: Abnormality of prenatal development or birth, Obesity, Death in infancy, Hypertyrosinemia, Neonatal death, Death in childhood, Hyperphenylalaninemia

\n\n+5. Propionic acidemia:
This is a rare genetic disorder caused by a deficiency of the enzyme propionyl-CoA carboxylase. It can lead to intellectual disability, seizures, and death if left untreated.
Common symptoms: Elevated urinary carboxylic acid
Not common symptoms: Abnormality of prenatal development or birth, Obesity, Death in infancy, Hypertyrosinemia, Neonatal death, Death in childhood, Hyperphenylalaninemia

Based on the patient's symptoms, I would like to order further tests to confirm the diagnosis."
['Phenylketonuria'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Phenylketonuria (PKU):
This is a genetic disorder that affects the breakdown of the amino acid phenylalanine. The patient's symptoms that match PKU include Hyperphenylalaninemia, Intellectual disability, and Seizure. However, PKU does not typically cause Hyperactivity, Obesity, Hypertyrosinemia, Severe short stature, or Elevated urinary carboxylic acid.

\n\n+2. Homocystinuria:
This is a rare genetic disorder that affects the metabolism of the amino acid methionine. The patient's symptoms that match Homocystinuria include Intellectual disability, Seizure, and Elevated urinary carboxylic acid. However, Homocystinuria does not typically cause Hyperactivity, Obesity, Hypertyrosinemia, or Severe short stature.

\n\n+3. Tyrosinemia type 1:
This is a rare genetic disorder that affects the breakdown of the amino acid tyrosine. The patient's symptoms that match Tyrosinemia type 1 include Hypertyrosinemia, Elevated urinary carboxylic acid, and Death in childhood or early adulthood. However, Tyrosinemia type 1 does not typically cause Hyperactivity, Intellectual disability, Seizure, or Obesity.

\n\n+4. Maple syrup urine disease (MSUD):
This is a rare genetic disorder that affects the breakdown of certain amino acids. The patient's symptoms that match MSUD include Intellectual disability, Seizure, and Elevated urinary carboxylic acid. However, MSUD does not typically cause Hyperactivity, Obesity, Hypertyrosinemia, or Severe short stature.

\n\n+5. Mucopolysaccharidosis type I (MPS I):
This is a rare genetic disorder that affects the breakdown of sugar molecules. The patient's symptoms that match MPS I include Intellectual disability, Seizure, and Severe short stature. However, MPS I does not typically cause Hyperactivity, Obesity, Hypertyrosinemia, or Elevated urinary carboxylic acid.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms."
['Vitamin B12-unresponsive methylmalonic acidemia'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Methylmalonic Acidemia (MMA):
This is a rare genetic disorder caused by a deficiency of the enzyme methylmalonyl-CoA mutase. Symptoms in common: Methylmalonic acidemia, Methylmalonic aciduria, Metabolic acidosis, Hyperammonemia, Vomiting. Symptoms not in common: None.

\n\n+2. Propionic Acidemia:
This is a rare genetic disorder caused by a deficiency of the enzyme propionyl-CoA carboxylase. Symptoms in common: Metabolic acidosis, Hyperammonemia, Vomiting, Leukopenia, Thrombocytopenia. Symptoms not in common: Seizure, Generalized hypotonia, Death in infancy, Neonatal death.

\n\n+3. Isovaleric Acidemia:
This is a rare genetic disorder caused by a deficiency of the enzyme isovaleryl-CoA dehydrogenase. Symptoms in common: Metabolic acidosis, Vomiting, Leukopenia, Thrombocytopenia. Symptoms not in common: Seizure, Generalized hypotonia, Death in infancy, Neonatal death, Hyperammonemia, Methylmalonic acidemia, Methylmalonic aciduria.

\n\n+4. Maple Syrup Urine Disease (MSUD):
This is a rare genetic disorder caused by a deficiency of the enzyme branched-chain alpha-keto acid dehydrogenase complex. Symptoms in common: Metabolic acidosis, Vomiting, Leukopenia, Thrombocytopenia. Symptoms not in common: Seizure, Generalized hypotonia, Death in infancy, Neonatal death, Hyperammonemia, Methylmalonic acidemia, Methylmalonic aciduria.

\n\n+5. Glutaric Acidemia Type I:
This is a rare genetic disorder caused by a deficiency of the enzyme glutaryl-CoA dehydrogenase. Symptoms in common: Metabolic acidosis, Vomiting, Leukopenia, Thrombocytopenia. Symptoms not in common: Seizure, Generalized hypotonia, Death in infancy, Neonatal death, Hyperammonemia, Methylmalonic acidemia, Methylmalonic aciduria.

\n\n+6. Multiple Carboxylase Deficiency:
This is a rare genetic disorder caused by a deficiency of the enzyme holocarboxylase synthetase. Symptoms in common: Metabolic acidosis, Vomiting, Leukopenia, Thrombocytopenia. Symptoms not in common: Seizure, Generalized hypotonia, Death in infancy, Neonatal death, Hyperammonemia, Methylmalonic acidemia, Methylmalonic aciduria.

Based on the patient's symptoms, Methylmalonic Acidemia (MMA) appears to be the most likely diagnosis. However, further testing and evaluation are necessary to confirm the diagnosis and rule out other potential causes."
['Medium chain acyl-CoA dehydrogenase deficiency'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Carnitine Palmitoyltransferase I Deficiency:
This is a rare genetic disorder that affects the breakdown of fatty acids. The patient's symptoms of abnormal circulating carnitine concentration and abnormality of prenatal development or birth are consistent with this disease. However, the patient does not exhibit symptoms of muscle weakness, seizures, or hypoglycemia, which are commonly associated with this condition.

\n\n+2. Carnitine-Acylcarnitine Translocase Deficiency:
This is another rare genetic disorder that affects the transport of fatty acids into the mitochondria. The patient's symptoms of abnormal circulating carnitine concentration, abnormality of prenatal development or birth, and neonatal death are consistent with this disease. However, the patient does not exhibit symptoms of cardiomyopathy, which is commonly associated with this condition.

\n\n+3. Very-Long-Chain Acyl-CoA Dehydrogenase Deficiency:
This is a rare genetic disorder that affects the breakdown of fatty acids. The patient's symptoms of abnormal circulating carnitine concentration, abnormality of prenatal development or birth, and death in infancy are consistent with this disease. However, the patient does not exhibit symptoms of muscle weakness, seizures, or hypoglycemia, which are commonly associated with this condition.

\n\n+4. Carnitine Deficiency:
This is a condition characterized by a lack of carnitine in the body. The patient's symptoms of abnormal circulating carnitine concentration and abnormality of prenatal development or birth are consistent with this disease. However, the patient does not exhibit symptoms of muscle weakness, fatigue, or heart problems, which are commonly associated with this condition.

\n\n+5. Barth Syndrome:
This is a rare genetic disorder that affects the production of cardiolipin, a type of lipid found in the mitochondria. The patient's symptoms of abnormal circulating carnitine concentration, abnormality of prenatal development or birth, and neonatal death are consistent with this disease. However, the patient does not exhibit symptoms of cardiomyopathy, muscle weakness, or neutropenia, which are commonly associated with this condition.

These are just a few potential diseases that may be causing the patient's symptoms. Further testing and evaluation are necessary to determine the underlying cause of their condition."
['Vitamin B12-unresponsive methylmalonic acidemia'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Methylmalonic Acidemia:
This is a rare genetic disorder that affects the body's ability to break down certain amino acids. The patient's symptoms of Methylmalonic aciduria, Metabolic acidosis, and Hyperammonemia are consistent with this disease. However, the patient does not exhibit the symptom of developmental delays, which is commonly seen in Methylmalonic Acidemia.

\n\n+2. Propionic Acidemia:
This is another rare genetic disorder that affects the body's ability to break down certain amino acids. The patient's symptoms of Metabolic acidosis, Hyperammonemia, and Vomiting are consistent with this disease. However, the patient does not exhibit the symptom of seizures, which is commonly seen in Propionic Acidemia.

\n\n+3. Isovaleric Acidemia:
This is a rare genetic disorder that affects the body's ability to break down the amino acid leucine. The patient's symptoms of Metabolic acidosis, Hyperammonemia, and Vomiting are consistent with this disease. However, the patient does not exhibit the symptom of a characteristic ""sweaty feet"" odor, which is commonly seen in Isovaleric Acidemia.

\n\n+4. Maple Syrup Urine Disease:
This is a rare genetic disorder that affects the body's ability to break down certain amino acids. The patient's symptoms of Metabolic acidosis, Hyperammonemia, and Vomiting are consistent with this disease. However, the patient does not exhibit the symptom of a characteristic maple syrup-like odor in their urine, which is commonly seen in Maple Syrup Urine Disease.

\n\n+5. Homocystinuria:
This is a rare genetic disorder that affects the body's ability to break down the amino acid methionine. The patient's symptoms of Metabolic acidosis and Hyperammonemia are consistent with this disease. However, the patient does not exhibit the symptom of intellectual disability, which is commonly seen in Homocystinuria.

\n\n+6. Citrullinemia:
This is a rare genetic disorder that affects the body's ability to break down the amino acid citrulline. The patient's symptoms of Hyperammonemia and Vomiting are consistent with this disease. However, the patient does not exhibit the symptom of intellectual disability, which is commonly seen in Citrullinemia.

Further testing and evaluation are needed to determine the underlying cause of the patient's symptoms and to rule out other potential diseases."
['Ornithine transcarbamylase deficiency'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Ornithine Transcarbamylase Deficiency:
This is a rare genetic disorder that affects the urea cycle, leading to the accumulation of ammonia in the blood. The patient's symptoms of Hyperammonemia, Oroticaciduria, and Seizure are consistent with this disease. However, the patient does not exhibit symptoms of intellectual disability, which is often seen in this condition.

\n\n+2. Citrullinemia:
This is another genetic disorder that affects the urea cycle, leading to the buildup of citrulline in the blood. The patient's symptoms of Hyperammonemia, Seizure, and Cerebral edema are consistent with this disease. However, the patient does not exhibit symptoms of delayed speech and language development, which is often seen in this condition.

\n\n+3. Argininosuccinic Aciduria:
This is a rare genetic disorder that affects the urea cycle, leading to the accumulation of argininosuccinic acid in the blood. The patient's symptoms of Hyperammonemia, Oroticaciduria, and Seizure are consistent with this disease. However, the patient does not exhibit symptoms of intellectual disability, which is often seen in this condition.

\n\n+4. Carbamoyl Phosphate Synthetase I Deficiency:
This is a rare genetic disorder that affects the urea cycle, leading to the accumulation of ammonia in the blood. The patient's symptoms of Hyperammonemia, Seizure, and Cerebral edema are consistent with this disease. However, the patient does not exhibit symptoms of vomiting and lethargy, which are often seen in this condition.

\n\n+5. N-Acetylglutamate Synthase Deficiency:
This is a rare genetic disorder that affects the urea cycle, leading to the accumulation of ammonia in the blood. The patient's symptoms of Hyperammonemia, Seizure, and Cerebral edema are consistent with this disease. However, the patient does not exhibit symptoms of vomiting and diarrhea, which are often seen in this condition.

\n\n+6. Hyperornithinemia-Hyperammonemia-Homocitrullinuria Syndrome:
This is a rare genetic disorder that affects the urea cycle, leading to the accumulation of ammonia in the blood. The patient's symptoms of Hyperammonemia, Oroticaciduria, and Seizure are consistent with this disease. However, the patient does not exhibit symptoms of intellectual disability, which is often seen in this condition.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms and to rule out other potential diseases."
['Biotinidase deficiency'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Menkes Syndrome:
This is a rare genetic disorder that affects the production of copper in the body. The patient's symptoms of Seizure, Generalized hypotonia, Growth delay, and Alopecia are consistent with this disease. However, Menkes Syndrome typically presents with kinky or brittle hair, which is not mentioned in the patient's symptoms. Additionally, the patient's symptoms of Death in infancy, Fasciculations, and Elevated urinary carboxylic acid are not typical of Menkes Syndrome.

\n\n+2. Methylmalonic Acidemia:
This is a genetic disorder that affects the body's ability to break down certain amino acids. The patient's symptoms of Seizure, Growth delay, and Elevated urinary carboxylic acid are consistent with this disease. However, Methylmalonic Acidemia typically presents with vomiting, diarrhea, and lethargy, which are not mentioned in the patient's symptoms. The patient's symptoms of Generalized hypotonia, Death in infancy, Alopecia, and Fasciculations are not typical of Methylmalonic Acidemia.

\n\n+3. Propionic Acidemia:
This is a genetic disorder that affects the body's ability to break down certain amino acids. The patient's symptoms of Seizure, Growth delay, and Elevated urinary carboxylic acid are consistent with this disease. However, Propionic Acidemia typically presents with vomiting, diarrhea, and lethargy, which are not mentioned in the patient's symptoms. The patient's symptoms of Generalized hypotonia, Death in infancy, Alopecia, and Fasciculations are not typical of Propionic Acidemia.

\n\n+4. Isovaleric Acidemia:
This is a genetic disorder that affects the body's ability to break down certain amino acids. The patient's symptoms of Seizure, Growth delay, and Elevated urinary carboxylic acid are consistent with this disease. However, Isovaleric Acidemia typically presents with vomiting, diarrhea, and lethargy, which are not mentioned in the patient's symptoms. The patient's symptoms of Generalized hypotonia, Death in infancy, Alopecia, and Fasciculations are not typical of Isovaleric Acidemia.

\n\n+5. Glutaric Acidemia Type I:
This is a genetic disorder that affects the body's ability to break down certain amino acids. The patient's symptoms of Seizure, Growth delay, and Elevated urinary carboxylic acid are consistent with this disease. However, Glutaric Acidemia Type I typically presents with macrocephaly (an enlarged head) and a characteristic ""cherry red"" spot on the retina, which are not mentioned in the patient's symptoms. The patient's symptoms of Generalized hypotonia, Death in infancy, Alopecia, and Fasciculations are not typical of Glutaric Acidemia Type I.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms."
['Phenylketonuria'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Homocystinuria:
This is a rare genetic disorder caused by a deficiency of the enzyme cystathionine beta-synthase. It can lead to elevated levels of homocysteine in the blood, which can cause a range of symptoms including obesity, hypercholesterolemia, and early death. 
Common symptoms: Obesity, Hypercholesterolemia, Death in early adulthood
Not common symptoms: Hypertyrosinemia, Hyperphenylalaninemia

\n\n+2. Phenylketonuria (PKU):
This is a genetic disorder caused by a deficiency of the enzyme phenylalanine hydroxylase, which is necessary for breaking down the amino acid phenylalanine. It can lead to elevated levels of phenylalanine in the blood, causing a range of symptoms including hyperphenylalaninemia and intellectual disability. 
Common symptoms: Hyperphenylalaninemia
Not common symptoms: Obesity, Hypercholesterolemia, Hypertyrosinemia, Death in early adulthood

\n\n+3. Tyrosinemia type I:
This is a rare genetic disorder caused by a deficiency of the enzyme fumarylacetoacetate hydrolase, which is necessary for breaking down the amino acid tyrosine. It can lead to elevated levels of tyrosine in the blood, causing a range of symptoms including hypertyrosinemia and liver and kidney damage. 
Common symptoms: Hypertyrosinemia
Not common symptoms: Obesity, Hypercholesterolemia, Hyperphenylalaninemia, Death in early adulthood

\n\n+4. Familial hypercholesterolemia:
This is a genetic disorder caused by a mutation in the LDL receptor gene, which is necessary for removing low-density lipoprotein (LDL) cholesterol from the blood. It can lead to very high levels of LDL cholesterol, causing a range of symptoms including hypercholesterolemia and early death from heart disease. 
Common symptoms: Hypercholesterolemia, Death in early adulthood
Not common symptoms: Obesity, Hypertyrosinemia, Hyperphenylalaninemia

\n\n+5. Prader-Willi syndrome:
This is a rare genetic disorder caused by a deletion of genes on chromosome 15. It can lead to a range of symptoms including obesity, intellectual disability, and short stature. 
Common symptoms: Obesity
Not common symptoms: Hypercholesterolemia, Hypertyrosinemia, Hyperphenylalaninemia, Death in early adulthood

Based on the patient's symptoms, I believe that Homocystinuria is the most likely diagnosis. However, further testing is necessary to confirm this diagnosis and rule out other potential causes."
['Phenylketonuria'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. **Menkes Syndrome**: A rare genetic disorder that affects the production of copper in the body.

Common symptoms: Premature birth, Severe short stature, Neonatal death
Not common symptoms: Hypospadias, Hypertyrosinemia, Hyperphenylalaninemia, Hernia

\n\n+2. **Tyrosinemia Type I**: A genetic disorder caused by a deficiency of the enzyme fumarylacetoacetate hydrolase.

Common symptoms: Hypertyrosinemia, Neonatal death
Not common symptoms: Hypospadias, Premature birth, Severe short stature, Hyperphenylalaninemia, Hernia

\n\n+3. **Phenylketonuria (PKU)**: A genetic disorder caused by a deficiency of the enzyme phenylalanine hydroxylase.

Common symptoms: Hyperphenylalaninemia
Not common symptoms: Hypospadias, Premature birth, Severe short stature, Hypertyrosinemia, Neonatal death, Hernia

\n\n+4. **Prune Belly Syndrome**: A rare genetic disorder that affects the development of the abdominal muscles.

Common symptoms: Hypospadias, Hernia
Not common symptoms: Premature birth, Severe short stature, Hypertyrosinemia, Hyperphenylalaninemia, Neonatal death

\n\n+5. **Smith-Lemli-Opitz Syndrome**: A genetic disorder caused by a deficiency of the enzyme 7-dehydrocholesterol reductase.

Common symptoms: Premature birth, Severe short stature
Not common symptoms: Hypospadias, Hypertyrosinemia, Hyperphenylalaninemia, Neonatal death, Hernia

\n\n+6. **Multiple Pterygium Syndrome**: A rare genetic disorder that affects the development of the muscles and skeleton.

Common symptoms: Premature birth, Severe short stature
Not common symptoms: Hypospadias, Hypertyrosinemia, Hyperphenylalaninemia, Neonatal death, Hernia

Please note that this is not an exhaustive list, and further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms."
['Smith-Lemli-Opitz syndrome'],ERROR
['Glutaryl-CoA dehydrogenase deficiency'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Glutaric Acidemia Type I:
This is a rare genetic disorder caused by a deficiency of the enzyme glutaryl-CoA dehydrogenase. It affects the breakdown of certain amino acids and can lead to a buildup of toxic compounds in the body.

Common symptoms: Glutaric aciduria, Elevated circulating glutaric acid concentration, Ataxia, Progressive neurologic deterioration, Death in infancy, Death in childhood
Not common symptoms: Dehydration, Fever, Diarrhea, Opisthotonus, Athetosis, Decreased plasma free carnitine, Abnormal circulating acylcarnitine concentration

\n\n+2. Carnitine Palmitoyltransferase I Deficiency:
This is a rare genetic disorder that affects the body's ability to break down fatty acids for energy. It can lead to a buildup of toxic compounds in the body.

Common symptoms: Decreased plasma free carnitine, Abnormal circulating acylcarnitine concentration, Ataxia, Progressive neurologic deterioration
Not common symptoms: Glutaric aciduria, Elevated circulating glutaric acid concentration, Dehydration, Fever, Diarrhea, Opisthotonus, Athetosis, Death in infancy, Death in childhood

\n\n+3. Maple Syrup Urine Disease:
This is a rare genetic disorder caused by a deficiency of the enzyme branched-chain alpha-keto acid dehydrogenase complex. It affects the breakdown of certain amino acids and can lead to a buildup of toxic compounds in the body.

Common symptoms: Ataxia, Progressive neurologic deterioration, Death in infancy, Death in childhood
Not common symptoms: Glutaric aciduria, Elevated circulating glutaric acid concentration, Dehydration, Fever, Diarrhea, Opisthotonus, Athetosis, Decreased plasma free carnitine, Abnormal circulating acylcarnitine concentration

\n\n+4. Methylmalonic Acidemia:
This is a rare genetic disorder caused by a deficiency of the enzyme methylmalonyl-CoA mutase. It affects the breakdown of certain amino acids and can lead to a buildup of toxic compounds in the body.

Common symptoms: Ataxia, Progressive neurologic deterioration, Dehydration, Fever
Not common symptoms: Glutaric aciduria, Elevated circulating glutaric acid concentration, Diarrhea, Opisthotonus, Athetosis, Death in infancy, Death in childhood, Decreased plasma free carnitine, Abnormal circulating acylcarnitine concentration

\n\n+5. Propionic Acidemia:
This is a rare genetic disorder caused by a deficiency of the enzyme propionyl-CoA carboxylase. It affects the breakdown of certain amino acids and can lead to a buildup of toxic compounds in the body.

Common symptoms: Ataxia, Progressive neurologic deterioration, Dehydration, Fever, Diarrhea
Not common symptoms: Glutaric aciduria, Elevated circulating glutaric acid concentration, Opisthotonus, Athetosis, Death in infancy, Death in childhood, Decreased plasma free carnitine, Abnormal circulating acylcarnitine concentration

Based on the patient's symptoms, Glutaric Acidemia Type I appears to be the most likely diagnosis. However, further testing and evaluation are necessary to confirm the diagnosis and rule out other potential causes."
['Phenylketonuria'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Homocystinuria:
This is a rare genetic disorder caused by a deficiency of the enzyme cystathionine beta-synthase. It can lead to abnormal development, intellectual disability, and blood clots.

Common symptoms: Abnormality of prenatal development or birth, Motor delay, Generalized hypotonia
Not common symptoms: Hip dysplasia, Death in infancy, Hypertyrosinemia, Neonatal death, Hyperphenylalaninemia

\n\n+2. Phenylketonuria (PKU):
This is a genetic disorder caused by a deficiency of the enzyme phenylalanine hydroxylase, which is necessary to break down the amino acid phenylalanine. If left untreated, it can lead to intellectual disability and seizures.

Common symptoms: Hyperphenylalaninemia
Not common symptoms: Abnormality of prenatal development or birth, Motor delay, Generalized hypotonia, Hip dysplasia, Death in infancy, Hypertyrosinemia, Neonatal death

\n\n+3. Tyrosinemia type I:
This is a rare genetic disorder caused by a deficiency of the enzyme fumarylacetoacetate hydrolase, which is necessary to break down the amino acid tyrosine. If left untreated, it can lead to liver and kidney damage.

Common symptoms: Hypertyrosinemia
Not common symptoms: Abnormality of prenatal development or birth, Motor delay, Generalized hypotonia, Hip dysplasia, Death in infancy, Neonatal death, Hyperphenylalaninemia

\n\n+4. Spinal muscular atrophy (SMA):
This is a genetic disorder that affects the nerve cells responsible for controlling voluntary muscle movement. It can lead to muscle weakness, wasting, and paralysis.

Common symptoms: Motor delay, Generalized hypotonia
Not common symptoms: Abnormality of prenatal development or birth, Hip dysplasia, Death in infancy, Hypertyrosinemia, Neonatal death, Hyperphenylalaninemia

\n\n+5. Ehlers-Danlos syndrome:
This is a group of genetic disorders that affect the body's connective tissue, which provides support to various organs and tissues. It can lead to skin hyperextensibility, joint hypermobility, and tissue fragility.

Common symptoms: Hip dysplasia
Not common symptoms: Abnormality of prenatal development or birth, Motor delay, Generalized hypotonia, Death in infancy, Hypertyrosinemia, Neonatal death, Hyperphenylalaninemia

\n\n+6. Mucopolysaccharidosis type I (MPS I):
This is a rare genetic disorder caused by a deficiency of the enzyme alpha-L-iduronidase, which is necessary to break down sugar molecules called glycosaminoglycans. If left untreated, it can lead to intellectual disability, skeletal deformities, and death.

Common symptoms: Abnormality of prenatal development or birth, Death in infancy, Neonatal death
Not common symptoms: Motor delay, Generalized hypotonia, Hip dysplasia, Hypertyrosinemia, Hyperphenylalaninemia

After reviewing these potential diseases, I will need to conduct further tests and examinations to determine the underlying cause of the patient's symptoms."
['Phenylketonuria'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Menkes Syndrome:
This is a rare genetic disorder that affects the production of copper in the body. Symptoms in common with the patient: Abnormality of prenatal development or birth, Generalized hypotonia, Seizure, Death in infancy. Symptoms not in common: Retrognathia, Opisthotonus, Hypertyrosinemia, Hyperphenylalaninemia.

\n\n+2. Homocystinuria:
This is a genetic disorder that affects the metabolism of the amino acid methionine. Symptoms in common with the patient: Abnormality of prenatal development or birth, Seizure, Generalized hypotonia, Death in infancy. Symptoms not in common: Retrognathia, Opisthotonus, Hypertyrosinemia, Hyperphenylalaninemia, Apnea, Neonatal death, Death in childhood.

\n\n+3. Phenylketonuria (PKU):
This is a genetic disorder that affects the metabolism of the amino acid phenylalanine. Symptoms in common with the patient: Hyperphenylalaninemia, Abnormality of prenatal development or birth, Seizure, Generalized hypotonia, Death in infancy. Symptoms not in common: Retrognathia, Opisthotonus, Hypertyrosinemia, Apnea, Neonatal death, Death in childhood.

\n\n+4. Tyrosinemia Type I:
This is a genetic disorder that affects the metabolism of the amino acid tyrosine. Symptoms in common with the patient: Hypertyrosinemia, Abnormality of prenatal development or birth, Seizure, Generalized hypotonia, Death in infancy. Symptoms not in common: Retrognathia, Opisthotonus, Hyperphenylalaninemia, Apnea, Neonatal death, Death in childhood.

\n\n+5. Mucopolysaccharidosis Type I (Hurler Syndrome):
This is a genetic disorder that affects the metabolism of sugar molecules. Symptoms in common with the patient: Abnormality of prenatal development or birth, Seizure, Generalized hypotonia, Death in infancy. Symptoms not in common: Retrognathia, Opisthotonus, Hypertyrosinemia, Hyperphenylalaninemia, Apnea, Neonatal death, Death in childhood.

\n\n+6. Peroxisomal Biogenesis Disorder:
This is a group of genetic disorders that affect the function of peroxisomes, which are organelles involved in cellular metabolism. Symptoms in common with the patient: Abnormality of prenatal development or birth, Seizure, Generalized hypotonia, Death in infancy. Symptoms not in common: Retrognathia, Opisthotonus, Hypertyrosinemia, Hyperphenylalaninemia, Apnea, Neonatal death, Death in childhood.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms."
['Tyrosinemia type 1'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Phenylketonuria (PKU):
This genetic disorder affects the breakdown of the amino acid phenylalanine. The patient's symptoms that match PKU include: Hyperphenylalaninemia, Intellectual disability, and Seizure. However, the patient does not exhibit other common PKU symptoms such as skin problems, light skin and hair, and musty body odor.

\n\n+2. Tyrosinemia type I:
This rare genetic disorder affects the breakdown of the amino acid tyrosine. The patient's symptoms that match Tyrosinemia type I include: Hypertyrosinemia, Elevated circulating alpha-fetoprotein concentration, and Abnormal circulating aspartate family amino acid concentration. However, the patient does not exhibit other common Tyrosinemia type I symptoms such as liver and kidney problems, and rickets.

\n\n+3. Mucopolysaccharidosis type VII:
This lysosomal storage disorder affects the breakdown of sugar molecules. The patient's symptoms that match Mucopolysaccharidosis type VII include: Intellectual disability, Motor delay, and Elevated circulating alkaline phosphatase concentration. However, the patient does not exhibit other common Mucopolysaccharidosis type VII symptoms such as coarse facial features, joint stiffness, and clouded corneas.

\n\n+4. Smith-Lemli-Opitz syndrome:
This genetic disorder affects the production of cholesterol. The patient's symptoms that match Smith-Lemli-Opitz syndrome include: Intellectual disability, Motor delay, and Autistic behavior. However, the patient does not exhibit other common Smith-Lemli-Opitz syndrome symptoms such as physical deformities, poor muscle tone, and feeding difficulties.

\n\n+5. Peroxisomal biogenesis disorder:
This group of genetic disorders affects the function of peroxisomes, which are involved in fatty acid breakdown. The patient's symptoms that match Peroxisomal biogenesis disorder include: Intellectual disability, Motor delay, and Seizure. However, the patient does not exhibit other common Peroxisomal biogenesis disorder symptoms such as vision and hearing problems, and liver dysfunction.

\n\n+6. Menkes disease:
This genetic disorder affects the production of copper, an essential mineral. The patient's symptoms that match Menkes disease include: Intellectual disability, Motor delay, and Decreased serum iron. However, the patient does not exhibit other common Menkes disease symptoms such as kinky hair, weak muscles, and seizures.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms and to rule out other potential diseases."
['Classic galactosemia'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Galactosemia:
This is a rare genetic disorder that affects the body's ability to metabolize galactose, a sugar found in milk. The patient's symptoms of Vomiting, Increased total bilirubin, and Hypergalactosemia are consistent with this disease. However, the patient does not exhibit symptoms of intellectual disability, which is often seen in galactosemia patients.

\n\n+2. Crigler-Najjar Syndrome:
This is a rare genetic disorder that affects the metabolism of bilirubin, leading to increased levels in the blood. The patient's symptoms of Increased total bilirubin and Vomiting are consistent with this disease. However, the patient does not exhibit symptoms of jaundice, which is a hallmark of Crigler-Najjar Syndrome.

\n\n+3. Gilbert's Syndrome:
This is a mild genetic disorder that affects the metabolism of bilirubin, leading to increased levels in the blood. The patient's symptoms of Increased total bilirubin and Vomiting are consistent with this disease. However, the patient does not exhibit symptoms of fatigue, which is often seen in Gilbert's Syndrome patients.

\n\n+4. Hereditary Fructose Intolerance:
This is a rare genetic disorder that affects the body's ability to metabolize fructose, a sugar found in fruits and vegetables. The patient's symptoms of Vomiting and Hypergalactosemia are consistent with this disease. However, the patient does not exhibit symptoms of hypoglycemia, which is often seen in Hereditary Fructose Intolerance patients.

\n\n+5. Lucey-Driscoll Syndrome:
This is a rare genetic disorder that affects the metabolism of bilirubin, leading to increased levels in the blood. The patient's symptoms of Increased total bilirubin and Vomiting are consistent with this disease. However, the patient does not exhibit symptoms of jaundice, which is a hallmark of Lucey-Driscoll Syndrome.

\n\n+6. Classic Galactosemia:
This is a severe genetic disorder that affects the body's ability to metabolize galactose, a sugar found in milk. The patient's symptoms of Death in infancy, Neonatal death, Vomiting, Increased total bilirubin, and Hypergalactosemia are consistent with this disease.

After reviewing the patient's symptoms and medical history, I believe that Classic Galactosemia is the most likely diagnosis. However, further testing and evaluation are necessary to confirm this diagnosis and rule out other potential causes."
['Phenylketonuria'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Phenylketonuria (PKU):
This is a genetic disorder that affects the body's ability to break down the amino acid phenylalanine. Symptoms in common: Hyperphenylalaninemia, Abnormal circulating tyrosine concentration. Symptoms not in common: None.

\n\n+2. Tyrosinemia type 1:
This is a rare genetic disorder caused by a deficiency of the enzyme fumarylacetoacetate hydrolase. Symptoms in common: Abnormal circulating tyrosine concentration, Hyperphenylalaninemia. Symptoms not in common: Death in infancy, Neonatal death.

\n\n+3. Maple syrup urine disease (MSUD):
This is a rare genetic disorder caused by a deficiency of the enzyme branched-chain alpha-keto acid dehydrogenase complex. Symptoms in common: Abnormality of prenatal development or birth, Death in infancy, Neonatal death. Symptoms not in common: Hyperphenylalaninemia, Abnormal circulating tyrosine concentration.

\n\n+4. Homocystinuria:
This is a rare genetic disorder caused by a deficiency of the enzyme cystathionine beta-synthase. Symptoms in common: Abnormality of prenatal development or birth, Hyperphenylalaninemia. Symptoms not in common: Death in infancy, Neonatal death, Abnormal circulating tyrosine concentration.

\n\n+5. Hawkinsinuria:
This is a rare genetic disorder caused by a deficiency of the enzyme 4-hydroxyphenylpyruvate dioxygenase. Symptoms in common: Abnormal circulating tyrosine concentration, Hyperphenylalaninemia. Symptoms not in common: Abnormality of prenatal development or birth, Death in infancy, Neonatal death.

Based on the patient's symptoms, I believe that Phenylketonuria (PKU) is the most likely diagnosis. However, further testing is necessary to confirm this diagnosis and rule out other potential causes."
['Biotinidase deficiency'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Carnitine Palmitoyltransferase I Deficiency:
This is a rare genetic disorder that affects the body's ability to break down fatty acids. The patient's symptoms of abnormal circulating carnitine concentration and obesity are consistent with this disease. However, the patient does not exhibit symptoms of hypoketotic hypoglycemia, which is typically seen in this condition.

\n\n+2. Carnitine-Acylcarnitine Translocase Deficiency:
This is another rare genetic disorder that affects the transport of fatty acids into the mitochondria. The patient's symptoms of abnormal circulating carnitine concentration, obesity, and death in childhood are consistent with this disease. However, the patient does not exhibit symptoms of cardiomyopathy, which is typically seen in this condition.

\n\n+3. Very-Long-Chain Acyl-CoA Dehydrogenase Deficiency:
This is a rare genetic disorder that affects the breakdown of fatty acids. The patient's symptoms of abnormal circulating carnitine concentration, obesity, and death in childhood are consistent with this disease. However, the patient does not exhibit symptoms of muscle weakness, which is typically seen in this condition.

\n\n+4. Medium-Chain Acyl-CoA Dehydrogenase Deficiency:
This is a rare genetic disorder that affects the breakdown of fatty acids. The patient's symptoms of abnormal circulating carnitine concentration, obesity, and death in childhood are consistent with this disease. However, the patient does not exhibit symptoms of hypoglycemia, which is typically seen in this condition.

\n\n+5. Glutaric Acidemia Type II:
This is a rare genetic disorder that affects the breakdown of fatty acids and amino acids. The patient's symptoms of abnormal circulating carnitine concentration, obesity, and death in childhood are consistent with this disease. However, the patient does not exhibit symptoms of developmental delay, which is typically seen in this condition.

\n\n+6. Multiple Acyl-CoA Dehydrogenase Deficiency:
This is a rare genetic disorder that affects the breakdown of fatty acids and amino acids. The patient's symptoms of abnormal circulating carnitine concentration, obesity, and death in childhood are consistent with this disease. However, the patient does not exhibit symptoms of muscle weakness, which is typically seen in this condition.

Further testing and evaluation are needed to determine the underlying cause of the patient's symptoms and to rule out other potential diseases."
['Phenylketonuria'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Tyrosinemia Type I:
This is a rare genetic disorder caused by a deficiency of the enzyme fumarylacetoacetate hydrolase. Symptoms in common with the patient: Abnormality of prenatal development or birth, Intellectual disability, Death in infancy, Hypertyrosinemia. Symptoms not in common: None.

\n\n+2. Phenylketonuria (PKU):
This is a genetic disorder caused by a deficiency of the enzyme phenylalanine hydroxylase. Symptoms in common with the patient: Intellectual disability, Hyperphenylalaninemia. Symptoms not in common: Abnormality of prenatal development or birth, Death in infancy, Neonatal death, Death in adolescence.

\n\n+3. Homocystinuria:
This is a rare genetic disorder caused by a deficiency of the enzyme cystathionine beta-synthase. Symptoms in common with the patient: Intellectual disability, Abnormality of prenatal development or birth. Symptoms not in common: Death in infancy, Hypertyrosinemia, Neonatal death, Death in adolescence, Hyperphenylalaninemia.

\n\n+4. Maple Syrup Urine Disease (MSUD):
This is a rare genetic disorder caused by a deficiency of the enzyme branched-chain alpha-keto acid dehydrogenase complex. Symptoms in common with the patient: Intellectual disability, Death in infancy, Neonatal death. Symptoms not in common: Abnormality of prenatal development or birth, Hypertyrosinemia, Hyperphenylalaninemia, Death in adolescence.

\n\n+5. Methylmalonic Acidemia:
This is a rare genetic disorder caused by a deficiency of the enzyme methylmalonyl-CoA mutase. Symptoms in common with the patient: Intellectual disability, Death in infancy, Neonatal death. Symptoms not in common: Abnormality of prenatal development or birth, Hypertyrosinemia, Hyperphenylalaninemia, Death in adolescence.

\n\n+6. Isovaleric Acidemia:
This is a rare genetic disorder caused by a deficiency of the enzyme isovaleryl-CoA dehydrogenase. Symptoms in common with the patient: Intellectual disability, Death in infancy, Neonatal death. Symptoms not in common: Abnormality of prenatal development or birth, Hypertyrosinemia, Hyperphenylalaninemia, Death in adolescence.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms and to rule out other potential diseases."
['Smith-Lemli-Opitz syndrome'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Smith-Lemli-Opitz syndrome:
This rare genetic disorder affects the development of multiple body systems. Common symptoms include microcephaly, intellectual disability, and physical deformities such as syndactyly. The patient's symptoms that match this disease include Microcephaly, Intellectual disability, Syndactyly, and Elevated 8-dehydrocholesterol. However, the patient does not exhibit other common symptoms such as cleft palate or heart defects.

\n\n+2. CHARGE syndrome:
This genetic disorder affects various body systems, including the eyes, ears, and heart. Common symptoms include coloboma, heart defects, and intellectual disability. The patient's symptoms that match this disease include Low-set ears, Strabismus, Ptosis, Intellectual disability, and Syndactyly. However, the patient does not exhibit other common symptoms such as heart defects or coloboma.

\n\n+3. Mucolipidosis IV:
This rare genetic disorder affects the body's ability to break down fats and carbohydrates. Common symptoms include intellectual disability, seizures, and delayed development. The patient's symptoms that match this disease include Intellectual disability, Motor delay, and Generalized hypotonia. However, the patient does not exhibit other common symptoms such as seizures or corneal clouding.

\n\n+4. Zellweger syndrome:
This rare genetic disorder affects the development of the brain and other organs. Common symptoms include intellectual disability, seizures, and physical deformities such as microcephaly. The patient's symptoms that match this disease include Microcephaly, Intellectual disability, Lethargy, and Generalized hypotonia. However, the patient does not exhibit other common symptoms such as seizures or liver dysfunction.

\n\n+5. Antley-Bixler syndrome:
This rare genetic disorder affects the development of the skull and other bones. Common symptoms include craniosynostosis, intellectual disability, and physical deformities such as syndactyly. The patient's symptoms that match this disease include Syndactyly, Intellectual disability, and Strabismus. However, the patient does not exhibit other common symptoms such as craniosynostosis or heart defects.

\n\n+6. 7-Dehydrocholesterol reductase deficiency:
This rare genetic disorder affects the production of cholesterol. Common symptoms include intellectual disability, seizures, and physical deformities such as microcephaly. The patient's symptoms that match this disease include Microcephaly, Intellectual disability, Elevated 8-dehydrocholesterol, and Elevated circulating 7-dehydrocholesterol concentration. However, the patient does not exhibit other common symptoms such as seizures or liver dysfunction.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms and to rule out other potential diseases."
['Canavan disease'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Glutamine synthetase deficiency: 
This rare genetic disorder affects the brain and can cause a range of symptoms, including cerebral atrophy, hypotonia, and abnormal amino acid concentrations. The patient's symptoms that match this disease include: Abnormal circulating aspartate family amino acid concentration, Cerebral atrophy, Generalized hypotonia. The patient's symptoms that do not match this disease include: Strabismus, Hyporeflexia, Obesity, Death in infancy, Fever.

\n\n+2. Argininosuccinic aciduria: 
This is a rare genetic disorder that affects the urea cycle, leading to a buildup of toxic substances in the blood. The patient's symptoms that match this disease include: Abnormal circulating aspartate family amino acid concentration, Cerebral atrophy, Hypotonia. The patient's symptoms that do not match this disease include: Strabismus, Hyporeflexia, Obesity, Death in infancy, Fever.

\n\n+3. Citrullinemia: 
This is a rare genetic disorder that affects the urea cycle, leading to a buildup of toxic substances in the blood. The patient's symptoms that match this disease include: Abnormal circulating aspartate family amino acid concentration, Cerebral atrophy, Hypotonia. The patient's symptoms that do not match this disease include: Strabismus, Hyporeflexia, Obesity, Death in infancy, Fever.

\n\n+4. Homocystinuria: 
This is a rare genetic disorder that affects the metabolism of certain amino acids. The patient's symptoms that match this disease include: Abnormal circulating aspartate family amino acid concentration, Cerebral atrophy, Hypotonia. The patient's symptoms that do not match this disease include: Strabismus, Hyporeflexia, Obesity, Death in infancy, Fever.

\n\n+5. Molybdenum cofactor deficiency: 
This is a rare genetic disorder that affects the metabolism of certain amino acids. The patient's symptoms that match this disease include: Cerebral atrophy, Hypotonia, Seizures (not listed, but often associated with this disease). The patient's symptoms that do not match this disease include: Strabismus, Hyporeflexia, Obesity, Death in infancy, Fever, Abnormal circulating aspartate family amino acid concentration.

\n\n+6. Peroxisomal biogenesis disorder: 
This is a group of rare genetic disorders that affect the function of peroxisomes, which are important for cellular metabolism. The patient's symptoms that match this disease include: Cerebral atrophy, Hypotonia, Death in infancy. The patient's symptoms that do not match this disease include: Strabismus, Hyporeflexia, Obesity, Fever, Abnormal circulating aspartate family amino acid concentration.

\n\n+7. Zellweger syndrome: 
This is a rare genetic disorder that affects the function of peroxisomes, which are important for cellular metabolism. The patient's symptoms that match this disease include: Cerebral atrophy, Hypotonia, Death in infancy. The patient's symptoms that do not match this disease include: Strabismus, Hyporeflexia, Obesity, Fever, Abnormal circulating aspartate family amino acid concentration.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms."
['Phenylketonuria'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Phenylketonuria (PKU):
This is a genetic disorder that affects the body's ability to break down the amino acid phenylalanine. Symptoms in common: Hyperphenylalaninemia. Symptoms not in common: Coarctation of aorta, Fever, Pneumonia.

\n\n+2. Homocystinuria:
This is a rare genetic disorder that affects the body's ability to process certain amino acids. Symptoms in common: Hyperphenylalaninemia. Symptoms not in common: Coarctation of aorta, Fever, Pneumonia, Death in infancy, Death in childhood, Death in adolescence, Death in early adulthood.

\n\n+3. Tyrosinemia type I:
This is a rare genetic disorder that affects the body's ability to break down the amino acid tyrosine. Symptoms in common: Hypertyrosinemia. Symptoms not in common: Coarctation of aorta, Fever, Pneumonia, Death in infancy, Death in childhood, Death in adolescence, Death in early adulthood.

\n\n+4. Maple syrup urine disease (MSUD):
This is a rare genetic disorder that affects the body's ability to break down certain amino acids. Symptoms in common: Death in infancy, Death in childhood. Symptoms not in common: Coarctation of aorta, Fever, Pneumonia, Hypertyrosinemia, Hyperphenylalaninemia.

\n\n+5. Propionic acidemia:
This is a rare genetic disorder that affects the body's ability to break down certain amino acids. Symptoms in common: Death in infancy, Death in childhood. Symptoms not in common: Coarctation of aorta, Fever, Pneumonia, Hypertyrosinemia, Hyperphenylalaninemia.

\n\n+6. Methylmalonic acidemia:
This is a rare genetic disorder that affects the body's ability to break down certain amino acids. Symptoms in common: Death in infancy, Death in childhood. Symptoms not in common: Coarctation of aorta, Fever, Pneumonia, Hypertyrosinemia, Hyperphenylalaninemia.

\n\n+7. Isovaleric acidemia:
This is a rare genetic disorder that affects the body's ability to break down certain amino acids. Symptoms in common: Death in infancy, Death in childhood. Symptoms not in common: Coarctation of aorta, Fever, Pneumonia, Hypertyrosinemia, Hyperphenylalaninemia.

\n\n+8. Gaucher disease:
This is a genetic disorder that affects the body's ability to break down certain fatty substances. Symptoms in common: Death in infancy, Death in childhood. Symptoms not in common: Coarctation of aorta, Fever, Pneumonia, Hypertyrosinemia, Hyperphenylalaninemia.

\n\n+9. Niemann-Pick disease:
This is a genetic disorder that affects the body's ability to break down certain fatty substances. Symptoms in common: Death in infancy, Death in childhood. Symptoms not in common: Coarctation of aorta, Fever, Pneumonia, Hypertyrosinemia, Hyperphenylalaninemia.

\n\n+10. Familial hypercholesterolemia:
This is a genetic disorder that affects the body's ability to regulate cholesterol levels. Symptoms in common: Obesity. Symptoms not in common: Death in infancy, Death in childhood, Coarctation of aorta, Fever, Pneumonia, Hypertyrosinemia, Hyperphenylalaninemia.

Further testing and evaluation are needed to determine the underlying cause of the patient's symptoms."
['Classic homocystinuria'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Homocystinuria:
This is a rare genetic disorder caused by a deficiency of the enzyme cystathionine beta-synthase. It affects the metabolism of the amino acid methionine, leading to elevated levels of homocysteine in the blood and urine.
Common symptoms: Hyperhomocystinemia, Hypermethioninemia, Aminoaciduria
Not common symptoms: Abnormality of prenatal development or birth, Death in infancy, Neonatal death, Death in childhood

\n\n+2. Methionine adenosyltransferase deficiency:
This is a rare genetic disorder that affects the metabolism of methionine, leading to elevated levels of methionine in the blood and urine.
Common symptoms: Hypermethioninemia, Aminoaciduria
Not common symptoms: Abnormality of prenatal development or birth, Death in infancy, Neonatal death, Death in childhood, Hyperhomocystinemia

\n\n+3. Cystathioninuria:
This is a rare genetic disorder caused by a deficiency of the enzyme cystathionase, which is involved in the breakdown of the amino acid cystathionine.
Common symptoms: Aminoaciduria
Not common symptoms: Abnormality of prenatal development or birth, Death in infancy, Neonatal death, Death in childhood, Hyperhomocystinemia, Hypermethioninemia

\n\n+4. Methylmalonic acidemia:
This is a rare genetic disorder caused by a deficiency of the enzyme methylmalonyl-CoA mutase, which is involved in the breakdown of certain amino acids.
Common symptoms: Aminoaciduria
Not common symptoms: Abnormality of prenatal development or birth, Death in infancy, Neonatal death, Death in childhood, Hyperhomocystinemia, Hypermethioninemia

\n\n+5. Propionic acidemia:
This is a rare genetic disorder caused by a deficiency of the enzyme propionyl-CoA carboxylase, which is involved in the breakdown of certain amino acids.
Common symptoms: Aminoaciduria
Not common symptoms: Abnormality of prenatal development or birth, Death in infancy, Neonatal death, Death in childhood, Hyperhomocystinemia, Hypermethioninemia

\n\n+6. Methylmalonyl-CoA epimerase deficiency:
This is a rare genetic disorder caused by a deficiency of the enzyme methylmalonyl-CoA epimerase, which is involved in the breakdown of certain amino acids.
Common symptoms: Aminoaciduria
Not common symptoms: Abnormality of prenatal development or birth, Death in infancy, Neonatal death, Death in childhood, Hyperhomocystinemia, Hypermethioninemia

Based on the patient's symptoms, I believe that Homocystinuria is the most likely diagnosis. However, further testing and evaluation are necessary to confirm this diagnosis and rule out other potential causes."
[],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Dihydropyrimidine Dehydrogenase Deficiency:
This is a rare genetic disorder that affects the breakdown of pyrimidines. The patient's symptoms of Abnormal circulating pyrimidine concentration and Uraciluria are consistent with this disease. However, the patient does not exhibit other common symptoms such as seizures, intellectual disability, and autistic-like behavior.

\n\n+2. Pyrimidine 5'-Nucleotidase Deficiency:
This is a rare genetic disorder that affects the breakdown of pyrimidines. The patient's symptoms of Abnormal circulating pyrimidine concentration and Uraciluria are consistent with this disease. However, the patient does not exhibit other common symptoms such as intellectual disability, seizures, and anemia.

\n\n+3. Beta-Ureidopropionase Deficiency:
This is a rare genetic disorder that affects the breakdown of pyrimidines. The patient's symptoms of Abnormal circulating pyrimidine concentration and Uraciluria are consistent with this disease. However, the patient does not exhibit other common symptoms such as intellectual disability, seizures, and autistic-like behavior.

\n\n+4. Dihydropyrimidinase Deficiency:
This is a rare genetic disorder that affects the breakdown of pyrimidines. The patient's symptoms of Abnormal circulating pyrimidine concentration and Uraciluria are consistent with this disease. However, the patient does not exhibit other common symptoms such as intellectual disability, seizures, and autistic-like behavior.

\n\n+5. MNGIE (Mitochondrial Neurogastrointestinal Encephalomyopathy):
This is a rare genetic disorder that affects the mitochondria. The patient's symptoms of Ataxia, Generalized hypotonia, and Death in childhood are consistent with this disease. However, the patient does not exhibit other common symptoms such as gastrointestinal dysmotility, ophthalmoparesis, and peripheral neuropathy.

\n\n+6. Leigh Syndrome:
This is a rare genetic disorder that affects the mitochondria. The patient's symptoms of Ataxia, Generalized hypotonia, and Death in childhood are consistent with this disease. However, the patient does not exhibit other common symptoms such as seizures, intellectual disability, and brain lesions.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms."
['Phenylketonuria'],"The patient presents with a unique set of symptoms. After reviewing the patient's medical history and conducting a thorough examination, I have narrowed down the potential diagnoses to the following:

\n\n+1. Tyrosinemia Type I:
This is a rare genetic disorder caused by a deficiency of the enzyme fumarylacetoacetate hydrolase. It is characterized by elevated levels of tyrosine in the blood and urine, leading to liver and kidney damage.

Common symptoms: Hypertyrosinemia
Not common symptoms: Hyperphenylalaninemia (although some patients may exhibit mild elevations in phenylalanine levels)

\n\n+2. Phenylketonuria (PKU):
This is a genetic disorder caused by a deficiency of the enzyme phenylalanine hydroxylase. It is characterized by elevated levels of phenylalanine in the blood, which can lead to intellectual disability and other neurological problems if left untreated.

Common symptoms: Hyperphenylalaninemia
Not common symptoms: Hypertyrosinemia, Death in early adulthood (PKU patients typically have a normal life expectancy with proper treatment)

\n\n+3. Hawkinsinuria:
This is a rare genetic disorder caused by a deficiency of the enzyme 4-hydroxyphenylpyruvate dioxygenase. It is characterized by elevated levels of tyrosine and phenylalanine in the urine, as well as the presence of a unique metabolite called hawkinsin.

Common symptoms: Hypertyrosinemia, Hyperphenylalaninemia
Not common symptoms: Death in early adulthood (Hawkinsinuria patients typically have a normal life expectancy)

\n\n+4. Maple Syrup Urine Disease (MSUD):
This is a rare genetic disorder caused by a deficiency of the enzyme branched-chain alpha-keto acid dehydrogenase complex. It is characterized by elevated levels of certain amino acids in the blood and urine, leading to intellectual disability and other neurological problems if left untreated.

Not common symptoms: Hypertyrosinemia, Hyperphenylalaninemia, Death in early adulthood (MSUD patients typically have a normal life expectancy with proper treatment)

\n\n+5. Homocystinuria:
This is a rare genetic disorder caused by a deficiency of the enzyme cystathionine beta-synthase. It is characterized by elevated levels of homocysteine in the blood and urine, leading to intellectual disability, seizures, and other neurological problems.

Not common symptoms: Hypertyrosinemia, Hyperphenylalaninemia, Death in early adulthood (Homocystinuria patients typically have a normal life expectancy with proper treatment)

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms."
[],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Dihydropyrimidine Dehydrogenase Deficiency:
This is a rare genetic disorder that affects the breakdown of pyrimidines, leading to an accumulation of toxic compounds in the body. The patient's symptoms of Abnormal circulating pyrimidine concentration and Uraciluria are consistent with this disease. However, the patient does not exhibit symptoms of intellectual disability, seizures, or microcephaly, which are commonly associated with this condition.

\n\n+2. Pyrimidine 5'-Nucleotidase Deficiency:
This is a rare genetic disorder that affects the breakdown of pyrimidine nucleotides, leading to an accumulation of toxic compounds in the body. The patient's symptoms of Abnormal circulating pyrimidine concentration and Uraciluria are consistent with this disease. However, the patient does not exhibit symptoms of anemia, jaundice, or splenomegaly, which are commonly associated with this condition.

\n\n+3. Beta-Ureidopropionase Deficiency:
This is a rare genetic disorder that affects the breakdown of pyrimidines, leading to an accumulation of toxic compounds in the body. The patient's symptoms of Abnormal circulating pyrimidine concentration and Uraciluria are consistent with this disease. However, the patient does not exhibit symptoms of intellectual disability, seizures, or microcephaly, which are commonly associated with this condition.

\n\n+4. Dihydropyrimidinase Deficiency:
This is a rare genetic disorder that affects the breakdown of pyrimidines, leading to an accumulation of toxic compounds in the body. The patient's symptoms of Abnormal circulating pyrimidine concentration and Uraciluria are consistent with this disease. However, the patient does not exhibit symptoms of intellectual disability, seizures, or microcephaly, which are commonly associated with this condition.

\n\n+5. Pyrimidine Nucleoside Phosphorylase Deficiency:
This is a rare genetic disorder that affects the breakdown of pyrimidine nucleosides, leading to an accumulation of toxic compounds in the body. The patient's symptoms of Abnormal circulating pyrimidine concentration and Uraciluria are consistent with this disease. However, the patient does not exhibit symptoms of anemia, jaundice, or splenomegaly, which are commonly associated with this condition.

Based on the patient's symptoms, I believe that Dihydropyrimidine Dehydrogenase Deficiency is the most likely diagnosis. However, further testing and evaluation are necessary to confirm this diagnosis and rule out other potential causes."
['Tyrosinemia type 1'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Hereditary Tyrosinemia Type 1:
This is a rare genetic disorder caused by a deficiency of the enzyme fumarylacetoacetate hydrolase. Symptoms in common with the patient: Hypertyrosinemia, Aminoaciduria, Elevated circulating alpha-fetoprotein concentration. Symptoms not in common: None.

\n\n+2. Crigler-Najjar Syndrome:
This is a rare genetic disorder caused by a deficiency of the enzyme glucuronyltransferase. Symptoms in common with the patient: Elevated circulating alkaline phosphatase concentration, Abnormal circulating porphyrin concentration. Symptoms not in common: No reports of Ascites, Thrombocytosis, or Hernia.

\n\n+3. Gilbert's Syndrome:
This is a mild genetic disorder caused by a deficiency of the enzyme glucuronyltransferase. Symptoms in common with the patient: Elevated circulating alkaline phosphatase concentration, Abnormal circulating porphyrin concentration. Symptoms not in common: No reports of Ascites, Thrombocytosis, or Hernia.

\n\n+4. Alpha-1 Antitrypsin Deficiency:
This is a genetic disorder caused by a deficiency of the enzyme alpha-1 antitrypsin. Symptoms in common with the patient: Elevated circulating alkaline phosphatase concentration, Ascites. Symptoms not in common: No reports of Hypertyrosinemia, Aminoaciduria, or Elevated circulating alpha-fetoprotein concentration.

\n\n+5. Hereditary Fructose Intolerance:
This is a rare genetic disorder caused by a deficiency of the enzyme aldolase B. Symptoms in common with the patient: Hypoalbuminemia, Hypoproteinemia, Ascites. Symptoms not in common: No reports of Hypertyrosinemia, Aminoaciduria, or Elevated circulating alpha-fetoprotein concentration.

\n\n+6. Galactosemia:
This is a rare genetic disorder caused by a deficiency of the enzyme galactose-1-phosphate uridyltransferase. Symptoms in common with the patient: Hypoalbuminemia, Hypoproteinemia, Ascites. Symptoms not in common: No reports of Hypertyrosinemia, Aminoaciduria, or Elevated circulating alpha-fetoprotein concentration.

\n\n+7. Maple Syrup Urine Disease:
This is a rare genetic disorder caused by a deficiency of the enzyme branched-chain alpha-keto acid dehydrogenase complex. Symptoms in common with the patient: Aminoaciduria. Symptoms not in common: No reports of Ascites, Thrombocytosis, or Hernia.

\n\n+8. Homocystinuria:
This is a rare genetic disorder caused by a deficiency of the enzyme cystathionine beta-synthase. Symptoms in common with the patient: Aminoaciduria. Symptoms not in common: No reports of Ascites, Thrombocytosis, or Hernia.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms."
['Canavan disease'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Canavan disease:
This is a rare genetic disorder that affects the breakdown and use of aspartate, a type of amino acid. The patient's symptoms of abnormal circulating aspartate family amino acid concentration, seizure, and motor delay are consistent with this disease. However, Canavan disease typically does not result in death in infancy, which is a symptom the patient is experiencing.

\n\n+2. Aspartylglucosaminuria:
This is a lysosomal storage disorder caused by a deficiency of the enzyme aspartylglucosaminidase. The patient's symptoms of abnormal circulating aspartate family amino acid concentration and motor delay are consistent with this disease. However, Aspartylglucosaminuria typically does not result in seizures or death in infancy, which are symptoms the patient is experiencing.

\n\n+3. Argininosuccinic aciduria:
This is a rare genetic disorder that affects the breakdown of amino acids. The patient's symptoms of abnormal circulating aspartate family amino acid concentration, seizure, and motor delay are consistent with this disease. However, Argininosuccinic aciduria typically does not result in death in infancy, which is a symptom the patient is experiencing.

\n\n+4. Citrullinemia:
This is a rare genetic disorder that affects the breakdown of amino acids. The patient's symptoms of abnormal circulating aspartate family amino acid concentration, seizure, and motor delay are consistent with this disease. However, Citrullinemia typically does not result in death in infancy, which is a symptom the patient is experiencing.

\n\n+5. Ornithine transcarbamylase deficiency:
This is a rare genetic disorder that affects the breakdown of amino acids. The patient's symptoms of abnormal circulating aspartate family amino acid concentration, seizure, and motor delay are consistent with this disease. However, Ornithine transcarbamylase deficiency typically does not result in death in infancy, which is a symptom the patient is experiencing.

Based on these findings, I would like to order further testing to determine the underlying cause of the patient's symptoms."
['Isovaleric acidemia'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Isovaleric Acidemia:
This is a rare genetic disorder that affects the breakdown of certain amino acids. The patient's symptoms that match this disease include: Vomiting, Diarrhea, Abdominal pain, Gastrointestinal inflammation, Abnormal circulating glycine concentration, and Body odor. However, the patient does not exhibit Neonatal death or Death in infancy, which are common symptoms of this disease.

\n\n+2. Carnitine Palmitoyltransferase I Deficiency:
This is a rare genetic disorder that affects the breakdown of fatty acids. The patient's symptoms that match this disease include: Vomiting, Diarrhea, Abdominal pain, Abnormal circulating carnitine concentration, and Body odor. However, the patient does not exhibit Recurrent viral infections or Death in childhood, which are common symptoms of this disease.

\n\n+3. Multiple Carboxylase Deficiency:
This is a rare genetic disorder that affects the breakdown of certain amino acids. The patient's symptoms that match this disease include: Vomiting, Diarrhea, Abdominal pain, Gastrointestinal inflammation, Abnormal circulating glycine concentration, and Abnormal circulating carnitine concentration. However, the patient does not exhibit Death in infancy or Death in adolescence, which are common symptoms of this disease.

\n\n+4. Organic Acidemia:
This is a group of rare genetic disorders that affect the breakdown of certain amino acids. The patient's symptoms that match this disease include: Vomiting, Diarrhea, Abdominal pain, Gastrointestinal inflammation, Abnormal circulating glycine concentration, and Abnormal circulating carnitine concentration. However, the patient does not exhibit Death in childhood or Recurrent viral infections, which are common symptoms of this disease.

\n\n+5. Propionic Acidemia:
This is a rare genetic disorder that affects the breakdown of certain amino acids. The patient's symptoms that match this disease include: Vomiting, Diarrhea, Abdominal pain, Gastrointestinal inflammation, Abnormal circulating glycine concentration, and Body odor. However, the patient does not exhibit Death in infancy or Death in adolescence, which are common symptoms of this disease.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms and to rule out other potential diseases."
['Phenylketonuria'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Homocystinuria:
This is a rare genetic disorder caused by a deficiency of the enzyme cystathionine beta-synthase. It can lead to intellectual disability, hypertension, and elevated levels of homocysteine in the blood and urine. 
Common symptoms: Intellectual disability, Hypertension, Elevated urinary carboxylic acid
Not common symptoms: Obesity, Hypertyrosinemia, Hyperphenylalaninemia, Death in adolescence, Death in early adulthood

\n\n+2. Phenylketonuria (PKU):
This is a genetic disorder caused by a deficiency of the enzyme phenylalanine hydroxylase. It can lead to intellectual disability, seizures, and skin problems if left untreated. 
Common symptoms: Intellectual disability, Hyperphenylalaninemia
Not common symptoms: Hypertension, Obesity, Hypertyrosinemia, Death in adolescence, Death in early adulthood, Elevated urinary carboxylic acid

\n\n+3. Tyrosinemia type I:
This is a rare genetic disorder caused by a deficiency of the enzyme fumarylacetoacetate hydrolase. It can lead to liver and kidney problems, and if left untreated, can cause death in early childhood. 
Common symptoms: Hypertyrosinemia, Elevated urinary carboxylic acid, Death in early adulthood
Not common symptoms: Intellectual disability, Hypertension, Obesity, Hyperphenylalaninemia, Death in adolescence

\n\n+4. Maple syrup urine disease (MSUD):
This is a rare genetic disorder caused by a deficiency of the enzyme branched-chain alpha-keto acid dehydrogenase complex. It can lead to intellectual disability, seizures, and a characteristic sweet odor of the urine. 
Common symptoms: Intellectual disability, Elevated urinary carboxylic acid
Not common symptoms: Hypertension, Obesity, Hypertyrosinemia, Hyperphenylalaninemia, Death in adolescence, Death in early adulthood

\n\n+5. Hawkinsinuria:
This is a rare genetic disorder caused by a deficiency of the enzyme 4-hydroxyphenylpyruvate dioxygenase. It can lead to intellectual disability, seizures, and elevated levels of hawkinsin in the urine. 
Common symptoms: Intellectual disability, Elevated urinary carboxylic acid
Not common symptoms: Hypertension, Obesity, Hypertyrosinemia, Hyperphenylalaninemia, Death in adolescence, Death in early adulthood

After reviewing these potential diseases, I believe that further testing is necessary to determine the underlying cause of the patient's symptoms."
['Medium chain acyl-CoA dehydrogenase deficiency'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Carnitine Palmitoyltransferase I Deficiency:
This is a rare genetic disorder that affects the breakdown of fatty acids. The patient's symptoms that match this disease include: Abnormal circulating carnitine concentration, Hyperalaninemia. However, the patient does not exhibit symptoms such as hypoglycemia, muscle weakness, and liver dysfunction, which are commonly associated with this disease.

\n\n+2. Methylmalonic Acidemia:
This is a genetic disorder that affects the breakdown of certain amino acids. The patient's symptoms that match this disease include: Hyperalaninemia, Abnormality of prenatal development or birth, Death in infancy. However, the patient does not exhibit symptoms such as vomiting, seizures, and developmental delays, which are commonly associated with this disease.

\n\n+3. Propionic Acidemia:
This is a genetic disorder that affects the breakdown of certain amino acids. The patient's symptoms that match this disease include: Hyperalaninemia, Abnormality of prenatal development or birth, Death in infancy. However, the patient does not exhibit symptoms such as vomiting, seizures, and developmental delays, which are commonly associated with this disease.

\n\n+4. Isovaleric Acidemia:
This is a genetic disorder that affects the breakdown of certain amino acids. The patient's symptoms that match this disease include: Hyperalaninemia, Abnormality of prenatal development or birth, Death in infancy. However, the patient does not exhibit symptoms such as vomiting, seizures, and developmental delays, which are commonly associated with this disease.

\n\n+5. 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency:
This is a genetic disorder that affects the breakdown of fatty acids and amino acids. The patient's symptoms that match this disease include: Hyperalaninemia, Abnormal circulating carnitine concentration. However, the patient does not exhibit symptoms such as hypoglycemia, seizures, and developmental delays, which are commonly associated with this disease.

\n\n+6. Carnitine-Acylcarnitine Translocase Deficiency:
This is a genetic disorder that affects the transport of fatty acids into the mitochondria. The patient's symptoms that match this disease include: Abnormal circulating carnitine concentration, Hyperalaninemia. However, the patient does not exhibit symptoms such as hypoglycemia, muscle weakness, and liver dysfunction, which are commonly associated with this disease.

\n\n+7. Mitochondrial Trifunctional Protein Deficiency:
This is a genetic disorder that affects the breakdown of fatty acids. The patient's symptoms that match this disease include: Abnormal circulating carnitine concentration, Hyperalaninemia. However, the patient does not exhibit symptoms such as hypoglycemia, muscle weakness, and liver dysfunction, which are commonly associated with this disease.

\n\n+8. Very-Long-Chain Acyl-CoA Dehydrogenase Deficiency:
This is a genetic disorder that affects the breakdown of fatty acids. The patient's symptoms that match this disease include: Abnormal circulating carnitine concentration, Hyperalaninemia. However, the patient does not exhibit symptoms such as hypoglycemia, muscle weakness, and liver dysfunction, which are commonly associated with this disease.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms."
['Ornithine transcarbamylase deficiency'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Ornithine Transcarbamylase Deficiency:
This is a rare genetic disorder that affects the urea cycle, leading to a buildup of ammonia in the blood. The patient's symptoms of lethargy, drowsiness, and abnormal circulating ornithine concentration are consistent with this disease. However, the patient does not exhibit symptoms of seizures, vomiting, or developmental delays, which are also common in this condition.

\n\n+2. Hyperornithinemia-Hyperammonemia-Homocitrullinuria (HHH) Syndrome:
This is a rare genetic disorder that affects the breakdown of certain amino acids. The patient's symptoms of lethargy, drowsiness, and abnormal circulating ornithine concentration are consistent with this disease. However, the patient does not exhibit symptoms of seizures, intellectual disability, or muscle weakness, which are also common in this condition.

\n\n+3. Citrullinemia:
This is a rare genetic disorder that affects the urea cycle, leading to a buildup of ammonia in the blood. The patient's symptoms of lethargy, drowsiness, and orotic aciduria are consistent with this disease. However, the patient does not exhibit symptoms of seizures, vomiting, or developmental delays, which are also common in this condition.

\n\n+4. Argininosuccinic Aciduria:
This is a rare genetic disorder that affects the urea cycle, leading to a buildup of ammonia in the blood. The patient's symptoms of lethargy, drowsiness, and orotic aciduria are consistent with this disease. However, the patient does not exhibit symptoms of seizures, vomiting, or developmental delays, which are also common in this condition.

\n\n+5. Carbamoyl Phosphate Synthetase I Deficiency:
This is a rare genetic disorder that affects the urea cycle, leading to a buildup of ammonia in the blood. The patient's symptoms of lethargy, drowsiness, and orotic aciduria are consistent with this disease. However, the patient does not exhibit symptoms of seizures, vomiting, or developmental delays, which are also common in this condition.

\n\n+6. N-Acetylglutamate Synthase Deficiency:
This is a rare genetic disorder that affects the urea cycle, leading to a buildup of ammonia in the blood. The patient's symptoms of lethargy, drowsiness, and orotic aciduria are consistent with this disease. However, the patient does not exhibit symptoms of seizures, vomiting, or developmental delays, which are also common in this condition.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms and to rule out other potential diseases."
['Glutaryl-CoA dehydrogenase deficiency'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Glutaric acidemia type I:
This is a rare genetic disorder caused by a deficiency of the enzyme glutaryl-CoA dehydrogenase. It is characterized by the accumulation of glutaric acid and 3-hydroxyglutaric acid in the body, leading to damage to the brain and nervous system.

Common symptoms: Glutaric aciduria, Ataxia, Abnormal cerebral morphology, Decreased plasma free carnitine
Not common symptoms: Dystonia, Death in childhood, Abnormal myelination

\n\n+2. Leigh syndrome:
This is a rare genetic disorder that affects the brain and nervous system. It is caused by mutations in the mitochondrial DNA and is characterized by the degeneration of the brain and spinal cord.

Common symptoms: Ataxia, Abnormal cerebral morphology, Death in childhood
Not common symptoms: Glutaric aciduria, Dystonia, Decreased plasma free carnitine, Abnormal myelination

\n\n+3. Carnitine palmitoyltransferase I deficiency:
This is a rare genetic disorder that affects the breakdown of fatty acids in the body. It is characterized by a deficiency of the enzyme carnitine palmitoyltransferase I, leading to decreased levels of carnitine in the blood.

Common symptoms: Decreased plasma free carnitine
Not common symptoms: Ataxia, Dystonia, Abnormal cerebral morphology, Glutaric aciduria, Death in childhood, Abnormal myelination

\n\n+4. Dystonia 12:
This is a rare genetic disorder that affects the brain and nervous system. It is characterized by abnormal muscle contractions and spasms, leading to twisting and repetitive movements.

Common symptoms: Dystonia
Not common symptoms: Ataxia, Abnormal cerebral morphology, Glutaric aciduria, Death in childhood, Decreased plasma free carnitine, Abnormal myelination

\n\n+5. Canavan disease:
This is a rare genetic disorder that affects the brain and nervous system. It is caused by a deficiency of the enzyme aspartoacylase, leading to the accumulation of N-acetylaspartic acid in the brain.

Common symptoms: Abnormal cerebral morphology, Ataxia
Not common symptoms: Glutaric aciduria, Dystonia, Death in childhood, Decreased plasma free carnitine, Abnormal myelination

Further testing and evaluation are needed to determine the underlying cause of the patient's symptoms."
['Phenylketonuria'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Phenylketonuria (PKU):
This is a genetic disorder that affects the body's ability to break down the amino acid phenylalanine. Symptoms in common with the patient: Hyperphenylalaninemia. Symptoms not in common: None.

\n\n+2. Malignant Hyperphenylalaninemia:
This is a rare genetic disorder that affects the breakdown of phenylalanine. Symptoms in common with the patient: Hyperphenylalaninemia, Death in infancy. Symptoms not in common: None.

\n\n+3. Phenylalanine Hydroxylase Deficiency:
This is a genetic disorder that affects the body's ability to break down phenylalanine. Symptoms in common with the patient: Hyperphenylalaninemia. Symptoms not in common: None.

\n\n+4. Tetrahydrobiopterin Deficiency:
This is a rare genetic disorder that affects the production of tetrahydrobiopterin, a cofactor necessary for the breakdown of phenylalanine. Symptoms in common with the patient: Hyperphenylalaninemia, Death in infancy. Symptoms not in common: None.

\n\n+5. Dihydropteridine Reductase Deficiency:
This is a rare genetic disorder that affects the production of tetrahydrobiopterin. Symptoms in common with the patient: Hyperphenylalaninemia, Death in infancy. Symptoms not in common: None.

Based on the patient's symptoms, I believe that Phenylketonuria (PKU) is the most likely diagnosis. However, further testing is necessary to confirm this diagnosis and rule out other potential causes."
['Systemic primary carnitine deficiency'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Carnitine Palmitoyltransferase I Deficiency:
This is a rare genetic disorder that affects the breakdown of fatty acids. The patient's symptoms that match this disease include: Decreased plasma free carnitine, Hypoglycemia, Vomiting, Hepatomegaly, and Elevated circulating hepatic transaminase concentration. However, the patient does not exhibit symptoms such as seizures, muscle weakness, and developmental delay, which are commonly associated with this disease.

\n\n+2. Maple Syrup Urine Disease:
This is a rare genetic disorder that affects the breakdown of certain amino acids. The patient's symptoms that match this disease include: Encephalopathy, Coma, Irritability, and Abnormal circulating aspartate family amino acid concentration. However, the patient does not exhibit symptoms such as a distinctive sweet odor of urine, feeding difficulties, and intellectual disability, which are commonly associated with this disease.

\n\n+3. Mitochondrial Myopathies:
This is a group of genetic disorders that affect the mitochondria, the energy-producing structures within cells. The patient's symptoms that match this disease include: Generalized hypotonia, Cardiomyopathy, Anemia, and Hepatomegaly. However, the patient does not exhibit symptoms such as muscle weakness, exercise intolerance, and short stature, which are commonly associated with this disease.

\n\n+4. Porphyrin-Related Disorders:
This is a group of genetic disorders that affect the production of heme, a molecule essential for various bodily functions. The patient's symptoms that match this disease include: Abnormal circulating porphyrin concentration, Anemia, and Hepatomegaly. However, the patient does not exhibit symptoms such as skin blistering, abdominal pain, and neuropathy, which are commonly associated with this disease.

\n\n+5. Reye's Syndrome:
This is a rare but potentially life-threatening condition that affects the brain and liver. The patient's symptoms that match this disease include: Encephalopathy, Coma, Vomiting, Hepatomegaly, and Elevated circulating hepatic transaminase concentration. However, the patient does not exhibit symptoms such as fever, seizures, and respiratory failure, which are commonly associated with this disease.

\n\n+6. Systemic Primary Carnitine Deficiency:
This is a rare genetic disorder that affects the transport of carnitine, a molecule essential for energy production. The patient's symptoms that match this disease include: Decreased plasma free carnitine, Cardiomyopathy, Hepatomegaly, and Hypoglycemia. However, the patient does not exhibit symptoms such as muscle weakness, developmental delay, and intellectual disability, which are commonly associated with this disease.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms and to rule out other potential diseases."
['PMM2-CDG'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Joubert Syndrome:
This rare genetic disorder affects the cerebellum and brainstem, leading to abnormal brain development. Common symptoms include Strabismus, Nystagmus, Ataxia, Hyporeflexia, Motor delay, Cerebellar atrophy, and Generalized hypotonia. The patient's symptoms match most of these, but they do not exhibit the characteristic ""molar tooth sign"" on brain imaging, which is a hallmark of Joubert Syndrome.

\n\n+2. Lhermitte-Duclos Disease:
This rare brain disorder is characterized by abnormal growth of the cerebellum, leading to Ataxia, Nystagmus, and Strabismus. While the patient exhibits these symptoms, they do not have the typical skin lesions and benign tumors associated with Lhermitte-Duclos Disease.

\n\n+3. Pontocerebellar Hypoplasia:
This is a group of rare genetic disorders that affect the development of the brain, particularly the cerebellum and pons. Symptoms include Cerebellar atrophy, Ataxia, Hyporeflexia, Motor delay, and Generalized hypotonia. The patient's symptoms align with these, but they do not have the typical facial abnormalities and microcephaly associated with Pontocerebellar Hypoplasia.

\n\n+4. Walker-Warburg Syndrome:
This is a rare genetic disorder that affects the development of the brain and eyes. Symptoms include Strabismus, Nystagmus, Ataxia, Hyporeflexia, Motor delay, Cerebellar atrophy, and Generalized hypotonia. The patient's symptoms match most of these, but they do not have the typical eye abnormalities, such as microphthalmia and coloboma, associated with Walker-Warburg Syndrome.

\n\n+5. Cerebellar Agenesis:
This is a rare congenital disorder where the cerebellum fails to develop properly. Symptoms include Ataxia, Nystagmus, Strabismus, and Cerebellar atrophy. The patient's symptoms align with these, but they do not have the typical absence of the cerebellum on brain imaging, which is a hallmark of Cerebellar Agenesis.

\n\n+6. Dandy-Walker Syndrome:
This is a rare genetic disorder that affects the development of the brain, particularly the cerebellum and fourth ventricle. Symptoms include Ataxia, Nystagmus, Strabismus, Cerebellar atrophy, and Generalized hypotonia. The patient's symptoms match most of these, but they do not have the typical hydrocephalus and agenesis of the corpus callosum associated with Dandy-Walker Syndrome.

\n\n+7. Rhombencephalosynapsis:
This is a rare congenital disorder where the cerebellum and brainstem are fused. Symptoms include Ataxia, Nystagmus, Strabismus, and Cerebellar atrophy. The patient's symptoms align with these, but they do not have the typical fusion of the cerebellar hemispheres on brain imaging, which is a hallmark of Rhombencephalosynapsis.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms."
['Classic homocystinuria'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Homocystinuria:
This is a rare genetic disorder caused by a deficiency of the enzyme cystathionine beta-synthase. It affects the metabolism of the amino acid methionine, leading to elevated levels of homocysteine in the blood and urine.
Common symptoms: Hyperhomocystinemia, Hypermethioninemia, Aminoaciduria, Abnormal circulating alanine concentration
Not common symptoms: Myopia, Delayed speech and language development, Ectopia lentis, Intellectual disability, Death in infancy, Death in childhood, Dyskinesia

\n\n+2. Marfan syndrome:
This is a genetic disorder that affects the body's connective tissue, which provides support to various organs, bones, and other structures.
Common symptoms: Ectopia lentis, Myopia, Intellectual disability
Not common symptoms: Delayed speech and language development, Hyperhomocystinemia, Hypermethioninemia, Aminoaciduria, Abnormal circulating alanine concentration, Death in infancy, Death in childhood, Dyskinesia

\n\n+3. Methylmalonic acidemia:
This is a rare genetic disorder caused by a deficiency of the enzyme methylmalonyl-CoA mutase, which is necessary for the breakdown of certain amino acids.
Common symptoms: Hyperhomocystinemia, Hypermethioninemia, Aminoaciduria, Abnormal circulating alanine concentration
Not common symptoms: Myopia, Delayed speech and language development, Ectopia lentis, Intellectual disability, Death in infancy, Death in childhood, Dyskinesia

\n\n+4. Cystathioninuria:
This is a rare genetic disorder caused by a deficiency of the enzyme cystathionase, which is necessary for the breakdown of the amino acid cystathionine.
Common symptoms: Hyperhomocystinemia, Hypermethioninemia, Aminoaciduria, Abnormal circulating alanine concentration
Not common symptoms: Myopia, Delayed speech and language development, Ectopia lentis, Intellectual disability, Death in infancy, Death in childhood, Dyskinesia

\n\n+5. Sjgren-Larsson syndrome:
This is a rare genetic disorder caused by a deficiency of the enzyme fatty aldehyde dehydrogenase, which is necessary for the breakdown of fatty acids.
Common symptoms: Intellectual disability, Dyskinesia
Not common symptoms: Myopia, Delayed speech and language development, Ectopia lentis, Hyperhomocystinemia, Hypermethioninemia, Aminoaciduria, Abnormal circulating alanine concentration, Death in infancy, Death in childhood

After reviewing these potential diseases, I believe that Homocystinuria is the most likely diagnosis, given the patient's symptoms of Hyperhomocystinemia, Hypermethioninemia, Aminoaciduria, and Abnormal circulating alanine concentration. However, further testing and evaluation are necessary to confirm this diagnosis and rule out other potential causes."
['Ornithine transcarbamylase deficiency'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Urea Cycle Disorder:
This is a group of rare genetic disorders that affect the body's ability to remove ammonia from the blood. Symptoms in common: Hyperammonemia, Metabolic acidosis, Lethargy, Seizure, Fever, Death in childhood. Symptoms not in common: Ataxia, Hyperreflexia, Diarrhea, Drowsiness, Sleep abnormality, Fasciculations, Oroticaciduria, Death in adolescence.

\n\n+2. Maple Syrup Urine Disease (MSUD):
This is a rare genetic disorder that affects the breakdown of certain amino acids. Symptoms in common: Seizure, Lethargy, Metabolic acidosis, Fever, Death in childhood. Symptoms not in common: Ataxia, Hyperreflexia, Diarrhea, Drowsiness, Sleep abnormality, Fasciculations, Oroticaciduria, Hyperammonemia, Death in adolescence.

\n\n+3. Ornithine Transcarbamylase Deficiency (OTCD):
This is a rare genetic disorder that affects the urea cycle. Symptoms in common: Hyperammonemia, Metabolic acidosis, Lethargy, Seizure, Fever, Death in childhood. Symptoms not in common: Ataxia, Hyperreflexia, Diarrhea, Drowsiness, Sleep abnormality, Fasciculations, Oroticaciduria, Death in adolescence.

\n\n+4. Citrullinemia:
This is a rare genetic disorder that affects the urea cycle. Symptoms in common: Hyperammonemia, Metabolic acidosis, Lethargy, Seizure, Fever, Death in childhood. Symptoms not in common: Ataxia, Hyperreflexia, Diarrhea, Drowsiness, Sleep abnormality, Fasciculations, Oroticaciduria, Death in adolescence.

\n\n+5. Argininosuccinic Aciduria (ASA):
This is a rare genetic disorder that affects the urea cycle. Symptoms in common: Hyperammonemia, Metabolic acidosis, Lethargy, Seizure, Fever, Death in childhood. Symptoms not in common: Ataxia, Hyperreflexia, Diarrhea, Drowsiness, Sleep abnormality, Fasciculations, Oroticaciduria, Death in adolescence.

\n\n+6. Orotic Aciduria:
This is a rare genetic disorder that affects the metabolism of certain amino acids. Symptoms in common: Oroticaciduria, Hyperammonemia, Metabolic acidosis, Lethargy, Seizure, Fever. Symptoms not in common: Ataxia, Hyperreflexia, Diarrhea, Drowsiness, Sleep abnormality, Fasciculations, Death in childhood, Death in adolescence.

\n\n+7. Hyperornithinemia-Hyperammonemia-Homocitrullinuria (HHH) Syndrome:
This is a rare genetic disorder that affects the metabolism of certain amino acids. Symptoms in common: Hyperammonemia, Metabolic acidosis, Lethargy, Seizure, Fever, Death in childhood. Symptoms not in common: Ataxia, Hyperreflexia, Diarrhea, Drowsiness, Sleep abnormality, Fasciculations, Oroticaciduria, Death in adolescence.

\n\n+8. Molybdenum Cofactor Deficiency:
This is a rare genetic disorder that affects the metabolism of certain amino acids. Symptoms in common: Seizure, Lethargy, Metabolic acidosis, Fever, Death in childhood. Symptoms not in common: Ataxia, Hyperreflexia, Diarrhea, Drowsiness, Sleep abnormality, Fasciculations, Oroticaciduria, Hyperammonemia, Death in adolescence.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms."
['Smith-Lemli-Opitz syndrome'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Smith-Lemli-Opitz syndrome:
This is a rare genetic disorder that affects the development of the brain and body. The patient's symptoms that match this disease include Microcephaly, Ptosis, Strabismus, Intellectual disability, Ataxia, Generalized hypotonia, Hyperreflexia, Failure to thrive, and Feeding difficulties. However, the patient does not exhibit symptoms such as polydactyly, which is commonly seen in this disease.

\n\n+2. Lathosterolosis:
This is a rare genetic disorder that affects cholesterol synthesis. The patient's symptoms that match this disease include Microcephaly, Intellectual disability, Ataxia, Generalized hypotonia, Hyperreflexia, Failure to thrive, and Elevated 8-dehydrocholesterol. However, the patient does not exhibit symptoms such as ichthyosis, which is commonly seen in this disease.

\n\n+3. Desmosterolosis:
This is a rare genetic disorder that affects cholesterol synthesis. The patient's symptoms that match this disease include Microcephaly, Intellectual disability, Ataxia, Generalized hypotonia, Hyperreflexia, Failure to thrive, and Elevated 8-dehydrocholesterol. However, the patient does not exhibit symptoms such as cataracts, which are commonly seen in this disease.

\n\n+4. Antley-Bixler syndrome:
This is a rare genetic disorder that affects the development of the brain and body. The patient's symptoms that match this disease include Microcephaly, Ptosis, Strabismus, Intellectual disability, Ataxia, Generalized hypotonia, Hyperreflexia, Failure to thrive, and Feeding difficulties. However, the patient does not exhibit symptoms such as craniosynostosis, which is commonly seen in this disease.

\n\n+5. CHARGE syndrome:
This is a rare genetic disorder that affects the development of the brain and body. The patient's symptoms that match this disease include Microcephaly, Ptosis, Strabismus, Intellectual disability, Ataxia, Generalized hypotonia, Hyperreflexia, Failure to thrive, and Feeding difficulties. However, the patient does not exhibit symptoms such as coloboma, which is commonly seen in this disease.

\n\n+6. Mucolipidosis IV:
This is a rare genetic disorder that affects the development of the brain and body. The patient's symptoms that match this disease include Microcephaly, Intellectual disability, Ataxia, Generalized hypotonia, Hyperreflexia, Failure to thrive, and Feeding difficulties. However, the patient does not exhibit symptoms such as corneal clouding, which is commonly seen in this disease.

\n\n+7. Niemann-Pick disease type C:
This is a rare genetic disorder that affects the metabolism of lipids. The patient's symptoms that match this disease include Microcephaly, Intellectual disability, Ataxia, Generalized hypotonia, Hyperreflexia, Failure to thrive, and Feeding difficulties. However, the patient does not exhibit symptoms such as splenomegaly, which is commonly seen in this disease.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms and to rule out other potential diseases."
['Glycogen storage disease due to glycogen debranching enzyme deficiency'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Mitochondrial DNA Depletion Syndrome 4A:
This is a rare genetic disorder that affects the mitochondria, leading to impaired energy production. The patient's symptoms that match this disease include: Generalized hypotonia, Death in infancy, Increased circulating lactate concentration, Hypertriglyceridemia, Hepatomegaly, Neonatal death. However, the patient does not exhibit symptoms such as muscle weakness, seizures, or developmental delays, which are commonly associated with this disease.

\n\n+2. Mitochondrial Complex I Deficiency:
This is a genetic disorder that affects the mitochondria's ability to generate energy. The patient's symptoms that match this disease include: Increased circulating lactate concentration, Hypertriglyceridemia, Hepatomegaly, Abnormal circulating aspartate family amino acid concentration, Abnormal circulating alanine concentration. However, the patient does not exhibit symptoms such as developmental delays, intellectual disability, or muscle weakness, which are commonly associated with this disease.

\n\n+3. Lactic Acidosis:
This is a metabolic disorder characterized by the accumulation of lactic acid in the body. The patient's symptoms that match this disease include: Increased circulating lactate concentration, Hypertriglyceridemia, Hepatomegaly. However, the patient does not exhibit symptoms such as nausea, vomiting, or rapid breathing, which are commonly associated with this disease.

\n\n+4. Fatty Acid Oxidation Disorder:
This is a group of genetic disorders that affect the body's ability to break down fats for energy. The patient's symptoms that match this disease include: Hypertriglyceridemia, Hepatomegaly, Abnormal circulating creatine kinase concentration. However, the patient does not exhibit symptoms such as muscle weakness, rhabdomyolysis, or hypoglycemia, which are commonly associated with this disease.

\n\n+5. Pyruvate Carboxylase Deficiency:
This is a rare genetic disorder that affects the body's ability to convert pyruvate into oxaloacetate. The patient's symptoms that match this disease include: Increased circulating lactate concentration, Abnormal circulating aspartate family amino acid concentration, Abnormal circulating alanine concentration. However, the patient does not exhibit symptoms such as developmental delays, intellectual disability, or seizures, which are commonly associated with this disease.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms and to rule out other potential diseases."
['Glutaryl-CoA dehydrogenase deficiency'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Glutaric acidemia type I:
This is a rare genetic disorder caused by a deficiency of the enzyme glutaryl-CoA dehydrogenase. It affects the breakdown of certain amino acids and can lead to the accumulation of toxic compounds in the body.

Common symptoms: Glutaric aciduria, Microcephaly, Generalized hypotonia, Cerebral cortical atrophy, Death in infancy
Not common symptoms: Athetosis, Decreased plasma free carnitine, Abnormal circulating acylcarnitine concentration, Death in adolescence

\n\n+2. Carnitine palmitoyltransferase I deficiency:
This is a rare genetic disorder that affects the transport of fatty acids into the mitochondria, leading to impaired energy production.

Common symptoms: Decreased plasma free carnitine, Abnormal circulating acylcarnitine concentration
Not common symptoms: Microcephaly, Generalized hypotonia, Cerebral cortical atrophy, Glutaric aciduria, Athetosis, Death in infancy, Death in adolescence

\n\n+3. Leigh syndrome:
This is a rare genetic disorder that affects the mitochondria, leading to impaired energy production and progressive damage to the brain and other organs.

Common symptoms: Microcephaly, Generalized hypotonia, Cerebral cortical atrophy, Death in infancy
Not common symptoms: Glutaric aciduria, Athetosis, Decreased plasma free carnitine, Abnormal circulating acylcarnitine concentration, Death in adolescence

\n\n+4. MADD (Multiple Acyl-CoA Dehydrogenase Deficiency):
This is a rare genetic disorder that affects the breakdown of fatty acids and amino acids, leading to impaired energy production and the accumulation of toxic compounds.

Common symptoms: Decreased plasma free carnitine, Abnormal circulating acylcarnitine concentration, Death in infancy
Not common symptoms: Microcephaly, Generalized hypotonia, Cerebral cortical atrophy, Glutaric aciduria, Athetosis, Death in adolescence

\n\n+5. GA-II (Glutaric acidemia type II):
This is a rare genetic disorder caused by a deficiency of the enzyme electron transfer flavoprotein or ETF-ubiquinone oxidoreductase. It affects the breakdown of fatty acids and amino acids, leading to impaired energy production and the accumulation of toxic compounds.

Common symptoms: Glutaric aciduria, Decreased plasma free carnitine, Abnormal circulating acylcarnitine concentration
Not common symptoms: Microcephaly, Generalized hypotonia, Cerebral cortical atrophy, Athetosis, Death in infancy, Death in adolescence

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms and to rule out other potential diseases."
['Propionic acidemia'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Glycine Encephalopathy:
This disease matches the patient's symptoms of Hyperammonemia, Vomiting, Hyperglycinemia, Hyperglycinuria, and Abnormal circulating glutamine concentration. However, it does not explain the patient's Death in infancy, Death in childhood, Ichthyosis, Abnormal circulating carnitine concentration, or Elevated urinary carboxylic acid.

\n\n+2. Propionic Acidemia:
This disease shares similarities with the patient's symptoms of Vomiting, Hyperammonemia, and Elevated urinary carboxylic acid. However, it does not account for the patient's Death in infancy, Death in childhood, Hyperglycinemia, Hyperglycinuria, Ichthyosis, Abnormal circulating glutamine concentration, or Abnormal circulating carnitine concentration.

\n\n+3. Isovaleric Acidemia:
This disease matches the patient's symptoms of Vomiting, Hyperammonemia, and Elevated urinary carboxylic acid. However, it does not explain the patient's Death in infancy, Death in childhood, Hyperglycinemia, Hyperglycinuria, Ichthyosis, Abnormal circulating glutamine concentration, or Abnormal circulating carnitine concentration.

\n\n+4. Methylmalonic Acidemia:
This disease shares similarities with the patient's symptoms of Vomiting, Hyperammonemia, and Elevated urinary carboxylic acid. However, it does not account for the patient's Death in infancy, Death in childhood, Hyperglycinemia, Hyperglycinuria, Ichthyosis, Abnormal circulating glutamine concentration, or Abnormal circulating carnitine concentration.

\n\n+5. Non-Ketotic Hyperglycinemia:
This disease matches the patient's symptoms of Hyperglycinemia, Hyperglycinuria, and Abnormal circulating glutamine concentration. However, it does not explain the patient's Death in infancy, Death in childhood, Vomiting, Hyperammonemia, Ichthyosis, Abnormal circulating carnitine concentration, or Elevated urinary carboxylic acid.

\n\n+6. Carnitine Palmitoyltransferase I Deficiency:
This disease shares similarities with the patient's symptoms of Abnormal circulating carnitine concentration and Elevated urinary carboxylic acid. However, it does not account for the patient's Death in infancy, Death in childhood, Vomiting, Hyperammonemia, Hyperglycinemia, Hyperglycinuria, Ichthyosis, or Abnormal circulating glutamine concentration.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms and to rule out other potential diseases."
['Succinic semialdehyde dehydrogenase deficiency'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Methylmalonic Acidemia:
This is a rare genetic disorder caused by a deficiency of the enzyme methylmalonyl-CoA mutase. It affects the body's ability to break down certain amino acids and fatty acids.
Common symptoms: Abnormal circulating monocarboxylic acid concentration, Elevated urinary carboxylic acid
Not common symptoms: Intellectual disability, Motor delay, Abnormal facial shape, Abnormal calvaria morphology, Death in childhood

\n\n+2. Propionic Acidemia:
This is a rare genetic disorder caused by a deficiency of the enzyme propionyl-CoA carboxylase. It affects the body's ability to break down certain amino acids and fatty acids.
Common symptoms: Abnormal circulating monocarboxylic acid concentration, Elevated urinary carboxylic acid
Not common symptoms: Intellectual disability, Motor delay, Abnormal facial shape, Abnormal calvaria morphology, Death in childhood

\n\n+3. Isovaleric Acidemia:
This is a rare genetic disorder caused by a deficiency of the enzyme isovaleryl-CoA dehydrogenase. It affects the body's ability to break down the amino acid leucine.
Common symptoms: Abnormal circulating monocarboxylic acid concentration, Elevated urinary carboxylic acid
Not common symptoms: Intellectual disability, Motor delay, Abnormal facial shape, Abnormal calvaria morphology, Death in childhood

\n\n+4. 3-Methylcrotonyl-CoA Carboxylase Deficiency:
This is a rare genetic disorder caused by a deficiency of the enzyme 3-methylcrotonyl-CoA carboxylase. It affects the body's ability to break down the amino acid leucine.
Common symptoms: Abnormal circulating monocarboxylic acid concentration, Elevated urinary carboxylic acid
Not common symptoms: Intellectual disability, Motor delay, Abnormal facial shape, Abnormal calvaria morphology, Death in childhood

\n\n+5. Holocarboxylase Synthetase Deficiency:
This is a rare genetic disorder caused by a deficiency of the enzyme holocarboxylase synthetase. It affects the body's ability to break down certain amino acids and fatty acids.
Common symptoms: Abnormal circulating monocarboxylic acid concentration, Elevated urinary carboxylic acid, Intellectual disability, Motor delay
Not common symptoms: Abnormal facial shape, Abnormal calvaria morphology, Death in childhood

\n\n+6. Biotinidase Deficiency:
This is a rare genetic disorder caused by a deficiency of the enzyme biotinidase. It affects the body's ability to break down certain amino acids and fatty acids.
Common symptoms: Intellectual disability, Motor delay, Abnormal facial shape, Abnormal calvaria morphology
Not common symptoms: Abnormal circulating monocarboxylic acid concentration, Elevated urinary carboxylic acid, Death in childhood

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms."
['Classic galactosemia'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Galactosemia:
This is a rare genetic disorder that affects the body's ability to metabolize galactose, a sugar found in milk. Symptoms in common with the patient: Delayed speech and language development, Intellectual disability, Motor delay, Hepatic failure, Increased total bilirubin, Prolonged partial thromboplastin time, Abnormality of galactoside metabolism, Abnormal circulating aspartate family amino acid concentration, Abnormal circulating alanine concentration, Hypergalactosemia. Symptoms not in common: Diarrhea, Premature birth, Neonatal death, Death in childhood.

\n\n+2. Classic Galactosemia:
A severe form of galactosemia, this disease is caused by a complete deficiency of the enzyme galactose-1-phosphate uridyltransferase. Symptoms in common with the patient: Delayed speech and language development, Intellectual disability, Motor delay, Hepatic failure, Increased total bilirubin, Prolonged partial thromboplastin time, Abnormality of galactoside metabolism, Abnormal circulating aspartate family amino acid concentration, Abnormal circulating alanine concentration, Hypergalactosemia. Symptoms not in common: Diarrhea, Premature birth, Neonatal death, Death in childhood.

\n\n+3. Galactokinase Deficiency:
A rare genetic disorder that affects the body's ability to metabolize galactose. Symptoms in common with the patient: Delayed speech and language development, Intellectual disability, Motor delay, Hepatic failure, Increased total bilirubin, Abnormality of galactoside metabolism, Abnormal circulating aspartate family amino acid concentration, Abnormal circulating alanine concentration, Hypergalactosemia. Symptoms not in common: Diarrhea, Premature birth, Neonatal death, Death in childhood, Prolonged partial thromboplastin time.

\n\n+4. UDP-Galactose-4-Epimerase Deficiency:
A rare genetic disorder that affects the body's ability to metabolize galactose. Symptoms in common with the patient: Delayed speech and language development, Intellectual disability, Motor delay, Hepatic failure, Increased total bilirubin, Abnormality of galactoside metabolism, Abnormal circulating aspartate family amino acid concentration, Abnormal circulating alanine concentration, Hypergalactosemia. Symptoms not in common: Diarrhea, Premature birth, Neonatal death, Death in childhood, Prolonged partial thromboplastin time.

\n\n+5. Hereditary Fructose Intolerance:
A rare genetic disorder that affects the body's ability to metabolize fructose. Symptoms in common with the patient: Hepatic failure, Increased total bilirubin, Prolonged partial thromboplastin time, Diarrhea. Symptoms not in common: Delayed speech and language development, Intellectual disability, Motor delay, Premature birth, Neonatal death, Death in childhood, Abnormality of galactoside metabolism, Abnormal circulating aspartate family amino acid concentration, Abnormal circulating alanine concentration, Hypergalactosemia.

Please note that these are just potential diagnoses, and further testing and evaluation are necessary to confirm the diagnosis."
['Neonatal intrahepatic cholestasis due to citrin deficiency'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Citrullinemia Type I:
This is a rare genetic disorder that affects the urea cycle, leading to the accumulation of ammonia in the blood. The patient's symptoms that match this disease include: Hyperammonemia, Elevated plasma citrulline, Aminoaciduria. However, the patient does not exhibit symptoms such as intellectual disability, seizures, and developmental delays, which are commonly associated with Citrullinemia Type I.

\n\n+2. Argininosuccinic Aciduria:
This is a rare genetic disorder that affects the urea cycle, leading to the accumulation of ammonia in the blood. The patient's symptoms that match this disease include: Hyperammonemia, Aminoaciduria, Abnormal circulating proline concentration. However, the patient does not exhibit symptoms such as intellectual disability, seizures, and developmental delays, which are commonly associated with Argininosuccinic Aciduria.

\n\n+3. N-Acetylglutamate Synthase Deficiency:
This is a rare genetic disorder that affects the urea cycle, leading to the accumulation of ammonia in the blood. The patient's symptoms that match this disease include: Hyperammonemia, Elevated plasma citrulline, Aminoaciduria. However, the patient does not exhibit symptoms such as intellectual disability, seizures, and developmental delays, which are commonly associated with N-Acetylglutamate Synthase Deficiency.

\n\n+4. Ornithine Transcarbamylase Deficiency:
This is a rare genetic disorder that affects the urea cycle, leading to the accumulation of ammonia in the blood. The patient's symptoms that match this disease include: Hyperammonemia, Elevated plasma citrulline, Aminoaciduria. However, the patient does not exhibit symptoms such as intellectual disability, seizures, and developmental delays, which are commonly associated with Ornithine Transcarbamylase Deficiency.

\n\n+5. Carbamoyl Phosphate Synthetase I Deficiency:
This is a rare genetic disorder that affects the urea cycle, leading to the accumulation of ammonia in the blood. The patient's symptoms that match this disease include: Hyperammonemia, Elevated plasma citrulline, Aminoaciduria. However, the patient does not exhibit symptoms such as intellectual disability, seizures, and developmental delays, which are commonly associated with Carbamoyl Phosphate Synthetase I Deficiency.

\n\n+6. Citrullinemia Type II:
This is a rare genetic disorder that affects the urea cycle, leading to the accumulation of ammonia in the blood. The patient's symptoms that match this disease include: Hyperammonemia, Elevated plasma citrulline, Aminoaciduria. However, the patient does not exhibit symptoms such as intellectual disability, seizures, and developmental delays, which are commonly associated with Citrullinemia Type II.

Based on the patient's symptoms, I believe that Citrullinemia Type I is the most likely diagnosis. However, further testing and evaluation are necessary to confirm the diagnosis and rule out other potential causes."
['Phenylketonuria'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Tyrosinemia Type I:
This is a rare genetic disorder caused by a deficiency of the enzyme fumarylacetoacetate hydrolase. Symptoms in common with the patient: Hypertyrosinemia, Death in infancy, Death in childhood, Death in adolescence. Symptoms not in common: None.

\n\n+2. Phenylketonuria (PKU):
This is a genetic disorder caused by a deficiency of the enzyme phenylalanine hydroxylase. Symptoms in common with the patient: Hyperphenylalaninemia. Symptoms not in common: Death in infancy, Death in childhood, Death in adolescence, Fever, Recurrent viral infections, Abnormal circulating porphyrin concentration, Decreased circulating ferritin concentration, Elevated urinary carboxylic acid.

\n\n+3. Acute Porphyrins:
This is a group of rare genetic disorders that affect the production of heme, a molecule essential for various bodily functions. Symptoms in common with the patient: Abnormal circulating porphyrin concentration, Fever. Symptoms not in common: Death in infancy, Death in childhood, Death in adolescence, Hypertyrosinemia, Hyperphenylalaninemia, Recurrent viral infections, Decreased circulating ferritin concentration, Elevated urinary carboxylic acid.

\n\n+4. Hereditary Hemochromatosis:
This is a genetic disorder that affects the body's ability to absorb iron from food. Symptoms in common with the patient: Decreased circulating ferritin concentration. Symptoms not in common: Death in infancy, Death in childhood, Death in adolescence, Hypertyrosinemia, Hyperphenylalaninemia, Fever, Recurrent viral infections, Abnormal circulating porphyrin concentration, Elevated urinary carboxylic acid.

\n\n+5. Organic Acidemia:
This is a group of rare genetic disorders that affect the body's ability to break down certain fats and proteins. Symptoms in common with the patient: Elevated urinary carboxylic acid. Symptoms not in common: Death in infancy, Death in childhood, Death in adolescence, Hypertyrosinemia, Hyperphenylalaninemia, Fever, Recurrent viral infections, Abnormal circulating porphyrin concentration, Decreased circulating ferritin concentration.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms and to rule out other potential diseases."
['Maple syrup urine disease'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Maple Syrup Urine Disease (MSUD): 
This is a rare genetic disorder that affects the breakdown of certain amino acids. The patient's symptoms that match MSUD include: Abnormal circulating leucine concentration, Elevated urinary carboxylic acid, and Body odor. However, the patient does not exhibit other common symptoms of MSUD, such as intellectual disability, seizures, and feeding difficulties.

\n\n+2. Glutaric Acidemia Type I (GA1): 
This is a rare genetic disorder that affects the breakdown of certain amino acids. The patient's symptoms that match GA1 include: Lethargy, Generalized hypotonia, Tremor, Death in infancy, Opisthotonus, and Elevated urinary carboxylic acid. However, the patient does not exhibit other common symptoms of GA1, such as macrocephaly and subdural hematoma.

\n\n+3. Isovaleric Acidemia (IVA): 
This is a rare genetic disorder that affects the breakdown of certain amino acids. The patient's symptoms that match IVA include: Lethargy, Generalized hypotonia, Tremor, Death in infancy, and Elevated urinary carboxylic acid. However, the patient does not exhibit other common symptoms of IVA, such as vomiting, diarrhea, and seizures.

\n\n+4. Methylmalonic Acidemia (MMA): 
This is a rare genetic disorder that affects the breakdown of certain amino acids. The patient's symptoms that match MMA include: Lethargy, Generalized hypotonia, Tremor, Death in infancy, and Elevated urinary carboxylic acid. However, the patient does not exhibit other common symptoms of MMA, such as vomiting, diarrhea, and seizures.

\n\n+5. Propionic Acidemia (PA): 
This is a rare genetic disorder that affects the breakdown of certain amino acids. The patient's symptoms that match PA include: Lethargy, Generalized hypotonia, Tremor, Death in infancy, and Elevated urinary carboxylic acid. However, the patient does not exhibit other common symptoms of PA, such as vomiting, diarrhea, and seizures.

\n\n+6. 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency (HMGCLD): 
This is a rare genetic disorder that affects the breakdown of certain amino acids. The patient's symptoms that match HMGCLD include: Lethargy, Generalized hypotonia, Tremor, Death in infancy, and Elevated urinary carboxylic acid. However, the patient does not exhibit other common symptoms of HMGCLD, such as hypoglycemia and metabolic acidosis.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms and to rule out other potential diseases."
['Phenylketonuria'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Menkes disease:
This is a rare genetic disorder that affects the production of copper in the body. Symptoms in common with the patient: Generalized hypotonia, Death in infancy, Premature birth, Anemia, Decreased circulating ferritin concentration, Decreased serum iron. Symptoms not in common: Hypertyrosinemia, Hyperphenylalaninemia, Abnormality of vitamin D metabolism, Pregnancy exposure.

\n\n+2. Phenylketonuria (PKU):
This is a genetic disorder that affects the breakdown of the amino acid phenylalanine. Symptoms in common with the patient: Hyperphenylalaninemia, Death in infancy, Death in childhood. Symptoms not in common: Generalized hypotonia, Premature birth, Anemia, Hypertyrosinemia, Decreased circulating ferritin concentration, Decreased serum iron, Abnormality of vitamin D metabolism, Pregnancy exposure.

\n\n+3. Tyrosinemia type I:
This is a rare genetic disorder that affects the breakdown of the amino acid tyrosine. Symptoms in common with the patient: Hypertyrosinemia, Death in infancy, Death in childhood, Anemia. Symptoms not in common: Generalized hypotonia, Premature birth, Hyperphenylalaninemia, Decreased circulating ferritin concentration, Decreased serum iron, Abnormality of vitamin D metabolism, Pregnancy exposure.

\n\n+4. Iron deficiency anemia:
This is a common condition where the body does not have enough iron to produce hemoglobin. Symptoms in common with the patient: Anemia, Decreased circulating ferritin concentration, Decreased serum iron. Symptoms not in common: Generalized hypotonia, Death in infancy, Premature birth, Hypertyrosinemia, Hyperphenylalaninemia, Abnormality of vitamin D metabolism, Pregnancy exposure.

\n\n+5. Vitamin D deficiency:
This is a condition where the body does not have enough vitamin D, which is essential for bone health. Symptoms in common with the patient: Abnormality of vitamin D metabolism. Symptoms not in common: Generalized hypotonia, Death in infancy, Premature birth, Anemia, Hypertyrosinemia, Hyperphenylalaninemia, Decreased circulating ferritin concentration, Decreased serum iron, Pregnancy exposure.

\n\n+6. Preeclampsia:
This is a pregnancy complication characterized by high blood pressure and damage to organs such as the kidneys and liver. Symptoms in common with the patient: Pregnancy exposure, Premature birth. Symptoms not in common: Generalized hypotonia, Death in infancy, Anemia, Hypertyrosinemia, Hyperphenylalaninemia, Decreased circulating ferritin concentration, Decreased serum iron, Abnormality of vitamin D metabolism.

After reviewing these potential diseases, I will need to conduct further tests and examinations to determine the underlying cause of the patient's symptoms."
['Smith-Lemli-Opitz syndrome'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Smith-Lemli-Opitz syndrome:
This is a rare genetic disorder that affects the development of multiple body systems. The patient's symptoms that match this disease include: Hypertelorism, Anteverted nares, Delayed speech and language development, Intellectual disability, Seizure, Motor delay, Abnormal foot morphology, Hypocholesterolemia, Elevated 8-dehydrocholesterol, and Elevated circulating 7-dehydrocholesterol concentration. However, the patient does not exhibit the following symptoms commonly associated with this disease: Polydactyly, Cleft palate, and Cardiac defects.

\n\n+2. Lujan-Fryns syndrome:
This is a rare genetic disorder characterized by intellectual disability, behavioral problems, and distinct physical features. The patient's symptoms that match this disease include: Hypertelorism, Anteverted nares, Delayed speech and language development, Intellectual disability, Hyperactivity, and Seizure. However, the patient does not exhibit the following symptoms commonly associated with this disease: Tall stature, Long fingers, and Cardiac defects.

\n\n+3. Mucolipidosis IV:
This is a rare genetic disorder that affects the body's ability to break down and recycle fats and sugars. The patient's symptoms that match this disease include: Delayed speech and language development, Intellectual disability, Seizure, Motor delay, and Abnormal foot morphology. However, the patient does not exhibit the following symptoms commonly associated with this disease: Corneal clouding, Retinal degeneration, and Gastric problems.

\n\n+4. Coffin-Siris syndrome:
This is a rare genetic disorder that affects the development of multiple body systems. The patient's symptoms that match this disease include: Hypertelorism, Anteverted nares, Delayed speech and language development, Intellectual disability, Hyperactivity, and Abnormal foot morphology. However, the patient does not exhibit the following symptoms commonly associated with this disease: Coarse facial features, Inguinal hernia, and Cardiac defects.

\n\n+5. Sjgren-Larsson syndrome:
This is a rare genetic disorder that affects the development of the brain and nervous system. The patient's symptoms that match this disease include: Delayed speech and language development, Intellectual disability, Seizure, and Motor delay. However, the patient does not exhibit the following symptoms commonly associated with this disease: Ichthyosis, Spasticity, and Dysmetria.

\n\n+6. 7-Dehydrocholesterol reductase deficiency:
This is a rare genetic disorder that affects the production of cholesterol. The patient's symptoms that match this disease include: Hypocholesterolemia, Elevated 8-dehydrocholesterol, and Elevated circulating 7-dehydrocholesterol concentration. However, the patient does not exhibit the following symptoms commonly associated with this disease: Polydactyly, Cleft palate, and Cardiac defects.

After reviewing these potential diseases, I believe that further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms."
['Vitamin B12-unresponsive methylmalonic acidemia'],ERROR
[],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Dihydropyrimidine Dehydrogenase Deficiency:
This is a rare genetic disorder that affects the breakdown of pyrimidines. The patient's symptoms of Abnormal circulating pyrimidine concentration and Uraciluria are consistent with this disease. However, the patient does not exhibit symptoms of intellectual disability, seizures, or gastrointestinal problems, which are commonly associated with this condition.

\n\n+2. Pyrimidine 5'-Nucleotidase Deficiency:
This is a rare genetic disorder that affects the breakdown of pyrimidines. The patient's symptoms of Abnormal circulating pyrimidine concentration and Uraciluria are consistent with this disease. However, the patient does not exhibit symptoms of anemia, jaundice, or splenomegaly, which are commonly associated with this condition.

\n\n+3. Molybdenum Cofactor Deficiency:
This is a rare genetic disorder that affects the metabolism of sulfur-containing compounds. The patient's symptoms of Ataxia, Lethargy, and Generalized hypotonia are consistent with this disease. However, the patient does not exhibit symptoms of seizures, microcephaly, or facial dysmorphism, which are commonly associated with this condition.

\n\n+4. Sulfite Oxidase Deficiency:
This is a rare genetic disorder that affects the metabolism of sulfur-containing compounds. The patient's symptoms of Ataxia, Lethargy, and Generalized hypotonia are consistent with this disease. However, the patient does not exhibit symptoms of seizures, microcephaly, or lens dislocation, which are commonly associated with this condition.

\n\n+5. Leigh Syndrome:
This is a rare genetic disorder that affects the mitochondria. The patient's symptoms of Ataxia, Lethargy, and Generalized hypotonia are consistent with this disease. However, the patient does not exhibit symptoms of seizures, vomiting, or liver dysfunction, which are commonly associated with this condition.

\n\n+6. Pyruvate Dehydrogenase Deficiency:
This is a rare genetic disorder that affects the metabolism of carbohydrates. The patient's symptoms of Ataxia, Lethargy, and Generalized hypotonia are consistent with this disease. However, the patient does not exhibit symptoms of seizures, developmental delay, or lactic acidosis, which are commonly associated with this condition.

\n\n+7. Folinic Acid-Responsive Seizures:
This is a rare genetic disorder that affects the metabolism of folate. The patient's symptoms of Ataxia, Lethargy, and Generalized hypotonia are consistent with this disease. However, the patient does not exhibit symptoms of seizures, which are commonly associated with this condition.

\n\n+8. Methylene Tetrahydrofolate Reductase Deficiency:
This is a rare genetic disorder that affects the metabolism of folate. The patient's symptoms of Ataxia, Lethargy, and Generalized hypotonia are consistent with this disease. However, the patient does not exhibit symptoms of seizures, developmental delay, or homocystinuria, which are commonly associated with this condition.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms."
['Isovaleric acidemia'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Non-ketotic hyperglycinemia (NKH): 
This is a rare genetic disorder that affects the breakdown of certain amino acids. The patient's symptoms of Abnormality of prenatal development or birth, Hyperammonemia, Abnormal circulating glycine concentration, and Death in infancy are consistent with NKH. However, the patient does not exhibit symptoms of intellectual disability, seizures, or muscle weakness, which are also common in NKH.

\n\n+2. Propionic acidemia:
This is a rare genetic disorder that affects the breakdown of certain amino acids and fats. The patient's symptoms of Hyperammonemia, Abnormal circulating carnitine concentration, and Death in infancy are consistent with propionic acidemia. However, the patient does not exhibit symptoms of vomiting, diarrhea, or developmental delays, which are also common in propionic acidemia.

\n\n+3. Isovaleric acidemia:
This is a rare genetic disorder that affects the breakdown of certain amino acids and fats. The patient's symptoms of Hyperammonemia, Abnormal circulating carnitine concentration, and Death in infancy are consistent with isovaleric acidemia. However, the patient does not exhibit symptoms of vomiting, diarrhea, or developmental delays, which are also common in isovaleric acidemia.

\n\n+4. Methylmalonic acidemia:
This is a rare genetic disorder that affects the breakdown of certain amino acids and fats. The patient's symptoms of Hyperammonemia, Abnormal circulating carnitine concentration, and Death in infancy are consistent with methylmalonic acidemia. However, the patient does not exhibit symptoms of vomiting, diarrhea, or developmental delays, which are also common in methylmalonic acidemia.

\n\n+5. Carnitine-acylcarnitine translocase deficiency:
This is a rare genetic disorder that affects the transport of fatty acids into the mitochondria. The patient's symptoms of Abnormal circulating carnitine concentration, Hyperammonemia, and Death in infancy are consistent with carnitine-acylcarnitine translocase deficiency. However, the patient does not exhibit symptoms of hypoglycemia, cardiomyopathy, or muscle weakness, which are also common in this disorder.

\n\n+6. Carnitine palmitoyltransferase I deficiency:
This is a rare genetic disorder that affects the breakdown of fatty acids. The patient's symptoms of Abnormal circulating carnitine concentration, Hyperammonemia, and Death in infancy are consistent with carnitine palmitoyltransferase I deficiency. However, the patient does not exhibit symptoms of hypoglycemia, cardiomyopathy, or muscle weakness, which are also common in this disorder.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms and to rule out other potential diagnoses."
['Biotinidase deficiency'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Glutaric acidemia type I:
This is a rare genetic disorder that affects the breakdown of certain amino acids. The patient's symptoms of elevated urinary carboxylic acid and seizures are consistent with this disease. However, not all patients with Glutaric acidemia type I experience generalized hypotonia or death in infancy, so further testing is needed to confirm this diagnosis.

\n\n+2. Methylmalonic acidemia:
This is another rare genetic disorder that affects the breakdown of certain amino acids. The patient's symptoms of elevated urinary carboxylic acid and seizures are consistent with this disease. Additionally, some patients with Methylmalonic acidemia may experience generalized hypotonia. However, death in infancy is not a typical symptom of this disease.

\n\n+3. Propionic acidemia:
This is a rare genetic disorder that affects the breakdown of certain amino acids. The patient's symptoms of elevated urinary carboxylic acid and seizures are consistent with this disease. Additionally, some patients with Propionic acidemia may experience generalized hypotonia. However, death in infancy is not a typical symptom of this disease.

\n\n+4. Isovaleric acidemia:
This is a rare genetic disorder that affects the breakdown of certain amino acids. The patient's symptoms of elevated urinary carboxylic acid and seizures are consistent with this disease. However, generalized hypotonia and death in infancy are not typical symptoms of this disease.

\n\n+5. Zellweger syndrome:
This is a rare genetic disorder that affects the breakdown of certain fatty acids. The patient's symptoms of seizures, generalized hypotonia, and death in infancy are consistent with this disease. However, elevated urinary carboxylic acid is not a typical symptom of this disease.

Further testing and evaluation are needed to determine the underlying cause of the patient's symptoms and to confirm a diagnosis."
['Medium chain acyl-CoA dehydrogenase deficiency'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Glutaric acidemia type II:
This is a rare genetic disorder that affects the breakdown of certain amino acids and fatty acids. The patient's symptoms of delayed speech and language development, abnormality of prenatal development or birth, and decreased plasma free carnitine are consistent with this disease. However, the patient does not exhibit symptoms of muscle weakness, seizures, or intellectual disability, which are commonly associated with glutaric acidemia type II.

\n\n+2. Carnitine palmitoyltransferase I deficiency:
This is a rare genetic disorder that affects the breakdown of fatty acids. The patient's symptoms of decreased plasma free carnitine and decreased 3-hydroxyacyl-CoA dehydrogenase level are consistent with this disease. However, the patient does not exhibit symptoms of hypoketotic hypoglycemia, liver dysfunction, or muscle weakness, which are commonly associated with carnitine palmitoyltransferase I deficiency.

\n\n+3. Mitochondrial trifunctional protein deficiency:
This is a rare genetic disorder that affects the breakdown of fatty acids. The patient's symptoms of delayed speech and language development, abnormality of prenatal development or birth, and decreased 3-hydroxyacyl-CoA dehydrogenase level are consistent with this disease. However, the patient does not exhibit symptoms of muscle weakness, seizures, or liver dysfunction, which are commonly associated with mitochondrial trifunctional protein deficiency.

\n\n+4. Lethal acyl-CoA dehydrogenase family member 9 deficiency:
This is a rare genetic disorder that affects the breakdown of fatty acids. The patient's symptoms of death in infancy, neonatal death, and death in childhood are consistent with this disease. However, the patient does not exhibit symptoms of muscle weakness, seizures, or intellectual disability, which are commonly associated with lethal acyl-CoA dehydrogenase family member 9 deficiency.

\n\n+5. Very long-chain acyl-CoA dehydrogenase deficiency:
This is a rare genetic disorder that affects the breakdown of fatty acids. The patient's symptoms of delayed speech and language development, abnormality of prenatal development or birth, and decreased plasma free carnitine are consistent with this disease. However, the patient does not exhibit symptoms of muscle weakness, seizures, or liver dysfunction, which are commonly associated with very long-chain acyl-CoA dehydrogenase deficiency.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms and to rule out other potential diseases."
['Maple syrup urine disease'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Maple Syrup Urine Disease (MSUD): 
This rare genetic disorder affects the breakdown of certain amino acids. The patient's symptoms that match MSUD include: Seizure, Motor delay, Generalized hypotonia, Metabolic acidosis, Dyspnea, Apnea, Feeding difficulties, and Body odor. However, the patient does not exhibit the characteristic ""maple syrup"" odor in their urine, which is a hallmark of this disease.

\n\n+2. Valine Transaminase Deficiency:
This is a rare genetic disorder that affects the breakdown of the amino acid valine. The patient's symptoms that match this disease include: Hypervalinemia, Hyperleucinemia, and Hyperisoleucinemia. However, the patient does not exhibit any signs of intellectual disability or developmental delays, which are common in this condition.

\n\n+3. Methylmalonic Acidemia (MMA):
This is a rare genetic disorder that affects the breakdown of certain amino acids and fats. The patient's symptoms that match MMA include: Metabolic acidosis, Seizure, Motor delay, Generalized hypotonia, Dyspnea, Apnea, and Feeding difficulties. However, the patient does not exhibit any signs of kidney damage or failure, which are common in this condition.

\n\n+4. Propionic Acidemia (PA):
This is a rare genetic disorder that affects the breakdown of certain amino acids and fats. The patient's symptoms that match PA include: Metabolic acidosis, Seizure, Motor delay, Generalized hypotonia, Dyspnea, Apnea, and Feeding difficulties. However, the patient does not exhibit any signs of cardiac problems or pancreatitis, which are common in this condition.

\n\n+5. Isovaleric Acidemia (IVA):
This is a rare genetic disorder that affects the breakdown of the amino acid leucine. The patient's symptoms that match IVA include: Metabolic acidosis, Seizure, Motor delay, Generalized hypotonia, Dyspnea, Apnea, and Body odor. However, the patient does not exhibit any signs of vomiting or diarrhea, which are common in this condition.

\n\n+6. 3-Methylcrotonyl-CoA Carboxylase Deficiency (3MCCD):
This is a rare genetic disorder that affects the breakdown of the amino acid leucine. The patient's symptoms that match 3MCCD include: Metabolic acidosis, Seizure, Motor delay, Generalized hypotonia, Dyspnea, Apnea, and Feeding difficulties. However, the patient does not exhibit any signs of intellectual disability or developmental delays, which are common in this condition.

\n\n+7. Spastic Tetraplegic Cerebral Palsy:
This is a neurological disorder that affects muscle tone and movement. The patient's symptoms that match this condition include: Spastic diplegia, Spastic tetraplegia, Motor delay, and Generalized hypotonia. However, the patient does not exhibit any signs of intellectual disability or developmental delays, which are common in this condition.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms."
['Propionic acidemia'],ERROR
['L-2-hydroxyglutaric aciduria'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. L-2-Hydroxyglutaric Aciduria:
This is a rare genetic disorder characterized by elevated levels of L-2-hydroxyglutaric acid in the urine and blood. The patient's symptoms of Intellectual disability, Seizure, Ataxia, Tremor, and L-2-hydroxyglutaric aciduria are all consistent with this disease. However, the patient does not exhibit symptoms of delayed speech development, which is commonly seen in this condition.

\n\n+2. Glutaric Acidemia Type I:
This is a rare genetic disorder caused by a deficiency of the enzyme glutaryl-CoA dehydrogenase. The patient's symptoms of Intellectual disability, Seizure, Ataxia, and Death in childhood are all consistent with this disease. However, the patient does not exhibit symptoms of macrocephaly (enlarged head) or hepatomegaly (enlarged liver), which are commonly seen in this condition.

\n\n+3. D-2-Hydroxyglutaric Aciduria:
This is a rare genetic disorder characterized by elevated levels of D-2-hydroxyglutaric acid in the urine and blood. The patient's symptoms of Intellectual disability, Seizure, Ataxia, and Tremor are all consistent with this disease. However, the patient does not exhibit symptoms of developmental delay or hypotonia (low muscle tone), which are commonly seen in this condition.

\n\n+4. Canavan Disease:
This is a rare genetic disorder caused by a deficiency of the enzyme aspartoacylase. The patient's symptoms of Intellectual disability, Seizure, and Death in childhood are all consistent with this disease. However, the patient does not exhibit symptoms of macrocephaly (enlarged head) or white matter degeneration, which are commonly seen in this condition.

\n\n+5. Methylmalonic Acidemia:
This is a rare genetic disorder caused by a deficiency of the enzyme methylmalonyl-CoA mutase. The patient's symptoms of Intellectual disability, Seizure, and Ataxia are all consistent with this disease. However, the patient does not exhibit symptoms of metabolic acidosis or hyperammonemia, which are commonly seen in this condition.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms and to rule out other potential diseases."
['Canavan disease'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Citrullinemia type I:
This is a rare genetic disorder that affects the metabolism of certain amino acids. The patient's symptoms of abnormal circulating aspartate family amino acid concentration and motor delay are consistent with this disease. However, the patient does not exhibit other common symptoms of Citrullinemia type I, such as seizures, vomiting, and lethargy.

\n\n+2. Argininosuccinic aciduria:
This is another rare genetic disorder that affects the metabolism of amino acids. The patient's symptoms of abnormal circulating aspartate family amino acid concentration and motor delay are consistent with this disease. However, the patient does not exhibit other common symptoms of Argininosuccinic aciduria, such as seizures, intellectual disability, and brittle hair.

\n\n+3. Aspartylglycosaminuria:
This is a rare genetic disorder that affects the breakdown of certain proteins. The patient's symptoms of abnormal circulating aspartate family amino acid concentration and motor delay are consistent with this disease. However, the patient does not exhibit other common symptoms of Aspartylglycosaminuria, such as intellectual disability, coarse facial features, and recurrent respiratory infections.

\n\n+4. Canavan disease:
This is a rare genetic disorder that affects the breakdown of certain proteins. The patient's symptoms of motor delay and death in infancy are consistent with this disease. However, the patient does not exhibit other common symptoms of Canavan disease, such as intellectual disability, seizures, and macrocephaly.

\n\n+5. Aspartylglucosaminuria:
This is a rare genetic disorder that affects the breakdown of certain proteins. The patient's symptoms of abnormal circulating aspartate family amino acid concentration and motor delay are consistent with this disease. However, the patient does not exhibit other common symptoms of Aspartylglucosaminuria, such as intellectual disability, coarse facial features, and recurrent respiratory infections.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms and to rule out other potential diseases."
['Citrullinemia type I'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Citrullinemia Type I:
This is a rare genetic disorder that affects the urea cycle, leading to the accumulation of ammonia in the blood. The patient's symptoms of Hyperammonemia, Elevated plasma citrulline, and Death in infancy are consistent with this disease. However, the patient does not exhibit symptoms of intellectual disability, seizures, or developmental delays, which are also common in Citrullinemia Type I.

\n\n+2. Argininosuccinic Aciduria:
This is another rare genetic disorder that affects the urea cycle, leading to the accumulation of ammonia in the blood. The patient's symptoms of Hyperammonemia, Elevated plasma citrulline, and Neonatal death are consistent with this disease. However, the patient does not exhibit symptoms of seizures, intellectual disability, or muscle weakness, which are also common in Argininosuccinic Aciduria.

\n\n+3. Carbamoyl Phosphate Synthetase I Deficiency:
This is a rare genetic disorder that affects the urea cycle, leading to the accumulation of ammonia in the blood. The patient's symptoms of Hyperammonemia, Elevated plasma citrulline, and Death in infancy are consistent with this disease. However, the patient does not exhibit symptoms of seizures, intellectual disability, or developmental delays, which are also common in Carbamoyl Phosphate Synthetase I Deficiency.

\n\n+4. Ornithine Transcarbamylase Deficiency:
This is a rare genetic disorder that affects the urea cycle, leading to the accumulation of ammonia in the blood. The patient's symptoms of Hyperammonemia, Elevated plasma citrulline, and Neonatal death are consistent with this disease. However, the patient does not exhibit symptoms of seizures, intellectual disability, or developmental delays, which are also common in Ornithine Transcarbamylase Deficiency.

\n\n+5. N-Acetylglutamate Synthase Deficiency:
This is a rare genetic disorder that affects the urea cycle, leading to the accumulation of ammonia in the blood. The patient's symptoms of Hyperammonemia, Elevated plasma citrulline, and Death in infancy are consistent with this disease. However, the patient does not exhibit symptoms of seizures, intellectual disability, or developmental delays, which are also common in N-Acetylglutamate Synthase Deficiency.

\n\n+6. Crigler-Najjar Syndrome:
This is a rare genetic disorder that affects the metabolism of bilirubin, leading to increased levels of bilirubin in the blood. The patient's symptom of Increased total bilirubin is consistent with this disease. However, the patient does not exhibit symptoms of jaundice, kernicterus, or intellectual disability, which are also common in Crigler-Najjar Syndrome.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms and to rule out other potential diseases."
['3-hydroxy-3-methylglutaric aciduria'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. 3-Methylglutaconic aciduria type I:
This is a rare genetic disorder that affects the breakdown of certain fatty acids. The patient's symptoms that match this disease include: Lethargy, Metabolic acidosis, Hypoglycemia, Hyperammonemia, Vomiting, Dicarboxylic aciduria, 3-Methylglutaric aciduria. However, the patient does not exhibit the typical symptoms of developmental delay, intellectual disability, and muscle weakness.

\n\n+2. 3-Methylglutaconic aciduria type IV:
This is another rare genetic disorder that affects the breakdown of certain fatty acids. The patient's symptoms that match this disease include: Lethargy, Metabolic acidosis, Hypoglycemia, Hyperammonemia, Vomiting, Dicarboxylic aciduria, 3-Methylglutaric aciduria, Death in infancy. However, the patient does not exhibit the typical symptoms of seizures, intellectual disability, and muscle weakness.

\n\n+3. Carnitine palmitoyltransferase I deficiency:
This is a rare genetic disorder that affects the breakdown of fatty acids. The patient's symptoms that match this disease include: Lethargy, Metabolic acidosis, Hypoglycemia, Hyperammonemia, Vomiting, Hepatomegaly. However, the patient does not exhibit the typical symptoms of seizures, muscle weakness, and intellectual disability.

\n\n+4. Medium-chain acyl-CoA dehydrogenase deficiency:
This is a rare genetic disorder that affects the breakdown of fatty acids. The patient's symptoms that match this disease include: Lethargy, Metabolic acidosis, Hypoglycemia, Hyperammonemia, Vomiting, Hepatomegaly, Death in infancy. However, the patient does not exhibit the typical symptoms of seizures, intellectual disability, and muscle weakness.

\n\n+5. Multiple carboxylase deficiency:
This is a rare genetic disorder that affects the breakdown of certain amino acids and fatty acids. The patient's symptoms that match this disease include: Lethargy, Metabolic acidosis, Hypoglycemia, Hyperammonemia, Vomiting, Diarrhea, Hepatomegaly, Drowsiness, Sleep abnormality, Elevated urinary carboxylic acid. However, the patient does not exhibit the typical symptoms of skin rash, hair loss, and intellectual disability.

\n\n+6. Propionic acidemia:
This is a rare genetic disorder that affects the breakdown of certain amino acids. The patient's symptoms that match this disease include: Lethargy, Metabolic acidosis, Hypoglycemia, Hyperammonemia, Vomiting, Diarrhea, Hepatomegaly, Drowsiness, Sleep abnormality, Elevated urinary carboxylic acid. However, the patient does not exhibit the typical symptoms of intellectual disability, seizures, and muscle weakness.

\n\n+7. Methylmalonic acidemia:
This is a rare genetic disorder that affects the breakdown of certain amino acids. The patient's symptoms that match this disease include: Lethargy, Metabolic acidosis, Hypoglycemia, Hyperammonemia, Vomiting, Diarrhea, Hepatomegaly, Drowsiness, Sleep abnormality, Elevated urinary carboxylic acid. However, the patient does not exhibit the typical symptoms of intellectual disability, seizures, and muscle weakness.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms and to rule out other potential diseases."
['Cystinuria'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Niemann-Pick Disease: 
This is a rare genetic disorder that affects the metabolism of lipids. The patient's symptoms of Seizure, Death in infancy, and Splenomegaly are consistent with this disease. However, Respiratory insufficiency is not typically associated with Niemann-Pick Disease.

\n\n+2. Mucolipidosis IV: 
This is a rare genetic disorder that affects the transport of lipids and mucopolysaccharides. The patient's symptoms of Seizure, Death in infancy, and Respiratory insufficiency are consistent with this disease. However, Splenomegaly is not typically associated with Mucolipidosis IV.

\n\n+3. Gaucher Disease: 
This is a genetic disorder that affects the breakdown of glucocerebroside. The patient's symptoms of Splenomegaly and Respiratory insufficiency are consistent with this disease. However, Seizure and Death in infancy are not typically associated with Gaucher Disease.

\n\n+4. Sandhoff Disease: 
This is a rare genetic disorder that affects the breakdown of lipids. The patient's symptoms of Seizure, Death in infancy, and Respiratory insufficiency are consistent with this disease. However, Splenomegaly is not typically associated with Sandhoff Disease.

\n\n+5. GM1 Gangliosidosis: 
This is a rare genetic disorder that affects the breakdown of lipids. The patient's symptoms of Seizure, Death in infancy, and Respiratory insufficiency are consistent with this disease. However, Splenomegaly is not typically associated with GM1 Gangliosidosis.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms."
['Vitamin B12-unresponsive methylmalonic acidemia'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Propionic Acidemia:
This is a rare genetic disorder that affects the body's ability to break down certain amino acids. The patient's symptoms that match this disease include: Hyperammonemia, Vomiting, Hypoproteinemia, Increased blood urea nitrogen, Feeding difficulties, and Decreased serum creatinine. However, the patient does not exhibit symptoms such as seizures, which are commonly associated with Propionic Acidemia.

\n\n+2. Methylmalonic Acidemia:
This is another rare genetic disorder that affects the body's ability to break down certain amino acids. The patient's symptoms that match this disease include: Methylmalonic aciduria, Hyperammonemia, Vomiting, Hypoproteinemia, Increased blood urea nitrogen, Feeding difficulties, and Decreased serum creatinine. However, the patient does not exhibit symptoms such as seizures, which are commonly associated with Methylmalonic Acidemia.

\n\n+3. Isovaleric Acidemia:
This is a rare genetic disorder that affects the body's ability to break down certain amino acids. The patient's symptoms that match this disease include: Vomiting, Hypoproteinemia, Increased blood urea nitrogen, Feeding difficulties, and Decreased serum creatinine. However, the patient does not exhibit symptoms such as a characteristic ""sweaty feet"" odor, which is commonly associated with Isovaleric Acidemia.

\n\n+4. Maple Syrup Urine Disease:
This is a rare genetic disorder that affects the body's ability to break down certain amino acids. The patient's symptoms that match this disease include: Intellectual disability, Motor delay, Generalized hypotonia, Vomiting, and Feeding difficulties. However, the patient does not exhibit symptoms such as a characteristic ""maple syrup"" odor in their urine, which is commonly associated with Maple Syrup Urine Disease.

\n\n+5. Multiple Carboxylase Deficiency:
This is a rare genetic disorder that affects the body's ability to break down certain amino acids. The patient's symptoms that match this disease include: Intellectual disability, Motor delay, Generalized hypotonia, Vomiting, Hypoproteinemia, Increased blood urea nitrogen, Feeding difficulties, and Decreased serum creatinine. However, the patient does not exhibit symptoms such as skin rash and hair loss, which are commonly associated with Multiple Carboxylase Deficiency.

\n\n+6. Holocarboxylase Synthetase Deficiency:
This is a rare genetic disorder that affects the body's ability to break down certain amino acids. The patient's symptoms that match this disease include: Intellectual disability, Motor delay, Generalized hypotonia, Vomiting, Hypoproteinemia, Increased blood urea nitrogen, Feeding difficulties, and Decreased serum creatinine. However, the patient does not exhibit symptoms such as skin rash and hair loss, which are commonly associated with Holocarboxylase Synthetase Deficiency.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms and to rule out other potential diseases."
['Phenylketonuria'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Tyrosinemia Type I:
This is a rare genetic disorder caused by a deficiency of the enzyme fumarylacetoacetate hydrolase. Symptoms in common with the patient: Hypertyrosinemia, Death in infancy, Death in childhood. Symptoms not in common: None.

\n\n+2. Phenylketonuria (PKU):
This is a genetic disorder caused by a deficiency of the enzyme phenylalanine hydroxylase. Symptoms in common with the patient: Hyperphenylalaninemia. Symptoms not in common: Death in infancy, Death in childhood, Recurrent viral infections, Elevated urinary carboxylic acid.

\n\n+3. Maple Syrup Urine Disease (MSUD):
This is a rare genetic disorder caused by a deficiency of the enzyme branched-chain alpha-keto acid dehydrogenase complex. Symptoms in common with the patient: Elevated urinary carboxylic acid. Symptoms not in common: Death in infancy, Death in childhood, Hypertyrosinemia, Hyperphenylalaninemia, Recurrent viral infections.

\n\n+4. Organic Acidemia:
This is a group of rare genetic disorders caused by a deficiency of enzymes involved in the breakdown of organic acids. Symptoms in common with the patient: Elevated urinary carboxylic acid, Recurrent viral infections. Symptoms not in common: Death in infancy, Death in childhood, Hypertyrosinemia, Hyperphenylalaninemia.

\n\n+5. Combined Immunodeficiency:
This is a group of rare genetic disorders that affect the immune system. Symptoms in common with the patient: Recurrent viral infections. Symptoms not in common: Death in infancy, Death in childhood, Hypertyrosinemia, Hyperphenylalaninemia, Elevated urinary carboxylic acid.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms and to rule out other potential diseases."
['Phenylketonuria'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Homocystinuria:
This is a rare genetic disorder caused by a deficiency of the enzyme cystathionine beta-synthase. It can cause a range of symptoms including intellectual disability, seizures, and blood clots. 
Common symptoms: Intellectual disability, Abnormality of prenatal development or birth
Not common symptoms: Strabismus, Obesity, Death in infancy, Hypertyrosinemia, Neonatal death, Hyperphenylalaninemia, Death in adolescence, Death in early adulthood

\n\n+2. Phenylketonuria (PKU):
This is a genetic disorder caused by a deficiency of the enzyme phenylalanine hydroxylase. It can cause intellectual disability, seizures, and skin problems if left untreated. 
Common symptoms: Intellectual disability, Hyperphenylalaninemia
Not common symptoms: Strabismus, Abnormality of prenatal development or birth, Obesity, Death in infancy, Hypertyrosinemia, Neonatal death, Death in adolescence, Death in early adulthood

\n\n+3. Tyrosinemia type 1:
This is a rare genetic disorder caused by a deficiency of the enzyme fumarylacetoacetate hydrolase. It can cause liver and kidney problems, as well as an increased risk of liver cancer. 
Common symptoms: Hypertyrosinemia
Not common symptoms: Strabismus, Abnormality of prenatal development or birth, Intellectual disability, Obesity, Death in infancy, Neonatal death, Hyperphenylalaninemia, Death in adolescence, Death in early adulthood

\n\n+4. Prader-Willi syndrome:
This is a rare genetic disorder caused by a deletion of genes on chromosome 15. It can cause short stature, obesity, and intellectual disability. 
Common symptoms: Obesity, Intellectual disability, Abnormality of prenatal development or birth
Not common symptoms: Strabismus, Death in infancy, Hypertyrosinemia, Neonatal death, Hyperphenylalaninemia, Death in adolescence, Death in early adulthood

\n\n+5. Mucopolysaccharidosis type I (MPS I):
This is a rare genetic disorder caused by a deficiency of the enzyme alpha-L-iduronidase. It can cause a range of symptoms including intellectual disability, joint problems, and respiratory issues. 
Common symptoms: Intellectual disability, Abnormality of prenatal development or birth
Not common symptoms: Strabismus, Obesity, Death in infancy, Hypertyrosinemia, Neonatal death, Hyperphenylalaninemia, Death in adolescence, Death in early adulthood

\n\n+6. Maple syrup urine disease (MSUD):
This is a rare genetic disorder caused by a deficiency of the enzyme branched-chain alpha-keto acid dehydrogenase complex. It can cause intellectual disability, seizures, and a characteristic sweet odor of the urine. 
Common symptoms: Intellectual disability
Not common symptoms: Strabismus, Abnormality of prenatal development or birth, Obesity, Death in infancy, Hypertyrosinemia, Neonatal death, Hyperphenylalaninemia, Death in adolescence, Death in early adulthood

Further testing and evaluation are needed to determine the underlying cause of the patient's symptoms."
['Ornithine transcarbamylase deficiency'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Ornithine transcarbamylase deficiency:
This is a rare genetic disorder that affects the urea cycle, leading to the accumulation of ammonia in the blood. The patient's symptoms that match this disease include: Hyperammonemia, Vomiting, Abnormal bleeding. However, the patient does not exhibit: Seizures, Developmental delay, which are common symptoms of this disease.

\n\n+2. Citrullinemia:
This is a rare genetic disorder that affects the urea cycle, leading to the accumulation of citrulline in the blood. The patient's symptoms that match this disease include: Hyperammonemia, Vomiting, Abnormal bleeding. However, the patient does not exhibit: Seizures, Developmental delay, which are common symptoms of this disease.

\n\n+3. Argininosuccinic aciduria:
This is a rare genetic disorder that affects the urea cycle, leading to the accumulation of argininosuccinic acid in the blood. The patient's symptoms that match this disease include: Hyperammonemia, Vomiting, Abnormal bleeding, Oroticaciduria. However, the patient does not exhibit: Seizures, Developmental delay, which are common symptoms of this disease.

\n\n+4. Carbamoyl phosphate synthetase I deficiency:
This is a rare genetic disorder that affects the urea cycle, leading to the accumulation of ammonia in the blood. The patient's symptoms that match this disease include: Hyperammonemia, Vomiting, Abnormal bleeding. However, the patient does not exhibit: Seizures, Developmental delay, which are common symptoms of this disease.

\n\n+5. N-acetylglutamate synthase deficiency:
This is a rare genetic disorder that affects the urea cycle, leading to the accumulation of ammonia in the blood. The patient's symptoms that match this disease include: Hyperammonemia, Vomiting, Abnormal bleeding. However, the patient does not exhibit: Seizures, Developmental delay, which are common symptoms of this disease.

\n\n+6. Orotic aciduria:
This is a rare genetic disorder that affects the metabolism of orotic acid. The patient's symptoms that match this disease include: Oroticaciduria, Abnormal bleeding. However, the patient does not exhibit: Megaloblastic anemia, which is a common symptom of this disease.

\n\n+7. Urea cycle disorder:
This is a group of rare genetic disorders that affect the urea cycle, leading to the accumulation of ammonia in the blood. The patient's symptoms that match this disease include: Hyperammonemia, Vomiting, Abnormal bleeding, Oroticaciduria. However, the patient does not exhibit: Seizures, Developmental delay, which are common symptoms of this disease.

After reviewing these potential diseases, I believe that further testing is necessary to determine the underlying cause of the patient's symptoms."
['L-2-hydroxyglutaric aciduria'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. L-2-Hydroxyglutaric Aciduria:
This is a rare genetic disorder characterized by elevated levels of L-2-hydroxyglutaric acid in the urine and blood. The patient's symptoms of Intellectual disability, Generalized hypotonia, Hyperreflexia, Hyperammonemia, Abnormal cerebral morphology, and L-2-hydroxyglutaric acidemia are all consistent with this disease. However, the patient does not exhibit seizures, which are commonly seen in this condition.

\n\n+2. Canavan Disease:
This is a genetic disorder caused by a deficiency of the enzyme aspartoacylase. The patient's symptoms of Intellectual disability, Generalized hypotonia, Abnormal cerebral morphology, and Abnormal myelination are all consistent with this disease. However, the patient does not exhibit macrocephaly, which is a hallmark of Canavan disease.

\n\n+3. Maple Syrup Urine Disease:
This is a rare genetic disorder caused by a deficiency of the enzyme branched-chain alpha-keto acid dehydrogenase complex. The patient's symptoms of Intellectual disability, Generalized hypotonia, Hyperreflexia, and Abnormal cerebral morphology are all consistent with this disease. However, the patient does not exhibit the characteristic maple syrup-like odor of their urine, which is a distinctive feature of this condition.

\n\n+4. Glutaric Acidemia Type I:
This is a rare genetic disorder caused by a deficiency of the enzyme glutaryl-CoA dehydrogenase. The patient's symptoms of Intellectual disability, Generalized hypotonia, Hyperreflexia, and Abnormal cerebral morphology are all consistent with this disease. However, the patient does not exhibit macrocephaly or a high risk of developing a subdural hematoma, which are common features of this condition.

\n\n+5. Methylmalonic Acidemia:
This is a rare genetic disorder caused by a deficiency of the enzyme methylmalonyl-CoA mutase. The patient's symptoms of Intellectual disability, Generalized hypotonia, Hyperreflexia, and Hyperammonemia are all consistent with this disease. However, the patient does not exhibit the characteristic metabolic acidosis or ketosis, which are common features of this condition.

\n\n+6. Propionic Acidemia:
This is a rare genetic disorder caused by a deficiency of the enzyme propionyl-CoA carboxylase. The patient's symptoms of Intellectual disability, Generalized hypotonia, Hyperreflexia, and Hyperammonemia are all consistent with this disease. However, the patient does not exhibit the characteristic metabolic acidosis or ketosis, which are common features of this condition.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms and to rule out other potential diseases."
['PMM2-CDG'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Joubert Syndrome:
This rare genetic disorder affects brain development, particularly the cerebellum and brainstem. It can cause intellectual disability, ataxia, and cerebellar atrophy, all of which are present in the patient. However, Joubert Syndrome is not typically associated with thromboembolism, stroke-like episodes, or death in infancy.

\n\n+2. Lhermitte-Duclos Disease:
This rare brain disorder is characterized by abnormal growth of the cerebellum, which can lead to ataxia, intellectual disability, and cerebellar atrophy. While the patient's symptoms align with this disease, Lhermitte-Duclos Disease is not typically associated with thromboembolism, stroke-like episodes, or death in infancy.

\n\n+3. Pontocerebellar Hypoplasia:
This is a group of rare genetic disorders that affect the development of the brain, particularly the cerebellum and pons. It can cause intellectual disability, ataxia, and cerebellar atrophy, all of which are present in the patient. However, Pontocerebellar Hypoplasia is not typically associated with thromboembolism or stroke-like episodes, and death in infancy is not a common feature.

\n\n+4. Cerebellar Agenesis:
This rare congenital disorder is characterized by the complete or partial absence of the cerebellum, which can cause ataxia, intellectual disability, and cerebellar agenesis, all of which are present in the patient. However, Cerebellar Agenesis is not typically associated with thromboembolism, stroke-like episodes, or death in infancy.

\n\n+5. MASA Syndrome:
This rare genetic disorder affects the development of the brain and spinal cord, causing intellectual disability, ataxia, and cerebellar atrophy, all of which are present in the patient. While MASA Syndrome can cause stroke-like episodes, it is not typically associated with thromboembolism or death in infancy.

\n\n+6. Aicardi-Goutires Syndrome:
This rare genetic disorder affects the brain and spinal cord, causing intellectual disability, ataxia, and cerebellar atrophy, all of which are present in the patient. While Aicardi-Goutires Syndrome can cause stroke-like episodes, it is not typically associated with thromboembolism or death in infancy.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms."
['Phenylketonuria'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Tyrosinemia Type I:
This is a rare genetic disorder caused by a deficiency of the enzyme fumarylacetoacetate hydrolase. Symptoms in common with the patient: Hypertyrosinemia, Death in infancy, Neonatal death. Symptoms not in common: None.

\n\n+2. Phenylketonuria (PKU):
This is a genetic disorder caused by a deficiency of the enzyme phenylalanine hydroxylase. Symptoms in common with the patient: Hyperphenylalaninemia, Premature birth. Symptoms not in common: Death in infancy, Neonatal death, Hypertyrosinemia.

\n\n+3. Maple Syrup Urine Disease (MSUD):
This is a rare genetic disorder caused by a deficiency of the enzyme branched-chain alpha-keto acid dehydrogenase complex. Symptoms in common with the patient: Premature birth, Death in infancy, Neonatal death. Symptoms not in common: Hypertyrosinemia, Hyperphenylalaninemia.

\n\n+4. Homocystinuria:
This is a rare genetic disorder caused by a deficiency of the enzyme cystathionine beta-synthase. Symptoms in common with the patient: Premature birth, Death in infancy. Symptoms not in common: Hypertyrosinemia, Hyperphenylalaninemia, Neonatal death.

\n\n+5. Methylmalonic Acidemia:
This is a rare genetic disorder caused by a deficiency of the enzyme methylmalonyl-CoA mutase. Symptoms in common with the patient: Premature birth, Death in infancy, Neonatal death. Symptoms not in common: Hypertyrosinemia, Hyperphenylalaninemia.

Based on these findings, I would like to conduct further tests to determine the underlying cause of the patient's symptoms."
['Propionic acidemia'],ERROR
['Wilson disease'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Wilson's Disease:
This is a genetic disorder that affects the body's ability to metabolize copper. The patient's symptoms of decreased circulating ceruloplasmin concentration and decreased circulating copper concentration are consistent with this disease. However, the patient's polydipsia and elevated circulating hepatic transaminase concentration are not typical symptoms of Wilson's Disease.

\n\n+2. Hemochromatosis:
This is a genetic disorder that affects the body's ability to absorb iron. While the patient's elevated circulating hepatic transaminase concentration could be related to this disease, the other symptoms do not match. Polydipsia is not typically associated with hemochromatosis, and the patient's decreased circulating ceruloplasmin and copper concentrations are not characteristic of this disease.

\n\n+3. Menkes Syndrome:
This is a rare genetic disorder that affects the body's ability to metabolize copper. The patient's symptoms of decreased circulating ceruloplasmin and copper concentrations are consistent with this disease. However, Menkes Syndrome typically presents in infancy, and the patient's death in adolescence is not a typical feature of this disease. Polydipsia is also not typically associated with Menkes Syndrome.

\n\n+4. Aceruloplasminemia:
This is a rare genetic disorder that affects the body's ability to metabolize iron and copper. The patient's symptoms of decreased circulating ceruloplasmin and copper concentrations are consistent with this disease. However, the patient's polydipsia and elevated circulating hepatic transaminase concentration are not typical symptoms of aceruloplasminemia.

\n\n+5. Copper Deficiency:
This is a nutritional disorder caused by a lack of copper in the diet. The patient's symptoms of decreased circulating ceruloplasmin and copper concentrations are consistent with this disease. However, the patient's polydipsia, elevated circulating hepatic transaminase concentration, and death in adolescence are not typical symptoms of copper deficiency.

After reviewing these potential diseases, I believe that Wilson's Disease is the most likely diagnosis, given the patient's symptoms of decreased circulating ceruloplasmin and copper concentrations. However, further testing is needed to confirm this diagnosis and rule out other potential causes."
['Ornithine transcarbamylase deficiency'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Glutamic Aciduria Type I:
This is a rare genetic disorder caused by a deficiency of the enzyme glutaryl-CoA dehydrogenase. It affects the breakdown of certain amino acids, leading to the accumulation of toxic compounds in the body.

Common symptoms: Seizure, Lethargy, Generalized hypotonia, Vomiting, Drowsiness, Hyperglutaminemia
Not common symptoms: Oroticaciduria, Neonatal death (although death in infancy is possible)

\n\n+2. Urea Cycle Disorder:
This is a group of rare genetic disorders that affect the body's ability to remove ammonia from the blood. Ammonia is a toxic compound that can cause brain damage and death.

Common symptoms: Vomiting, Lethargy, Seizure, Hyperglutaminemia
Not common symptoms: Generalized hypotonia, Sleep abnormality, Oroticaciduria, Neonatal death

\n\n+3. Pyridoxine-Dependent Epilepsy:
This is a rare genetic disorder caused by a deficiency of the enzyme alpha-aminoadipic semialdehyde synthase. It leads to the accumulation of toxic compounds in the brain, causing seizures and other neurological symptoms.

Common symptoms: Seizure, Lethargy, Sleep abnormality
Not common symptoms: Generalized hypotonia, Vomiting, Hyperglutaminemia, Oroticaciduria, Neonatal death

\n\n+4. Orotic Aciduria:
This is a rare genetic disorder caused by a deficiency of the enzyme orotate phosphoribosyltransferase. It affects the body's ability to synthesize certain nucleotides, leading to a range of symptoms.

Common symptoms: Oroticaciduria
Not common symptoms: Seizure, Lethargy, Generalized hypotonia, Vomiting, Drowsiness, Sleep abnormality, Hyperglutaminemia, Neonatal death

\n\n+5. Non-Ketotic Hyperglycinemia:
This is a rare genetic disorder caused by a deficiency of the enzyme glycine cleavage system. It leads to the accumulation of glycine in the body, causing a range of symptoms.

Common symptoms: Seizure, Lethargy, Generalized hypotonia, Vomiting, Drowsiness
Not common symptoms: Sleep abnormality, Hyperglutaminemia, Oroticaciduria, Neonatal death

Based on the patient's symptoms, I believe that Glutamic Aciduria Type I is the most likely diagnosis. However, further testing is needed to confirm this diagnosis and rule out other potential causes."
['Classic galactosemia'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Galactosemia:
This is a rare genetic disorder that affects the body's ability to metabolize galactose, a sugar found in milk. The patient's symptoms that match this disease include: Hypergalactosemia, Abnormality of galactoside metabolism, Feeding difficulties. However, the patient does not exhibit symptoms such as jaundice, liver damage, or kidney stones, which are commonly associated with Galactosemia.

\n\n+2. GM1 Gangliosidosis:
This is a lysosomal storage disorder caused by a deficiency of the enzyme beta-galactosidase. The patient's symptoms that match this disease include: Microcephaly, Delayed speech and language development, Intellectual disability, Motor delay, Generalized hypotonia, Death in infancy. However, the patient does not exhibit symptoms such as cherry-red spots on the macula, which are commonly associated with GM1 Gangliosidosis.

\n\n+3. Mucolipidosis IV:
This is a lysosomal storage disorder caused by a deficiency of the enzyme mucolipin. The patient's symptoms that match this disease include: Microcephaly, Delayed speech and language development, Intellectual disability, Motor delay, Generalized hypotonia, Feeding difficulties. However, the patient does not exhibit symptoms such as corneal clouding, which are commonly associated with Mucolipidosis IV.

\n\n+4. Sialidosis:
This is a lysosomal storage disorder caused by a deficiency of the enzyme sialidase. The patient's symptoms that match this disease include: Microcephaly, Delayed speech and language development, Intellectual disability, Motor delay, Generalized hypotonia, Abnormal circulating porphyrin concentration. However, the patient does not exhibit symptoms such as cherry-red spots on the macula, which are commonly associated with Sialidosis.

\n\n+5. Schindler Disease:
This is a lysosomal storage disorder caused by a deficiency of the enzyme alpha-N-acetylgalactosaminidase. The patient's symptoms that match this disease include: Microcephaly, Delayed speech and language development, Intellectual disability, Motor delay, Generalized hypotonia, Abnormality of galactoside metabolism. However, the patient does not exhibit symptoms such as skin lesions, which are commonly associated with Schindler Disease.

\n\n+6. Iron Deficiency Anemia:
This is a condition caused by a lack of iron in the body. The patient's symptoms that match this disease include: Anemia, Decreased circulating ferritin concentration, Decreased serum iron. However, the patient does not exhibit symptoms such as pale skin, weakness, or shortness of breath, which are commonly associated with Iron Deficiency Anemia.

\n\n+7. Peroxisomal Biogenesis Disorder:
This is a group of disorders caused by defects in the biogenesis of peroxisomes. The patient's symptoms that match this disease include: Microcephaly, Delayed speech and language development, Intellectual disability, Motor delay, Generalized hypotonia, Abnormality of prenatal development or birth. However, the patient does not exhibit symptoms such as facial dysmorphism, which are commonly associated with Peroxisomal Biogenesis Disorder.

\n\n+8. Zellweger Syndrome:
This is a peroxisomal biogenesis disorder caused by a defect in the PEX1 gene. The patient's symptoms that match this disease include: Microcephaly, Delayed speech and language development, Intellectual disability, Motor delay, Generalized hypotonia, Abnormality of prenatal development or birth, Death in infancy. However, the patient does not exhibit symptoms such as facial dysmorphism, which are commonly associated with Zellweger Syndrome.

These are the potential diseases that may be causing the patient's symptoms. Further testing and evaluation are necessary to determine the underlying cause of their condition."
['Biotinidase deficiency'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Propionic Acidemia:
This is a rare genetic disorder that affects the body's ability to break down certain fats and proteins. It can cause a range of symptoms, including hyperammonemia, which is elevated levels of ammonia in the blood. The patient's symptoms of hyperammonemia and death in childhood are consistent with this disease. However, obesity and abnormal foot morphology are not typically associated with propionic acidemia.

\n\n+2. Methylmalonic Acidemia:
Similar to propionic acidemia, this is a genetic disorder that affects the body's ability to break down fats and proteins. It can cause hyperammonemia, which is consistent with the patient's symptoms. However, obesity and abnormal foot morphology are not typically associated with methylmalonic acidemia, and death in childhood is not always a symptom.

\n\n+3. Carnitine Palmitoyltransferase I Deficiency:
This is a rare genetic disorder that affects the body's ability to break down fats for energy. It can cause hyperammonemia, which is consistent with the patient's symptoms. However, obesity and abnormal foot morphology are not typically associated with this disease, and death in childhood is not always a symptom.

\n\n+4. Argininosuccinic Aciduria:
This is a rare genetic disorder that affects the body's ability to break down ammonia. It can cause hyperammonemia, which is consistent with the patient's symptoms. The patient's symptoms of death in childhood are also consistent with this disease. However, obesity and abnormal foot morphology are not typically associated with argininosuccinic aciduria.

\n\n+5. Citrullinemia:
This is a rare genetic disorder that affects the body's ability to break down ammonia. It can cause hyperammonemia, which is consistent with the patient's symptoms. The patient's symptoms of death in childhood are also consistent with this disease. However, obesity and abnormal foot morphology are not typically associated with citrullinemia.

\n\n+6. Ornithine Transcarbamylase Deficiency:
This is a rare genetic disorder that affects the body's ability to break down ammonia. It can cause hyperammonemia, which is consistent with the patient's symptoms. The patient's symptoms of death in childhood are also consistent with this disease. However, obesity and abnormal foot morphology are not typically associated with ornithine transcarbamylase deficiency.

\n\n+7. Carbamoyl Phosphate Synthetase I Deficiency:
This is a rare genetic disorder that affects the body's ability to break down ammonia. It can cause hyperammonemia, which is consistent with the patient's symptoms. The patient's symptoms of death in childhood are also consistent with this disease. However, obesity and abnormal foot morphology are not typically associated with carbamoyl phosphate synthetase I deficiency.

After reviewing these potential diseases, I believe that further testing is necessary to determine the underlying cause of the patient's symptoms."
['Canavan disease'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Canavan disease:
This is a rare genetic disorder that affects the breakdown and use of aspartate, a type of amino acid. The patient's symptoms of Abnormal circulating aspartate family amino acid concentration, Hyperactivity, and Abnormal myelination are consistent with this disease. However, Canavan disease typically presents with intellectual disability, seizures, and muscle weakness, which are not mentioned in the patient's symptoms.

\n\n+2. Aspartylglucosaminuria:
This is a lysosomal storage disorder caused by a deficiency of the enzyme aspartylglucosaminidase. The patient's symptoms of Abnormal circulating aspartate family amino acid concentration and Feeding difficulties are consistent with this disease. However, Aspartylglucosaminuria typically presents with intellectual disability, coarse facial features, and skeletal abnormalities, which are not mentioned in the patient's symptoms.

\n\n+3. Citrullinemia:
This is a rare genetic disorder that affects the breakdown of certain amino acids. The patient's symptoms of Abnormal circulating aspartate family amino acid concentration and Hyperactivity are consistent with this disease. However, Citrullinemia typically presents with seizures, intellectual disability, and developmental delays, which are not mentioned in the patient's symptoms.

\n\n+4. Argininosuccinic aciduria:
This is a rare genetic disorder that affects the breakdown of certain amino acids. The patient's symptoms of Abnormal circulating aspartate family amino acid concentration and Hyperactivity are consistent with this disease. However, Argininosuccinic aciduria typically presents with seizures, intellectual disability, and developmental delays, which are not mentioned in the patient's symptoms.

\n\n+5. Maple syrup urine disease:
This is a rare genetic disorder that affects the breakdown of certain amino acids. The patient's symptoms of Abnormal circulating aspartate family amino acid concentration and Feeding difficulties are consistent with this disease. However, Maple syrup urine disease typically presents with intellectual disability, seizures, and a characteristic sweet odor of the urine, which are not mentioned in the patient's symptoms.

\n\n+6. Non-ketotic hyperglycinemia:
This is a rare genetic disorder that affects the breakdown of certain amino acids. The patient's symptoms of Abnormal circulating aspartate family amino acid concentration and Death in infancy are consistent with this disease. However, Non-ketotic hyperglycinemia typically presents with seizures, intellectual disability, and developmental delays, which are not mentioned in the patient's symptoms.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms and to rule out other potential diseases."
['Phenylketonuria'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Phenylketonuria (PKU):
This is a genetic disorder that affects the body's ability to break down the amino acid phenylalanine. It is characterized by hyperphenylalaninemia, which is an elevated level of phenylalanine in the blood. 
Common symptoms: Hyperphenylalaninemia, Abnormality of prenatal development or birth
Not common symptoms: None

\n\n+2. Maple syrup urine disease (MSUD):
This is a rare genetic disorder that affects the breakdown of certain amino acids. It is characterized by the accumulation of toxic compounds in the body, which can lead to death in infancy if left untreated.
Common symptoms: Abnormality of prenatal development or birth, Death in infancy, Neonatal death
Not common symptoms: Hyperphenylalaninemia

\n\n+3. Homocystinuria:
This is a rare genetic disorder that affects the metabolism of the amino acid methionine. It is characterized by elevated levels of homocysteine in the blood and urine, which can lead to a range of symptoms including developmental delays and blood clots.
Common symptoms: Abnormality of prenatal development or birth
Not common symptoms: Death in infancy, Neonatal death, Hyperphenylalaninemia

\n\n+4. Tyrosinemia type 1:
This is a rare genetic disorder that affects the breakdown of the amino acid tyrosine. It is characterized by elevated levels of tyrosine in the blood, which can lead to liver and kidney damage if left untreated.
Common symptoms: Abnormality of prenatal development or birth
Not common symptoms: Death in infancy, Neonatal death, Hyperphenylalaninemia

\n\n+5. Methylmalonic acidemia:
This is a rare genetic disorder that affects the breakdown of certain amino acids. It is characterized by the accumulation of toxic compounds in the body, which can lead to a range of symptoms including developmental delays and metabolic acidosis.
Common symptoms: Abnormality of prenatal development or birth
Not common symptoms: Death in infancy, Neonatal death, Hyperphenylalaninemia

Based on the patient's symptoms, I believe that Phenylketonuria (PKU) is the most likely diagnosis. However, further testing is needed to confirm this diagnosis and rule out other potential causes."
['Phenylketonuria'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Phenylketonuria (PKU):
This is a genetic disorder that affects the breakdown of the amino acid phenylalanine. The patient's symptoms of Delayed speech and language development, Abnormality of prenatal development or birth, Hyperphenylalaninemia, and Death in infancy are consistent with PKU. However, the patient does not exhibit symptoms of intellectual disability, seizures, or skin problems, which are also common in PKU patients.

\n\n+2. Tyrosinemia type I:
This is a rare genetic disorder caused by a deficiency of the enzyme fumarylacetoacetate hydrolase. The patient's symptoms of Hypertyrosinemia, Death in infancy, and Death in childhood are consistent with Tyrosinemia type I. However, the patient does not exhibit symptoms of liver or kidney dysfunction, which are common in Tyrosinemia type I patients.

\n\n+3. Homocystinuria:
This is a rare genetic disorder caused by a deficiency of the enzyme cystathionine beta-synthase. The patient's symptoms of Delayed speech and language development, Abnormality of prenatal development or birth, and Death in infancy are consistent with Homocystinuria. However, the patient does not exhibit symptoms of intellectual disability, seizures, or blood clots, which are common in Homocystinuria patients.

\n\n+4. Maple syrup urine disease (MSUD):
This is a rare genetic disorder caused by a deficiency of the enzyme branched-chain alpha-keto acid dehydrogenase complex. The patient's symptoms of Delayed speech and language development, Abnormality of prenatal development or birth, and Death in infancy are consistent with MSUD. However, the patient does not exhibit symptoms of intellectual disability, seizures, or a characteristic maple syrup-like odor in their urine, which are common in MSUD patients.

\n\n+5. Methylmalonic acidemia:
This is a rare genetic disorder caused by a deficiency of the enzyme methylmalonyl-CoA mutase. The patient's symptoms of Delayed speech and language development, Abnormality of prenatal development or birth, and Death in infancy are consistent with Methylmalonic acidemia. However, the patient does not exhibit symptoms of intellectual disability, seizures, or metabolic acidosis, which are common in Methylmalonic acidemia patients.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms and to rule out other potential diseases."
[],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Barth Syndrome:
This is a rare genetic disorder that affects the heart and skeletal muscles. The patient's symptoms of Ventricular septal defect, Cardiomyopathy, and Pulmonic stenosis are consistent with this disease. However, Barth Syndrome typically presents with neutropenia, which is not mentioned in the patient's symptoms.

\n\n+2. Noonan Syndrome:
This genetic disorder can cause a range of symptoms, including heart defects and muscle weakness. The patient's symptoms of Ventricular septal defect, Pulmonic stenosis, and Generalized hypotonia are consistent with this disease. However, Noonan Syndrome often presents with distinctive facial features and short stature, which are not mentioned in the patient's symptoms.

\n\n+3. Pompe Disease:
This is a lysosomal storage disorder that can cause muscle weakness, heart problems, and respiratory issues. The patient's symptoms of Generalized hypotonia, Cardiomyopathy, and Death in infancy are consistent with this disease. However, Pompe Disease typically presents with enlarged liver and spleen, which are not mentioned in the patient's symptoms.

\n\n+4. Marfan Syndrome:
This genetic disorder affects the body's connective tissue and can cause a range of symptoms, including heart problems and muscle weakness. The patient's symptoms of Ventricular septal defect, Pulmonic stenosis, and Generalized hypotonia are consistent with this disease. However, Marfan Syndrome often presents with tall stature, long limbs, and eye problems, which are not mentioned in the patient's symptoms.

\n\n+5. Alport Syndrome:
This is a genetic disorder that affects the kidneys and can cause hearing loss and eye problems. The patient's symptom of Nephritis is consistent with this disease. However, Alport Syndrome typically presents with progressive kidney disease, which is not mentioned in the patient's symptoms.

\n\n+6. Williams Syndrome:
This genetic disorder can cause a range of symptoms, including heart defects, muscle weakness, and developmental delays. The patient's symptoms of Ventricular septal defect, Pulmonic stenosis, and Generalized hypotonia are consistent with this disease. However, Williams Syndrome often presents with distinctive facial features, short stature, and intellectual disability, which are not mentioned in the patient's symptoms.

Further testing and evaluation are needed to determine the underlying cause of the patient's symptoms."
['Phenylketonuria'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Homocystinuria:
This is a rare genetic disorder caused by a deficiency of the enzyme cystathionine beta-synthase. It can cause a range of symptoms including irritability, spasticity, and hyperreflexia, which the patient is experiencing. However, homocystinuria is not typically associated with death in infancy, neonatal death, or recurrent viral infections, which the patient also has.

\n\n+2. Tyrosinemia type I:
This is a rare genetic disorder caused by a deficiency of the enzyme fumarylacetoacetate hydrolase. It can cause hypertyrosinemia, which the patient has, as well as liver and kidney damage. However, tyrosinemia type I is not typically associated with spasticity, hyperreflexia, or recurrent viral infections.

\n\n+3. Phenylketonuria (PKU):
This is a genetic disorder caused by a deficiency of the enzyme phenylalanine hydroxylase. It can cause hyperphenylalaninemia, which the patient has, as well as intellectual disability and seizures if left untreated. However, PKU is not typically associated with death in infancy, neonatal death, or recurrent viral infections.

\n\n+4. Maple syrup urine disease (MSUD):
This is a rare genetic disorder caused by a deficiency of the enzyme branched-chain alpha-keto acid dehydrogenase complex. It can cause irritability, spasticity, and hyperreflexia, which the patient is experiencing. However, MSUD is not typically associated with hypertyrosinemia, hyperphenylalaninemia, or recurrent viral infections.

\n\n+5. Mucopolysaccharidosis type I (MPS I):
This is a rare genetic disorder caused by a deficiency of the enzyme alpha-L-iduronidase. It can cause death in infancy, neonatal death, and recurrent viral infections, which the patient has. However, MPS I is not typically associated with hypertyrosinemia, hyperphenylalaninemia, or spasticity.

\n\n+6. Adrenoleukodystrophy (ALD):
This is a rare genetic disorder caused by a deficiency of the enzyme acyl-CoA synthetase. It can cause death in childhood, death in adolescence, and recurrent viral infections, which the patient has. However, ALD is not typically associated with hypertyrosinemia, hyperphenylalaninemia, or spasticity.

Further testing and evaluation are needed to determine the underlying cause of the patient's symptoms."
['Medium chain acyl-CoA dehydrogenase deficiency'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Carnitine Palmitoyltransferase I Deficiency:
This is a rare genetic disorder that affects the breakdown of fatty acids. The patient's symptoms of abnormal circulating carnitine concentration and abnormality of prenatal development or birth are consistent with this disease. However, the patient does not exhibit symptoms of muscle weakness, seizures, or hypoglycemia, which are commonly associated with this condition.

\n\n+2. Carnitine-Acylcarnitine Translocase Deficiency:
This is another rare genetic disorder that affects the transport of fatty acids into the mitochondria. The patient's symptoms of abnormal circulating carnitine concentration, abnormality of prenatal development or birth, and neonatal death are consistent with this disease. However, the patient does not exhibit symptoms of cardiomyopathy, which is commonly associated with this condition.

\n\n+3. Very-Long-Chain Acyl-CoA Dehydrogenase Deficiency:
This is a rare genetic disorder that affects the breakdown of fatty acids. The patient's symptoms of abnormal circulating carnitine concentration, abnormality of prenatal development or birth, and death in infancy are consistent with this disease. However, the patient does not exhibit symptoms of muscle weakness, seizures, or hypoglycemia, which are commonly associated with this condition.

\n\n+4. Carnitine Deficiency:
This is a condition characterized by a lack of carnitine in the body. The patient's symptoms of abnormal circulating carnitine concentration and abnormality of prenatal development or birth are consistent with this disease. However, the patient does not exhibit symptoms of muscle weakness, fatigue, or heart problems, which are commonly associated with this condition.

\n\n+5. Barth Syndrome:
This is a rare genetic disorder that affects the production of cardiolipin, a type of lipid found in the mitochondria. The patient's symptoms of abnormal circulating carnitine concentration, abnormality of prenatal development or birth, and neonatal death are consistent with this disease. However, the patient does not exhibit symptoms of cardiomyopathy, muscle weakness, or neutropenia, which are commonly associated with this condition.

These are just a few potential diseases that may be causing the patient's symptoms. Further testing and evaluation are necessary to determine the underlying cause of their condition."
['Phenylketonuria'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Phenylketonuria (PKU):
This is a genetic disorder that affects the breakdown of the amino acid phenylalanine. Symptoms in common: 'Delayed speech and language development', 'Hyperphenylalaninemia'. Symptoms not in common: None.

\n\n+2. Tyrosinemia type I:
This is a rare genetic disorder caused by a deficiency of the enzyme fumarylacetoacetate hydrolase. Symptoms in common: 'Hypertyrosinemia', 'Death in infancy', 'Death in childhood'. Symptoms not in common: 'Delayed speech and language development', 'Generalized hypotonia'.

\n\n+3. Homocystinuria:
This is a rare genetic disorder caused by a deficiency of the enzyme cystathionine beta-synthase. Symptoms in common: 'Delayed speech and language development', 'Abnormality of prenatal development or birth'. Symptoms not in common: 'Hypertyrosinemia', 'Neonatal death', 'Death in childhood'.

\n\n+4. Maple syrup urine disease (MSUD):
This is a rare genetic disorder caused by a deficiency of the enzyme branched-chain alpha-keto acid dehydrogenase complex. Symptoms in common: 'Delayed speech and language development', 'Generalized hypotonia', 'Death in infancy'. Symptoms not in common: 'Hypertyrosinemia', 'Hyperphenylalaninemia'.

\n\n+5. Methylmalonic acidemia:
This is a rare genetic disorder caused by a deficiency of the enzyme methylmalonyl-CoA mutase. Symptoms in common: 'Delayed speech and language development', 'Generalized hypotonia', 'Death in infancy'. Symptoms not in common: 'Hypertyrosinemia', 'Hyperphenylalaninemia'.

\n\n+6. Propionic acidemia:
This is a rare genetic disorder caused by a deficiency of the enzyme propionyl-CoA carboxylase. Symptoms in common: 'Delayed speech and language development', 'Generalized hypotonia', 'Death in infancy'. Symptoms not in common: 'Hypertyrosinemia', 'Hyperphenylalaninemia'.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms."
['Glutaryl-CoA dehydrogenase deficiency'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Glutaric Acidemia Type I:
This is a rare genetic disorder caused by a deficiency of the enzyme glutaryl-CoA dehydrogenase. It affects the breakdown of certain amino acids and can lead to a buildup of toxic compounds in the body.

Common symptoms: Glutaric aciduria, Elevated circulating glutaric acid concentration, Decreased plasma free carnitine, Elevated urinary carboxylic acid
Uncommon symptoms: Seizure, Encephalopathy, Death in infancy, Opisthotonus, Death in childhood

\n\n+2. Glutaric Acidemia Type II:
This is another rare genetic disorder caused by a deficiency of the enzyme electron transfer flavoprotein (ETF) or ETF-ubiquinone oxidoreductase. It affects the breakdown of fatty acids and can lead to a buildup of toxic compounds in the body.

Common symptoms: Glutaric aciduria, Elevated circulating glutaric acid concentration, Decreased plasma free carnitine, Elevated urinary carboxylic acid
Uncommon symptoms: Seizure, Encephalopathy, Death in infancy, Opisthotonus, Death in childhood

\n\n+3. Carnitine Deficiency:
This is a condition where the body is unable to produce or obtain enough carnitine, a nutrient that plays a crucial role in energy production.

Common symptoms: Decreased plasma free carnitine
Uncommon symptoms: Seizure, Encephalopathy, Death in infancy, Opisthotonus, Death in childhood, Glutaric aciduria, Elevated circulating glutaric acid concentration, Elevated urinary carboxylic acid

\n\n+4. Maple Syrup Urine Disease:
This is a rare genetic disorder caused by a deficiency of the enzyme branched-chain alpha-keto acid dehydrogenase complex. It affects the breakdown of certain amino acids and can lead to a buildup of toxic compounds in the body.

Common symptoms: Seizure, Encephalopathy, Death in infancy
Uncommon symptoms: Opisthotonus, Death in childhood, Glutaric aciduria, Elevated circulating glutaric acid concentration, Decreased plasma free carnitine, Elevated urinary carboxylic acid

\n\n+5. Methylmalonic Acidemia:
This is a rare genetic disorder caused by a deficiency of the enzyme methylmalonyl-CoA mutase. It affects the breakdown of certain amino acids and can lead to a buildup of toxic compounds in the body.

Common symptoms: Elevated urinary carboxylic acid
Uncommon symptoms: Seizure, Encephalopathy, Death in infancy, Opisthotonus, Death in childhood, Glutaric aciduria, Elevated circulating glutaric acid concentration, Decreased plasma free carnitine

Please note that these are just potential diagnoses, and further testing and evaluation are necessary to confirm the exact cause of the patient's symptoms."
[],ERROR
['PMM2-CDG'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. **Cerebrohepatorenal syndrome**: 
This rare genetic disorder affects the brain, liver, and kidneys. Common symptoms include intellectual disability, ataxia, motor delay, cerebellar atrophy, and generalized hypotonia, all of which the patient exhibits. However, the patient does not display symptoms of kidney dysfunction, which is typically present in this condition.

\n\n+2. **Glycogen storage disease type IV**: 
This inherited disorder affects the metabolism of glycogen, leading to liver and muscle damage. The patient's symptoms of cirrhosis, hepatic fibrosis, and death in infancy are consistent with this condition. However, the patient does not exhibit muscle weakness or cramping, which is typically seen in this disease.

\n\n+3. **Antithrombin III deficiency**: 
This rare genetic disorder affects blood clotting, leading to an increased risk of thromboembolism. The patient's symptoms of reduced antithrombin III activity and thromboembolism are consistent with this condition. However, the patient does not exhibit symptoms of deep vein thrombosis or pulmonary embolism, which are typically seen in this disease.

\n\n+4. **Berardinelli-Seip congenital lipodystrophy**: 
This rare genetic disorder affects fat distribution, leading to lipodystrophy. The patient's symptoms of lipodystrophy and death in adolescence are consistent with this condition. However, the patient does not exhibit symptoms of insulin resistance or diabetes, which are typically seen in this disease.

\n\n+5. **Joubert syndrome**: 
This rare genetic disorder affects brain development, leading to intellectual disability, ataxia, and cerebellar atrophy. The patient's symptoms of strabismus, intellectual disability, ataxia, and cerebellar atrophy are consistent with this condition. However, the patient does not exhibit symptoms of retinal dystrophy or kidney dysfunction, which are typically seen in this disease.

\n\n+6. **Dandy-Walker syndrome**: 
This rare genetic disorder affects brain development, leading to intellectual disability, ataxia, and cerebellar atrophy. The patient's symptoms of intellectual disability, ataxia, and cerebellar atrophy are consistent with this condition. However, the patient does not exhibit symptoms of hydrocephalus or agenesis of the corpus callosum, which are typically seen in this disease.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms and to rule out other potential diseases."
['Canavan disease'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Argininosuccinic aciduria:
This is a rare genetic disorder that affects the urea cycle, leading to the accumulation of toxic compounds in the blood. The patient's symptoms that match this disease include: Irritability, Seizure, Generalized hypotonia, Hyperreflexia, Feeding difficulties. However, the patient does not exhibit the following symptoms commonly associated with this disease: Vomiting, Lethargy, Developmental delays.

\n\n+2. Maple syrup urine disease:
This is a rare genetic disorder that affects the breakdown of certain amino acids. The patient's symptoms that match this disease include: Irritability, Seizure, Generalized hypotonia, Feeding difficulties, Abnormal circulating aspartate family amino acid concentration. However, the patient does not exhibit the following symptoms commonly associated with this disease: Sweet-smelling urine, Developmental delays, Intellectual disability.

\n\n+3. Homocystinuria:
This is a rare genetic disorder that affects the metabolism of the amino acid methionine. The patient's symptoms that match this disease include: Irritability, Seizure, Generalized hypotonia, Hyperreflexia, Abnormal circulating aspartate family amino acid concentration. However, the patient does not exhibit the following symptoms commonly associated with this disease: Ectopia lentis, Osteoporosis, Intellectual disability.

\n\n+4. Methylmalonic acidemia:
This is a rare genetic disorder that affects the breakdown of certain amino acids. The patient's symptoms that match this disease include: Irritability, Seizure, Generalized hypotonia, Feeding difficulties, Abnormal circulating aspartate family amino acid concentration. However, the patient does not exhibit the following symptoms commonly associated with this disease: Vomiting, Lethargy, Developmental delays.

\n\n+5. Menkes disease:
This is a rare genetic disorder that affects the production of copper in the body. The patient's symptoms that match this disease include: Irritability, Seizure, Generalized hypotonia, Hyperreflexia, Feeding difficulties. However, the patient does not exhibit the following symptoms commonly associated with this disease: Kinky hair, Pale skin, Intellectual disability.

\n\n+6. Non-ketotic hyperglycinemia:
This is a rare genetic disorder that affects the breakdown of the amino acid glycine. The patient's symptoms that match this disease include: Irritability, Seizure, Generalized hypotonia, Hyperreflexia, Abnormal circulating aspartate family amino acid concentration, Death in infancy, Opisthotonus. However, the patient does not exhibit the following symptoms commonly associated with this disease: Lethargy, Respiratory failure.

After reviewing these potential diseases, I believe that further testing is necessary to determine the underlying cause of the patient's symptoms."
['Phenylketonuria'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Tyrosinemia Type I:
This is a rare genetic disorder caused by a deficiency of the enzyme fumarylacetoacetate hydrolase. Symptoms in common with the patient: Abnormality of prenatal development or birth, Hypertyrosinemia, Gastrointestinal inflammation, Neonatal death. Symptoms not in common: None.

\n\n+2. Phenylketonuria (PKU):
This is a genetic disorder caused by a deficiency of the enzyme phenylalanine hydroxylase. Symptoms in common with the patient: Abnormality of prenatal development or birth, Hyperphenylalaninemia. Symptoms not in common: Death in infancy, Gastrointestinal inflammation, Neonatal death.

\n\n+3. Maple Syrup Urine Disease (MSUD):
This is a rare genetic disorder caused by a deficiency of the enzyme branched-chain alpha-keto acid dehydrogenase complex. Symptoms in common with the patient: Abnormality of prenatal development or birth, Death in infancy, Neonatal death. Symptoms not in common: Hypertyrosinemia, Hyperphenylalaninemia, Gastrointestinal inflammation.

\n\n+4. Homocystinuria:
This is a rare genetic disorder caused by a deficiency of the enzyme cystathionine beta-synthase. Symptoms in common with the patient: Abnormality of prenatal development or birth, Death in infancy. Symptoms not in common: Hypertyrosinemia, Hyperphenylalaninemia, Gastrointestinal inflammation, Neonatal death.

\n\n+5. Citrullinemia:
This is a rare genetic disorder caused by a deficiency of the enzyme argininosuccinate synthase. Symptoms in common with the patient: Abnormality of prenatal development or birth, Death in infancy. Symptoms not in common: Hypertyrosinemia, Hyperphenylalaninemia, Gastrointestinal inflammation, Neonatal death.

Based on the patient's symptoms, Tyrosinemia Type I appears to be the most likely diagnosis. However, further testing and evaluation are necessary to confirm the diagnosis and rule out other potential causes."
['Maple syrup urine disease'],ERROR
['Acute intermittent porphyria'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Acute Porphyria: 
This is a group of rare genetic disorders that can cause abdominal pain, among other symptoms. The patient's elevated urinary delta-aminolevulinic acid (ALA) is also consistent with this diagnosis. However, Acute Porphyria typically does not result in death in childhood, so this symptom does not align with the patient's presentation.

\n\n+2. Lead Poisoning: 
Lead poisoning can cause abdominal pain and elevated levels of ALA in the urine. However, it is not typically associated with death in childhood, and the patient's symptoms do not suggest exposure to lead.

\n\n+3. AIP (Acute Intermittent Porphyria): 
AIP is a genetic disorder that can cause abdominal pain, elevated ALA levels, and even death in childhood. This diagnosis is highly consistent with the patient's symptoms, and I would like to order further testing to confirm or rule out this possibility.

\n\n+4. Variegate Porphyria: 
This is another genetic disorder that can cause abdominal pain and elevated ALA levels. While it is possible that the patient has Variegate Porphyria, the symptom of death in childhood is less common in this condition, making AIP a more likely diagnosis.

\n\n+5. Hereditary Coproporphyria: 
This is a rare genetic disorder that can cause abdominal pain and elevated ALA levels. However, it is not typically associated with death in childhood, and the patient's symptoms do not suggest this diagnosis.

Based on the patient's symptoms, I believe that AIP (Acute Intermittent Porphyria) is the most likely diagnosis. I would like to order further testing, including genetic testing and a urine porphobilinogen (PBG) test, to confirm this diagnosis."
['Vitamin B12-unresponsive methylmalonic acidemia'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Methylmalonic acidemia:
This is a rare genetic disorder caused by a deficiency of the enzyme methylmalonyl-CoA mutase. It is characterized by the accumulation of methylmalonic acid in the blood, leading to metabolic acidosis, seizures, and developmental delays. 
Common symptoms: Seizure, Metabolic acidosis, Methylmalonic aciduria
Not common symptoms: Death in infancy, Neonatal death (although possible, not always present)

\n\n+2. Methylmalonyl-CoA mutase deficiency:
This is a rare genetic disorder caused by a deficiency of the enzyme methylmalonyl-CoA mutase. It is characterized by the accumulation of methylmalonic acid in the blood, leading to metabolic acidosis, seizures, and developmental delays. 
Common symptoms: Seizure, Metabolic acidosis, Methylmalonic aciduria
Not common symptoms: Death in infancy, Neonatal death (although possible, not always present)

\n\n+3. Combined malonic and methylmalonic aciduria (CMAMMA):
This is a rare genetic disorder caused by a deficiency of the enzymes malonyl-CoA decarboxylase and methylmalonyl-CoA mutase. It is characterized by the accumulation of malonic acid and methylmalonic acid in the blood, leading to metabolic acidosis, seizures, and developmental delays. 
Common symptoms: Seizure, Metabolic acidosis, Methylmalonic aciduria
Not common symptoms: Death in infancy, Neonatal death (although possible, not always present)

\n\n+4. Isovaleric acidemia:
This is a rare genetic disorder caused by a deficiency of the enzyme isovaleryl-CoA dehydrogenase. It is characterized by the accumulation of isovaleric acid in the blood, leading to metabolic acidosis, seizures, and developmental delays. 
Common symptoms: Seizure, Metabolic acidosis
Not common symptoms: Death in infancy, Neonatal death, Methylmalonic aciduria

\n\n+5. Propionic acidemia:
This is a rare genetic disorder caused by a deficiency of the enzyme propionyl-CoA carboxylase. It is characterized by the accumulation of propionic acid in the blood, leading to metabolic acidosis, seizures, and developmental delays. 
Common symptoms: Seizure, Metabolic acidosis
Not common symptoms: Death in infancy, Neonatal death, Methylmalonic aciduria

Based on the patient's symptoms, I believe that Methylmalonic acidemia or Methylmalonyl-CoA mutase deficiency are the most likely diagnoses. However, further testing is necessary to confirm the diagnosis and rule out other potential causes."
['Alkaptonuria'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. **Glutaric Acidemia Type I**: 
This is a rare genetic disorder that affects the breakdown of certain amino acids. The patient's symptoms that match this disease include: Seizure, Lethargy, Generalized hypotonia, Growth delay, Drowsiness, and Sleep abnormality. However, the patient does not exhibit the symptom of macrocephaly (enlarged head) which is commonly seen in this disease.

\n\n+2. **Mucopolysaccharidosis Type VII**: 
This is a lysosomal storage disorder caused by the deficiency of an enzyme needed to break down sugar molecules. The patient's symptoms that match this disease include: Seizure, Lethargy, Generalized hypotonia, Growth delay, and Dark urine. However, the patient does not exhibit the symptoms of coarse facial features, joint stiffness, and corneal clouding which are commonly seen in this disease.

\n\n+3. **Gaucher Disease Type 2**: 
This is a lysosomal storage disorder caused by the deficiency of an enzyme needed to break down fatty substances. The patient's symptoms that match this disease include: Seizure, Lethargy, Generalized hypotonia, Growth delay, and Drowsiness. However, the patient does not exhibit the symptoms of enlarged liver and spleen, and difficulty swallowing which are commonly seen in this disease.

\n\n+4. **Krabbe Disease**: 
This is a lysosomal storage disorder caused by the deficiency of an enzyme needed to break down fatty substances. The patient's symptoms that match this disease include: Seizure, Lethargy, Generalized hypotonia, Growth delay, and Drowsiness. However, the patient does not exhibit the symptoms of vision loss, and muscle weakness which are commonly seen in this disease.

\n\n+5. **Menkes Syndrome**: 
This is a genetic disorder that affects the production of an enzyme needed for copper transport. The patient's symptoms that match this disease include: Seizure, Lethargy, Generalized hypotonia, Growth delay, and Drowsiness. However, the patient does not exhibit the symptoms of kinky hair, and loose skin which are commonly seen in this disease.

\n\n+6. **Zellweger Syndrome**: 
This is a genetic disorder that affects the function of peroxisomes, which are involved in the breakdown of fatty acids. The patient's symptoms that match this disease include: Seizure, Lethargy, Generalized hypotonia, Growth delay, Drowsiness, and Death in childhood. However, the patient does not exhibit the symptoms of facial dysmorphism, and liver dysfunction which are commonly seen in this disease.

Further testing and evaluation are needed to determine the underlying cause of the patient's symptoms and to rule out other potential diseases."
['Maple syrup urine disease'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Maple Syrup Urine Disease: 
This disease is a rare genetic disorder that affects the breakdown of certain amino acids. The patient's symptoms of Aminoaciduria, Abnormal circulating leucine concentration, Abnormal circulating isoleucine concentration, and Abnormal circulating valine concentration are all consistent with this disease. However, Maple Syrup Urine Disease typically presents with a distinctive sweet odor in the urine, which is not mentioned in the patient's symptoms.

\n\n+2. Isovaleric Acidemia:
This is another rare genetic disorder that affects the breakdown of the amino acid leucine. The patient's symptoms of Abnormal circulating leucine concentration and Aminoaciduria are consistent with this disease. However, Isovaleric Acidemia often presents with vomiting, diarrhea, and a strong ""sweaty feet"" odor, which are not mentioned in the patient's symptoms.

\n\n+3. Methylmalonic Acidemia:
This is a genetic disorder that affects the breakdown of certain amino acids and fatty acids. The patient's symptoms of Aminoaciduria, Abnormal circulating leucine concentration, and Abnormal circulating isoleucine concentration are all consistent with this disease. However, Methylmalonic Acidemia often presents with vomiting, diarrhea, and developmental delays, which are not mentioned in the patient's symptoms.

\n\n+4. Propionic Acidemia:
This is a rare genetic disorder that affects the breakdown of certain amino acids and fatty acids. The patient's symptoms of Aminoaciduria, Abnormal circulating leucine concentration, and Abnormal circulating isoleucine concentration are all consistent with this disease. However, Propionic Acidemia often presents with vomiting, diarrhea, and developmental delays, which are not mentioned in the patient's symptoms.

\n\n+5. MSUD Type 1:
This is a severe form of Maple Syrup Urine Disease that presents in infancy. The patient's symptoms of Seizure, Death in infancy, Neonatal death, Aminoaciduria, Abnormal circulating leucine concentration, Abnormal circulating isoleucine concentration, and Abnormal circulating valine concentration are all consistent with this disease.

Please note that a definitive diagnosis can only be made with further testing and evaluation. These potential diseases are based on the patient's symptoms and may not be the only possible causes of their condition."
['Very long chain acyl-CoA dehydrogenase deficiency'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Carnitine Palmitoyltransferase I Deficiency:
This is a rare genetic disorder that affects the body's ability to break down fats for energy. The patient's symptoms that match this disease include: Abnormal circulating carnitine concentration, Hypoglycemia, Hepatomegaly, and Cardiomegaly. However, the patient does not exhibit symptoms of muscle weakness, seizures, or developmental delays, which are commonly associated with this disease.

\n\n+2. Carnitine-Acylcarnitine Translocase Deficiency:
This is another rare genetic disorder that affects the transport of fatty acids into the mitochondria. The patient's symptoms that match this disease include: Abnormal circulating carnitine concentration, Hypoglycemia, Hepatomegaly, Cardiomegaly, and Death in infancy. However, the patient does not exhibit symptoms of muscle weakness, seizures, or developmental delays, which are commonly associated with this disease.

\n\n+3. Very-Long-Chain Acyl-CoA Dehydrogenase Deficiency:
This is a rare genetic disorder that affects the breakdown of fatty acids. The patient's symptoms that match this disease include: Hypoglycemia, Hepatomegaly, Cardiomegaly, and Abnormal circulating carnitine concentration. However, the patient does not exhibit symptoms of muscle weakness, seizures, or developmental delays, which are commonly associated with this disease.

\n\n+4. Medium-Chain Acyl-CoA Dehydrogenase Deficiency:
This is a rare genetic disorder that affects the breakdown of fatty acids. The patient's symptoms that match this disease include: Hypoglycemia, Hepatomegaly, Cardiomegaly, and Abnormal circulating carnitine concentration. However, the patient does not exhibit symptoms of muscle weakness, seizures, or developmental delays, which are commonly associated with this disease.

\n\n+5. Glutaric Acidemia Type II:
This is a rare genetic disorder that affects the breakdown of fatty acids and amino acids. The patient's symptoms that match this disease include: Hypoglycemia, Hepatomegaly, Cardiomegaly, Dicarboxylic aciduria, and Abnormal circulating carnitine concentration. However, the patient does not exhibit symptoms of muscle weakness, seizures, or developmental delays, which are commonly associated with this disease.

\n\n+6. Multiple Acyl-CoA Dehydrogenase Deficiency:
This is a rare genetic disorder that affects the breakdown of fatty acids and amino acids. The patient's symptoms that match this disease include: Hypoglycemia, Hepatomegaly, Cardiomegaly, Dicarboxylic aciduria, and Abnormal circulating carnitine concentration. However, the patient does not exhibit symptoms of muscle weakness, seizures, or developmental delays, which are commonly associated with this disease.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms and to rule out other potential diseases."
['3-hydroxy-3-methylglutaric aciduria'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Glutaric Aciduria Type I:
This is a rare genetic disorder caused by a deficiency of the enzyme glutaryl-CoA dehydrogenase. Symptoms in common with the patient: Glutaric aciduria, Metabolic acidosis, Hypoglycemia, Vomiting, Lethargy, Seizure, Progressive neurologic deterioration. Symptoms not in common: None.

\n\n+2. Isovaleric Acidemia:
This is a rare genetic disorder caused by a deficiency of the enzyme isovaleryl-CoA dehydrogenase. Symptoms in common with the patient: Metabolic acidosis, Hypoglycemia, Vomiting, Lethargy, Seizure, Death in infancy. Symptoms not in common: Glutaric aciduria, 3-Methylglutaric aciduria, Abnormal circulating glycine concentration, Elevated urinary carboxylic acid.

\n\n+3. Multiple Carboxylase Deficiency:
This is a rare genetic disorder caused by a deficiency of the enzyme holocarboxylase synthetase. Symptoms in common with the patient: Metabolic acidosis, Hypoglycemia, Vomiting, Lethargy, Seizure, Death in infancy, Elevated urinary carboxylic acid. Symptoms not in common: Glutaric aciduria, 3-Methylglutaric aciduria, Abnormal circulating glycine concentration.

\n\n+4. Propionic Acidemia:
This is a rare genetic disorder caused by a deficiency of the enzyme propionyl-CoA carboxylase. Symptoms in common with the patient: Metabolic acidosis, Hypoglycemia, Vomiting, Lethargy, Seizure, Death in infancy. Symptoms not in common: Glutaric aciduria, 3-Methylglutaric aciduria, Abnormal circulating glycine concentration, Elevated urinary carboxylic acid.

\n\n+5. Methylmalonic Acidemia:
This is a rare genetic disorder caused by a deficiency of the enzyme methylmalonyl-CoA mutase. Symptoms in common with the patient: Metabolic acidosis, Hypoglycemia, Vomiting, Lethargy, Seizure, Death in infancy. Symptoms not in common: Glutaric aciduria, 3-Methylglutaric aciduria, Abnormal circulating glycine concentration, Elevated urinary carboxylic acid.

\n\n+6. Non-Ketotic Hyperglycinemia:
This is a rare genetic disorder caused by a deficiency of the enzyme glycine cleavage system. Symptoms in common with the patient: Abnormal circulating glycine concentration, Seizure, Lethargy, Death in infancy. Symptoms not in common: Metabolic acidosis, Hypoglycemia, Vomiting, Glutaric aciduria, 3-Methylglutaric aciduria, Elevated urinary carboxylic acid.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms."
['MODY'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Diabetes Mellitus:
This disease is characterized by high blood sugar levels, which can lead to glycosuria (excess glucose in the urine). The patient's symptoms of glycosuria and hypoglycemia (low blood sugar) are consistent with this diagnosis. However, the patient's abnormal circulating porphyrin concentration is not typically associated with diabetes mellitus.

\n\n+2. Porphyria:
This group of disorders is characterized by abnormal production of porphyrins, which can lead to a range of symptoms including abnormal circulating porphyrin concentration. The patient's symptoms of abnormal circulating porphyrin concentration are consistent with this diagnosis. However, the patient's symptoms of hypoglycemia and glycosuria are not typically associated with porphyria.

\n\n+3. Adrenal Insufficiency:
This disease is characterized by inadequate production of hormones by the adrenal glands, which can lead to hypoglycemia. The patient's symptoms of hypoglycemia are consistent with this diagnosis. However, the patient's symptoms of glycosuria and abnormal circulating porphyrin concentration are not typically associated with adrenal insufficiency.

\n\n+4. Pheochromocytoma:
This rare tumor of the adrenal glands can cause a range of symptoms including hypoglycemia and abnormal circulating porphyrin concentration. The patient's symptoms of hypoglycemia and abnormal circulating porphyrin concentration are consistent with this diagnosis. However, the patient's symptoms of glycosuria are not typically associated with pheochromocytoma.

\n\n+5. Insulinoma:
This rare tumor of the pancreas can cause hypoglycemia due to excessive insulin production. The patient's symptoms of hypoglycemia are consistent with this diagnosis. However, the patient's symptoms of glycosuria and abnormal circulating porphyrin concentration are not typically associated with insulinoma.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms and to rule out other potential diagnoses."
['Phenylketonuria'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Phenylketonuria (PKU):
This is a genetic disorder that affects the breakdown of the amino acid phenylalanine. The patient's symptoms of 'Abnormality of prenatal development or birth', 'Hyperphenylalaninemia' are consistent with PKU. However, PKU patients typically do not exhibit 'Death in infancy' or 'Neonatal death' unless left untreated.

\n\n+2. Maple syrup urine disease (MSUD):
This is a rare genetic disorder that affects the breakdown of certain amino acids. The patient's symptoms of 'Abnormality of prenatal development or birth', 'Death in infancy', and 'Neonatal death' are consistent with MSUD. However, MSUD patients typically do not exhibit 'Hyperphenylalaninemia'.

\n\n+3. Homocystinuria:
This is a genetic disorder that affects the breakdown of the amino acid homocysteine. The patient's symptoms of 'Abnormality of prenatal development or birth' and 'Hyperphenylalaninemia' are consistent with Homocystinuria. However, Homocystinuria patients typically do not exhibit 'Death in infancy' or 'Neonatal death'.

\n\n+4. Tyrosinemia type 1:
This is a genetic disorder that affects the breakdown of the amino acid tyrosine. The patient's symptoms of 'Abnormality of prenatal development or birth' and 'Death in infancy' are consistent with Tyrosinemia type 1. However, Tyrosinemia type 1 patients typically do not exhibit 'Hyperphenylalaninemia'.

\n\n+5. Methylmalonic acidemia:
This is a genetic disorder that affects the breakdown of certain amino acids. The patient's symptoms of 'Abnormality of prenatal development or birth' and 'Neonatal death' are consistent with Methylmalonic acidemia. However, Methylmalonic acidemia patients typically do not exhibit 'Hyperphenylalaninemia'.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms."
['Glutaryl-CoA dehydrogenase deficiency'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Glutaric acidemia type I:
This is a rare genetic disorder caused by a deficiency of the enzyme glutaryl-CoA dehydrogenase. It affects the breakdown of certain amino acids and can lead to the accumulation of toxic compounds in the body.

Common symptoms: Glutaric aciduria, Macrocephaly, Hydrocephalus, Seizure, Lethargy, Dystonia, Hyperreflexia, Death in infancy, Cerebral atrophy, Opisthotonus, Drowsiness, Sleep abnormality, Upper airway obstruction, Increased CSF protein concentration
Uncommon symptoms: Anemia, Fever, Vomiting, Fasciculations, Recurrent viral infections, Chronic pulmonary obstruction, Death in childhood, Death in adolescence

\n\n+2. Canavan disease:
This is a rare genetic disorder caused by a deficiency of the enzyme aspartoacylase. It affects the breakdown of certain amino acids and can lead to the accumulation of toxic compounds in the brain.

Common symptoms: Macrocephaly, Hydrocephalus, Seizure, Lethargy, Dystonia, Hyperreflexia, Death in infancy, Cerebral atrophy, Opisthotonus, Drowsiness, Sleep abnormality
Uncommon symptoms: Anemia, Fever, Vomiting, Fasciculations, Glutaric aciduria, Recurrent viral infections, Chronic pulmonary obstruction, Death in childhood, Death in adolescence, Upper airway obstruction, Increased CSF protein concentration

\n\n+3. Alexander disease:
This is a rare genetic disorder caused by mutations in the GFAP gene. It affects the production of a protein called glial fibrillary acidic protein, which is essential for the development and maintenance of the central nervous system.

Common symptoms: Macrocephaly, Hydrocephalus, Seizure, Lethargy, Dystonia, Hyperreflexia, Death in infancy, Cerebral atrophy, Opisthotonus, Drowsiness, Sleep abnormality
Uncommon symptoms: Anemia, Fever, Vomiting, Fasciculations, Glutaric aciduria, Recurrent viral infections, Chronic pulmonary obstruction, Death in childhood, Death in adolescence, Upper airway obstruction, Increased CSF protein concentration

\n\n+4. Mucopolysaccharidosis type I (Hurler syndrome):
This is a rare genetic disorder caused by a deficiency of the enzyme alpha-L-iduronidase. It affects the breakdown of certain sugars and can lead to the accumulation of toxic compounds in the body.

Common symptoms: Hydrocephalus, Macrocephaly, Seizure, Lethargy, Dystonia, Hyperreflexia, Death in infancy, Cerebral atrophy, Opisthotonus, Drowsiness, Sleep abnormality
Uncommon symptoms: Anemia, Fever, Vomiting, Fasciculations, Glutaric aciduria, Recurrent viral infections, Chronic pulmonary obstruction, Death in childhood, Death in adolescence, Upper airway obstruction, Increased CSF protein concentration

\n\n+5. Leigh syndrome:
This is a rare genetic disorder caused by mutations in the mitochondrial DNA. It affects the production of energy in the cells and can lead to the accumulation of toxic compounds in the body.

Common symptoms: Seizure, Lethargy, Dystonia, Hyperreflexia, Death in infancy, Cerebral atrophy, Opisthotonus, Drowsiness, Sleep abnormality
Uncommon symptoms: Anemia, Fever, Vomiting, Fasciculations, Glutaric aciduria, Recurrent viral infections, Chronic pulmonary obstruction, Death in childhood, Death in adolescence, Upper airway obstruction, Increased CSF protein concentration, Hydrocephalus, Macrocephaly

Please note that this is not an exhaustive list, and further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms."
['Phenylketonuria'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Tyrosinemia Type I:
This is a rare genetic disorder caused by a deficiency of the enzyme fumarylacetoacetate hydrolase. Symptoms in common with the patient: Abnormality of prenatal development or birth, Hypertyrosinemia, Death in infancy, Neonatal death, Death in childhood. Symptoms not in common: None.

\n\n+2. Phenylketonuria (PKU):
This is a genetic disorder caused by a deficiency of the enzyme phenylalanine hydroxylase. Symptoms in common with the patient: Hyperphenylalaninemia, Abnormality of prenatal development or birth, Death in infancy, Death in childhood. Symptoms not in common: None.

\n\n+3. Maple Syrup Urine Disease (MSUD):
This is a rare genetic disorder caused by a deficiency of the enzyme branched-chain alpha-keto acid dehydrogenase complex. Symptoms in common with the patient: Abnormality of prenatal development or birth, Death in infancy, Death in childhood. Symptoms not in common: Hypertyrosinemia, Hyperphenylalaninemia.

\n\n+4. Homocystinuria:
This is a rare genetic disorder caused by a deficiency of the enzyme cystathionine beta-synthase. Symptoms in common with the patient: Abnormality of prenatal development or birth, Death in infancy, Death in childhood. Symptoms not in common: Hypertyrosinemia, Hyperphenylalaninemia.

\n\n+5. Methylmalonic Acidemia:
This is a rare genetic disorder caused by a deficiency of the enzyme methylmalonyl-CoA mutase. Symptoms in common with the patient: Abnormality of prenatal development or birth, Death in infancy, Death in childhood. Symptoms not in common: Hypertyrosinemia, Hyperphenylalaninemia.

Based on the patient's symptoms, I believe that Tyrosinemia Type I and Phenylketonuria (PKU) are the most likely diagnoses. However, further testing and evaluation are necessary to confirm the diagnosis and rule out other potential causes."
['Phenylketonuria'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Tyrosinemia Type I:
This is a rare genetic disorder caused by a deficiency of the enzyme fumarylacetoacetate hydrolase. It is characterized by elevated levels of tyrosine in the blood and urine, which can lead to liver and kidney damage.

Common symptoms: Hypertyrosinemia
Not common symptoms: Hyperphenylalaninemia, Preeclampsia, Death in early adulthood (although if left untreated, Tyrosinemia Type I can lead to early death)

\n\n+2. Phenylketonuria (PKU):
This is a genetic disorder caused by a deficiency of the enzyme phenylalanine hydroxylase. It is characterized by elevated levels of phenylalanine in the blood, which can lead to intellectual disability and other neurological problems if left untreated.

Common symptoms: Hyperphenylalaninemia
Not common symptoms: Hypertyrosinemia, Preeclampsia, Death in early adulthood (although if left untreated, PKU can lead to intellectual disability and other neurological problems)

\n\n+3. Homocystinuria:
This is a rare genetic disorder caused by a deficiency of the enzyme cystathionine beta-synthase. It is characterized by elevated levels of homocysteine in the blood, which can lead to blood clots, heart problems, and intellectual disability.

Common symptoms: None
Not common symptoms: Hypertyrosinemia, Hyperphenylalaninemia, Preeclampsia, Death in early adulthood (although Homocystinuria can increase the risk of blood clots and heart problems)

\n\n+4. Maple Syrup Urine Disease (MSUD):
This is a rare genetic disorder caused by a deficiency of the enzyme branched-chain alpha-keto acid dehydrogenase complex. It is characterized by elevated levels of branched-chain amino acids in the blood, which can lead to intellectual disability, seizures, and death if left untreated.

Common symptoms: None
Not common symptoms: Hypertyrosinemia, Hyperphenylalaninemia, Preeclampsia, Death in early adulthood (although MSUD can lead to intellectual disability, seizures, and death if left untreated)

\n\n+5. Eclampsia:
This is a rare but life-threatening complication of pregnancy characterized by seizures and hypertension. It is often preceded by preeclampsia.

Common symptoms: Preeclampsia
Not common symptoms: Hypertyrosinemia, Hyperphenylalaninemia, Death in early adulthood (although eclampsia can lead to maternal and fetal mortality)

Based on the patient's symptoms, I believe that Tyrosinemia Type I and Phenylketonuria (PKU) are the most likely diagnoses. However, further testing and evaluation are necessary to confirm the diagnosis and rule out other potential causes."
['Phenylketonuria'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Tyrosinemia Type I:
This is a rare genetic disorder caused by a deficiency of the enzyme fumarylacetoacetate hydrolase. Symptoms in common with the patient: Hypertyrosinemia, Elevated urinary carboxylic acid, Death in infancy, Neonatal death. Symptoms not in common: None.

\n\n+2. Phenylketonuria (PKU):
This is a genetic disorder caused by a deficiency of the enzyme phenylalanine hydroxylase. Symptoms in common with the patient: Hyperphenylalaninemia, Death in infancy, Death in early adulthood. Symptoms not in common: Abnormality of prenatal development or birth.

\n\n+3. Maple Syrup Urine Disease (MSUD):
This is a rare genetic disorder caused by a deficiency of the enzyme branched-chain alpha-keto acid dehydrogenase complex. Symptoms in common with the patient: Elevated urinary carboxylic acid, Death in infancy, Neonatal death. Symptoms not in common: Abnormality of prenatal development or birth, Hypertyrosinemia, Hyperphenylalaninemia.

\n\n+4. Homocystinuria:
This is a rare genetic disorder caused by a deficiency of the enzyme cystathionine beta-synthase. Symptoms in common with the patient: Elevated urinary carboxylic acid, Death in early adulthood. Symptoms not in common: Abnormality of prenatal development or birth, Hypertyrosinemia, Hyperphenylalaninemia, Death in infancy, Neonatal death.

\n\n+5. Methylmalonic Acidemia:
This is a rare genetic disorder caused by a deficiency of the enzyme methylmalonyl-CoA mutase. Symptoms in common with the patient: Elevated urinary carboxylic acid, Death in infancy, Neonatal death. Symptoms not in common: Abnormality of prenatal development or birth, Hypertyrosinemia, Hyperphenylalaninemia.

After reviewing these potential diseases, I believe that Tyrosinemia Type I is the most likely diagnosis, given the patient's symptoms. However, further testing and evaluation are necessary to confirm this diagnosis."
['Phenylketonuria'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Tyrosinemia Type I:
This is a rare genetic disorder caused by a deficiency of the enzyme fumarylacetoacetate hydrolase. Symptoms in common with the patient: Abnormality of prenatal development or birth, Hypertyrosinemia, Death in infancy, Neonatal death, Death in childhood. Symptoms not in common: None.

\n\n+2. Phenylketonuria (PKU):
This is a genetic disorder caused by a deficiency of the enzyme phenylalanine hydroxylase. Symptoms in common with the patient: Hyperphenylalaninemia, Abnormality of prenatal development or birth, Death in infancy, Death in childhood. Symptoms not in common: None.

\n\n+3. Homocystinuria:
This is a rare genetic disorder caused by a deficiency of the enzyme cystathionine beta-synthase. Symptoms in common with the patient: Abnormality of prenatal development or birth, Death in infancy, Death in childhood. Symptoms not in common: Hypertyrosinemia, Hyperphenylalaninemia.

\n\n+4. Maple Syrup Urine Disease (MSUD):
This is a rare genetic disorder caused by a deficiency of the enzyme branched-chain alpha-keto acid dehydrogenase complex. Symptoms in common with the patient: Abnormality of prenatal development or birth, Death in infancy, Death in childhood. Symptoms not in common: Hypertyrosinemia, Hyperphenylalaninemia.

\n\n+5. Citrullinemia:
This is a rare genetic disorder caused by a deficiency of the enzyme argininosuccinate synthase. Symptoms in common with the patient: Abnormality of prenatal development or birth, Death in infancy, Death in childhood. Symptoms not in common: Hypertyrosinemia, Hyperphenylalaninemia.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms and to rule out other potential diseases."
['Hereditary orotic aciduria'],ERROR
['Holocarboxylase synthetase deficiency'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Propionic Acidemia:
This is a rare genetic disorder caused by a deficiency of the enzyme propionyl-CoA carboxylase. The patient's symptoms that match this disease include: Propionyl-CoA carboxylase deficiency, Hyperammonemia, Metabolic acidosis, Anemia, Diarrhea, Tachypnea, Abnormal circulating glycine concentration, Abnormal circulating monocarboxylic acid concentration, and Elevated urinary carboxylic acid. However, the patient does not exhibit symptoms of intellectual disability, seizures, or developmental delays, which are commonly associated with this disease.

\n\n+2. Methylmalonic Acidemia:
This is another rare genetic disorder caused by a deficiency of the enzyme methylmalonyl-CoA mutase. The patient's symptoms that match this disease include: Metabolic acidosis, Hyperammonemia, Anemia, Diarrhea, Tachypnea, Abnormal circulating glycine concentration, Abnormal circulating monocarboxylic acid concentration, and Elevated urinary carboxylic acid. However, the patient does not exhibit symptoms of intellectual disability, seizures, or developmental delays, which are commonly associated with this disease.

\n\n+3. Isovaleric Acidemia:
This is a rare genetic disorder caused by a deficiency of the enzyme isovaleryl-CoA dehydrogenase. The patient's symptoms that match this disease include: Metabolic acidosis, Hyperammonemia, Anemia, Diarrhea, Tachypnea, Abnormal circulating glycine concentration, Abnormal circulating monocarboxylic acid concentration, and Elevated urinary carboxylic acid. However, the patient does not exhibit symptoms of a characteristic ""sweaty feet"" odor, which is commonly associated with this disease.

\n\n+4. Pyruvate Carboxylase Deficiency:
This is a rare genetic disorder caused by a deficiency of the enzyme pyruvate carboxylase. The patient's symptoms that match this disease include: Decreased pyruvate carboxylase activity, Metabolic acidosis, Hyperammonemia, Anemia, Diarrhea, Tachypnea, Abnormal circulating glycine concentration, and Abnormal circulating monocarboxylic acid concentration. However, the patient does not exhibit symptoms of intellectual disability, seizures, or developmental delays, which are commonly associated with this disease.

\n\n+5. Multiple Carboxylase Deficiency:
This is a rare genetic disorder caused by a deficiency of multiple carboxylase enzymes. The patient's symptoms that match this disease include: Propionyl-CoA carboxylase deficiency, Decreased pyruvate carboxylase activity, Metabolic acidosis, Hyperammonemia, Anemia, Diarrhea, Tachypnea, Abnormal circulating glycine concentration, Abnormal circulating monocarboxylic acid concentration, and Elevated urinary carboxylic acid. However, the patient does not exhibit symptoms of intellectual disability, seizures, or developmental delays, which are commonly associated with this disease.

\n\n+6. Holocarboxylase Synthetase Deficiency:
This is a rare genetic disorder caused by a deficiency of the enzyme holocarboxylase synthetase. The patient's symptoms that match this disease include: Propionyl-CoA carboxylase deficiency, Decreased pyruvate carboxylase activity, Metabolic acidosis, Hyperammonemia, Anemia, Diarrhea, Tachypnea, Abnormal circulating glycine concentration, Abnormal circulating monocarboxylic acid concentration, and Elevated urinary carboxylic acid. However, the patient does not exhibit symptoms of intellectual disability, seizures, or developmental delays, which are commonly associated with this disease.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms and to rule out other potential diseases."
['Ornithine transcarbamylase deficiency'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Ornithine Transcarbamylase Deficiency (OTCD):
This is a rare genetic disorder that affects the urea cycle, leading to the accumulation of ammonia in the blood. The patient's symptoms that match this disease include Hyperammonemia, Vomiting, Lethargy, and Drowsiness. However, the patient does not exhibit symptoms such as seizures, developmental delays, or intellectual disability, which are commonly associated with OTCD.

\n\n+2. Citrullinemia:
This is a rare genetic disorder that affects the urea cycle, leading to the accumulation of citrulline in the blood. The patient's symptoms that match this disease include Hyperammonemia, Vomiting, Lethargy, and Drowsiness. However, the patient does not exhibit symptoms such as seizures, developmental delays, or intellectual disability, which are commonly associated with Citrullinemia.

\n\n+3. Argininosuccinic Aciduria (ASA):
This is a rare genetic disorder that affects the urea cycle, leading to the accumulation of argininosuccinic acid in the blood. The patient's symptoms that match this disease include Hyperammonemia, Vomiting, Lethargy, and Drowsiness. However, the patient does not exhibit symptoms such as seizures, developmental delays, or intellectual disability, which are commonly associated with ASA.

\n\n+4. Urea Cycle Disorder (UCD):
This is a group of rare genetic disorders that affect the urea cycle, leading to the accumulation of ammonia in the blood. The patient's symptoms that match this disease include Hyperammonemia, Vomiting, Lethargy, and Drowsiness. However, the patient does not exhibit symptoms such as seizures, developmental delays, or intellectual disability, which are commonly associated with UCD.

\n\n+5. Orotic Aciduria:
This is a rare genetic disorder that affects the metabolism of orotic acid, leading to the accumulation of orotic acid in the urine. The patient's symptoms that match this disease include Oroticaciduria, Hyperammonemia, and Vomiting. However, the patient does not exhibit symptoms such as megaloblastic anemia, which is commonly associated with Orotic Aciduria.

\n\n+6. Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes (MELAS):
This is a rare genetic disorder that affects the mitochondria, leading to energy production defects. The patient's symptoms that match this disease include Apathy, Ataxia, Lethargy, and Sleep abnormality. However, the patient does not exhibit symptoms such as seizures, stroke-like episodes, or muscle weakness, which are commonly associated with MELAS.

\n\n+7. Leigh Syndrome:
This is a rare genetic disorder that affects the mitochondria, leading to energy production defects. The patient's symptoms that match this disease include Apathy, Ataxia, Lethargy, and Sleep abnormality. However, the patient does not exhibit symptoms such as seizures, muscle weakness, or optic atrophy, which are commonly associated with Leigh Syndrome.

Based on the patient's symptoms, I believe that Ornithine Transcarbamylase Deficiency (OTCD) or Orotic Aciduria are the most likely diagnoses. However, further testing and evaluation are necessary to confirm the diagnosis and rule out other potential causes."
[],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Multiple Acyl-CoA Dehydrogenase Deficiency (MADD):
This is a rare genetic disorder that affects the body's ability to break down fats and carbohydrates. The patient's symptoms of vomiting, abnormal circulating carnitine concentration, and decreased 3-hydroxyacyl-CoA dehydrogenase level are consistent with MADD. However, the patient does not exhibit symptoms of hypotonia, seizures, or developmental delays, which are commonly seen in MADD patients.

\n\n+2. Ethylmalonic Encephalopathy (EE):
This is a rare genetic disorder that affects the brain and nervous system. The patient's symptoms of ethylmalonic aciduria, vomiting, and death in childhood or adolescence are consistent with EE. However, the patient does not exhibit symptoms of seizures, hypotonia, or developmental delays, which are commonly seen in EE patients.

\n\n+3. Mitochondrial Trifunctional Protein Deficiency (MTPD):
This is a rare genetic disorder that affects the mitochondria, the energy-producing structures within cells. The patient's symptoms of vomiting, abnormal circulating carnitine concentration, and decreased 3-hydroxyacyl-CoA dehydrogenase level are consistent with MTPD. However, the patient does not exhibit symptoms of hypotonia, seizures, or developmental delays, which are commonly seen in MTPD patients.

\n\n+4. Carnitine Palmitoyltransferase I Deficiency (CPT I):
This is a rare genetic disorder that affects the body's ability to break down fats. The patient's symptoms of vomiting, abnormal circulating carnitine concentration, and decreased 3-hydroxyacyl-CoA dehydrogenase level are consistent with CPT I. However, the patient does not exhibit symptoms of hypoketotic hypoglycemia, which is commonly seen in CPT I patients.

\n\n+5. Very Long-Chain Acyl-CoA Dehydrogenase Deficiency (VLCADD):
This is a rare genetic disorder that affects the body's ability to break down fats. The patient's symptoms of vomiting, abnormal circulating carnitine concentration, and decreased 3-hydroxyacyl-CoA dehydrogenase level are consistent with VLCADD. However, the patient does not exhibit symptoms of hypoketotic hypoglycemia, which is commonly seen in VLCADD patients.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms and to rule out other potential diseases."
['Smith-Lemli-Opitz syndrome'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Smith-Lemli-Opitz syndrome:
This is a rare genetic disorder that affects the development of multiple body systems. The patient's symptoms that match this disease include: Low-set ears, Wide nasal bridge, Anteverted nares, Ptosis, Syndactyly, Intellectual disability, Motor delay, Generalized hypotonia, Feeding difficulties. The patient does not exhibit: None of the symptoms listed are inconsistent with this disease.

\n\n+2. Lenz-Majewski hyperostotic dwarfism:
This is a rare genetic disorder that affects bone growth and development. The patient's symptoms that match this disease include: Low-set ears, Wide nasal bridge, Ptosis, Intellectual disability, Motor delay, Generalized hypotonia. The patient does not exhibit: Syndactyly, Death in infancy, Neonatal death, Elevated 8-dehydrocholesterol, Elevated circulating 7-dehydrocholesterol concentration.

\n\n+3. CHARGE syndrome:
This is a rare genetic disorder that affects multiple body systems. The patient's symptoms that match this disease include: Low-set ears, Wide nasal bridge, Ptosis, Intellectual disability, Motor delay, Generalized hypotonia, Feeding difficulties. The patient does not exhibit: Syndactyly, Death in infancy, Neonatal death, Elevated 8-dehydrocholesterol, Elevated circulating 7-dehydrocholesterol concentration.

\n\n+4. RSH/Smith-Lemli-Opitz syndrome:
This is a rare genetic disorder that affects cholesterol synthesis. The patient's symptoms that match this disease include: Low-set ears, Wide nasal bridge, Anteverted nares, Ptosis, Syndactyly, Intellectual disability, Motor delay, Generalized hypotonia, Feeding difficulties, Hypocholesterolemia, Elevated 8-dehydrocholesterol, Elevated circulating 7-dehydrocholesterol concentration. The patient does not exhibit: None of the symptoms listed are inconsistent with this disease.

\n\n+5. MEND syndrome:
This is a rare genetic disorder that affects cholesterol synthesis. The patient's symptoms that match this disease include: Low-set ears, Wide nasal bridge, Anteverted nares, Ptosis, Syndactyly, Intellectual disability, Motor delay, Generalized hypotonia, Feeding difficulties, Hypocholesterolemia, Elevated 8-dehydrocholesterol, Elevated circulating 7-dehydrocholesterol concentration. The patient does not exhibit: Death in infancy, Neonatal death.

After reviewing these potential diseases, I believe that the patient's symptoms are most consistent with Smith-Lemli-Opitz syndrome or RSH/Smith-Lemli-Opitz syndrome. Further testing and evaluation are necessary to confirm the diagnosis."
['L-2-hydroxyglutaric aciduria'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. L-2-Hydroxyglutaric Aciduria:
This is a rare genetic disorder characterized by elevated levels of L-2-hydroxyglutaric acid in the urine and blood. The patient's symptoms of Intellectual disability, Ataxia, Tremor, and L-2-hydroxyglutaric aciduria are consistent with this disease. However, the patient does not exhibit symptoms of seizures, which are commonly associated with this condition.

\n\n+2. Canavan Disease:
This is a genetic disorder caused by a deficiency of the enzyme aspartoacylase. The patient's symptoms of Intellectual disability, Ataxia, and Cerebral atrophy are consistent with this disease. However, the patient does not exhibit symptoms of macrocephaly (enlarged head) or white matter degeneration, which are commonly associated with this condition.

\n\n+3. Glutaric Acidemia Type I:
This is a genetic disorder caused by a deficiency of the enzyme glutaryl-CoA dehydrogenase. The patient's symptoms of Intellectual disability, Ataxia, Tremor, and Death in infancy are consistent with this disease. However, the patient does not exhibit symptoms of macrocephaly or hepatomegaly (enlarged liver), which are commonly associated with this condition.

\n\n+4. Leigh Syndrome:
This is a rare genetic disorder caused by mutations in the mitochondrial DNA. The patient's symptoms of Intellectual disability, Ataxia, Tremor, and Cerebral atrophy are consistent with this disease. However, the patient does not exhibit symptoms of muscle weakness or vision loss, which are commonly associated with this condition.

\n\n+5. Methylmalonic Acidemia:
This is a genetic disorder caused by a deficiency of the enzyme methylmalonyl-CoA mutase. The patient's symptoms of Intellectual disability, Ataxia, and Death in infancy are consistent with this disease. However, the patient does not exhibit symptoms of metabolic acidosis or hyperammonemia, which are commonly associated with this condition.

\n\n+6. Propionic Acidemia:
This is a genetic disorder caused by a deficiency of the enzyme propionyl-CoA carboxylase. The patient's symptoms of Intellectual disability, Ataxia, and Death in infancy are consistent with this disease. However, the patient does not exhibit symptoms of metabolic acidosis or hyperammonemia, which are commonly associated with this condition.

\n\n+7. Isovaleric Acidemia:
This is a genetic disorder caused by a deficiency of the enzyme isovaleryl-CoA dehydrogenase. The patient's symptoms of Intellectual disability, Ataxia, and Death in infancy are consistent with this disease. However, the patient does not exhibit symptoms of metabolic acidosis or hyperammonemia, which are commonly associated with this condition.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms and to rule out other potential diseases."
['3-hydroxy-3-methylglutaric aciduria'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. 3-Methylglutaconic Aciduria Type I:
This is a rare genetic disorder that affects the breakdown of certain fatty acids. The patient's symptoms that match this disease include: 3-Methylglutaconic aciduria, Dicarboxylic aciduria, and Elevated urinary carboxylic acid. However, the patient does not exhibit other common symptoms of this disease, such as intellectual disability and delayed speech.

\n\n+2. 3-Methylglutaconic Aciduria Type IV:
This is another rare genetic disorder that affects the breakdown of fatty acids. The patient's symptoms that match this disease include: 3-Methylglutaconic aciduria, Dicarboxylic aciduria, and Elevated urinary carboxylic acid. However, the patient does not exhibit other common symptoms of this disease, such as intellectual disability, delayed speech, and muscle weakness.

\n\n+3. Glutaric Acidemia Type I:
This is a rare genetic disorder that affects the breakdown of certain amino acids. The patient's symptoms that match this disease include: Metabolic acidosis, Opisthotonus, and Elevated urinary carboxylic acid. However, the patient does not exhibit other common symptoms of this disease, such as macrocephaly and intellectual disability.

\n\n+4. Methylmalonic Acidemia:
This is a rare genetic disorder that affects the breakdown of certain amino acids. The patient's symptoms that match this disease include: Metabolic acidosis, Seizure, and Elevated urinary carboxylic acid. However, the patient does not exhibit other common symptoms of this disease, such as vomiting, diarrhea, and developmental delays.

\n\n+5. Propionic Acidemia:
This is a rare genetic disorder that affects the breakdown of certain amino acids. The patient's symptoms that match this disease include: Metabolic acidosis, Seizure, and Elevated urinary carboxylic acid. However, the patient does not exhibit other common symptoms of this disease, such as vomiting, diarrhea, and developmental delays.

\n\n+6. Isovaleric Acidemia:
This is a rare genetic disorder that affects the breakdown of certain amino acids. The patient's symptoms that match this disease include: Metabolic acidosis, Seizure, and Elevated urinary carboxylic acid. However, the patient does not exhibit other common symptoms of this disease, such as vomiting, diarrhea, and developmental delays.

\n\n+7. Multiple Carboxylase Deficiency:
This is a rare genetic disorder that affects the breakdown of certain amino acids. The patient's symptoms that match this disease include: Metabolic acidosis, Seizure, and Elevated urinary carboxylic acid. However, the patient does not exhibit other common symptoms of this disease, such as skin rash, hair loss, and developmental delays.

Based on these findings, I recommend further testing to determine the underlying cause of the patient's symptoms."
['L-2-hydroxyglutaric aciduria'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. **Gaucher Disease**: A genetic disorder that affects the breakdown of fatty substances in the body.

Common symptoms: Skin rash, Fever, Elevated circulating C-reactive protein concentration
Not common symptoms: Obsolete Eczematoid dermatitis, Seizure, Death in infancy, L-2-hydroxyglutaric aciduria, Decreased serum iron

\n\n+2. **L-2-Hydroxyglutaric Aciduria**: A rare genetic disorder that affects the breakdown of certain amino acids.

Common symptoms: L-2-hydroxyglutaric aciduria, Seizure
Not common symptoms: Obsolete Eczematoid dermatitis, Skin rash, Fever, Elevated circulating C-reactive protein concentration, Death in infancy, Decreased serum iron

\n\n+3. **Hereditary Hemochromatosis**: A genetic disorder that affects the body's ability to absorb iron.

Common symptoms: Decreased serum iron
Not common symptoms: Obsolete Eczematoid dermatitis, Skin rash, Fever, Elevated circulating C-reactive protein concentration, Seizure, Death in infancy, L-2-hydroxyglutaric aciduria

\n\n+4. **Meningococcemia**: A bacterial infection that causes inflammation of the lining around the brain and spinal cord.

Common symptoms: Fever, Elevated circulating C-reactive protein concentration, Skin rash
Not common symptoms: Obsolete Eczematoid dermatitis, Seizure, Death in infancy, L-2-hydroxyglutaric aciduria, Decreased serum iron

\n\n+5. **Neonatal Sepsis**: A bacterial infection that occurs in newborns.

Common symptoms: Fever, Elevated circulating C-reactive protein concentration, Death in infancy
Not common symptoms: Obsolete Eczematoid dermatitis, Skin rash, Seizure, L-2-hydroxyglutaric aciduria, Decreased serum iron

\n\n+6. **Erythema Multiforme**: A skin condition that causes a rash and blisters.

Common symptoms: Skin rash
Not common symptoms: Obsolete Eczematoid dermatitis, Fever, Elevated circulating C-reactive protein concentration, Seizure, Death in infancy, L-2-hydroxyglutaric aciduria, Decreased serum iron

Please note that this is not an exhaustive list, and further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms."
['X-linked hypophosphatemia'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Hypophosphatasia:
This is a rare genetic disorder that affects the development of bones and teeth. The patient's symptoms of Hypophosphatemia, Abnormal limb bone morphology, and Elevated circulating alkaline phosphatase concentration are consistent with this disease. However, the patient does not exhibit symptoms of impaired cognitive development, which is often seen in Hypophosphatasia patients.

\n\n+2. Rickets:
This is a condition that affects bone development in children, often due to a lack of vitamin D or calcium. The patient's symptoms of Hypophosphatemia, Abnormal limb bone morphology, and Elevated circulating alkaline phosphatase concentration are similar to those seen in Rickets patients. However, the patient does not exhibit symptoms of bowed legs or stunted growth, which are common in Rickets cases.

\n\n+3. Fanconi Syndrome:
This is a rare genetic disorder that affects the kidneys and can lead to a range of symptoms. The patient's symptoms of Nephritis, Hypophosphatemia, and Abnormal circulating hormone concentration are consistent with Fanconi Syndrome. However, the patient does not exhibit symptoms of proteinuria or aminoaciduria, which are often seen in Fanconi Syndrome patients.

\n\n+4. McCune-Albright Syndrome:
This is a rare genetic disorder that affects the bones, skin, and endocrine system. The patient's symptoms of Abnormal limb bone morphology, Abnormal circulating hormone concentration, and Elevated circulating alkaline phosphatase concentration are similar to those seen in McCune-Albright Syndrome patients. However, the patient does not exhibit symptoms of caf-au-lait spots or polyostotic fibrous dysplasia, which are common in McCune-Albright Syndrome cases.

\n\n+5. X-Linked Hypophosphatemic Rickets:
This is a genetic disorder that affects the development of bones and teeth. The patient's symptoms of Hypophosphatemia, Abnormal limb bone morphology, and Elevated circulating alkaline phosphatase concentration are consistent with X-Linked Hypophosphatemic Rickets. However, the patient does not exhibit symptoms of short stature or dental abnormalities, which are often seen in X-Linked Hypophosphatemic Rickets patients.

Further testing and evaluation are needed to determine the underlying cause of the patient's symptoms and to rule out other potential diseases."
['Propionic acidemia'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Propionic Acidemia:
This is a rare genetic disorder that affects the body's ability to break down certain amino acids. The patient's symptoms that match this disease include: Hyperammonemia, Hyperglycinemia, Hyperglycinuria, Elevated circulating alkaline phosphatase concentration, Abnormal circulating aspartate family amino acid concentration, Abnormal circulating alanine concentration, Abnormal circulating carnitine concentration, Abnormal circulating serine concentration, and Elevated urinary carboxylic acid. However, the patient does not exhibit symptoms of intellectual disability, seizures, or muscle weakness, which are commonly associated with Propionic Acidemia.

\n\n+2. Isovaleric Acidemia:
This is another rare genetic disorder that affects the body's ability to break down the amino acid leucine. The patient's symptoms that match this disease include: Delayed speech and language development, Skin rash, Leukopenia, Hyperammonemia, Hyperglycinemia, Hyperglycinuria, and Elevated urinary carboxylic acid. However, the patient does not exhibit symptoms of vomiting, diarrhea, or seizures, which are commonly associated with Isovaleric Acidemia.

\n\n+3. Methylmalonic Acidemia:
This is a rare genetic disorder that affects the body's ability to break down certain amino acids. The patient's symptoms that match this disease include: Delayed speech and language development, Skin rash, Leukopenia, Hyperammonemia, Hyperglycinemia, Hyperglycinuria, and Elevated urinary carboxylic acid. However, the patient does not exhibit symptoms of intellectual disability, seizures, or muscle weakness, which are commonly associated with Methylmalonic Acidemia.

\n\n+4. Glycine Encephalopathy:
This is a rare genetic disorder that affects the body's ability to break down the amino acid glycine. The patient's symptoms that match this disease include: Delayed speech and language development, Hyperglycinemia, Hyperglycinuria, and Abnormal circulating serine concentration. However, the patient does not exhibit symptoms of seizures, intellectual disability, or muscle weakness, which are commonly associated with Glycine Encephalopathy.

\n\n+5. Carnitine Palmitoyltransferase I Deficiency:
This is a rare genetic disorder that affects the body's ability to break down fatty acids. The patient's symptoms that match this disease include: Abnormal circulating carnitine concentration and Elevated urinary carboxylic acid. However, the patient does not exhibit symptoms of muscle weakness, seizures, or intellectual disability, which are commonly associated with Carnitine Palmitoyltransferase I Deficiency.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms and to rule out other potential diseases."
"['Methylmalonic acidemia with homocystinuria, type cblC']","After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Methylmalonic Acidemia:
This is a rare genetic disorder caused by a deficiency of the enzyme methylmalonyl-CoA mutase. It affects the body's ability to break down certain amino acids and fatty acids.
Common symptoms: Methylmalonic aciduria, Delayed speech and language development, Generalized hypotonia, Hyperhomocystinemia, Decreased plasma free carnitine
Not common symptoms: Gastrointestinal inflammation, Abnormal cerebral white matter morphology, Neonatal death, Death in infancy, Death in childhood

\n\n+2. Homocystinuria:
This is a rare genetic disorder caused by a deficiency of the enzyme cystathionine beta-synthase. It affects the body's ability to break down the amino acid methionine.
Common symptoms: Hyperhomocystinemia, Delayed speech and language development, Generalized hypotonia
Not common symptoms: Methylmalonic aciduria, Gastrointestinal inflammation, Abnormal cerebral white matter morphology, Neonatal death, Death in infancy, Death in childhood, Decreased plasma free carnitine

\n\n+3. Carnitine Palmitoyltransferase I Deficiency:
This is a rare genetic disorder caused by a deficiency of the enzyme carnitine palmitoyltransferase I. It affects the body's ability to break down fatty acids for energy.
Common symptoms: Decreased plasma free carnitine, Generalized hypotonia
Not common symptoms: Methylmalonic aciduria, Hyperhomocystinemia, Delayed speech and language development, Gastrointestinal inflammation, Abnormal cerebral white matter morphology, Neonatal death, Death in infancy, Death in childhood

\n\n+4. Methylmalonyl-CoA Epimerase Deficiency:
This is a rare genetic disorder caused by a deficiency of the enzyme methylmalonyl-CoA epimerase. It affects the body's ability to break down certain amino acids and fatty acids.
Common symptoms: Methylmalonic aciduria, Delayed speech and language development, Generalized hypotonia, Hyperhomocystinemia
Not common symptoms: Gastrointestinal inflammation, Abnormal cerebral white matter morphology, Neonatal death, Death in infancy, Death in childhood, Decreased plasma free carnitine

\n\n+5. Combined Malonic and Methylmalonic Aciduria (CMAMMA):
This is a rare genetic disorder caused by a deficiency of the enzymes malonyl-CoA decarboxylase and methylmalonyl-CoA mutase. It affects the body's ability to break down certain amino acids and fatty acids.
Common symptoms: Methylmalonic aciduria, Delayed speech and language development, Generalized hypotonia, Hyperhomocystinemia, Decreased plasma free carnitine
Not common symptoms: Gastrointestinal inflammation, Abnormal cerebral white matter morphology, Neonatal death, Death in infancy, Death in childhood

Please note that these are just potential diagnoses based on the symptoms presented, and further testing and evaluation are necessary to confirm the diagnosis."
['Biotinidase deficiency'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Maple Syrup Urine Disease:
This rare genetic disorder affects the breakdown of certain amino acids, leading to the accumulation of toxic compounds in the body. The patient's symptoms of elevated urinary carboxylic acid are consistent with this disease. However, the patient does not exhibit the characteristic sweet odor of urine, which is a hallmark of this condition.

\n\n+2. Propionic Acidemia:
This inherited disorder affects the metabolism of propionic acid, leading to the buildup of toxic compounds in the body. The patient's symptoms of elevated urinary carboxylic acid and neonatal death are consistent with this disease. However, the patient does not exhibit the characteristic developmental delays and intellectual disability often seen in this condition.

\n\n+3. Methylmalonic Acidemia:
This genetic disorder affects the metabolism of methylmalonic acid, leading to the accumulation of toxic compounds in the body. The patient's symptoms of elevated urinary carboxylic acid and neonatal death are consistent with this disease. However, the patient does not exhibit the characteristic muscle weakness and seizures often seen in this condition.

\n\n+4. Isovaleric Acidemia:
This rare genetic disorder affects the breakdown of the amino acid leucine, leading to the accumulation of toxic compounds in the body. The patient's symptoms of elevated urinary carboxylic acid and neonatal death are consistent with this disease. However, the patient does not exhibit the characteristic sweaty feet odor, which is a hallmark of this condition.

\n\n+5. Glutaric Acidemia Type I:
This inherited disorder affects the breakdown of the amino acids lysine and hydroxylysine, leading to the accumulation of toxic compounds in the body. The patient's symptoms of elevated urinary carboxylic acid and neonatal death are consistent with this disease. However, the patient does not exhibit the characteristic macrocephaly (enlarged head) and intellectual disability often seen in this condition.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms and to rule out other potential diseases."
['Carbamoyl-phosphate synthetase 1 deficiency'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Ornithine Transcarbamylase Deficiency:
This is a rare genetic disorder that affects the urea cycle, leading to the accumulation of ammonia in the blood. Symptoms in common: Hyperammonemia, Lethargy, Drowsiness, Feeding difficulties. Symptoms not in common: None.

\n\n+2. Argininosuccinic Aciduria:
This is a rare genetic disorder that affects the urea cycle, leading to the accumulation of ammonia in the blood. Symptoms in common: Hyperammonemia, Lethargy, Drowsiness, Feeding difficulties. Symptoms not in common: Spasticity, Generalized hypotonia, Hyperreflexia.

\n\n+3. Citrullinemia:
This is a rare genetic disorder that affects the urea cycle, leading to the accumulation of ammonia in the blood. Symptoms in common: Hyperammonemia, Lethargy, Drowsiness, Feeding difficulties. Symptoms not in common: Spasticity, Generalized hypotonia, Hyperreflexia.

\n\n+4. Maple Syrup Urine Disease:
This is a rare genetic disorder that affects the breakdown of certain amino acids. Symptoms in common: Lethargy, Drowsiness, Feeding difficulties. Symptoms not in common: Hyperammonemia, Spasticity, Generalized hypotonia, Hyperreflexia, Death in infancy, Neonatal death.

\n\n+5. Methylmalonic Acidemia:
This is a rare genetic disorder that affects the breakdown of certain amino acids. Symptoms in common: Lethargy, Drowsiness, Feeding difficulties. Symptoms not in common: Hyperammonemia, Spasticity, Generalized hypotonia, Hyperreflexia, Death in infancy, Neonatal death.

\n\n+6. Propionic Acidemia:
This is a rare genetic disorder that affects the breakdown of certain amino acids. Symptoms in common: Lethargy, Drowsiness, Feeding difficulties. Symptoms not in common: Hyperammonemia, Spasticity, Generalized hypotonia, Hyperreflexia, Death in infancy, Neonatal death.

\n\n+7. Urea Cycle Disorder:
This is a group of rare genetic disorders that affect the urea cycle, leading to the accumulation of ammonia in the blood. Symptoms in common: Hyperammonemia, Lethargy, Drowsiness, Feeding difficulties. Symptoms not in common: Spasticity, Generalized hypotonia, Hyperreflexia.

\n\n+8. Non-Ketotic Hyperglycinemia:
This is a rare genetic disorder that affects the breakdown of certain amino acids. Symptoms in common: Lethargy, Drowsiness, Feeding difficulties. Symptoms not in common: Hyperammonemia, Spasticity, Generalized hypotonia, Hyperreflexia, Death in infancy, Neonatal death.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms."
['Vitamin B12-unresponsive methylmalonic acidemia'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Methylmalonic Acidemia:
This is a rare genetic disorder caused by a deficiency of the enzyme methylmalonyl-CoA mutase. The patient's symptoms of 'Metabolic acidosis' and 'Decreased methylmalonyl-CoA mutase activity' are consistent with this disease. However, not all patients with Methylmalonic Acidemia experience 'Death in infancy' or 'Death in childhood', so further testing is needed to confirm this diagnosis.

\n\n+2. Methylmalonyl-CoA Mutase Deficiency:
This is another rare genetic disorder that affects the breakdown of certain amino acids. The patient's symptoms of 'Decreased methylmalonyl-CoA mutase activity' and 'Metabolic acidosis' are consistent with this disease. However, this disease does not typically cause 'Death in infancy' or 'Death in childhood', so further testing is needed to confirm this diagnosis.

\n\n+3. Vitamin B12 Deficiency:
Vitamin B12 is essential for the breakdown of fatty acids and amino acids. A deficiency in this vitamin can cause 'Metabolic acidosis' and 'Decreased methylmalonyl-CoA mutase activity', which are both present in the patient. However, Vitamin B12 Deficiency does not typically cause 'Death in infancy' or 'Death in childhood', so further testing is needed to confirm this diagnosis.

\n\n+4. Propionic Acidemia:
This is a rare genetic disorder caused by a deficiency of the enzyme propionyl-CoA carboxylase. The patient's symptoms of 'Metabolic acidosis' and 'Death in infancy' are consistent with this disease. However, not all patients with Propionic Acidemia experience 'Decreased methylmalonyl-CoA mutase activity' or 'Death in childhood', so further testing is needed to confirm this diagnosis.

\n\n+5. Isovaleric Acidemia:
This is a rare genetic disorder caused by a deficiency of the enzyme isovaleryl-CoA dehydrogenase. The patient's symptoms of 'Metabolic acidosis' and 'Death in infancy' are consistent with this disease. However, not all patients with Isovaleric Acidemia experience 'Decreased methylmalonyl-CoA mutase activity' or 'Death in childhood', so further testing is needed to confirm this diagnosis.

Further testing and evaluation are needed to determine the underlying cause of the patient's symptoms and to rule out other potential diseases."
[],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Hereditary Spherocytosis:
This disease is a genetic disorder that affects the red blood cells, leading to hemolytic anemia. The patient's symptoms that match this disease include Hemolytic anemia and Increased total bilirubin. However, the patient does not exhibit other common symptoms of this disease, such as jaundice, fatigue, and pale skin.

\n\n+2. Porphyrin-Associated Disorders:
This group of diseases is caused by abnormalities in the production of heme, a molecule essential for various bodily functions. The patient's symptoms that match this disease include Abnormal circulating porphyrin concentration and Increased circulating lactate dehydrogenase concentration. However, the patient does not exhibit other common symptoms of this disease, such as abdominal pain, neuropathy, and skin sensitivity to sunlight.

\n\n+3. Mitochondrial Myopathies:
This group of diseases affects the mitochondria, the energy-producing structures within cells. The patient's symptoms that match this disease include Metabolic acidosis, Increased circulating lactate dehydrogenase concentration, and Hyperactivity. However, the patient does not exhibit other common symptoms of this disease, such as muscle weakness, seizures, and developmental delays.

\n\n+4. Adenosine Deaminase Deficiency:
This is a rare genetic disorder that affects the immune system, leading to recurrent viral infections. The patient's symptoms that match this disease include Recurrent viral infections and Hyperactivity. However, the patient does not exhibit other common symptoms of this disease, such as enlarged lymph nodes, liver damage, and developmental delays.

\n\n+5. Aromatic L-Amino Acid Decarboxylase Deficiency:
This is a rare genetic disorder that affects the production of neurotransmitters, leading to Hyperactivity and Spasticity. The patient's symptoms that match this disease include Hyperactivity, Spasticity, and Death in infancy. However, the patient does not exhibit other common symptoms of this disease, such as seizures, developmental delays, and intellectual disability.

\n\n+6. Methylmalonic Acidemia:
This is a rare genetic disorder that affects the metabolism of certain amino acids, leading to Metabolic acidosis and Hyperactivity. The patient's symptoms that match this disease include Metabolic acidosis, Hyperactivity, and Increased circulating lactate dehydrogenase concentration. However, the patient does not exhibit other common symptoms of this disease, such as vomiting, seizures, and developmental delays.

After reviewing these potential diseases, I will need to conduct further tests and examinations to determine the underlying cause of the patient's symptoms."
['Neonatal intrahepatic cholestasis due to citrin deficiency'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Citrullinemia Type I:
This is a rare genetic disorder that affects the urea cycle, leading to the accumulation of ammonia in the blood. The patient's symptoms that match this disease include: Hyperammonemia, Elevated plasma citrulline, Respiratory distress, Apnea, and Hypoxemia. However, the patient does not exhibit symptoms of intellectual disability, seizures, or developmental delays, which are commonly associated with Citrullinemia Type I.

\n\n+2. Ornithine Transcarbamylase Deficiency:
This is a genetic disorder that affects the urea cycle, leading to the accumulation of ammonia in the blood. The patient's symptoms that match this disease include: Hyperammonemia, Respiratory distress, Apnea, and Hypoxemia. However, the patient does not exhibit symptoms of vomiting, lethargy, or seizures, which are commonly associated with Ornithine Transcarbamylase Deficiency.

\n\n+3. Carbamoyl Phosphate Synthetase I Deficiency:
This is a rare genetic disorder that affects the urea cycle, leading to the accumulation of ammonia in the blood. The patient's symptoms that match this disease include: Hyperammonemia, Respiratory distress, Apnea, and Hypoxemia. However, the patient does not exhibit symptoms of seizures, intellectual disability, or developmental delays, which are commonly associated with Carbamoyl Phosphate Synthetase I Deficiency.

\n\n+4. Argininosuccinic Aciduria:
This is a rare genetic disorder that affects the urea cycle, leading to the accumulation of ammonia in the blood. The patient's symptoms that match this disease include: Hyperammonemia, Respiratory distress, Apnea, and Hypoxemia. However, the patient does not exhibit symptoms of intellectual disability, seizures, or developmental delays, which are commonly associated with Argininosuccinic Aciduria.

\n\n+5. Neonatal Citrullinemia:
This is a rare genetic disorder that affects the urea cycle, leading to the accumulation of ammonia in the blood. The patient's symptoms that match this disease include: Hyperammonemia, Elevated plasma citrulline, Respiratory distress, Apnea, and Hypoxemia. However, the patient does not exhibit symptoms of intellectual disability, seizures, or developmental delays, which are commonly associated with Neonatal Citrullinemia.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms and to rule out other potential diseases."
[],ERROR
['Dihydropteridine reductase deficiency'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. **PKU (Phenylketonuria)**: 
This genetic disorder affects the body's ability to break down the amino acid phenylalanine. 
Common symptoms: Intellectual disability, Seizure, Motor delay, Generalized hypotonia, Hyperphenylalaninemia
Not common symptoms: Microcephaly, Nystagmus, Abnormality of prenatal development or birth, Alopecia, Cerebral atrophy, Abnormal cerebral white matter morphology, Hypertyrosinemia, Neonatal death, Death in infancy, Death in childhood

\n\n+2. **Homocystinuria**: 
A rare genetic disorder caused by a defect in the enzyme cystathionine beta-synthase. 
Common symptoms: Intellectual disability, Seizure, Motor delay, Generalized hypotonia
Not common symptoms: Microcephaly, Nystagmus, Abnormality of prenatal development or birth, Alopecia, Cerebral atrophy, Abnormal cerebral white matter morphology, Hypertyrosinemia, Neonatal death, Death in infancy, Death in childhood, Hyperphenylalaninemia

\n\n+3. **Tyrosinemia type 1**: 
A rare genetic disorder caused by a deficiency of the enzyme fumarylacetoacetate hydrolase. 
Common symptoms: Hypertyrosinemia, Liver and kidney damage
Not common symptoms: Microcephaly, Nystagmus, Abnormality of prenatal development or birth, Intellectual disability, Seizure, Motor delay, Generalized hypotonia, Alopecia, Cerebral atrophy, Abnormal cerebral white matter morphology, Hyperphenylalaninemia, Neonatal death, Death in infancy, Death in childhood

\n\n+4. **Cerebral Organoid Dysplasia**: 
A rare genetic disorder characterized by abnormal development of the brain. 
Common symptoms: Microcephaly, Intellectual disability, Seizure, Motor delay, Generalized hypotonia, Cerebral atrophy, Abnormal cerebral white matter morphology
Not common symptoms: Nystagmus, Abnormality of prenatal development or birth, Alopecia, Hypertyrosinemia, Hyperphenylalaninemia, Neonatal death, Death in infancy, Death in childhood

\n\n+5. **Menkes disease**: 
A rare genetic disorder caused by a defect in the ATP7A gene. 
Common symptoms: Intellectual disability, Seizure, Motor delay, Generalized hypotonia, Alopecia
Not common symptoms: Microcephaly, Nystagmus, Abnormality of prenatal development or birth, Cerebral atrophy, Abnormal cerebral white matter morphology, Hypertyrosinemia, Hyperphenylalaninemia, Neonatal death, Death in infancy, Death in childhood

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms."
[],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Nonketotic Hyperglycinemia (NKH): 
This is a rare genetic disorder that affects the breakdown of certain amino acids. The patient's symptoms that match this disease include: Abnormal circulating glycine concentration, Feeding difficulties, Functional abnormality of the gastrointestinal tract, and Death in infancy. However, the patient does not exhibit seizures, intellectual disability, or hypotonia, which are common symptoms of NKH.

\n\n+2. Ethylmalonic Encephalopathy (EE): 
This is a rare inherited disorder that affects the brain and muscles. The patient's symptoms that match this disease include: Ethylmalonic aciduria, Cytochrome C oxidase-negative muscle fibers, and Feeding difficulties. However, the patient does not exhibit seizures, intellectual disability, or hypotonia, which are common symptoms of EE.

\n\n+3. Glycine Encephalopathy (GE): 
This is a rare genetic disorder that affects the breakdown of glycine. The patient's symptoms that match this disease include: Abnormal circulating glycine concentration, Feeding difficulties, and Functional abnormality of the gastrointestinal tract. However, the patient does not exhibit seizures, intellectual disability, or hypotonia, which are common symptoms of GE.

\n\n+4. Staphylococcal Scalded Skin Syndrome (SSSS): 
This is a bacterial infection that causes a skin rash. The patient's symptoms that match this disease include: Erythematous plaque, Erythematous macule, and Erythematous papule. However, the patient does not exhibit fever, skin peeling, or pus-filled blisters, which are common symptoms of SSSS.

\n\n+5. Maple Syrup Urine Disease (MSUD): 
This is a rare genetic disorder that affects the breakdown of certain amino acids. The patient's symptoms that match this disease include: Glycosuria and Feeding difficulties. However, the patient does not exhibit intellectual disability, seizures, or a sweet-smelling urine, which are common symptoms of MSUD.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms and to rule out other potential diseases."
['Carbamoyl-phosphate synthetase 1 deficiency'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Citrullinemia Type I:
This is a rare genetic disorder that affects the urea cycle, leading to the accumulation of ammonia in the blood. The patient's symptoms that match this disease include: Hyperammonemia, Low plasma citrulline, and Hypoargininemia. However, the patient does not exhibit symptoms such as vomiting, lethargy, and developmental delays, which are commonly associated with Citrullinemia Type I.

\n\n+2. Argininosuccinic Aciduria:
This is another rare genetic disorder that affects the urea cycle, leading to the accumulation of ammonia in the blood. The patient's symptoms that match this disease include: Hyperammonemia, Oroticaciduria, and Low plasma citrulline. However, the patient does not exhibit symptoms such as vomiting, diarrhea, and intellectual disability, which are commonly associated with Argininosuccinic Aciduria.

\n\n+3. Carbamoyl Phosphate Synthetase I Deficiency:
This is a rare genetic disorder that affects the urea cycle, leading to the accumulation of ammonia in the blood. The patient's symptoms that match this disease include: Hyperammonemia, Low plasma citrulline, and Neonatal death. However, the patient does not exhibit symptoms such as vomiting, lethargy, and seizures, which are commonly associated with Carbamoyl Phosphate Synthetase I Deficiency.

\n\n+4. Ornithine Transcarbamylase Deficiency:
This is a rare genetic disorder that affects the urea cycle, leading to the accumulation of ammonia in the blood. The patient's symptoms that match this disease include: Hyperammonemia, Oroticaciduria, and Low plasma citrulline. However, the patient does not exhibit symptoms such as vomiting, lethargy, and developmental delays, which are commonly associated with Ornithine Transcarbamylase Deficiency.

\n\n+5. N-Acetylglutamate Synthase Deficiency:
This is a rare genetic disorder that affects the urea cycle, leading to the accumulation of ammonia in the blood. The patient's symptoms that match this disease include: Hyperammonemia, Low plasma citrulline, and Neonatal death. However, the patient does not exhibit symptoms such as vomiting, lethargy, and seizures, which are commonly associated with N-Acetylglutamate Synthase Deficiency.

\n\n+6. Argininemia:
This is a rare genetic disorder that affects the urea cycle, leading to the accumulation of arginine in the blood. The patient's symptoms that match this disease include: Hypoargininemia, Seizure, and Cerebral edema. However, the patient does not exhibit symptoms such as intellectual disability, muscle weakness, and skin lesions, which are commonly associated with Argininemia.

\n\n+7. Hyperornithinemia-Hyperammonemia-Homocitrullinuria Syndrome:
This is a rare genetic disorder that affects the urea cycle, leading to the accumulation of ammonia in the blood. The patient's symptoms that match this disease include: Hyperammonemia, Low plasma citrulline, and Oroticaciduria. However, the patient does not exhibit symptoms such as vomiting, lethargy, and developmental delays, which are commonly associated with Hyperornithinemia-Hyperammonemia-Homocitrullinuria Syndrome.

Based on the patient's symptoms, I believe that Citrullinemia Type I and Argininosuccinic Aciduria are the most likely diagnoses. However, further testing and evaluation are necessary to confirm the diagnosis and rule out other potential causes."
['Canavan disease'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Glycine Encephalopathy:
This is a rare genetic disorder that affects the breakdown of glycine, an amino acid. The patient's symptoms that match this disease include: Hyperammonemia, Abnormal circulating glycine concentration, Seizure, and Death in infancy. However, the patient does not exhibit the typical symptoms of lethargy, hypotonia, and developmental delay.

\n\n+2. Maple Syrup Urine Disease:
This is a rare genetic disorder that affects the breakdown of certain amino acids. The patient's symptoms that match this disease include: Aminoaciduria, Abnormal circulating aspartate family amino acid concentration, and Seizure. However, the patient does not exhibit the typical symptoms of sweet-smelling urine, feeding difficulties, and intellectual disability.

\n\n+3. Isovaleric Acidemia:
This is a rare genetic disorder that affects the breakdown of the amino acid leucine. The patient's symptoms that match this disease include: Aminoaciduria, Abnormal circulating aspartate family amino acid concentration, and Seizure. However, the patient does not exhibit the typical symptoms of vomiting, diarrhea, and a strong ""cheesy"" odor.

\n\n+4. Propionic Acidemia:
This is a rare genetic disorder that affects the breakdown of the amino acids isoleucine, valine, and methionine. The patient's symptoms that match this disease include: Aminoaciduria, Abnormal circulating aspartate family amino acid concentration, and Seizure. However, the patient does not exhibit the typical symptoms of vomiting, diarrhea, and a strong ""sweaty feet"" odor.

\n\n+5. Methylmalonic Acidemia:
This is a rare genetic disorder that affects the breakdown of the amino acids isoleucine, valine, and methionine. The patient's symptoms that match this disease include: Aminoaciduria, Abnormal circulating aspartate family amino acid concentration, and Seizure. However, the patient does not exhibit the typical symptoms of vomiting, diarrhea, and a strong ""fruity"" odor.

\n\n+6. Sjgren-Larsson Syndrome:
This is a rare genetic disorder that affects the breakdown of fatty acids. The patient's symptoms that match this disease include: Skin rash, Erythematous plaque, Erythematous macule, and Erythematous papule. However, the patient does not exhibit the typical symptoms of intellectual disability, spasticity, and speech difficulties.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms and to rule out other potential diseases."
['Maple syrup urine disease'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Maple Syrup Urine Disease: 
This rare genetic disorder affects the breakdown of certain amino acids. The patient's symptoms that match this disease include: Seizure, Feeding difficulties, Respiratory insufficiency, and Death in infancy. However, the patient does not exhibit the characteristic sweet odor of urine, which is a hallmark of this disease.

\n\n+2. Valine Transaminase Deficiency: 
This is a rare genetic disorder that affects the breakdown of the amino acid valine. The patient's symptoms that match this disease include: Hypervalinemia, Hyperleucinemia, and Hyperisoleucinemia. However, the patient does not exhibit any signs of intellectual disability, which is often associated with this disease.

\n\n+3. Methylmalonic Acidemia: 
This is a rare genetic disorder that affects the breakdown of certain amino acids. The patient's symptoms that match this disease include: Seizure, Feeding difficulties, Respiratory insufficiency, and Sepsis. However, the patient does not exhibit any signs of metabolic acidosis, which is often associated with this disease.

\n\n+4. Propionic Acidemia: 
This is a rare genetic disorder that affects the breakdown of certain amino acids. The patient's symptoms that match this disease include: Seizure, Feeding difficulties, Respiratory insufficiency, and Sepsis. However, the patient does not exhibit any signs of metabolic acidosis, which is often associated with this disease.

\n\n+5. Isovaleric Acidemia: 
This is a rare genetic disorder that affects the breakdown of the amino acid leucine. The patient's symptoms that match this disease include: Seizure, Feeding difficulties, and Respiratory insufficiency. However, the patient does not exhibit any signs of a characteristic sweaty feet odor, which is often associated with this disease.

\n\n+6. MSUD-like Disorder: 
This is a rare genetic disorder that affects the breakdown of certain amino acids. The patient's symptoms that match this disease include: Seizure, Feeding difficulties, Respiratory insufficiency, and Death in infancy. However, the patient does not exhibit any signs of intellectual disability, which is often associated with this disease.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms and to rule out other potential diseases."
['Medium chain acyl-CoA dehydrogenase deficiency'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Carnitine Palmitoyltransferase II Deficiency:
This is a rare genetic disorder that affects the breakdown of fatty acids. The patient's symptoms of abnormal circulating carnitine concentration and decreased 3-hydroxyacyl-CoA dehydrogenase level are consistent with this disease. However, the patient does not exhibit symptoms of muscle weakness, seizures, or developmental delays, which are commonly associated with this condition.

\n\n+2. Glutaric Acidemia Type II:
This is a rare genetic disorder that affects the breakdown of fatty acids and amino acids. The patient's symptoms of abnormal circulating carnitine concentration, decreased 3-hydroxyacyl-CoA dehydrogenase level, and obesity are consistent with this disease. However, the patient does not exhibit symptoms of developmental delays, seizures, or muscle weakness, which are commonly associated with this condition.

\n\n+3. Very Long-Chain Acyl-CoA Dehydrogenase Deficiency:
This is a rare genetic disorder that affects the breakdown of fatty acids. The patient's symptoms of abnormal circulating carnitine concentration, decreased 3-hydroxyacyl-CoA dehydrogenase level, and obesity are consistent with this disease. However, the patient does not exhibit symptoms of muscle weakness, seizures, or developmental delays, which are commonly associated with this condition.

\n\n+4. Mitochondrial Trifunctional Protein Deficiency:
This is a rare genetic disorder that affects the breakdown of fatty acids. The patient's symptoms of abnormal circulating carnitine concentration, decreased 3-hydroxyacyl-CoA dehydrogenase level, and obesity are consistent with this disease. However, the patient does not exhibit symptoms of muscle weakness, seizures, or developmental delays, which are commonly associated with this condition.

\n\n+5. Lethal Acyl-CoA Dehydrogenase Family Member 9 Deficiency:
This is a rare genetic disorder that affects the breakdown of fatty acids. The patient's symptoms of abnormal circulating carnitine concentration, decreased 3-hydroxyacyl-CoA dehydrogenase level, and death in infancy/neonatal death are consistent with this disease. However, the patient does not exhibit symptoms of muscle weakness, seizures, or developmental delays, which are commonly associated with this condition.

\n\n+6. Barth Syndrome:
This is a rare genetic disorder that affects the breakdown of fatty acids and is characterized by abnormalities in prenatal development or birth. The patient's symptoms of abnormality of prenatal development or birth, obesity, and abnormal circulating carnitine concentration are consistent with this disease. However, the patient does not exhibit symptoms of muscle weakness, seizures, or developmental delays, which are commonly associated with this condition.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms and to rule out other potential diseases."
['Phenylketonuria'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Phenylketonuria (PKU):
This is a genetic disorder that affects the breakdown of the amino acid phenylalanine. The patient's symptoms of Intellectual disability, Seizure, Motor delay, Hyperphenylalaninemia, and Dyskinesia are all consistent with PKU. However, the patient does not exhibit symptoms of musty body odor, which is commonly seen in PKU patients.

\n\n+2. Tyrosinemia type I:
This is a rare genetic disorder caused by a deficiency of the enzyme fumarylacetoacetate hydrolase. The patient's symptoms of Intellectual disability, Seizure, Motor delay, Hypertyrosinemia, and Death in infancy/childhood are all consistent with Tyrosinemia type I. However, the patient does not exhibit symptoms of liver and kidney dysfunction, which are commonly seen in Tyrosinemia type I patients.

\n\n+3. Maple syrup urine disease (MSUD):
This is a rare genetic disorder caused by a deficiency of the enzyme branched-chain alpha-keto acid dehydrogenase complex. The patient's symptoms of Intellectual disability, Seizure, Motor delay, and Death in infancy/childhood are all consistent with MSUD. However, the patient does not exhibit symptoms of a characteristic maple syrup-like odor in their urine, which is commonly seen in MSUD patients.

\n\n+4. Homocystinuria:
This is a rare genetic disorder caused by a deficiency of the enzyme cystathionine beta-synthase. The patient's symptoms of Intellectual disability, Seizure, and Motor delay are all consistent with Homocystinuria. However, the patient does not exhibit symptoms of dislocated lenses, which are commonly seen in Homocystinuria patients.

\n\n+5. Mucopolysaccharidosis type I (MPS I):
This is a rare genetic disorder caused by a deficiency of the enzyme alpha-L-iduronidase. The patient's symptoms of Intellectual disability, Seizure, and Motor delay are all consistent with MPS I. However, the patient does not exhibit symptoms of coarse facial features, which are commonly seen in MPS I patients.

\n\n+6. Leigh syndrome:
This is a rare genetic disorder caused by a deficiency of the enzyme complex I. The patient's symptoms of Intellectual disability, Seizure, Motor delay, and Abnormal cerebral white matter morphology are all consistent with Leigh syndrome. However, the patient does not exhibit symptoms of muscle weakness, which are commonly seen in Leigh syndrome patients.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms and to rule out other potential diseases."
['Wilson disease'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Menkes Syndrome:
This is a rare genetic disorder that affects the body's ability to absorb copper. The patient's symptoms that match this disease include: Decreased circulating ceruloplasmin concentration, Increased urinary copper concentration, Decreased circulating copper concentration, and Copper accumulation in liver. However, Menkes Syndrome typically presents with kinky hair, intellectual disability, and seizures, which are not mentioned in the patient's symptoms.

\n\n+2. Wilson's Disease:
This is a genetic disorder that affects the body's ability to remove excess copper. The patient's symptoms that match this disease include: Elevated circulating hepatic transaminase concentration, Abnormal circulating aspartate family amino acid concentration, Abnormal circulating alanine concentration, Copper accumulation in liver, and Death in adolescence. However, Wilson's Disease typically presents with neurological symptoms such as tremors, muscle stiffness, and psychiatric disturbances, which are not mentioned in the patient's symptoms.

\n\n+3. Indian Childhood Cirrhosis:
This is a rare liver disease that affects children. The patient's symptoms that match this disease include: Hepatomegaly, Elevated circulating hepatic transaminase concentration, and Copper accumulation in liver. However, Indian Childhood Cirrhosis typically presents with jaundice, vomiting, and abdominal distension, which are not mentioned in the patient's symptoms.

\n\n+4. Aceruloplasminemia:
This is a rare genetic disorder that affects the body's ability to transport copper. The patient's symptoms that match this disease include: Decreased circulating ceruloplasmin concentration, Decreased circulating copper concentration, and Copper accumulation in liver. However, Aceruloplasminemia typically presents with neurological symptoms such as dementia, seizures, and retinal degeneration, which are not mentioned in the patient's symptoms.

\n\n+5. Mitochondrial DNA Depletion Syndrome:
This is a group of genetic disorders that affect the mitochondria, the energy-producing structures within cells. The patient's symptoms that match this disease include: Generalized hypotonia, Hepatomegaly, and Death in childhood. However, Mitochondrial DNA Depletion Syndrome typically presents with a range of other symptoms including seizures, developmental delay, and muscle weakness, which are not mentioned in the patient's symptoms.

Further testing and evaluation are needed to determine the underlying cause of the patient's symptoms and to rule out other potential diseases."
['PMM2-CDG'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Joubert Syndrome:
This rare genetic disorder affects the cerebellum and brainstem, leading to intellectual disability, ataxia, and abnormal facial features. The patient's symptoms that match this disease include: Strabismus, Intellectual disability, Ataxia, Cerebellar atrophy, and Abnormal facial shape. However, the patient does not exhibit the typical symptom of polydactyly (extra fingers or toes) commonly seen in Joubert Syndrome.

\n\n+2. Dandy-Walker Syndrome:
This congenital brain malformation affects the cerebellum and fourth ventricle, leading to intellectual disability, ataxia, and abnormal facial features. The patient's symptoms that match this disease include: Intellectual disability, Ataxia, Cerebellar atrophy, Abnormal facial shape, and Abnormal calvaria morphology. However, the patient does not exhibit the typical symptom of hydrocephalus (fluid accumulation in the brain) commonly seen in Dandy-Walker Syndrome.

\n\n+3. Lissencephaly:
This rare brain malformation is characterized by a smooth brain surface and intellectual disability. The patient's symptoms that match this disease include: Intellectual disability, Ataxia, and Abnormal facial shape. However, the patient does not exhibit the typical symptom of seizures commonly seen in Lissencephaly.

\n\n+4. Pontocerebellar Hypoplasia:
This rare genetic disorder affects the development of the brain, leading to intellectual disability, ataxia, and abnormal facial features. The patient's symptoms that match this disease include: Intellectual disability, Ataxia, Cerebellar atrophy, and Abnormal facial shape. However, the patient does not exhibit the typical symptom of microcephaly (small head size) commonly seen in Pontocerebellar Hypoplasia.

\n\n+5. Walker-Warburg Syndrome:
This rare genetic disorder affects the development of the brain and eyes, leading to intellectual disability, ataxia, and abnormal facial features. The patient's symptoms that match this disease include: Intellectual disability, Ataxia, Cerebellar atrophy, Abnormal facial shape, and Death in infancy. However, the patient does not exhibit the typical symptom of retinal dysplasia (abnormal retinal development) commonly seen in Walker-Warburg Syndrome.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms and to rule out other potential diseases."
['Phenylketonuria'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Tyrosinemia Type I:
This is a rare genetic disorder caused by a deficiency of the enzyme fumarylacetoacetate hydrolase. Symptoms in common with the patient: Abnormality of prenatal development or birth, Hypertyrosinemia, Death in infancy, Neonatal death. Symptoms not in common: None.

\n\n+2. Phenylketonuria (PKU):
This is a genetic disorder caused by a deficiency of the enzyme phenylalanine hydroxylase. Symptoms in common with the patient: Hyperphenylalaninemia. Symptoms not in common: Abnormality of prenatal development or birth, Death in infancy, Neonatal death, Hypertyrosinemia.

\n\n+3. Maple Syrup Urine Disease (MSUD):
This is a rare genetic disorder caused by a deficiency of the enzyme branched-chain alpha-keto acid dehydrogenase complex. Symptoms in common with the patient: Abnormality of prenatal development or birth, Death in infancy, Neonatal death. Symptoms not in common: Hypertyrosinemia, Hyperphenylalaninemia.

\n\n+4. Homocystinuria:
This is a rare genetic disorder caused by a deficiency of the enzyme cystathionine beta-synthase. Symptoms in common with the patient: Abnormality of prenatal development or birth, Death in infancy. Symptoms not in common: Hypertyrosinemia, Hyperphenylalaninemia, Neonatal death, Death in adolescence.

\n\n+5. Methylmalonic Acidemia:
This is a rare genetic disorder caused by a deficiency of the enzyme methylmalonyl-CoA mutase. Symptoms in common with the patient: Abnormality of prenatal development or birth, Death in infancy, Neonatal death. Symptoms not in common: Hypertyrosinemia, Hyperphenylalaninemia, Death in adolescence.

\n\n+6. Isovaleric Acidemia:
This is a rare genetic disorder caused by a deficiency of the enzyme isovaleryl-CoA dehydrogenase. Symptoms in common with the patient: Abnormality of prenatal development or birth, Death in infancy, Neonatal death. Symptoms not in common: Hypertyrosinemia, Hyperphenylalaninemia, Death in adolescence.

Based on these findings, I would like to conduct further tests to determine the underlying cause of the patient's symptoms."
['Glutaryl-CoA dehydrogenase deficiency'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Glutaric acidemia type I:
This is a rare genetic disorder caused by a deficiency of the enzyme glutaryl-CoA dehydrogenase. It affects the breakdown of certain amino acids and can lead to the accumulation of toxic compounds in the body.

Common symptoms: Glutaric aciduria, Abnormal circulating lysine concentration, Macrocephaly, Abnormal cerebral morphology
Not common symptoms: Hypercalcemia, Abnormal circulating carnitine concentration

\n\n+2. Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS):
This is a rare genetic disorder that affects the mitochondria, the energy-producing structures within cells. It can cause a range of symptoms, including muscle weakness, seizures, and stroke-like episodes.

Common symptoms: Increased circulating lactate concentration, Abnormal cerebral morphology, Generalized hypotonia
Not common symptoms: Glutaric aciduria, Hypercalcemia, Abnormal circulating lysine concentration

\n\n+3. Carnitine palmitoyltransferase I deficiency:
This is a rare genetic disorder that affects the breakdown of fatty acids in the body. It can cause a range of symptoms, including muscle weakness, seizures, and developmental delays.

Common symptoms: Abnormal circulating carnitine concentration, Generalized hypotonia, Death in infancy
Not common symptoms: Glutaric aciduria, Hypercalcemia, Macrocephaly

\n\n+4. Lactic acidosis:
This is a condition in which the body produces too much lactic acid, leading to a range of symptoms including muscle weakness, fatigue, and difficulty breathing.

Common symptoms: Increased circulating lactate concentration, Generalized hypotonia, Death in infancy
Not common symptoms: Glutaric aciduria, Hypercalcemia, Macrocephaly

\n\n+5. Hypercalcemia:
This is a condition in which there is too much calcium in the blood. It can cause a range of symptoms, including muscle weakness, fatigue, and kidney stones.

Common symptoms: Hypercalcemia
Not common symptoms: Glutaric aciduria, Macrocephaly, Abnormal cerebral morphology

After reviewing these potential diseases, I believe that further testing is necessary to determine the underlying cause of the patient's symptoms."
['Phenylketonuria'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Tyrosinemia Type I:
This is a rare genetic disorder caused by a deficiency of the enzyme fumarylacetoacetate hydrolase. Symptoms in common with the patient: Abnormality of prenatal development or birth, Hypertyrosinemia, Death in infancy, Neonatal death, Death in childhood. Symptoms not in common: None.

\n\n+2. Phenylketonuria (PKU):
This is a genetic disorder caused by a deficiency of the enzyme phenylalanine hydroxylase. Symptoms in common with the patient: Hyperphenylalaninemia, Abnormality of prenatal development or birth, Death in infancy, Death in childhood. Symptoms not in common: None.

\n\n+3. Homocystinuria:
This is a rare genetic disorder caused by a deficiency of the enzyme cystathionine beta-synthase. Symptoms in common with the patient: Abnormality of prenatal development or birth, Death in infancy, Death in childhood. Symptoms not in common: Hypertyrosinemia, Hyperphenylalaninemia.

\n\n+4. Maple Syrup Urine Disease (MSUD):
This is a rare genetic disorder caused by a deficiency of the enzyme branched-chain alpha-keto acid dehydrogenase complex. Symptoms in common with the patient: Abnormality of prenatal development or birth, Death in infancy, Death in childhood. Symptoms not in common: Hypertyrosinemia, Hyperphenylalaninemia.

\n\n+5. Citrullinemia:
This is a rare genetic disorder caused by a deficiency of the enzyme argininosuccinate synthase. Symptoms in common with the patient: Abnormality of prenatal development or birth, Death in infancy, Death in childhood. Symptoms not in common: Hypertyrosinemia, Hyperphenylalaninemia.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms and to rule out other potential diseases."
['Phenylketonuria'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here is the list:

\n\n+1. Maternal Phenylketonuria (PKU): 
This is a rare genetic disorder caused by a mother's untreated PKU, which can affect fetal development. 
Common symptoms: Microcephaly, Abnormality of prenatal development or birth, Small for gestational age, Severe short stature, Death in infancy, Death in childhood
Not common symptoms: Pericardial effusion, Pleural effusion, Hypertyrosinemia, Hyperphenylalaninemia, Feeding difficulties

\n\n+2. Tyrosinemia Type 1:
This is a rare genetic disorder caused by a deficiency of the enzyme fumarylacetoacetate hydrolase, which affects the breakdown of tyrosine. 
Common symptoms: Hypertyrosinemia, Liver and kidney problems (not mentioned in the patient's symptoms)
Not common symptoms: Microcephaly, Abnormality of prenatal development or birth, Small for gestational age, Death in infancy, Death in childhood, Pericardial effusion, Pleural effusion, Severe short stature, Hyperphenylalaninemia, Feeding difficulties

\n\n+3. Phenylketonuria (PKU):
This is a genetic disorder caused by a deficiency of the enzyme phenylalanine hydroxylase, which affects the breakdown of phenylalanine. 
Common symptoms: Hyperphenylalaninemia, Microcephaly, Severe short stature, Feeding difficulties
Not common symptoms: Abnormality of prenatal development or birth, Small for gestational age, Death in infancy, Death in childhood, Pericardial effusion, Pleural effusion, Hypertyrosinemia

\n\n+4. Homocystinuria:
This is a genetic disorder caused by a deficiency of the enzyme cystathionine beta-synthase, which affects the breakdown of homocysteine. 
Common symptoms: Microcephaly, Severe short stature, Feeding difficulties
Not common symptoms: Abnormality of prenatal development or birth, Small for gestational age, Death in infancy, Death in childhood, Pericardial effusion, Pleural effusion, Hypertyrosinemia, Hyperphenylalaninemia

\n\n+5. Mucopolysaccharidosis Type VII:
This is a rare genetic disorder caused by a deficiency of the enzyme beta-glucuronidase, which affects the breakdown of mucopolysaccharides. 
Common symptoms: Severe short stature, Feeding difficulties
Not common symptoms: Microcephaly, Abnormality of prenatal development or birth, Small for gestational age, Death in infancy, Death in childhood, Pericardial effusion, Pleural effusion, Hypertyrosinemia, Hyperphenylalaninemia

After reviewing these potential diseases, I would like to conduct further tests to determine the underlying cause of the patient's symptoms."
['Ornithine transcarbamylase deficiency'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Ornithine Transcarbamylase Deficiency (OTCD): 
This is a rare genetic disorder that affects the urea cycle, leading to the accumulation of ammonia in the blood. 
Common symptoms: Hyperammonemia, Vomiting, Hyperglutaminemia, Oroticaciduria, Death in childhood
Uncommon symptoms: None

\n\n+2. Citrullinemia: 
A rare genetic disorder that affects the urea cycle, leading to the accumulation of citrulline in the blood. 
Common symptoms: Hyperammonemia, Vomiting, Hyperglutaminemia
Uncommon symptoms: Oroticaciduria, Death in childhood

\n\n+3. Argininosuccinic Aciduria (ASA): 
A rare genetic disorder that affects the urea cycle, leading to the accumulation of argininosuccinic acid in the blood. 
Common symptoms: Hyperammonemia, Vomiting, Hyperglutaminemia
Uncommon symptoms: Oroticaciduria, Death in childhood

\n\n+4. Carbamoyl Phosphate Synthetase I Deficiency (CPSID): 
A rare genetic disorder that affects the urea cycle, leading to the accumulation of ammonia in the blood. 
Common symptoms: Hyperammonemia, Vomiting, Hyperglutaminemia
Uncommon symptoms: Oroticaciduria, Death in childhood

\n\n+5. N-Acetylglutamate Synthase Deficiency (NAGSD): 
A rare genetic disorder that affects the urea cycle, leading to the accumulation of ammonia in the blood. 
Common symptoms: Hyperammonemia, Vomiting, Hyperglutaminemia
Uncommon symptoms: Oroticaciduria, Death in childhood

Based on the patient's symptoms, Ornithine Transcarbamylase Deficiency (OTCD) appears to be the most likely diagnosis. However, further testing and evaluation are necessary to confirm the diagnosis and rule out other potential causes."
['Phenylketonuria'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Phenylketonuria (PKU):
This is a genetic disorder that affects the body's ability to break down the amino acid phenylalanine. Symptoms in common: Hyperphenylalaninemia, Abnormal circulating tyrosine concentration, Elevated urinary carboxylic acid. Symptoms not in common: None.

\n\n+2. Homocystinuria:
This is a rare genetic disorder that affects the body's ability to process certain amino acids. Symptoms in common: Abnormality of prenatal development or birth, Elevated urinary carboxylic acid. Symptoms not in common: Obesity, Death in infancy, Neonatal death, Death in early adulthood.

\n\n+3. Maple syrup urine disease (MSUD):
This is a rare genetic disorder that affects the body's ability to break down certain amino acids. Symptoms in common: Abnormality of prenatal development or birth, Elevated urinary carboxylic acid, Death in infancy, Neonatal death. Symptoms not in common: Obesity, Hyperphenylalaninemia, Abnormal circulating tyrosine concentration, Death in early adulthood.

\n\n+4. Tyrosinemia type 1:
This is a rare genetic disorder that affects the body's ability to break down the amino acid tyrosine. Symptoms in common: Abnormal circulating tyrosine concentration, Elevated urinary carboxylic acid, Death in infancy, Neonatal death. Symptoms not in common: Obesity, Hyperphenylalaninemia, Abnormality of prenatal development or birth, Death in early adulthood.

\n\n+5. Methylmalonic acidemia:
This is a rare genetic disorder that affects the body's ability to break down certain amino acids. Symptoms in common: Elevated urinary carboxylic acid, Death in infancy, Neonatal death. Symptoms not in common: Obesity, Hyperphenylalaninemia, Abnormal circulating tyrosine concentration, Abnormality of prenatal development or birth, Death in early adulthood.

Based on the patient's symptoms, I believe that Phenylketonuria (PKU) is the most likely diagnosis. However, further testing is needed to confirm this diagnosis and rule out other potential causes."
['Pearson syndrome'],ERROR
['Smith-Lemli-Opitz syndrome'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Smith-Lemli-Opitz syndrome:
This is a rare genetic disorder that affects the development of the brain, heart, and other organs. The patient's symptoms that match this disease include: Broad philtrum, Long philtrum, Anteverted nares, Syndactyly, Generalized hypotonia, Feeding difficulties. However, the patient does not exhibit the following symptoms commonly associated with this disease: Intellectual disability, Microcephaly, Cardiac defects.

\n\n+2. Lathosterolosis:
This is a rare genetic disorder that affects cholesterol synthesis. The patient's symptoms that match this disease include: Hypocholesterolemia, Elevated 8-dehydrocholesterol, Elevated circulating 7-dehydrocholesterol concentration. However, the patient does not exhibit the following symptoms commonly associated with this disease: Intellectual disability, Seizures, Hepatosplenomegaly.

\n\n+3. Antley-Bixler syndrome:
This is a rare genetic disorder that affects the development of the skull and other bones. The patient's symptoms that match this disease include: Syndactyly, Generalized hypotonia, Feeding difficulties. However, the patient does not exhibit the following symptoms commonly associated with this disease: Craniosynostosis, Radiohumeral synostosis, Joint contractures.

\n\n+4. CHARGE syndrome:
This is a rare genetic disorder that affects the development of multiple organs and tissues. The patient's symptoms that match this disease include: Broad philtrum, Long philtrum, Anteverted nares, Generalized hypotonia, Feeding difficulties. However, the patient does not exhibit the following symptoms commonly associated with this disease: Coloboma, Heart defects, Genital abnormalities.

\n\n+5. Desmosterolosis:
This is a rare genetic disorder that affects cholesterol synthesis. The patient's symptoms that match this disease include: Hypocholesterolemia, Elevated 8-dehydrocholesterol, Elevated circulating 7-dehydrocholesterol concentration. However, the patient does not exhibit the following symptoms commonly associated with this disease: Intellectual disability, Seizures, Dysmorphic features.

Based on these findings, I believe that Smith-Lemli-Opitz syndrome is the most likely diagnosis, given the patient's symptoms. However, further testing and evaluation are necessary to confirm this diagnosis and rule out other potential causes."
['Acute intermittent porphyria'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Cystic Fibrosis: 
This genetic disorder affects the respiratory, digestive, and reproductive systems. It is characterized by thick, sticky mucus that clogs the airways and digestive tract. 
Common symptoms: Vomiting, Abdominal pain, Recurrent viral infections
Not common symptoms: Death in childhood (although it can occur in severe cases, it's not a guaranteed outcome)

\n\n+2. Shwachman-Diamond Syndrome: 
A rare genetic disorder that affects the pancreas, bone marrow, and skeletal system. It is characterized by pancreatic insufficiency, bone marrow dysfunction, and skeletal abnormalities. 
Common symptoms: Vomiting, Abdominal pain, Recurrent viral infections
Not common symptoms: Death in childhood (although it can occur in severe cases, it's not a guaranteed outcome)

\n\n+3. Pearson Syndrome: 
A rare genetic disorder that affects the mitochondria, the energy-producing structures within cells. It is characterized by pancreatic dysfunction, anemia, and recurrent infections. 
Common symptoms: Vomiting, Abdominal pain, Recurrent viral infections
Not common symptoms: Death in childhood (although it can occur in severe cases, it's not a guaranteed outcome)

\n\n+4. Severe Combined Immunodeficiency (SCID): 
A group of rare genetic disorders that affect the immune system, making it difficult for the body to fight off infections. 
Common symptoms: Recurrent viral infections, Death in childhood
Not common symptoms: Vomiting, Abdominal pain

\n\n+5. Pancreatic Insufficiency: 
A condition where the pancreas is unable to produce enough digestive enzymes, leading to malabsorption of nutrients. 
Common symptoms: Vomiting, Abdominal pain
Not common symptoms: Recurrent viral infections, Death in childhood

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms."
['Citrullinemia type I'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Citrullinemia Type I:
This is a rare genetic disorder that affects the urea cycle, leading to the accumulation of ammonia in the blood. The patient's symptoms that match this disease include: Hyperammonemia, Elevated plasma citrulline, Abnormal circulating arginine concentration. However, the patient does not exhibit symptoms such as intellectual disability, seizures, and developmental delays, which are commonly associated with Citrullinemia Type I.

\n\n+2. Argininosuccinic Aciduria:
This is a rare genetic disorder that affects the urea cycle, leading to the accumulation of ammonia in the blood. The patient's symptoms that match this disease include: Argininuria, Hyperammonemia, Abnormal circulating arginine concentration. However, the patient does not exhibit symptoms such as intellectual disability, seizures, and developmental delays, which are commonly associated with Argininosuccinic Aciduria.

\n\n+3. Carbamoyl Phosphate Synthetase I Deficiency:
This is a rare genetic disorder that affects the urea cycle, leading to the accumulation of ammonia in the blood. The patient's symptoms that match this disease include: Hyperammonemia, Metabolic acidosis, Neonatal death. However, the patient does not exhibit symptoms such as intellectual disability, seizures, and developmental delays, which are commonly associated with Carbamoyl Phosphate Synthetase I Deficiency.

\n\n+4. Ornithine Transcarbamylase Deficiency:
This is a rare genetic disorder that affects the urea cycle, leading to the accumulation of ammonia in the blood. The patient's symptoms that match this disease include: Hyperammonemia, Metabolic acidosis, Neonatal death. However, the patient does not exhibit symptoms such as intellectual disability, seizures, and developmental delays, which are commonly associated with Ornithine Transcarbamylase Deficiency.

\n\n+5. N-Acetylglutamate Synthase Deficiency:
This is a rare genetic disorder that affects the urea cycle, leading to the accumulation of ammonia in the blood. The patient's symptoms that match this disease include: Hyperammonemia, Metabolic acidosis, Neonatal death. However, the patient does not exhibit symptoms such as intellectual disability, seizures, and developmental delays, which are commonly associated with N-Acetylglutamate Synthase Deficiency.

\n\n+6. Glycine Encephalopathy:
This is a rare genetic disorder that affects the breakdown of glycine in the body. The patient's symptoms that match this disease include: Hyperglycinuria, Hyperglutaminemia. However, the patient does not exhibit symptoms such as intellectual disability, seizures, and developmental delays, which are commonly associated with Glycine Encephalopathy.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms and to rule out other potential diseases."
[],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Methylmalonic Acidemia (MMA):
This is a rare genetic disorder caused by a deficiency of the enzyme methylmalonyl-CoA mutase. Symptoms in common with the patient: Methylmalonic acidemia, Methylmalonic aciduria, Delayed speech and language development, Generalized hypotonia, Lethargy, Drowsiness, Sleep abnormality. Symptoms not in common: None.

\n\n+2. Propionic Acidemia:
This is a rare genetic disorder caused by a deficiency of the enzyme propionyl-CoA carboxylase. Symptoms in common with the patient: Delayed speech and language development, Lethargy, Generalized hypotonia, Dehydration, Hyperammonemia, Drowsiness, Sleep abnormality. Symptoms not in common: Methylmalonic acidemia, Methylmalonic aciduria.

\n\n+3. Isovaleric Acidemia:
This is a rare genetic disorder caused by a deficiency of the enzyme isovaleryl-CoA dehydrogenase. Symptoms in common with the patient: Delayed speech and language development, Lethargy, Generalized hypotonia, Dehydration, Hyperammonemia, Drowsiness, Sleep abnormality. Symptoms not in common: Methylmalonic acidemia, Methylmalonic aciduria, Hyperhomocystinemia.

\n\n+4. Carnitine Deficiency:
This is a rare genetic disorder caused by a deficiency of the enzyme carnitine palmitoyltransferase. Symptoms in common with the patient: Delayed speech and language development, Lethargy, Generalized hypotonia, Decreased plasma free carnitine. Symptoms not in common: Methylmalonic acidemia, Methylmalonic aciduria, Hyperammonemia, Hyperhomocystinemia.

\n\n+5. Homocystinuria:
This is a rare genetic disorder caused by a deficiency of the enzyme cystathionine beta-synthase. Symptoms in common with the patient: Hyperhomocystinemia, Delayed speech and language development, Lethargy, Generalized hypotonia. Symptoms not in common: Methylmalonic acidemia, Methylmalonic aciduria, Dehydration, Hyperammonemia.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms and to rule out other potential diseases."
['Very long chain acyl-CoA dehydrogenase deficiency'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Carnitine Palmitoyltransferase I Deficiency:
This is a rare genetic disorder that affects the breakdown of fatty acids. The patient's symptoms that match this disease include: Hyperammonemia, Decreased plasma free carnitine, Abnormal circulating aspartate family amino acid concentration, Abnormal circulating alanine concentration. However, the patient does not exhibit symptoms such as seizures, developmental delay, or muscle weakness, which are commonly associated with this disease.

\n\n+2. Carnitine Palmitoyltransferase II Deficiency:
This is another rare genetic disorder that affects the breakdown of fatty acids. The patient's symptoms that match this disease include: Hyperammonemia, Decreased plasma free carnitine, Abnormal circulating aspartate family amino acid concentration, Abnormal circulating alanine concentration. However, the patient does not exhibit symptoms such as muscle pain, weakness, or rhabdomyolysis, which are commonly associated with this disease.

\n\n+3. Propionic Acidemia:
This is a rare genetic disorder that affects the breakdown of certain amino acids. The patient's symptoms that match this disease include: Hyperammonemia, Abnormal circulating aspartate family amino acid concentration, Abnormal circulating alanine concentration, Premature birth, Neonatal death. However, the patient does not exhibit symptoms such as vomiting, diarrhea, or developmental delay, which are commonly associated with this disease.

\n\n+4. Isovaleric Acidemia:
This is a rare genetic disorder that affects the breakdown of certain amino acids. The patient's symptoms that match this disease include: Hyperammonemia, Abnormal circulating aspartate family amino acid concentration, Abnormal circulating alanine concentration, Premature birth, Neonatal death. However, the patient does not exhibit symptoms such as vomiting, diarrhea, or a characteristic ""sweaty feet"" odor, which are commonly associated with this disease.

\n\n+5. Methylmalonic Acidemia:
This is a rare genetic disorder that affects the breakdown of certain amino acids. The patient's symptoms that match this disease include: Hyperammonemia, Abnormal circulating aspartate family amino acid concentration, Abnormal circulating alanine concentration, Premature birth, Neonatal death. However, the patient does not exhibit symptoms such as vomiting, diarrhea, or developmental delay, which are commonly associated with this disease.

\n\n+6. Holocarboxylase Synthetase Deficiency:
This is a rare genetic disorder that affects the breakdown of certain amino acids. The patient's symptoms that match this disease include: Hyperammonemia, Abnormal circulating aspartate family amino acid concentration, Abnormal circulating alanine concentration, Premature birth, Neonatal death. However, the patient does not exhibit symptoms such as skin rash, hair loss, or developmental delay, which are commonly associated with this disease.

\n\n+7. Citrullinemia:
This is a rare genetic disorder that affects the breakdown of certain amino acids. The patient's symptoms that match this disease include: Hyperammonemia, Abnormal circulating aspartate family amino acid concentration, Abnormal circulating alanine concentration. However, the patient does not exhibit symptoms such as seizures, developmental delay, or intellectual disability, which are commonly associated with this disease.

\n\n+8. Argininosuccinic Aciduria:
This is a rare genetic disorder that affects the breakdown of certain amino acids. The patient's symptoms that match this disease include: Hyperammonemia, Abnormal circulating aspartate family amino acid concentration, Abnormal circulating alanine concentration. However, the patient does not exhibit symptoms such as seizures, developmental delay, or intellectual disability, which are commonly associated with this disease.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms and to rule out other potential diseases."
['Phenylketonuria'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Tyrosinemia Type I:
This is a rare genetic disorder caused by a deficiency of the enzyme fumarylacetoacetate hydrolase. Symptoms in common with the patient: Abnormality of prenatal development or birth, Death in infancy, Hypertyrosinemia, Neonatal death. Symptoms not in common: Upper airway obstruction, Chronic pulmonary obstruction, Hyperphenylalaninemia.

\n\n+2. Phenylketonuria (PKU):
This is a genetic disorder caused by a deficiency of the enzyme phenylalanine hydroxylase. Symptoms in common with the patient: Hyperphenylalaninemia, Abnormality of prenatal development or birth. Symptoms not in common: Death in infancy, Upper airway obstruction, Hypertyrosinemia, Neonatal death, Chronic pulmonary obstruction.

\n\n+3. Cystic Fibrosis:
This is a genetic disorder that affects the respiratory, digestive, and reproductive systems. Symptoms in common with the patient: Upper airway obstruction, Chronic pulmonary obstruction. Symptoms not in common: Abnormality of prenatal development or birth, Death in infancy, Hypertyrosinemia, Neonatal death, Hyperphenylalaninemia.

\n\n+4. Meconium Aspiration Syndrome:
This is a condition that occurs when a newborn inhales meconium, a dark green fecal material, into their lungs. Symptoms in common with the patient: Upper airway obstruction, Neonatal death. Symptoms not in common: Abnormality of prenatal development or birth, Death in infancy, Hypertyrosinemia, Hyperphenylalaninemia, Chronic pulmonary obstruction.

\n\n+5. Diaphragmatic Hernia:
This is a birth defect in which there is an abnormal opening in the diaphragm, allowing abdominal organs to move into the chest cavity. Symptoms in common with the patient: Abnormality of prenatal development or birth, Upper airway obstruction, Neonatal death. Symptoms not in common: Death in infancy, Hypertyrosinemia, Hyperphenylalaninemia, Chronic pulmonary obstruction.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms."
['Medium chain acyl-CoA dehydrogenase deficiency'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Carnitine Palmitoyltransferase I Deficiency:
This is a rare genetic disorder that affects the body's ability to break down fats for energy. The patient's symptoms that match this disease include: Decreased plasma free carnitine, Decreased 3-hydroxyacyl-CoA dehydrogenase level. However, the patient does not exhibit symptoms such as seizures, developmental delay, and muscle weakness, which are commonly associated with this disease.

\n\n+2. Methylmalonic Acidemia:
This is a genetic disorder that affects the body's ability to break down certain amino acids. The patient's symptoms that match this disease include: Abnormal circulating vitamin B12 concentration, Decreased circulating ferritin concentration. However, the patient does not exhibit symptoms such as developmental delay, intellectual disability, and seizures, which are commonly associated with this disease.

\n\n+3. Carnitine-Acylcarnitine Translocase Deficiency:
This is a rare genetic disorder that affects the body's ability to transport fatty acids into the mitochondria. The patient's symptoms that match this disease include: Decreased plasma free carnitine, Hypoxemia. However, the patient does not exhibit symptoms such as cardiomyopathy, muscle weakness, and developmental delay, which are commonly associated with this disease.

\n\n+4. Very-Long-Chain Acyl-CoA Dehydrogenase Deficiency:
This is a genetic disorder that affects the body's ability to break down fatty acids. The patient's symptoms that match this disease include: Decreased 3-hydroxyacyl-CoA dehydrogenase level, Hypoxemia. However, the patient does not exhibit symptoms such as muscle weakness, rhabdomyolysis, and cardiomyopathy, which are commonly associated with this disease.

\n\n+5. Gaucher Disease:
This is a genetic disorder that affects the body's ability to break down fatty substances. The patient's symptoms that match this disease include: Ileus, Peritoneal effusion. However, the patient does not exhibit symptoms such as anemia, thrombocytopenia, and hepatosplenomegaly, which are commonly associated with this disease.

\n\n+6. Zellweger Syndrome:
This is a rare genetic disorder that affects the development of the brain and other organs. The patient's symptoms that match this disease include: Spasticity, Death in infancy, Premature birth, Neonatal death, Death in childhood. However, the patient does not exhibit symptoms such as craniofacial abnormalities, intellectual disability, and seizures, which are commonly associated with this disease.

After reviewing these potential diseases, I believe that further testing is necessary to determine the underlying cause of the patient's symptoms."
['Phenylketonuria'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Tyrosinemia Type I:
This is a rare genetic disorder caused by a deficiency of the enzyme fumarylacetoacetate hydrolase. Symptoms in common with the patient: Death in infancy, Hypertyrosinemia, Death in childhood. Symptoms not in common: None.

\n\n+2. Phenylketonuria (PKU):
This is a genetic disorder caused by a deficiency of the enzyme phenylalanine hydroxylase. Symptoms in common with the patient: Hyperphenylalaninemia. Symptoms not in common: Death in infancy, Death in childhood, Death in adolescence, Recurrent viral infections.

\n\n+3. Adenosine Deaminase (ADA) Deficiency:
This is a rare genetic disorder that affects the immune system. Symptoms in common with the patient: Recurrent viral infections. Symptoms not in common: Death in infancy, Hypertyrosinemia, Death in childhood, Hyperphenylalaninemia, Death in adolescence.

\n\n+4. Mucopolysaccharidosis Type I (Hurler Syndrome):
This is a rare genetic disorder caused by a deficiency of the enzyme alpha-L-iduronidase. Symptoms in common with the patient: Death in childhood, Death in adolescence. Symptoms not in common: Hypertyrosinemia, Hyperphenylalaninemia, Recurrent viral infections.

\n\n+5. Homocystinuria:
This is a rare genetic disorder caused by a deficiency of the enzyme cystathionine beta-synthase. Symptoms in common with the patient: None. Symptoms not in common: All symptoms listed, as Homocystinuria typically presents with different symptoms such as intellectual disability, seizures, and blood clots.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms."
['3-methylcrotonyl-CoA carboxylase deficiency'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Non-ketotic hyperglycinemia (NKH): 
This is a rare genetic disorder that affects the breakdown of certain amino acids. The patient's symptoms of Abnormal circulating glycine concentration and Elevated urinary carboxylic acid are consistent with NKH. However, the patient does not exhibit seizures, which are a common symptom of NKH.

\n\n+2. Glycine encephalopathy:
This is a rare genetic disorder that affects the brain and nervous system. The patient's symptoms of Abnormal circulating glycine concentration and Aminoaciduria are consistent with glycine encephalopathy. However, the patient does not exhibit seizures, intellectual disability, or delayed development, which are common symptoms of glycine encephalopathy.

\n\n+3. Propionic acidemia:
This is a rare genetic disorder that affects the breakdown of certain amino acids. The patient's symptoms of Elevated urinary carboxylic acid and Aminoaciduria are consistent with propionic acidemia. However, the patient does not exhibit vomiting, diarrhea, or developmental delays, which are common symptoms of propionic acidemia.

\n\n+4. Methylmalonic acidemia:
This is a rare genetic disorder that affects the breakdown of certain amino acids. The patient's symptoms of Elevated urinary carboxylic acid and Aminoaciduria are consistent with methylmalonic acidemia. However, the patient does not exhibit vomiting, diarrhea, or developmental delays, which are common symptoms of methylmalonic acidemia.

\n\n+5. Isovaleric acidemia:
This is a rare genetic disorder that affects the breakdown of certain amino acids. The patient's symptoms of Elevated urinary carboxylic acid and Aminoaciduria are consistent with isovaleric acidemia. However, the patient does not exhibit vomiting, diarrhea, or developmental delays, which are common symptoms of isovaleric acidemia.

Based on the patient's symptoms, I believe that Non-ketotic hyperglycinemia (NKH) is the most likely diagnosis. However, further testing is needed to confirm this diagnosis and rule out other potential causes."
['Succinic semialdehyde dehydrogenase deficiency'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Glutaric Acidemia Type I:
This is a rare genetic disorder caused by a deficiency of the enzyme glutaryl-CoA dehydrogenase. It affects the breakdown of certain amino acids and can lead to the accumulation of toxic compounds in the body.

Common symptoms: Delayed speech and language development, Hyperactivity, Seizure, Ataxia, Motor delay, Generalized hypotonia, Elevated urinary carboxylic acid
Not common symptoms: Death in infancy, Death in childhood (although possible if left untreated)

\n\n+2. Canavan Disease:
This is a rare genetic disorder caused by a deficiency of the enzyme aspartoacylase. It affects the breakdown of certain fatty acids and can lead to the accumulation of toxic compounds in the brain.

Common symptoms: Delayed speech and language development, Hyperactivity, Seizure, Ataxia, Motor delay, Generalized hypotonia
Not common symptoms: Death in infancy, Death in childhood, Elevated urinary carboxylic acid

\n\n+3. Methylmalonic Acidemia:
This is a rare genetic disorder caused by a deficiency of the enzyme methylmalonyl-CoA mutase. It affects the breakdown of certain amino acids and can lead to the accumulation of toxic compounds in the body.

Common symptoms: Delayed speech and language development, Hyperactivity, Seizure, Ataxia, Motor delay, Generalized hypotonia, Elevated urinary carboxylic acid
Not common symptoms: Death in infancy, Death in childhood (although possible if left untreated)

\n\n+4. Propionic Acidemia:
This is a rare genetic disorder caused by a deficiency of the enzyme propionyl-CoA carboxylase. It affects the breakdown of certain amino acids and can lead to the accumulation of toxic compounds in the body.

Common symptoms: Delayed speech and language development, Hyperactivity, Seizure, Ataxia, Motor delay, Generalized hypotonia, Elevated urinary carboxylic acid
Not common symptoms: Death in infancy, Death in childhood (although possible if left untreated)

\n\n+5. Isovaleric Acidemia:
This is a rare genetic disorder caused by a deficiency of the enzyme isovaleryl-CoA dehydrogenase. It affects the breakdown of certain amino acids and can lead to the accumulation of toxic compounds in the body.

Common symptoms: Delayed speech and language development, Hyperactivity, Seizure, Ataxia, Motor delay, Generalized hypotonia, Elevated urinary carboxylic acid
Not common symptoms: Death in infancy, Death in childhood (although possible if left untreated)

Based on the patient's symptoms, I believe that Glutaric Acidemia Type I is the most likely diagnosis. However, further testing is necessary to confirm this diagnosis and rule out other potential causes."
['Argininosuccinic aciduria'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. **Maple Syrup Urine Disease**: 
This is a rare genetic disorder that affects the breakdown of certain amino acids. The patient's symptoms of **Metabolic acidosis**, **Vomiting**, and **Tachypnea** are consistent with this disease. However, the patient does not exhibit the characteristic sweet odor of urine, which is a hallmark of this disease.

\n\n+2. **Glycogen Storage Disease Type IV**: 
This is a rare genetic disorder that affects the storage and breakdown of glycogen. The patient's symptoms of **Hepatomegaly**, **Tachycardia**, and **Metabolic acidosis** are consistent with this disease. However, the patient does not exhibit the characteristic muscle weakness and hypotonia associated with this disease.

\n\n+3. **Propionic Acidemia**: 
This is a rare genetic disorder that affects the breakdown of certain amino acids. The patient's symptoms of **Metabolic acidosis**, **Vomiting**, and **Tachypnea** are consistent with this disease. However, the patient does not exhibit the characteristic developmental delays and intellectual disability associated with this disease.

\n\n+4. **Methylmalonic Acidemia**: 
This is a rare genetic disorder that affects the breakdown of certain amino acids. The patient's symptoms of **Metabolic acidosis**, **Vomiting**, and **Tachypnea** are consistent with this disease. However, the patient does not exhibit the characteristic developmental delays and intellectual disability associated with this disease.

\n\n+5. **Isobutyryl-CoA Dehydrogenase Deficiency**: 
This is a rare genetic disorder that affects the breakdown of certain amino acids. The patient's symptoms of **Metabolic acidosis**, **Vomiting**, and **Tachypnea** are consistent with this disease. However, the patient does not exhibit the characteristic developmental delays and intellectual disability associated with this disease.

\n\n+6. **Glutaric Acidemia Type II**: 
This is a rare genetic disorder that affects the breakdown of certain amino acids. The patient's symptoms of **Metabolic acidosis**, **Vomiting**, and **Tachypnea** are consistent with this disease. However, the patient does not exhibit the characteristic muscle weakness and hypotonia associated with this disease.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms and to rule out other potential diseases."
['Gyrate atrophy of choroid and retina'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Glycine Encephalopathy:
This disease matches the patient's symptoms of Hyperglycinemia, Anemia, Hyperammonemia, Severe short stature, Feeding difficulties, and Death in childhood. However, it does not explain the patient's Blindness, Malabsorption, Headache, Hypoargininemia, Death in adolescence, Death in early adulthood, Hyperornithinemia, or Abnormal circulating serine concentration.

\n\n+2. Arginino-Succinic Aciduria:
This disease shares similarities with the patient's symptoms of Hyperammonemia, Anemia, Hypoargininemia, and Feeding difficulties. However, it does not account for the patient's Blindness, Malabsorption, Headache, Hyperglycinemia, Severe short stature, Death in childhood, Death in adolescence, Death in early adulthood, Hyperornithinemia, or Abnormal circulating serine concentration.

\n\n+3. Ornithine Transcarbamylase Deficiency:
This disease matches the patient's symptoms of Hyperammonemia, Hyperornithinemia, and Anemia. However, it does not explain the patient's Blindness, Malabsorption, Headache, Hyperglycinemia, Severe short stature, Feeding difficulties, Hypoargininemia, Death in childhood, Death in adolescence, Death in early adulthood, or Abnormal circulating serine concentration.

\n\n+4. Citrullinemia:
This disease shares similarities with the patient's symptoms of Hyperammonemia, Anemia, and Feeding difficulties. However, it does not account for the patient's Blindness, Malabsorption, Headache, Hyperglycinemia, Severe short stature, Hypoargininemia, Death in childhood, Death in adolescence, Death in early adulthood, Hyperornithinemia, or Abnormal circulating serine concentration.

\n\n+5. Argininemia:
This disease matches the patient's symptoms of Hyperammonemia, Anemia, and Hypoargininemia. However, it does not explain the patient's Blindness, Malabsorption, Headache, Hyperglycinemia, Severe short stature, Feeding difficulties, Death in childhood, Death in adolescence, Death in early adulthood, Hyperornithinemia, or Abnormal circulating serine concentration.

\n\n+6. Non-Ketotic Hyperglycinemia:
This disease shares similarities with the patient's symptoms of Hyperglycinemia, Anemia, and Feeding difficulties. However, it does not account for the patient's Blindness, Malabsorption, Headache, Hyperammonemia, Severe short stature, Hypoargininemia, Death in childhood, Death in adolescence, Death in early adulthood, Hyperornithinemia, or Abnormal circulating serine concentration.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms and to rule out other potential diseases."
['Phenylketonuria'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Tyrosinemia Type I:
This is a rare genetic disorder caused by a deficiency of the enzyme fumarylacetoacetate hydrolase. Symptoms in common with the patient: Abnormality of prenatal development or birth, Hypertyrosinemia, Death in infancy, Neonatal death, Death in childhood. Symptoms not in common: None.

\n\n+2. Phenylketonuria (PKU):
This is a genetic disorder caused by a deficiency of the enzyme phenylalanine hydroxylase. Symptoms in common with the patient: Hyperphenylalaninemia, Abnormality of prenatal development or birth, Death in infancy, Death in childhood. Symptoms not in common: None.

\n\n+3. Maple Syrup Urine Disease (MSUD):
This is a rare genetic disorder caused by a deficiency of the enzyme branched-chain alpha-keto acid dehydrogenase complex. Symptoms in common with the patient: Abnormality of prenatal development or birth, Death in infancy, Death in childhood. Symptoms not in common: Hypertyrosinemia, Hyperphenylalaninemia.

\n\n+4. Homocystinuria:
This is a rare genetic disorder caused by a deficiency of the enzyme cystathionine beta-synthase. Symptoms in common with the patient: Abnormality of prenatal development or birth, Death in infancy, Death in childhood. Symptoms not in common: Hypertyrosinemia, Hyperphenylalaninemia.

\n\n+5. Methylmalonic Acidemia:
This is a rare genetic disorder caused by a deficiency of the enzyme methylmalonyl-CoA mutase. Symptoms in common with the patient: Abnormality of prenatal development or birth, Death in infancy, Death in childhood. Symptoms not in common: Hypertyrosinemia, Hyperphenylalaninemia.

Based on the patient's symptoms, I believe that Tyrosinemia Type I and Phenylketonuria (PKU) are the most likely diagnoses. However, further testing and evaluation are necessary to confirm the diagnosis and rule out other potential causes."
['Carbamoyl-phosphate synthetase 1 deficiency'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Ornithine Transcarbamylase Deficiency:
This is a rare genetic disorder that affects the urea cycle, leading to the accumulation of ammonia in the blood. The patient's symptoms that match this disease include Hyperammonemia, Cerebral edema, and Neonatal death. However, the patient does not exhibit symptoms such as seizures, vomiting, or lethargy, which are commonly associated with this disease.

\n\n+2. Citrullinemia:
This is a rare genetic disorder that affects the urea cycle, leading to the accumulation of citrulline in the blood. The patient's symptoms that match this disease include Hyperammonemia, Cerebral edema, and Neonatal death. However, the patient does not exhibit symptoms such as seizures, vomiting, or developmental delays, which are commonly associated with this disease.

\n\n+3. Argininosuccinic Aciduria:
This is a rare genetic disorder that affects the urea cycle, leading to the accumulation of argininosuccinic acid in the blood. The patient's symptoms that match this disease include Hyperammonemia, Cerebral edema, and Neonatal death. However, the patient does not exhibit symptoms such as seizures, vomiting, or intellectual disability, which are commonly associated with this disease.

\n\n+4. Carbamoyl Phosphate Synthetase I Deficiency:
This is a rare genetic disorder that affects the urea cycle, leading to the accumulation of ammonia in the blood. The patient's symptoms that match this disease include Hyperammonemia, Cerebral edema, and Neonatal death. However, the patient does not exhibit symptoms such as seizures, vomiting, or developmental delays, which are commonly associated with this disease.

\n\n+5. N-Acetylglutamate Synthase Deficiency:
This is a rare genetic disorder that affects the urea cycle, leading to the accumulation of ammonia in the blood. The patient's symptoms that match this disease include Hyperammonemia, Cerebral edema, and Neonatal death. However, the patient does not exhibit symptoms such as seizures, vomiting, or developmental delays, which are commonly associated with this disease.

\n\n+6. Propionic Acidemia:
This is a rare genetic disorder that affects the breakdown of certain amino acids, leading to the accumulation of propionic acid in the blood. The patient's symptoms that match this disease include Apathy, Generalized hypotonia, and Feeding difficulties. However, the patient does not exhibit symptoms such as seizures, vomiting, or intellectual disability, which are commonly associated with this disease.

\n\n+7. Methylmalonic Acidemia:
This is a rare genetic disorder that affects the breakdown of certain amino acids, leading to the accumulation of methylmalonic acid in the blood. The patient's symptoms that match this disease include Apathy, Generalized hypotonia, and Feeding difficulties. However, the patient does not exhibit symptoms such as seizures, vomiting, or intellectual disability, which are commonly associated with this disease.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms and to rule out other potential diseases."
['Canavan disease'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Canavan disease:
This is a rare genetic disorder that affects the breakdown and use of aspartate, a type of amino acid. Symptoms in common with the patient: Abnormal circulating aspartate family amino acid concentration, Seizure, Motor delay, Generalized hypotonia, Abnormal myelination. Symptoms not in common: None.

\n\n+2. Zellweger syndrome:
This is a rare genetic disorder that affects the development and function of peroxisomes, which are organelles found in cells. Symptoms in common with the patient: Seizure, Motor delay, Generalized hypotonia, Abnormal myelination, Death in infancy, Neonatal death. Symptoms not in common: Blindness, Nystagmus, Opisthotonus, Severe hearing impairment.

\n\n+3. MLD (Metachromatic Leukodystrophy):
This is a rare genetic disorder that affects the breakdown of fatty substances in the body. Symptoms in common with the patient: Seizure, Motor delay, Generalized hypotonia, Abnormal myelination, Severe hearing impairment. Symptoms not in common: Blindness, Nystagmus, Opisthotonus, Death in infancy, Neonatal death, Abnormal circulating aspartate family amino acid concentration.

\n\n+4. Krabbe disease:
This is a rare genetic disorder that affects the breakdown of fatty substances in the body. Symptoms in common with the patient: Seizure, Motor delay, Generalized hypotonia, Abnormal myelination, Death in infancy, Neonatal death. Symptoms not in common: Blindness, Nystagmus, Opisthotonus, Severe hearing impairment, Abnormal circulating aspartate family amino acid concentration.

\n\n+5. Menkes disease:
This is a rare genetic disorder that affects the production of copper in the body. Symptoms in common with the patient: Seizure, Motor delay, Generalized hypotonia, Abnormal myelination, Death in infancy, Neonatal death. Symptoms not in common: Blindness, Nystagmus, Opisthotonus, Severe hearing impairment, Abnormal circulating aspartate family amino acid concentration.

Based on these findings, I believe that Canavan disease is the most likely diagnosis, given the strong correlation between the patient's symptoms and those of the disease. However, further testing and evaluation are necessary to confirm this diagnosis and rule out other potential causes."
"['Methylmalonic acidemia with homocystinuria, type cblC']","After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Methylmalonic Acidemia:
This is a rare genetic disorder caused by a deficiency of the enzyme methylmalonyl-CoA mutase. Symptoms in common with the patient: Methylmalonic aciduria, Intellectual disability, Death in infancy, Premature birth, Respiratory insufficiency, Hyperhomocystinemia, Abnormal circulating carnitine concentration. Symptoms not in common: Hydrocephalus, Microcephaly, Strabismus, Nystagmus, Dyskinesia.

\n\n+2. Homocystinuria:
This is a rare genetic disorder caused by a deficiency of the enzyme cystathionine beta-synthase. Symptoms in common with the patient: Hyperhomocystinemia, Intellectual disability, Premature birth, Respiratory insufficiency. Symptoms not in common: Hydrocephalus, Microcephaly, Strabismus, Nystagmus, Methylmalonic aciduria, Abnormal circulating carnitine concentration, Dyskinesia, Death in infancy, Neonatal death, Death in childhood.

\n\n+3. Methylmalonyl-CoA Mutase Deficiency:
This is a rare genetic disorder caused by a deficiency of the enzyme methylmalonyl-CoA mutase. Symptoms in common with the patient: Methylmalonic aciduria, Intellectual disability, Death in infancy, Premature birth, Respiratory insufficiency, Hyperhomocystinemia, Abnormal circulating carnitine concentration. Symptoms not in common: Hydrocephalus, Microcephaly, Strabismus, Nystagmus, Dyskinesia, Neonatal death, Death in childhood.

\n\n+4. Propionic Acidemia:
This is a rare genetic disorder caused by a deficiency of the enzyme propionyl-CoA carboxylase. Symptoms in common with the patient: Intellectual disability, Death in infancy, Premature birth, Respiratory insufficiency, Hyperhomocystinemia, Abnormal circulating carnitine concentration. Symptoms not in common: Hydrocephalus, Microcephaly, Strabismus, Nystagmus, Methylmalonic aciduria, Dyskinesia, Neonatal death, Death in childhood.

\n\n+5. Holocarboxylase Synthetase Deficiency:
This is a rare genetic disorder caused by a deficiency of the enzyme holocarboxylase synthetase. Symptoms in common with the patient: Intellectual disability, Death in infancy, Premature birth, Respiratory insufficiency, Hyperhomocystinemia, Abnormal circulating carnitine concentration. Symptoms not in common: Hydrocephalus, Microcephaly, Strabismus, Nystagmus, Methylmalonic aciduria, Dyskinesia, Neonatal death, Death in childhood.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms and to rule out other potential diseases."
['Medium chain acyl-CoA dehydrogenase deficiency'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Carnitine Palmitoyltransferase II Deficiency:
This is a rare genetic disorder that affects the breakdown of fatty acids. The patient's symptoms that match this disease include: Abnormal circulating carnitine concentration, Decreased 3-hydroxyacyl-CoA dehydrogenase level. However, the patient does not exhibit symptoms such as muscle weakness, seizures, and developmental delays, which are commonly associated with this disease.

\n\n+2. Medium-Chain Acyl-CoA Dehydrogenase Deficiency (MCADD):
This is a genetic disorder that affects the breakdown of fatty acids. The patient's symptoms that match this disease include: Vomiting, Abnormal circulating carnitine concentration, Decreased 3-hydroxyacyl-CoA dehydrogenase level. However, the patient does not exhibit symptoms such as lethargy, hypoglycemia, and developmental delays, which are commonly associated with this disease.

\n\n+3. Very-Long-Chain Acyl-CoA Dehydrogenase Deficiency (VLCADD):
This is a genetic disorder that affects the breakdown of fatty acids. The patient's symptoms that match this disease include: Vomiting, Abnormal circulating carnitine concentration, Decreased 3-hydroxyacyl-CoA dehydrogenase level. However, the patient does not exhibit symptoms such as muscle weakness, cardiomyopathy, and developmental delays, which are commonly associated with this disease.

\n\n+4. Gaucher Disease:
This is a genetic disorder that affects the breakdown of fatty substances. The patient's symptoms that match this disease include: Abnormality of prenatal development or birth, Gastrointestinal inflammation. However, the patient does not exhibit symptoms such as anemia, fatigue, and enlargement of the liver and spleen, which are commonly associated with this disease.

\n\n+5. Zellweger Syndrome:
This is a rare genetic disorder that affects the breakdown of fatty acids. The patient's symptoms that match this disease include: Abnormality of prenatal development or birth, Death in infancy, Neonatal death. However, the patient does not exhibit symptoms such as seizures, hypotonia, and characteristic facial features, which are commonly associated with this disease.

\n\n+6. Mitochondrial Trifunctional Protein Deficiency:
This is a rare genetic disorder that affects the breakdown of fatty acids. The patient's symptoms that match this disease include: Vomiting, Abnormal circulating carnitine concentration, Decreased 3-hydroxyacyl-CoA dehydrogenase level. However, the patient does not exhibit symptoms such as muscle weakness, cardiomyopathy, and developmental delays, which are commonly associated with this disease.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms and to rule out other potential diseases."
['Biotinidase deficiency'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Ornithine Transcarbamylase Deficiency:
This is a rare genetic disorder that affects the urea cycle, leading to the accumulation of ammonia in the blood. The patient's symptoms of Hyperammonemia and Metabolic acidosis are consistent with this disease. However, the patient does not exhibit symptoms of seizures, developmental delays, or intellectual disability, which are commonly associated with this condition.

\n\n+2. Propionic Acidemia:
This is a rare genetic disorder that affects the breakdown of certain amino acids. The patient's symptoms of Metabolic acidosis, Leukopenia, and Hyperammonemia are consistent with this disease. However, the patient does not exhibit symptoms of seizures, vomiting, or developmental delays, which are commonly associated with this condition.

\n\n+3. Methylmalonic Acidemia:
This is a rare genetic disorder that affects the breakdown of certain amino acids. The patient's symptoms of Metabolic acidosis, Leukopenia, and Hyperammonemia are consistent with this disease. However, the patient does not exhibit symptoms of seizures, vomiting, or developmental delays, which are commonly associated with this condition.

\n\n+4. Isovaleric Acidemia:
This is a rare genetic disorder that affects the breakdown of certain amino acids. The patient's symptoms of Metabolic acidosis and Leukopenia are consistent with this disease. However, the patient does not exhibit symptoms of seizures, vomiting, or developmental delays, which are commonly associated with this condition.

\n\n+5. Glutaric Acidemia Type I:
This is a rare genetic disorder that affects the breakdown of certain amino acids. The patient's symptoms of Metabolic acidosis and Leukopenia are consistent with this disease. However, the patient does not exhibit symptoms of seizures, vomiting, or developmental delays, which are commonly associated with this condition.

\n\n+6. Zellweger Syndrome:
This is a rare genetic disorder that affects the breakdown of fatty acids. The patient's symptoms of Generalized hypotonia, Leukopenia, and Neonatal death are consistent with this disease. However, the patient does not exhibit symptoms of seizures, facial abnormalities, or liver dysfunction, which are commonly associated with this condition.

\n\n+7. Carnitine Palmitoyltransferase I Deficiency:
This is a rare genetic disorder that affects the breakdown of fatty acids. The patient's symptoms of Generalized hypotonia, Leukopenia, and Metabolic acidosis are consistent with this disease. However, the patient does not exhibit symptoms of seizures, vomiting, or developmental delays, which are commonly associated with this condition.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms and to rule out other potential diseases."
['Tyrosinemia type 2'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Tyrosinemia Type II:
This rare genetic disorder affects the breakdown of the amino acid tyrosine. It is characterized by eye problems, skin issues, and intellectual disability. 
Common symptoms: Keratitis, Conjunctivitis, Photophobia, Hyperkeratosis, Intellectual disability
Not common symptoms: Seizure, Death in childhood, Epiphora

\n\n+2. Tyrosinemia Type I:
This is a severe genetic disorder that affects the breakdown of tyrosine, leading to liver and kidney damage. It is characterized by hypertyrosinemia, liver dysfunction, and an increased risk of liver cancer.
Common symptoms: Hypertyrosinemia, Intellectual disability
Not common symptoms: Keratitis, Conjunctivitis, Photophobia, Hyperkeratosis, Seizure, Death in childhood, Epiphora

\n\n+3. Cerebrohepatorenal Syndrome:
This is a rare genetic disorder that affects the brain, liver, and kidneys. It is characterized by intellectual disability, seizures, and liver dysfunction.
Common symptoms: Intellectual disability, Seizure
Not common symptoms: Keratitis, Conjunctivitis, Photophobia, Hyperkeratosis, Hypertyrosinemia, Death in childhood, Epiphora

\n\n+4. Oculocutaneous Tyrosinemia:
This is a rare genetic disorder that affects the eyes and skin. It is characterized by eye problems, skin issues, and an increased risk of skin cancer.
Common symptoms: Keratitis, Conjunctivitis, Photophobia, Hyperkeratosis
Not common symptoms: Intellectual disability, Seizure, Hypertyrosinemia, Death in childhood, Epiphora

\n\n+5. Hawkinsinuria:
This is a rare genetic disorder that affects the breakdown of tyrosine. It is characterized by intellectual disability, seizures, and an increased risk of liver damage.
Common symptoms: Intellectual disability, Seizure
Not common symptoms: Keratitis, Conjunctivitis, Photophobia, Hyperkeratosis, Hypertyrosinemia, Death in childhood, Epiphora

\n\n+6. Richner-Hanhart Syndrome:
This is a rare genetic disorder that affects the eyes, skin, and nervous system. It is characterized by eye problems, skin issues, and intellectual disability.
Common symptoms: Keratitis, Conjunctivitis, Photophobia, Hyperkeratosis, Intellectual disability
Not common symptoms: Seizure, Hypertyrosinemia, Death in childhood, Epiphora

After reviewing these potential diseases, I believe that further testing is necessary to determine the underlying cause of the patient's symptoms."
['Phenylketonuria'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Phenylketonuria (PKU):
This is a genetic disorder that affects the body's ability to break down the amino acid phenylalanine. Symptoms in common: Hyperphenylalaninemia, Abnormal circulating tyrosine concentration. Symptoms not in common: None.

\n\n+2. Tyrosinemia type I:
This is a rare genetic disorder caused by a deficiency of the enzyme fumarylacetoacetate hydrolase. Symptoms in common: Abnormal circulating tyrosine concentration, Death in infancy, Death in early adulthood. Symptoms not in common: Abnormality of prenatal development or birth.

\n\n+3. Homocystinuria:
This is a rare genetic disorder caused by a deficiency of the enzyme cystathionine beta-synthase. Symptoms in common: Abnormality of prenatal development or birth, Death in infancy. Symptoms not in common: Hyperphenylalaninemia, Abnormal circulating tyrosine concentration.

\n\n+4. Maple syrup urine disease:
This is a rare genetic disorder caused by a deficiency of the enzyme branched-chain alpha-keto acid dehydrogenase complex. Symptoms in common: Abnormality of prenatal development or birth, Death in infancy, Death in early adulthood. Symptoms not in common: Hyperphenylalaninemia, Abnormal circulating tyrosine concentration.

\n\n+5. Methylmalonic acidemia:
This is a rare genetic disorder caused by a deficiency of the enzyme methylmalonyl-CoA mutase. Symptoms in common: Abnormality of prenatal development or birth, Death in infancy. Symptoms not in common: Hyperphenylalaninemia, Abnormal circulating tyrosine concentration.

\n\n+6. Propionic acidemia:
This is a rare genetic disorder caused by a deficiency of the enzyme propionyl-CoA carboxylase. Symptoms in common: Abnormality of prenatal development or birth, Death in infancy. Symptoms not in common: Hyperphenylalaninemia, Abnormal circulating tyrosine concentration.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms."
[],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Ornithine transcarbamylase deficiency:
This is a rare genetic disorder that affects the urea cycle, leading to the accumulation of ammonia in the blood. 
Common symptoms: Hyperammonemia, Seizure, Death in infancy, Neonatal death
Not common symptoms: Cyanosis, 3-hydroxydicarboxylic aciduria

\n\n+2. Carbamoyl phosphate synthetase I deficiency:
This is another rare genetic disorder that affects the urea cycle, leading to hyperammonemia. 
Common symptoms: Hyperammonemia, Seizure, Death in infancy, Neonatal death
Not common symptoms: Cyanosis, 3-hydroxydicarboxylic aciduria

\n\n+3. N-acetylglutamate synthase deficiency:
This is a rare genetic disorder that affects the urea cycle, leading to hyperammonemia. 
Common symptoms: Hyperammonemia, Seizure, Death in infancy, Neonatal death
Not common symptoms: Cyanosis, 3-hydroxydicarboxylic aciduria

\n\n+4. Mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase deficiency:
This is a rare genetic disorder that affects the breakdown of fatty acids and amino acids. 
Common symptoms: 3-hydroxydicarboxylic aciduria
Not common symptoms: Cyanosis, Seizure, Death in infancy, Neonatal death, Hyperammonemia

\n\n+5. Holocarboxylase synthetase deficiency:
This is a rare genetic disorder that affects the metabolism of biotin, a B-complex vitamin. 
Common symptoms: Seizure, Death in infancy, Neonatal death
Not common symptoms: Cyanosis, Hyperammonemia, 3-hydroxydicarboxylic aciduria

\n\n+6. Biotinidase deficiency:
This is a rare genetic disorder that affects the metabolism of biotin, a B-complex vitamin. 
Common symptoms: Seizure, Death in infancy, Neonatal death
Not common symptoms: Cyanosis, Hyperammonemia, 3-hydroxydicarboxylic aciduria

Based on the patient's symptoms, I believe that Ornithine transcarbamylase deficiency or Carbamoyl phosphate synthetase I deficiency are the most likely diagnoses. However, further testing is needed to confirm the diagnosis."
['Alkaptonuria'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Tyrosinemia Type 1:
This is a rare genetic disorder caused by a deficiency of the enzyme fumarylacetoacetate hydrolase. Symptoms in common with the patient: Vomiting, Dark urine. Symptoms not in common: Death in infancy (although it is a possible complication if left untreated).

\n\n+2. Maple Syrup Urine Disease:
This is a rare genetic disorder caused by a deficiency of the enzyme branched-chain alpha-keto acid dehydrogenase complex. Symptoms in common with the patient: Vomiting, Dark urine. Symptoms not in common: Death in infancy (although it is a possible complication if left untreated).

\n\n+3. Galactosemia:
This is a rare genetic disorder caused by a deficiency of the enzyme galactose-1-phosphate uridyltransferase. Symptoms in common with the patient: Vomiting. Symptoms not in common: Death in infancy (although it is a possible complication if left untreated), Dark urine.

\n\n+4. Hereditary Fructose Intolerance:
This is a rare genetic disorder caused by a deficiency of the enzyme aldolase B. Symptoms in common with the patient: Vomiting. Symptoms not in common: Death in infancy (although it is a possible complication if left untreated), Dark urine.

\n\n+5. Methylmalonic Acidemia:
This is a rare genetic disorder caused by a deficiency of the enzyme methylmalonyl-CoA mutase. Symptoms in common with the patient: Vomiting. Symptoms not in common: Death in infancy (although it is a possible complication if left untreated), Dark urine.

\n\n+6. Propionic Acidemia:
This is a rare genetic disorder caused by a deficiency of the enzyme propionyl-CoA carboxylase. Symptoms in common with the patient: Vomiting. Symptoms not in common: Death in infancy (although it is a possible complication if left untreated), Dark urine.

\n\n+7. Isovaleric Acidemia:
This is a rare genetic disorder caused by a deficiency of the enzyme isovaleryl-CoA dehydrogenase. Symptoms in common with the patient: Vomiting. Symptoms not in common: Death in infancy (although it is a possible complication if left untreated), Dark urine.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms."
['Maple syrup urine disease'],"After reviewing the patient's symptoms, I have compiled a list of potential diseases that may be causing their condition. Here are my findings:

\n\n+1. Maple Syrup Urine Disease (MSUD): 
This rare genetic disorder affects the breakdown of certain amino acids. The patient's symptoms that match MSUD include: Lethargy, Growth delay, Metabolic acidosis, Hyperammonemia, Drowsiness, Sleep abnormality, Feeding difficulties, and Elevated urinary carboxylic acid. However, the patient does not exhibit the characteristic ""maple syrup"" odor in their urine, which is a hallmark of this disease.

\n\n+2. Isovaleric Acidemia (IVA): 
This is another rare genetic disorder that affects the breakdown of the amino acid leucine. The patient's symptoms that match IVA include: Lethargy, Growth delay, Metabolic acidosis, Hyperammonemia, Drowsiness, Sleep abnormality, Feeding difficulties, and Elevated urinary carboxylic acid. However, the patient does not exhibit the characteristic sweaty feet odor, which is often seen in IVA patients.

\n\n+3. Methylmalonic Acidemia (MMA): 
This is a genetic disorder that affects the breakdown of certain amino acids and fats. The patient's symptoms that match MMA include: Lethargy, Growth delay, Metabolic acidosis, Hyperammonemia, Drowsiness, Sleep abnormality, Feeding difficulties, and Elevated urinary carboxylic acid. However, the patient does not exhibit the characteristic muscle weakness and developmental delays often seen in MMA patients.

\n\n+4. Propionic Acidemia (PA): 
This is a rare genetic disorder that affects the breakdown of certain amino acids and fats. The patient's symptoms that match PA include: Lethargy, Growth delay, Metabolic acidosis, Hyperammonemia, Drowsiness, Sleep abnormality, Feeding difficulties, and Elevated urinary carboxylic acid. However, the patient does not exhibit the characteristic skin rash and hair loss often seen in PA patients.

\n\n+5. Hyperammonemia-Hyperornithinemia-Homocitrullinuria (HHH) Syndrome: 
This is a rare genetic disorder that affects the breakdown of certain amino acids. The patient's symptoms that match HHH include: Lethargy, Growth delay, Metabolic acidosis, Hyperammonemia, Drowsiness, Sleep abnormality, Feeding difficulties, and Elevated urinary carboxylic acid. However, the patient does not exhibit the characteristic muscle weakness and developmental delays often seen in HHH patients.

\n\n+6. Valine Transaminase Deficiency: 
This is a rare genetic disorder that affects the breakdown of the amino acid valine. The patient's symptoms that match this disorder include: Lethargy, Growth delay, Metabolic acidosis, Hyperammonemia, Drowsiness, Sleep abnormality, Feeding difficulties, and Hypervalinemia. However, the patient does not exhibit the characteristic intellectual disability often seen in patients with this disorder.

Further testing and evaluation are necessary to determine the underlying cause of the patient's symptoms."
['Ornithine transcarbamylase deficiency'],ERROR
